NM_024675.4(PALB2):c.1082_1120del (p.Thr361_Glu373del) |
deletion |
Familial cancer of breast [RCV001344449]|Hereditary cancer-predisposing syndrome [RCV000568772] |
Chr16:23635426..23635464 [GRCh38] Chr16:23646747..23646785 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3013T>A (p.Phe1005Ile) |
single nucleotide variant |
Familial cancer of breast [RCV001858328]|Hereditary cancer-predisposing syndrome [RCV000568784] |
Chr16:23621462 [GRCh38] Chr16:23632783 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2642G>A (p.Gly881Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000526053]|Hereditary cancer-predisposing syndrome [RCV001016191]|not provided [RCV000590337] |
Chr16:23626342 [GRCh38] Chr16:23637663 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2088G>A (p.Thr696=) |
single nucleotide variant |
Familial cancer of breast [RCV001088154]|Hereditary cancer-predisposing syndrome [RCV001014387] |
Chr16:23630066 [GRCh38] Chr16:23641387 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3253T>C (p.Leu1085=) |
single nucleotide variant |
Familial cancer of breast [RCV005091317]|Hereditary cancer-predisposing syndrome [RCV000561034] |
Chr16:23607961 [GRCh38] Chr16:23619282 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3091A>G (p.Ile1031Val) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000561086] |
Chr16:23621384 [GRCh38] Chr16:23632705 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.1675C>T (p.Gln559Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000989568]|Gastric cancer [RCV003159958]|Hereditary cancer-predisposing syndrome [RCV000566479]|not provided [RCV001800773] |
Chr16:23634871 [GRCh38] Chr16:23646192 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.42G>A (p.Lys14=) |
single nucleotide variant |
Familial cancer of breast [RCV000526302]|Hereditary cancer-predisposing syndrome [RCV002330852] |
Chr16:23641116 [GRCh38] Chr16:23652437 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1994A>T (p.Asp665Val) |
single nucleotide variant |
Familial cancer of breast [RCV001324301]|Hereditary cancer-predisposing syndrome [RCV000563467] |
Chr16:23630160 [GRCh38] Chr16:23641481 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1086T>C (p.Leu362=) |
single nucleotide variant |
Familial cancer of breast [RCV000537867]|Hereditary cancer-predisposing syndrome [RCV000563563] |
Chr16:23635460 [GRCh38] Chr16:23646781 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.935G>A (p.Ser312Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000553560]|Hereditary cancer-predisposing syndrome [RCV000567058]|not provided [RCV001800745] |
Chr16:23635611 [GRCh38] Chr16:23646932 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2621C>A (p.Ala874Asp) |
single nucleotide variant |
Familial cancer of breast [RCV001351087]|Hereditary cancer-predisposing syndrome [RCV000561509] |
Chr16:23626363 [GRCh38] Chr16:23637684 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2866G>A (p.Glu956Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000548954]|Hereditary cancer-predisposing syndrome [RCV001016830]|not provided [RCV003478138]|not specified [RCV003493628] |
Chr16:23623099 [GRCh38] Chr16:23634420 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3236C>T (p.Ala1079Val) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315435]|Familial cancer of breast [RCV000555643]|Hereditary cancer-predisposing syndrome [RCV000574629]|not provided [RCV002254932]|not specified [RCV004767344] |
Chr16:23607978 [GRCh38] Chr16:23619299 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.442_457dup (p.Arg153fs) |
duplication |
Familial cancer of breast [RCV000556316]|Hereditary cancer-predisposing syndrome [RCV000567132] |
Chr16:23636088..23636089 [GRCh38] Chr16:23647409..23647410 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.481G>C (p.Asp161His) |
single nucleotide variant |
Familial cancer of breast [RCV000817677]|Hereditary cancer-predisposing syndrome [RCV000566918]|not provided [RCV003318597]|not specified [RCV002268179] |
Chr16:23636065 [GRCh38] Chr16:23647386 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2111T>G (p.Leu704Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000543544]|Hereditary cancer-predisposing syndrome [RCV002420405] |
Chr16:23630043 [GRCh38] Chr16:23641364 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3299_3306dup (p.Val1103fs) |
duplication |
Familial cancer of breast [RCV000543578]|Hereditary cancer-predisposing syndrome [RCV002323942]|not provided [RCV000657412] |
Chr16:23607907..23607908 [GRCh38] Chr16:23619228..23619229 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2095T>A (p.Ser699Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001222882]|Hereditary cancer-predisposing syndrome [RCV000561815] |
Chr16:23630059 [GRCh38] Chr16:23641380 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1490del (p.Asn497fs) |
deletion |
Familial cancer of breast [RCV000527507]|Familial cancer of breast [RCV003483659]|Hereditary cancer-predisposing syndrome [RCV000567362]|not provided [RCV004592564] |
Chr16:23635056 [GRCh38] Chr16:23646377 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|not provided |
NM_024675.4(PALB2):c.1293T>G (p.Ser431Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000530618]|Hereditary cancer-predisposing syndrome [RCV000575371]|not specified [RCV001821526] |
Chr16:23635253 [GRCh38] Chr16:23646574 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3152T>A (p.Ile1051Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000796970]|Hereditary cancer-predisposing syndrome [RCV000565402]|not provided [RCV005000245] |
Chr16:23614053 [GRCh38] Chr16:23625374 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2290A>G (p.Lys764Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000551829]|Hereditary cancer-predisposing syndrome [RCV000771302] |
Chr16:23629864 [GRCh38] Chr16:23641185 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1985A>G (p.Lys662Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000810498]|Hereditary cancer-predisposing syndrome [RCV000564025] |
Chr16:23630169 [GRCh38] Chr16:23641490 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1704_1707del (p.Lys569fs) |
deletion |
Breast carcinoma [RCV001644632]|Familial cancer of breast [RCV000524877]|Hereditary cancer-predisposing syndrome [RCV002404412] |
Chr16:23630447..23630450 [GRCh38] Chr16:23641768..23641771 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3518C>A (p.Ala1173Asp) |
single nucleotide variant |
Familial cancer of breast [RCV003476346]|Hereditary cancer-predisposing syndrome [RCV000564099] |
Chr16:23603502 [GRCh38] Chr16:23614823 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2338G>T (p.Gly780Cys) |
single nucleotide variant |
Familial cancer of breast [RCV002528995]|Hereditary cancer-predisposing syndrome [RCV000567772]|not provided [RCV004777752] |
Chr16:23629816 [GRCh38] Chr16:23641137 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2892A>G (p.Gly964=) |
single nucleotide variant |
Familial cancer of breast [RCV001398924]|Hereditary cancer-predisposing syndrome [RCV000565583]|not provided [RCV000932640]|not specified [RCV000614342] |
Chr16:23623073 [GRCh38] Chr16:23634394 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.801_802dup (p.Lys268fs) |
duplication |
Familial cancer of breast [RCV000544422]|Hereditary breast ovarian cancer syndrome [RCV000588990] |
Chr16:23635743..23635744 [GRCh38] Chr16:23647064..23647065 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1564C>G (p.Pro522Ala) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000565781] |
Chr16:23634982 [GRCh38] Chr16:23646303 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3154GAT[1] (p.Asp1053del) |
microsatellite |
Hereditary cancer-predisposing syndrome [RCV000565882]|not specified [RCV001821678] |
Chr16:23614046..23614048 [GRCh38] Chr16:23625367..23625369 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2072G>A (p.Ser691Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000530168]|Hereditary cancer-predisposing syndrome [RCV001014295]|not provided [RCV003441924] |
Chr16:23630082 [GRCh38] Chr16:23641403 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3157_3160del (p.Asp1053fs) |
deletion |
Familial cancer of breast [RCV000539893]|Hereditary cancer-predisposing syndrome [RCV000567119] |
Chr16:23614045..23614048 [GRCh38] Chr16:23625366..23625369 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1012C>A (p.Pro338Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001858211]|Hereditary cancer-predisposing syndrome [RCV000566139] |
Chr16:23635534 [GRCh38] Chr16:23646855 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.505C>T (p.Leu169Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000545210]|Hereditary cancer-predisposing syndrome [RCV004943962] |
Chr16:23636041 [GRCh38] Chr16:23647362 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2225C>T (p.Ser742Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000545177]|Hereditary cancer-predisposing syndrome [RCV000574306] |
Chr16:23629929 [GRCh38] Chr16:23641250 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2509G>C (p.Glu837Gln) |
single nucleotide variant |
Familial cancer of breast [RCV001305394]|Hereditary cancer-predisposing syndrome [RCV000566274]|not provided [RCV004592701] |
Chr16:23629645 [GRCh38] Chr16:23640966 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.276T>G (p.Thr92=) |
single nucleotide variant |
Familial cancer of breast [RCV000545630]|Hereditary cancer-predisposing syndrome [RCV002438334]|not specified [RCV003323597] |
Chr16:23636270 [GRCh38] Chr16:23647591 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1795del (p.Ser599fs) |
deletion |
Familial cancer of breast [RCV005091351]|Hereditary cancer-predisposing syndrome [RCV000563104] |
Chr16:23630359 [GRCh38] Chr16:23641680 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.600A>G (p.Leu200=) |
single nucleotide variant |
Familial cancer of breast [RCV001419088]|Hereditary cancer-predisposing syndrome [RCV000569277] |
Chr16:23635946 [GRCh38] Chr16:23647267 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1532G>A (p.Arg511Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000532982]|Hereditary cancer-predisposing syndrome [RCV002395344] |
Chr16:23635014 [GRCh38] Chr16:23646335 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1506G>C (p.Lys502Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000691734]|Hereditary cancer-predisposing syndrome [RCV000563604] |
Chr16:23635040 [GRCh38] Chr16:23646361 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.630A>G (p.Pro210=) |
single nucleotide variant |
Familial cancer of breast [RCV003500552]|Hereditary cancer-predisposing syndrome [RCV000565736] |
Chr16:23635916 [GRCh38] Chr16:23647237 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3130C>T (p.Gln1044Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000700246]|Hereditary breast ovarian cancer syndrome [RCV003155951]|Hereditary cancer-predisposing syndrome [RCV000565870] |
Chr16:23614075 [GRCh38] Chr16:23625396 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1939C>T (p.His647Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000692136]|Hereditary cancer-predisposing syndrome [RCV000567935]|not provided [RCV000587201] |
Chr16:23630215 [GRCh38] Chr16:23641536 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1685-2A>G |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005411471]|Familial cancer of breast [RCV001037839]|Hereditary cancer-predisposing syndrome [RCV000568799]|PALB2-related disorder [RCV004527630]|not provided [RCV000519126] |
Chr16:23630471 [GRCh38] Chr16:23641792 [GRCh37] Chr16:16p12.2 |
likely pathogenic|uncertain significance |
NM_024675.4(PALB2):c.892G>A (p.Val298Ile) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005357568]|Familial cancer of breast [RCV000551680]|Hereditary cancer-predisposing syndrome [RCV000563746]|not provided [RCV001800744] |
Chr16:23635654 [GRCh38] Chr16:23646975 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2608G>T (p.Val870Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000525255]|Hereditary cancer-predisposing syndrome [RCV000565637] |
Chr16:23626376 [GRCh38] Chr16:23637697 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3132A>T (p.Gln1044His) |
single nucleotide variant |
Familial cancer of breast [RCV000527442]|Hereditary cancer-predisposing syndrome [RCV000564415]|PALB2-related disorder [RCV004527638] |
Chr16:23614073 [GRCh38] Chr16:23625394 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1192del (p.Val398fs) |
deletion |
Familial cancer of breast [RCV000818431]|Hereditary cancer-predisposing syndrome [RCV000565917]|Malignant tumor of breast [RCV001357628]|Neoplasm of uterus [RCV002245019]|not provided [RCV002275087] |
Chr16:23635354 [GRCh38] Chr16:23646675 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2221G>A (p.Gly741Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000690008]|Hereditary cancer-predisposing syndrome [RCV000565945]|not provided [RCV001030287] |
Chr16:23629933 [GRCh38] Chr16:23641254 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2412T>C (p.Ser804=) |
single nucleotide variant |
Familial cancer of breast [RCV005056200]|Hereditary cancer-predisposing syndrome [RCV000565977] |
Chr16:23629742 [GRCh38] Chr16:23641063 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.41A>G (p.Lys14Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000550310] |
Chr16:23641117 [GRCh38] Chr16:23652438 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.651T>C (p.Asn217=) |
single nucleotide variant |
Familial cancer of breast [RCV002060523]|Hereditary cancer-predisposing syndrome [RCV000567939] |
Chr16:23635895 [GRCh38] Chr16:23647216 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2907G>A (p.Val969=) |
single nucleotide variant |
Familial cancer of breast [RCV000542295]|Hereditary cancer-predisposing syndrome [RCV002438335] |
Chr16:23623058 [GRCh38] Chr16:23634379 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1243A>T (p.Ser415Cys) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000560932] |
Chr16:23635303 [GRCh38] Chr16:23646624 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2619T>A (p.Ser873Arg) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000563907] |
Chr16:23626365 [GRCh38] Chr16:23637686 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.525A>G (p.Arg175=) |
single nucleotide variant |
Familial cancer of breast [RCV000529109]|Hereditary cancer-predisposing syndrome [RCV000567061]|not provided [RCV001697021]|not specified [RCV003479153] |
Chr16:23636021 [GRCh38] Chr16:23647342 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.927A>C (p.Ile309=) |
single nucleotide variant |
Familial cancer of breast [RCV000547368]|Hereditary cancer-predisposing syndrome [RCV000582870] |
Chr16:23635619 [GRCh38] Chr16:23646940 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.965A>G (p.Glu322Gly) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000568198] |
Chr16:23635581 [GRCh38] Chr16:23646902 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.509G>C (p.Arg170Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000818311]|Hereditary cancer-predisposing syndrome [RCV000564267]|not provided [RCV001030155] |
Chr16:23636037 [GRCh38] Chr16:23647358 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2947A>G (p.Thr983Ala) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000566438] |
Chr16:23623018 [GRCh38] Chr16:23634339 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1858G>C (p.Gly620Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000531505]|Hereditary cancer-predisposing syndrome [RCV004023846]|not provided [RCV001565817] |
Chr16:23630296 [GRCh38] Chr16:23641617 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3201+4del |
deletion |
Familial cancer of breast [RCV000635647]|Hereditary cancer-predisposing syndrome [RCV000568448] |
Chr16:23614000 [GRCh38] Chr16:23625321 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2461A>T (p.Asn821Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV001240791]|Hereditary cancer-predisposing syndrome [RCV000561459]|not specified [RCV003151105] |
Chr16:23629693 [GRCh38] Chr16:23641014 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.706T>A (p.Phe236Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000554280]|Hereditary cancer-predisposing syndrome [RCV002367813] |
Chr16:23635840 [GRCh38] Chr16:23647161 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1821C>T (p.Leu607=) |
single nucleotide variant |
Familial cancer of breast [RCV005091319]|Hereditary cancer-predisposing syndrome [RCV000568660]|not specified [RCV000780573] |
Chr16:23630333 [GRCh38] Chr16:23641654 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.7G>A (p.Glu3Lys) |
single nucleotide variant |
Familial cancer of breast [RCV001064138]|Hereditary cancer-predisposing syndrome [RCV000561851] |
Chr16:23641151 [GRCh38] Chr16:23652472 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2213G>A (p.Gly738Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000697044]|Hereditary cancer-predisposing syndrome [RCV000564730] |
Chr16:23629941 [GRCh38] Chr16:23641262 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1891T>C (p.Ser631Pro) |
single nucleotide variant |
Familial cancer of breast [RCV001341193]|Hereditary cancer-predisposing syndrome [RCV000564796]|not provided [RCV003159138] |
Chr16:23630263 [GRCh38] Chr16:23641584 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1063T>G (p.Leu355Val) |
single nucleotide variant |
Familial cancer of breast [RCV001047469]|Hereditary cancer-predisposing syndrome [RCV000564838] |
Chr16:23635483 [GRCh38] Chr16:23646804 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1886C>T (p.Ser629Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000532304]|Hereditary cancer-predisposing syndrome [RCV000771674]|not specified [RCV001280599] |
Chr16:23630268 [GRCh38] Chr16:23641589 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.290C>A (p.Ser97Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000554765]|Hereditary cancer-predisposing syndrome [RCV000580967] |
Chr16:23636256 [GRCh38] Chr16:23647577 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.679G>A (p.Ala227Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000549559]|Hereditary cancer-predisposing syndrome [RCV000565165]|not provided [RCV001538307]|not specified [RCV000588764] |
Chr16:23635867 [GRCh38] Chr16:23647188 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1684+1G>A |
single nucleotide variant |
Familial cancer of breast [RCV001046985]|Hereditary cancer-predisposing syndrome [RCV000564967]|not provided [RCV003736822] |
Chr16:23634861 [GRCh38] Chr16:23646182 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|uncertain significance |
NM_024675.4(PALB2):c.364G>A (p.Asp122Asn) |
single nucleotide variant |
Carcinoma of colon [RCV001030144]|Familial cancer of breast [RCV000822879]|Hereditary cancer-predisposing syndrome [RCV000568891]|not provided [RCV001692209] |
Chr16:23636182 [GRCh38] Chr16:23647503 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3455C>T (p.Pro1152Leu) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000562323] |
Chr16:23603565 [GRCh38] Chr16:23614886 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2382G>T (p.Arg794Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001049868]|Hereditary cancer-predisposing syndrome [RCV000562427] |
Chr16:23629772 [GRCh38] Chr16:23641093 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1731T>C (p.Asn577=) |
single nucleotide variant |
Familial cancer of breast [RCV005426182]|Hereditary cancer-predisposing syndrome [RCV000568996] |
Chr16:23630423 [GRCh38] Chr16:23641744 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2732C>A (p.Thr911Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000685459]|Hereditary cancer-predisposing syndrome [RCV000562850]|not provided [RCV003478238]|not specified [RCV001844198] |
Chr16:23626252 [GRCh38] Chr16:23637573 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1071_1072del (p.Pro358fs) |
microsatellite |
Familial cancer of breast [RCV003607309]|Hereditary cancer-predisposing syndrome [RCV000565551] |
Chr16:23635474..23635475 [GRCh38] Chr16:23646795..23646796 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.349C>A (p.Pro117Thr) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003444602]|Familial cancer of breast [RCV000684939]|Hereditary cancer-predisposing syndrome [RCV000567477]|not provided [RCV003237929] |
Chr16:23636197 [GRCh38] Chr16:23647518 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.905del (p.Asn302fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000565598] |
Chr16:23635641 [GRCh38] Chr16:23646962 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2452T>C (p.Phe818Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000546200]|Hereditary cancer-predisposing syndrome [RCV001180795] |
Chr16:23629702 [GRCh38] Chr16:23641023 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.833_834delinsAT (p.Leu278His) |
indel |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315409]|Familial cancer of breast [RCV000204991]|Familial cancer of breast [RCV002477318]|Hereditary cancer-predisposing syndrome [RCV000131311]|Malignant tumor of breast [RCV001005025]|PALB2-related disorder [RCV004528835]|not provided [RCV000160815]|not specified [RCV000121746] |
Chr16:23635712..23635713 [GRCh38] Chr16:23647033..23647034 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance|not provided |
PALB2:c.49-?_2586+?del |
deletion |
Fanconi anemia complementation group N [RCV000001303] |
Chr16:16p12 |
pathogenic |
PALB2, 1-BP DEL, 3116A |
deletion |
Fanconi anemia, complementation group N [RCV000001308]|Breast cancer, susceptibility to [RCV000001309]|Pancreatic cancer 3 [RCV000030870] |
Chr16:16p12 |
pathogenic|risk factor |
PALB2, 1-BP DEL, 1592T |
deletion |
Breast cancer, susceptibility to [RCV000001310] |
Chr16:16p12 |
risk factor |
PALB2, 4-BP DEL, 172TTGT |
deletion |
Pancreatic cancer 3 [RCV000001311] |
Chr16:16p12 |
risk factor |
PALB2, IVS5, G-T, -1 |
single nucleotide variant |
Pancreatic cancer 3 [RCV000001312] |
Chr16:16p12 |
risk factor |
PALB2, 3256C-T |
single nucleotide variant |
Pancreatic cancer 3 [RCV000001314] |
Chr16:16p12 |
risk factor |
NM_024675.4(PALB2):c.1915G>A (p.Glu639Lys) |
single nucleotide variant |
Familial cancer of breast [RCV005091318]|Hereditary cancer-predisposing syndrome [RCV000561094] |
Chr16:23630239 [GRCh38] Chr16:23641560 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3201G>A (p.Met1067Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000635884]|Hereditary cancer-predisposing syndrome [RCV000561229] |
Chr16:23614004 [GRCh38] Chr16:23625325 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1841T>C (p.Leu614Ser) |
single nucleotide variant |
Familial cancer of breast [RCV002526811]|Hereditary cancer-predisposing syndrome [RCV000561839]|not provided [RCV005000253] |
Chr16:23630313 [GRCh38] Chr16:23641634 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.999C>G (p.Thr333=) |
single nucleotide variant |
Familial cancer of breast [RCV000543845] |
Chr16:23635547 [GRCh38] Chr16:23646868 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2149G>A (p.Asp717Asn) |
single nucleotide variant |
Familial cancer of breast [RCV002528017]|Hereditary cancer-predisposing syndrome [RCV000562067] |
Chr16:23630005 [GRCh38] Chr16:23641326 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2837del (p.Ala946fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000562315] |
Chr16:23623128 [GRCh38] Chr16:23634449 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2026A>C (p.Ile676Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000764049]|Familial cancer of breast [RCV000989562]|Hereditary cancer-predisposing syndrome [RCV000563462] |
Chr16:23630128 [GRCh38] Chr16:23641449 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3159T>C (p.Asp1053=) |
single nucleotide variant |
Familial cancer of breast [RCV005427028]|Hereditary cancer-predisposing syndrome [RCV000562763]|not specified [RCV000606493] |
Chr16:23614046 [GRCh38] Chr16:23625367 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2131G>A (p.Val711Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000531730]|Hereditary cancer-predisposing syndrome [RCV000571134] |
Chr16:23630023 [GRCh38] Chr16:23641344 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2962_2963del (p.Gln988fs) |
deletion |
Familial cancer of breast [RCV003451224]|Hereditary cancer-predisposing syndrome [RCV000564176] |
Chr16:23623002..23623003 [GRCh38] Chr16:23634323..23634324 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3060A>G (p.Gln1020=) |
single nucleotide variant |
Familial cancer of breast [RCV001445003]|Hereditary cancer-predisposing syndrome [RCV000562992]|not provided [RCV001030373] |
Chr16:23621415 [GRCh38] Chr16:23632736 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.2319T>C (p.Thr773=) |
single nucleotide variant |
Familial cancer of breast [RCV000527401]|Hereditary cancer-predisposing syndrome [RCV000570160]|not specified [RCV001030297] |
Chr16:23629835 [GRCh38] Chr16:23641156 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.808A>G (p.Ser270Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000807027]|Hereditary cancer-predisposing syndrome [RCV000563900]|not provided [RCV000985895] |
Chr16:23635738 [GRCh38] Chr16:23647059 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2918C>T (p.Thr973Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000814692]|Hereditary cancer-predisposing syndrome [RCV000561217]|not provided [RCV000757593] |
Chr16:23623047 [GRCh38] Chr16:23634368 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2071A>G (p.Ser691Gly) |
single nucleotide variant |
Familial cancer of breast [RCV002526791]|Hereditary cancer-predisposing syndrome [RCV000561320] |
Chr16:23630083 [GRCh38] Chr16:23641404 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1165C>G (p.Leu389Val) |
single nucleotide variant |
Familial cancer of breast [RCV000552765]|Hereditary cancer-predisposing syndrome [RCV000777229]|not provided [RCV003236811] |
Chr16:23635381 [GRCh38] Chr16:23646702 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1945A>T (p.Lys649Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001224726]|Hereditary cancer-predisposing syndrome [RCV000563292] |
Chr16:23630209 [GRCh38] Chr16:23641530 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.718C>A (p.Pro240Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000530439]|Fanconi anemia complementation group N [RCV001118312]|Hereditary cancer-predisposing syndrome [RCV000568617]|not provided [RCV001030167] |
Chr16:23635828 [GRCh38] Chr16:23647149 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1326T>C (p.Asn442=) |
single nucleotide variant |
Familial cancer of breast [RCV000543081]|not specified [RCV000599738] |
Chr16:23635220 [GRCh38] Chr16:23646541 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1052C>T (p.Thr351Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000543661] |
Chr16:23635494 [GRCh38] Chr16:23646815 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.212-9C>T |
single nucleotide variant |
Familial cancer of breast [RCV000989580]|Hereditary cancer-predisposing syndrome [RCV000777568]|not specified [RCV000602709] |
Chr16:23636343 [GRCh38] Chr16:23647664 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.319T>A (p.Phe107Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000548393]|Hereditary cancer-predisposing syndrome [RCV005384761] |
Chr16:23636227 [GRCh38] Chr16:23647548 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1643C>T (p.Ser548Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000547156]|Hereditary cancer-predisposing syndrome [RCV000571222]|not provided [RCV002259347] |
Chr16:23634903 [GRCh38] Chr16:23646224 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3476G>T (p.Trp1159Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000547300]|Hereditary cancer-predisposing syndrome [RCV000564987]|not provided [RCV003329296]|not specified [RCV003317262] |
Chr16:23603544 [GRCh38] Chr16:23614865 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1292G>A (p.Ser431Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000635950]|Hereditary cancer-predisposing syndrome [RCV000561985]|not specified [RCV000780557] |
Chr16:23635254 [GRCh38] Chr16:23646575 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2234A>G (p.Lys745Arg) |
single nucleotide variant |
Carcinoma of colon [RCV001030288]|Familial cancer of breast [RCV000689640]|Familial cancer of breast [RCV002491122]|Hereditary cancer-predisposing syndrome [RCV000566180]|not provided [RCV001775883] |
Chr16:23629920 [GRCh38] Chr16:23641241 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1390A>G (p.Arg464Gly) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000562082] |
Chr16:23635156 [GRCh38] Chr16:23646477 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3231C>A (p.Pro1077=) |
single nucleotide variant |
Familial cancer of breast [RCV000554232]|Hereditary cancer-predisposing syndrome [RCV000566988] |
Chr16:23607983 [GRCh38] Chr16:23619304 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1627A>G (p.Lys543Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000635743]|Hereditary cancer-predisposing syndrome [RCV000565142]|not provided [RCV002274068] |
Chr16:23634919 [GRCh38] Chr16:23646240 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.828C>T (p.His276=) |
single nucleotide variant |
Familial cancer of breast [RCV000557022]|Familial ovarian cancer [RCV001357885]|Fanconi anemia complementation group N [RCV001118311]|Hereditary cancer-predisposing syndrome [RCV000567452]|Malignant tumor of breast [RCV001354533]|not provided [RCV001171908] |
Chr16:23635718 [GRCh38] Chr16:23647039 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.1702C>T (p.Gln568Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000549307]|Hereditary cancer-predisposing syndrome [RCV002413486] |
Chr16:23630452 [GRCh38] Chr16:23641773 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2895T>C (p.Asn965=) |
single nucleotide variant |
Familial cancer of breast [RCV000549312]|Hereditary cancer-predisposing syndrome [RCV003362834] |
Chr16:23623070 [GRCh38] Chr16:23634391 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1629G>C (p.Lys543Asn) |
single nucleotide variant |
Familial cancer of breast [RCV001858167]|Hereditary cancer-predisposing syndrome [RCV000566796] |
Chr16:23634917 [GRCh38] Chr16:23646238 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.90G>A (p.Lys30=) |
single nucleotide variant |
Familial cancer of breast [RCV001444109]|Hereditary cancer-predisposing syndrome [RCV000566824]|not provided [RCV003478215] |
Chr16:23638088 [GRCh38] Chr16:23649409 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.1565del (p.Pro522fs) |
deletion |
Familial cancer of breast [RCV000529207]|Hereditary cancer-predisposing syndrome [RCV003380605]|Malignant tumor of breast [RCV002231716] |
Chr16:23634981 [GRCh38] Chr16:23646302 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3217G>T (p.Val1073Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000529311]|Familial cancer of breast [RCV002483394]|Hereditary cancer-predisposing syndrome [RCV001019294] |
Chr16:23607997 [GRCh38] Chr16:23619318 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.636A>G (p.Pro212=) |
single nucleotide variant |
Familial cancer of breast [RCV001424874]|Hereditary cancer-predisposing syndrome [RCV000562362] |
Chr16:23635910 [GRCh38] Chr16:23647231 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3094A>G (p.Met1032Val) |
single nucleotide variant |
Familial cancer of breast [RCV001858156]|Hereditary cancer-predisposing syndrome [RCV000561174] |
Chr16:23621381 [GRCh38] Chr16:23632702 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1576C>G (p.His526Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000546388]|Hereditary cancer-predisposing syndrome [RCV000582966] |
Chr16:23634970 [GRCh38] Chr16:23646291 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.232del (p.Val78fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000562722] |
Chr16:23636314 [GRCh38] Chr16:23647635 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2503T>A (p.Ser835Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001858209]|Hereditary cancer-predisposing syndrome [RCV000562867] |
Chr16:23629651 [GRCh38] Chr16:23640972 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1286T>C (p.Ile429Thr) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000562896] |
Chr16:23635260 [GRCh38] Chr16:23646581 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3365A>T (p.Asp1122Val) |
single nucleotide variant |
not provided [RCV000520349] |
Chr16:23603655 [GRCh38] Chr16:23614976 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.480A>G (p.Arg160=) |
single nucleotide variant |
Familial cancer of breast [RCV002060483]|Hereditary cancer-predisposing syndrome [RCV000563026] |
Chr16:23636066 [GRCh38] Chr16:23647387 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.278G>A (p.Gly93Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000811865]|Hereditary cancer-predisposing syndrome [RCV000567128]|not provided [RCV003148792] |
Chr16:23636268 [GRCh38] Chr16:23647589 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2429C>T (p.Pro810Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000529562]|Hereditary cancer-predisposing syndrome [RCV000773135] |
Chr16:23629725 [GRCh38] Chr16:23641046 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2424A>G (p.Gly808=) |
single nucleotide variant |
Familial cancer of breast [RCV005422210]|Hereditary cancer-predisposing syndrome [RCV000565782] |
Chr16:23629730 [GRCh38] Chr16:23641051 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.736A>T (p.Thr246Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000699347]|Hereditary cancer-predisposing syndrome [RCV000567314]|not provided [RCV001775886] |
Chr16:23635810 [GRCh38] Chr16:23647131 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1266del (p.Lys422_Val423insTer) |
deletion |
Familial cancer of breast [RCV001220630]|Hereditary cancer-predisposing syndrome [RCV000567486]|PALB2-related disorder [RCV004545787]|not provided [RCV000657828] |
Chr16:23635280 [GRCh38] Chr16:23646601 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|not provided |
NM_024675.4(PALB2):c.48+1G>A |
single nucleotide variant |
Familial cancer of breast [RCV000635645]|Hereditary cancer-predisposing syndrome [RCV000561202]|not provided [RCV000708619] |
Chr16:23641109 [GRCh38] Chr16:23652430 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.2632G>T (p.Glu878Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000635833]|Hereditary cancer-predisposing syndrome [RCV000561696]|not provided [RCV001030334] |
Chr16:23626352 [GRCh38] Chr16:23637673 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1783G>A (p.Asp595Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000804639]|Hereditary cancer-predisposing syndrome [RCV000561858] |
Chr16:23630371 [GRCh38] Chr16:23641692 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1398T>G (p.Ser466=) |
single nucleotide variant |
Familial cancer of breast [RCV000537302]|Fanconi anemia complementation group N [RCV005398792]|Hereditary cancer-predisposing syndrome [RCV000573842]|PALB2-related disorder [RCV004541673]|not provided [RCV000611260] |
Chr16:23635148 [GRCh38] Chr16:23646469 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2896A>T (p.Ile966Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000525305] |
Chr16:23623069 [GRCh38] Chr16:23634390 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.995T>C (p.Leu332Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000554766]|Hereditary cancer-predisposing syndrome [RCV000561598]|not provided [RCV001800746] |
Chr16:23635551 [GRCh38] Chr16:23646872 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2202T>G (p.Thr734=) |
single nucleotide variant |
Familial cancer of breast [RCV003500566]|Hereditary cancer-predisposing syndrome [RCV000567529] |
Chr16:23629952 [GRCh38] Chr16:23641273 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.193C>G (p.Pro65Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000704290]|Hereditary cancer-predisposing syndrome [RCV000564430] |
Chr16:23637868 [GRCh38] Chr16:23649189 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1634A>G (p.Glu545Gly) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000561877] |
Chr16:23634912 [GRCh38] Chr16:23646233 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1066A>G (p.Lys356Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000544610]|Familial pancreatic carcinoma [RCV005357564]|Hereditary cancer-predisposing syndrome [RCV000575442]|not provided [RCV001538610]|not specified [RCV001174761] |
Chr16:23635480 [GRCh38] Chr16:23646801 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2156C>G (p.Pro719Arg) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000567922] |
Chr16:23629998 [GRCh38] Chr16:23641319 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.18G>A (p.Gly6=) |
single nucleotide variant |
Familial cancer of breast [RCV000544942]|Familial cancer of breast [RCV002497105]|Hereditary cancer-predisposing syndrome [RCV000575984] |
Chr16:23641140 [GRCh38] Chr16:23652461 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.371C>T (p.Thr124Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000693977]|Hereditary cancer-predisposing syndrome [RCV000562435]|not provided [RCV003235296]|not specified [RCV004689798] |
Chr16:23636175 [GRCh38] Chr16:23647496 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1870C>T (p.Leu624Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000804871]|Hereditary cancer-predisposing syndrome [RCV000568032] |
Chr16:23630284 [GRCh38] Chr16:23641605 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2418G>T (p.Pro806=) |
single nucleotide variant |
Familial cancer of breast [RCV001030306]|Hereditary cancer-predisposing syndrome [RCV000774630]|PALB2-related disorder [RCV004537940]|not provided [RCV001800743]|not specified [RCV000612786] |
Chr16:23629736 [GRCh38] Chr16:23641057 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1111G>A (p.Glu371Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000635715]|Hereditary cancer-predisposing syndrome [RCV000566028] |
Chr16:23635435 [GRCh38] Chr16:23646756 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.985_986del (p.Leu329fs) |
microsatellite |
Familial cancer of breast [RCV000553727] |
Chr16:23635560..23635561 [GRCh38] Chr16:23646881..23646882 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3324C>G (p.Tyr1108Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000550532]|Hereditary cancer-predisposing syndrome [RCV001019991]|not provided [RCV004592566] |
Chr16:23607890 [GRCh38] Chr16:23619211 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3394T>C (p.Leu1132=) |
single nucleotide variant |
Familial cancer of breast [RCV000528385]|Fanconi anemia complementation group N [RCV001121623]|Hereditary cancer-predisposing syndrome [RCV001020184]|not provided [RCV001796099]|not specified [RCV000602592] |
Chr16:23603626 [GRCh38] Chr16:23614947 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.3351-4T>C |
single nucleotide variant |
Familial cancer of breast [RCV000550872]|Hereditary cancer-predisposing syndrome [RCV002323943] |
Chr16:23603673 [GRCh38] Chr16:23614994 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1785T>C (p.Asp595=) |
single nucleotide variant |
Familial cancer of breast [RCV000526181]|Hereditary cancer-predisposing syndrome [RCV001013175]|PALB2-related disorder [RCV004537939]|not specified [RCV005239159] |
Chr16:23630369 [GRCh38] Chr16:23641690 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3246dup (p.Glu1083Ter) |
duplication |
Hereditary cancer-predisposing syndrome [RCV000564873] |
Chr16:23607967..23607968 [GRCh38] Chr16:23619288..23619289 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2613T>A (p.Asp871Glu) |
single nucleotide variant |
Familial cancer of breast [RCV003607308]|Hereditary cancer-predisposing syndrome [RCV000566434]|not specified [RCV005231083] |
Chr16:23626371 [GRCh38] Chr16:23637692 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3447C>G (p.Ala1149=) |
single nucleotide variant |
Familial cancer of breast [RCV001477692]|Hereditary cancer-predisposing syndrome [RCV001020323] |
Chr16:23603573 [GRCh38] Chr16:23614894 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2402A>G (p.Asp801Gly) |
single nucleotide variant |
Familial cancer of breast [RCV001306017]|Hereditary cancer-predisposing syndrome [RCV000563156] |
Chr16:23629752 [GRCh38] Chr16:23641073 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1710G>A (p.Glu570=) |
single nucleotide variant |
Familial cancer of breast [RCV005091350]|Hereditary cancer-predisposing syndrome [RCV000566692] |
Chr16:23630444 [GRCh38] Chr16:23641765 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.971A>C (p.Asn324Thr) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000580230] |
Chr16:23635575 [GRCh38] Chr16:23646896 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.305T>C (p.Val102Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000551090]|Hereditary cancer-predisposing syndrome [RCV000575360]|not provided [RCV001030141] |
Chr16:23636241 [GRCh38] Chr16:23647562 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2834+4T>C |
single nucleotide variant |
Familial cancer of breast [RCV000815391]|Hereditary cancer-predisposing syndrome [RCV000563717] |
Chr16:23624005 [GRCh38] Chr16:23635326 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1221_1222delinsTC (p.Glu407_Tyr408delinsAspHis) |
indel |
Hereditary cancer-predisposing syndrome [RCV000580322] |
Chr16:23635324..23635325 [GRCh38] Chr16:23646645..23646646 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2125A>T (p.Asn709Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV001213447]|Hereditary cancer-predisposing syndrome [RCV000580326] |
Chr16:23630029 [GRCh38] Chr16:23641350 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2305_2334del (p.Leu769_Ser778del) |
deletion |
Familial cancer of breast [RCV000663202]|Hereditary cancer-predisposing syndrome [RCV000580403] |
Chr16:23629820..23629849 [GRCh38] Chr16:23641141..23641170 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2431C>T (p.Pro811Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000800440]|Hereditary cancer-predisposing syndrome [RCV000580524] |
Chr16:23629723 [GRCh38] Chr16:23641044 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3165C>G (p.Tyr1055Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003451225]|Hereditary cancer-predisposing syndrome [RCV000565155] |
Chr16:23614040 [GRCh38] Chr16:23625361 [GRCh37] Chr16:16p12.2 |
pathogenic |
NC_000016.9:g.(?_23619179)_(23625418_?)dup |
duplication |
Familial cancer of breast [RCV000552382] |
Chr16:23607858..23614097 [GRCh38] Chr16:23619179..23625418 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2002del (p.Met668fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000567395] |
Chr16:23630152 [GRCh38] Chr16:23641473 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2218C>T (p.Gln740Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000989559]|Hereditary breast ovarian cancer syndrome [RCV000587693]|Hereditary cancer-predisposing syndrome [RCV000567438]|not provided [RCV003318598] |
Chr16:23629936 [GRCh38] Chr16:23641257 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2706T>C (p.Asp902=) |
single nucleotide variant |
Familial cancer of breast [RCV000526823] |
Chr16:23626278 [GRCh38] Chr16:23637599 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.635del (p.Pro212fs) |
deletion |
Familial cancer of breast [RCV000547909] |
Chr16:23635911 [GRCh38] Chr16:23647232 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2017G>A (p.Glu673Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000540647]|Hereditary cancer-predisposing syndrome [RCV000569513] |
Chr16:23630137 [GRCh38] Chr16:23641458 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.704C>T (p.Thr235Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000542532]|Hereditary cancer-predisposing syndrome [RCV000777204] |
Chr16:23635842 [GRCh38] Chr16:23647163 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.854C>G (p.Ser285Ter) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000561198] |
Chr16:23635692 [GRCh38] Chr16:23647013 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.968C>T (p.Ala323Val) |
single nucleotide variant |
Familial cancer of breast [RCV000635863]|Familial cancer of breast [RCV002476232]|Hereditary cancer-predisposing syndrome [RCV000564210]|not provided [RCV001800781]|not specified [RCV004586802] |
Chr16:23635578 [GRCh38] Chr16:23646899 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1873del (p.Glu625fs) |
deletion |
Familial cancer of breast [RCV001858213]|Hereditary cancer-predisposing syndrome [RCV000564651] |
Chr16:23630281 [GRCh38] Chr16:23641602 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2979G>A (p.Thr993=) |
single nucleotide variant |
Familial cancer of breast [RCV001489604]|Hereditary cancer-predisposing syndrome [RCV000564683] |
Chr16:23622986 [GRCh38] Chr16:23634307 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1653T>A (p.Tyr551Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005053882]|Familial cancer of breast [RCV000476387]|Fanconi anemia complementation group N [RCV000001302]|Hereditary cancer-predisposing syndrome [RCV000217204]|not provided [RCV000235772] |
Chr16:23634893 [GRCh38] Chr16:23646214 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|risk factor |
NM_024675.4(PALB2):c.3549C>G (p.Tyr1183Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005053883]|Familial cancer of breast [RCV000114634]|Fanconi anemia complementation group N [RCV000001304]|Hereditary cancer-predisposing syndrome [RCV000129158]|Inherited breast cancer and ovarian cancer [RCV005430457]|PALB2-related disorder [RCV004528063]|Pancreatic cancer, susceptibility to, 3 [RCV001355428]|not provided [RCV000212830]|not specified [RCV000121742] |
Chr16:23603471 [GRCh38] Chr16:23614792 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|risk factor|conflicting interpretations of pathogenicity|not provided |
NM_024675.4(PALB2):c.2962C>T (p.Gln988Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005053884]|Familial cancer of breast [RCV000662710]|Fanconi anemia complementation group N [RCV000001306]|Hereditary cancer-predisposing syndrome [RCV000129469]|not provided [RCV000657596] |
Chr16:23623003 [GRCh38] Chr16:23634324 [GRCh37] Chr16:16p12.2 |
pathogenic|risk factor |
NM_024675.4(PALB2):c.*232G>T |
single nucleotide variant |
Familial cancer of breast [RCV001030426]|Fanconi anemia complementation group N [RCV001121620] |
Chr16:23603227 [GRCh38] Chr16:23614548 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NC_000016.10:g.23603112T>G |
single nucleotide variant |
Familial cancer of breast [RCV001030427] |
Chr16:23603112 [GRCh38] Chr16:23614433 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.-104C>T |
single nucleotide variant |
Familial cancer of breast [RCV001030096] |
Chr16:23641261 [GRCh38] Chr16:23652582 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.-145G>C |
single nucleotide variant |
Familial cancer of breast [RCV001030095] |
Chr16:23641302 [GRCh38] Chr16:23652623 [GRCh37] Chr16:16p12.2 |
likely benign |
NC_000016.10:g.23641315C>G |
single nucleotide variant |
Familial cancer of breast [RCV001030094]|Fanconi anemia complementation group N [RCV000282144]|Hereditary cancer-predisposing syndrome [RCV000374410]|not provided [RCV000829438] |
Chr16:23641315 [GRCh38] Chr16:23652636 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NC_000016.10:g.23641351G>C |
single nucleotide variant |
Familial cancer of breast [RCV001030093] |
Chr16:23641351 [GRCh38] Chr16:23652672 [GRCh37] Chr16:16p12.2 |
likely benign |
NC_000016.10:g.23641384A>C |
single nucleotide variant |
Familial cancer of breast [RCV001030091] |
Chr16:23641384 [GRCh38] Chr16:23652705 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.3(PALB2):c.-200-?_3113+?del |
deletion |
Fanconi anemia, complementation group N [RCV000114442] |
|
pathogenic|uncertain significance |
NM_024675.4(PALB2):c.-25C>A |
single nucleotide variant |
Familial cancer of breast [RCV001030100] |
Chr16:23641182 [GRCh38] Chr16:23652503 [GRCh37] Chr16:16p12.2 |
likely benign |
NC_000016.10:g.23641516C>G |
single nucleotide variant |
Familial cancer of breast [RCV001030090] |
Chr16:23641516 [GRCh38] Chr16:23652837 [GRCh37] Chr16:16p12.2 |
benign |
NM_024675.4(PALB2):c.-46G>A |
single nucleotide variant |
Familial cancer of breast [RCV001030099] |
Chr16:23641203 [GRCh38] Chr16:23652524 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.-47G>A |
single nucleotide variant |
Familial cancer of breast [RCV001030098]|Fanconi anemia complementation group N [RCV000322920]|Hereditary breast ovarian cancer syndrome [RCV002225293]|Hereditary cancer-predisposing syndrome [RCV000379880]|not provided [RCV001689640]|not specified [RCV000248074] |
Chr16:23641204 [GRCh38] Chr16:23652525 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.-98C>A |
single nucleotide variant |
Familial cancer of breast [RCV001030097] |
Chr16:23641255 [GRCh38] Chr16:23652576 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1000T>G (p.Tyr334Asp) |
single nucleotide variant |
Familial cancer of breast [RCV001087026]|Fanconi anemia complementation group N [RCV000402501]|Hereditary cancer-predisposing syndrome [RCV000165476]|not provided [RCV000483117]|not specified [RCV004595925] |
Chr16:23635546 [GRCh38] Chr16:23646867 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1001A>G (p.Tyr334Cys) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798290]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359039]|Familial cancer of breast [RCV000114449]|Hereditary breast ovarian cancer syndrome [RCV003483471]|Hereditary cancer [RCV000415191]|Hereditary cancer-predisposing syndrome [RCV000116060]|PALB2-related disorder [RCV004529916]|not provided [RCV000212784]|not specified [RCV000781695] |
Chr16:23635545 [GRCh38] Chr16:23646866 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.1010T>C (p.Leu337Ser) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798291]|Familial cancer of breast [RCV000114450]|Fanconi anemia complementation group N [RCV001116860]|Hereditary cancer-predisposing syndrome [RCV000127306]|Malignant tumor of breast [RCV001354445]|not provided [RCV000755592]|not specified [RCV000121752] |
Chr16:23635536 [GRCh38] Chr16:23646857 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters|not provided |
NM_024675.4(PALB2):c.1027C>T (p.Gln343Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005053906]|Familial cancer of breast [RCV001040014]|Hereditary breast ovarian cancer syndrome [RCV003155912]|Hereditary cancer-predisposing syndrome [RCV000215551]|not provided [RCV001030193] |
Chr16:23635519 [GRCh38] Chr16:23646840 [GRCh37] Chr16:16p12.2 |
pathogenic|risk factor |
NM_024675.4(PALB2):c.1038A>G (p.Lys346=) |
single nucleotide variant |
Familial cancer of breast [RCV001030195]|Hereditary cancer-predisposing syndrome [RCV000564445] |
Chr16:23635508 [GRCh38] Chr16:23646829 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NC_000016.10:g.23635495_23635496delinsAGA |
indel |
Familial cancer of breast [RCV001030197] |
Chr16:23635495..23635496 [GRCh38] Chr16:23646816..23646817 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1050_1053del (p.Thr351fs) |
deletion |
Familial cancer of breast [RCV000470398]|Familial cancer of breast [RCV002477267]|Hereditary cancer-predisposing syndrome [RCV000129806]|Malignant tumor of breast [RCV001260315]|not provided [RCV000483096] |
Chr16:23635493..23635496 [GRCh38] Chr16:23646814..23646817 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1056_1057del (p.Lys353fs) |
microsatellite |
Familial cancer of breast [RCV000114457]|Hereditary cancer-predisposing syndrome [RCV000165605]|Lynch syndrome 1 [RCV003485539]|not provided [RCV003162527] |
Chr16:23635489..23635490 [GRCh38] Chr16:23646810..23646811 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.108+59C>G |
single nucleotide variant |
Familial cancer of breast [RCV001030119] |
Chr16:23638011 [GRCh38] Chr16:23649332 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1095G>C (p.Arg365Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001030199] |
Chr16:23635451 [GRCh38] Chr16:23646772 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.110G>A (p.Arg37His) |
single nucleotide variant |
Familial cancer of breast [RCV000114460]|Familial cancer of breast [RCV002483177]|Hereditary cancer-predisposing syndrome [RCV000116061]|PALB2-related disorder [RCV004739369]|not provided [RCV000212768]|not specified [RCV000780571] |
Chr16:23637951 [GRCh38] Chr16:23649272 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1145G>T (p.Ser382Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000114461]|Familial cancer of breast [RCV002483178]|Hereditary cancer-predisposing syndrome [RCV000567033]|not provided [RCV000483203] |
Chr16:23635401 [GRCh38] Chr16:23646722 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1194G>A (p.Val398=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001170350]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005234992]|Familial cancer of breast [RCV000114462]|Fanconi anemia complementation group N [RCV000327932]|Hereditary cancer-predisposing syndrome [RCV000127307]|Malignant tumor of breast [RCV001357080]|not provided [RCV000588666]|not specified [RCV000212786] |
Chr16:23635352 [GRCh38] Chr16:23646673 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.11C>T (p.Pro4Leu) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798292]|Familial cancer of breast [RCV000114464]|Familial cancer of breast [RCV000515208]|Hereditary cancer-predisposing syndrome [RCV000116063]|Malignant tumor of breast [RCV001358373]|PALB2-related disorder [RCV004739370]|not provided [RCV000590674]|not specified [RCV001797625] |
Chr16:23641147 [GRCh38] Chr16:23652468 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1222T>C (p.Tyr408His) |
single nucleotide variant |
Familial cancer of breast [RCV000802122]|Hereditary cancer-predisposing syndrome [RCV003362687]|Pancreatic cancer, susceptibility to, 3 [RCV001030206]|not provided [RCV001355987] |
Chr16:23635324 [GRCh38] Chr16:23646645 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1250C>A (p.Ser417Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000114466]|Fanconi anemia complementation group N [RCV005394371]|Hereditary breast ovarian cancer syndrome [RCV003483472]|Hereditary cancer-predisposing syndrome [RCV000116065]|PALB2-related disorder [RCV004739371]|not provided [RCV000590540]|not specified [RCV001255214] |
Chr16:23635296 [GRCh38] Chr16:23646617 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1314del (p.Phe440fs) |
deletion |
Familial cancer of breast [RCV003453033]|not provided [RCV001030215] |
Chr16:23635232 [GRCh38] Chr16:23646553 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1317G>A (p.Gly439=) |
single nucleotide variant |
Familial cancer of breast [RCV001030216]|Hereditary cancer-predisposing syndrome [RCV002381413] |
Chr16:23635229 [GRCh38] Chr16:23646550 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1317del (p.Phe440fs) |
deletion |
Familial cancer of breast [RCV000114470]|Hereditary breast ovarian cancer syndrome [RCV001193417]|Hereditary cancer-predisposing syndrome [RCV000129522]|PALB2-related cancer predisposition [RCV005364989]|not provided [RCV000212789] |
Chr16:23635229 [GRCh38] Chr16:23646550 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1380A>G (p.Gln460=) |
single nucleotide variant |
Familial cancer of breast [RCV001030220]|Hereditary cancer-predisposing syndrome [RCV001011264]|not specified [RCV005406824] |
Chr16:23635166 [GRCh38] Chr16:23646487 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.13C>T (p.Pro5Ser) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359040]|Familial cancer of breast [RCV000114472]|Hereditary cancer-predisposing syndrome [RCV000116068]|PALB2-related disorder [RCV004739372]|not provided [RCV000589509]|not specified [RCV001818256] |
Chr16:23641145 [GRCh38] Chr16:23652466 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1419A>C (p.Pro473=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492438]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315610]|Familial cancer of breast [RCV000114473]|Hereditary breast ovarian cancer syndrome [RCV002225294]|Hereditary cancer-predisposing syndrome [RCV000127309]|Malignant tumor of breast [RCV001358133]|not provided [RCV000585974]|not specified [RCV000212794] |
Chr16:23635127 [GRCh38] Chr16:23646448 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.1431C>T (p.Thr477=) |
single nucleotide variant |
Familial cancer of breast [RCV000114474]|Hereditary cancer-predisposing syndrome [RCV000454223]|PALB2-related disorder [RCV004542812]|not provided [RCV000859071]|not specified [RCV000599737] |
Chr16:23635115 [GRCh38] Chr16:23646436 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1461C>T (p.Val487=) |
single nucleotide variant |
Familial cancer of breast [RCV001030230]|Hereditary cancer-predisposing syndrome [RCV003162528] |
Chr16:23635085 [GRCh38] Chr16:23646406 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1470C>T (p.Pro490=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798293]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005234993]|Familial cancer of breast [RCV000114476]|Familial cancer of breast [RCV002490762]|Fanconi anemia complementation group N [RCV000276625]|Hereditary cancer-predisposing syndrome [RCV000127310]|not provided [RCV000586468]|not specified [RCV000212795] |
Chr16:23635076 [GRCh38] Chr16:23646397 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.1475G>T (p.Gly492Val) |
single nucleotide variant |
Familial cancer of breast [RCV001030233] |
Chr16:23635071 [GRCh38] Chr16:23646392 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1479del (p.Thr494fs) |
deletion |
Familial cancer of breast [RCV000114478]|Hereditary breast ovarian cancer syndrome [RCV001193415]|Hereditary cancer-predisposing syndrome [RCV000129889]|not provided [RCV000483204] |
Chr16:23635067 [GRCh38] Chr16:23646388 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1544A>G (p.Lys515Arg) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149776]|Familial cancer of breast [RCV000114479]|Familial ovarian cancer [RCV001355376]|Hereditary cancer [RCV004700413]|Hereditary cancer-predisposing syndrome [RCV000129175]|PALB2-related disorder [RCV004528789]|not provided [RCV000586359]|not specified [RCV000235723] |
Chr16:23635002 [GRCh38] Chr16:23646323 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1572A>G (p.Ser524=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798294]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005234994]|Familial cancer of breast [RCV000114480]|Fanconi anemia complementation group N [RCV000261837]|Hereditary cancer-predisposing syndrome [RCV000127311]|Malignant tumor of breast [RCV001357887]|not provided [RCV000488265]|not specified [RCV000212796] |
Chr16:23634974 [GRCh38] Chr16:23646295 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.1592del (p.Leu531fs) |
deletion |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005053907]|Familial cancer of breast [RCV000114482]|Familial pancreatic carcinoma [RCV005364990]|Hereditary breast ovarian cancer syndrome [RCV003155913]|Hereditary cancer-predisposing syndrome [RCV000132474]|not provided [RCV000212797] |
Chr16:23634954 [GRCh38] Chr16:23646275 [GRCh37] Chr16:16p12.2 |
pathogenic|risk factor |
NM_024675.4(PALB2):c.1606C>T (p.Leu536=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492439]|Familial cancer of breast [RCV001030239]|Familial cancer of breast [RCV002498478]|Hereditary cancer-predisposing syndrome [RCV000127312]|Malignant tumor of breast [RCV001355529]|not provided [RCV000587743]|not specified [RCV000212798] |
Chr16:23634940 [GRCh38] Chr16:23646261 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.1633G>T (p.Glu545Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000114484]|Gastric cancer [RCV003162529]|Hereditary cancer-predisposing syndrome [RCV000131237]|Malignant tumor of breast [RCV001357967]|PALB2-related disorder [RCV004529917]|not provided [RCV000255843] |
Chr16:23634913 [GRCh38] Chr16:23646234 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1656G>A (p.Gln552=) |
single nucleotide variant |
Familial cancer of breast [RCV001030243]|Hereditary cancer-predisposing syndrome [RCV002399478] |
Chr16:23634890 [GRCh38] Chr16:23646211 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1676A>G (p.Gln559Arg) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315611]|Familial cancer of breast [RCV000114486]|Familial cancer of breast [RCV002498479]|Fanconi anemia complementation group N [RCV000395533]|Fanconi anemia complementation group N [RCV005394372]|Hereditary breast ovarian cancer syndrome [RCV002225295]|Hereditary cancer-predisposing syndrome [RCV000128962]|not provided [RCV000755593]|not specified [RCV000121747] |
Chr16:23634870 [GRCh38] Chr16:23646191 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|not provided |
NM_024675.4(PALB2):c.1676_1677delinsG (p.Gln559fs) |
indel |
Familial cancer of breast [RCV001310143]|Fanconi anemia complementation group N [RCV001030245]|Hereditary breast ovarian cancer syndrome [RCV005359041]|Hereditary cancer-predisposing syndrome [RCV000572212]|not provided [RCV000478479] |
Chr16:23634869..23634870 [GRCh38] Chr16:23646190..23646191 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1684+1597T>C |
single nucleotide variant |
Familial cancer of breast [RCV001030250] |
Chr16:23633265 [GRCh38] Chr16:23644586 [GRCh37] Chr16:16p12.2 |
benign |
NM_024675.4(PALB2):c.1684+29A>G |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315612]|Familial cancer of breast [RCV001030246]|Hereditary breast ovarian cancer syndrome [RCV002225296]|Hereditary cancer-predisposing syndrome [RCV000210759]|not provided [RCV001668224]|not specified [RCV000248381] |
Chr16:23634833 [GRCh38] Chr16:23646154 [GRCh37] Chr16:16p12.2 |
benign |
NM_024675.4(PALB2):c.1684+18TGA[7] |
microsatellite |
Familial cancer of breast [RCV001030247]|not specified [RCV003321504] |
Chr16:23634821..23634823 [GRCh38] Chr16:23646142..23646144 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1684+18TGA[9] |
microsatellite |
Breast and/or ovarian cancer [RCV003149777]|Familial cancer of breast [RCV001030248]|Hereditary breast ovarian cancer syndrome [RCV002225297]|not provided [RCV001529629]|not specified [RCV002267851] |
Chr16:23634820..23634821 [GRCh38] Chr16:23646141..23646142 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1684+42_1684+43insATG |
insertion |
Familial cancer of breast [RCV001030249] |
Chr16:23634819..23634820 [GRCh38] Chr16:23646140..23646141 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1685-58C>A |
single nucleotide variant |
Familial cancer of breast [RCV001030252] |
Chr16:23630527 [GRCh38] Chr16:23641848 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1685-70T>G |
single nucleotide variant |
Familial cancer of breast [RCV001030251] |
Chr16:23630539 [GRCh38] Chr16:23641860 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1699C>T (p.His567Tyr) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359042]|Familial cancer of breast [RCV000114495]|Fanconi anemia complementation group N [RCV001292820]|Hereditary cancer-predisposing syndrome [RCV000116072]|PALB2-related disorder [RCV004529918]|not provided [RCV000588850]|not specified [RCV001171429] |
Chr16:23630455 [GRCh38] Chr16:23641776 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.172_175del (p.Gln60fs) |
microsatellite |
Breast and/or ovarian cancer [RCV001270993]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004764849]|Colorectal cancer [RCV001543616]|Familial cancer of breast [RCV000114496]|Familial cancer of breast [RCV002490763]|Fanconi anemia complementation group N [RCV001781441]|Fanconi anemia complementation group N [RCV005394373]|Hereditary breast ovarian cancer syndrome [RCV001193414]|Hereditary cancer-predisposing syndrome [RCV000116073]|PALB2-related disorder [RCV004739373]|Pancreatic cancer, susceptibility to, 3 [RCV000114497]|not provided [RCV000212770] |
Chr16:23637886..23637889 [GRCh38] Chr16:23649207..23649210 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|risk factor|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.1743A>G (p.Leu581=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492440]|Familial cancer of breast [RCV001030257]|Hereditary cancer-predisposing syndrome [RCV000220391]|PALB2-related disorder [RCV004529919]|not provided [RCV000829294]|not specified [RCV005229897] |
Chr16:23630411 [GRCh38] Chr16:23641732 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1810C>T (p.Leu604=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798295]|Familial cancer of breast [RCV001030261]|Familial ovarian cancer [RCV001355308]|Hereditary breast ovarian cancer syndrome [RCV002225298]|Hereditary cancer-predisposing syndrome [RCV000160816]|not provided [RCV000679761]|not specified [RCV000212801] |
Chr16:23630344 [GRCh38] Chr16:23641665 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.1881G>T (p.Val627=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149778]|Carcinoma of colon [RCV001358083]|Endometrial carcinoma [RCV001356841]|Familial cancer of breast [RCV001030265]|Familial cancer of breast [RCV002483179]|Hereditary cancer-predisposing syndrome [RCV000127291]|not provided [RCV000590744]|not specified [RCV000212802] |
Chr16:23630273 [GRCh38] Chr16:23641594 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.1935G>A (p.Glu645=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315613]|Familial cancer of breast [RCV000114501]|Familial cancer of breast [RCV002505026]|Hereditary cancer-predisposing syndrome [RCV000167184]|PALB2-related disorder [RCV004542813]|not provided [RCV002477268]|not specified [RCV000427468] |
Chr16:23630219 [GRCh38] Chr16:23641540 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1947dup (p.Glu650fs) |
duplication |
Breast and/or ovarian cancer [RCV003149779]|Familial cancer of breast [RCV000114502]|Hereditary cancer-predisposing syndrome [RCV000584219] |
Chr16:23630206..23630207 [GRCh38] Chr16:23641527..23641528 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.196C>T (p.Gln66Ter) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798296]|Familial cancer of breast [RCV000114503]|Fanconi anemia complementation group N [RCV005016383]|Hereditary breast ovarian cancer syndrome [RCV000588616]|Hereditary cancer-predisposing syndrome [RCV000163078]|not provided [RCV000235795] |
Chr16:23637865 [GRCh38] Chr16:23649186 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.2014G>C (p.Glu672Gln) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315614]|Familial cancer of breast [RCV000114504]|Familial cancer of breast [RCV002498480]|Fanconi anemia complementation group N [RCV000395482]|Hereditary breast ovarian cancer syndrome [RCV002225299]|Hereditary cancer-predisposing syndrome [RCV000127292]|Malignant tumor of breast [RCV001269351]|Ovarian cancer [RCV003153363]|not provided [RCV000857375]|not specified [RCV000121756] |
Chr16:23630140 [GRCh38] Chr16:23641461 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|not provided |
NM_024675.4(PALB2):c.212-180T>G |
single nucleotide variant |
Familial cancer of breast [RCV001030127] |
Chr16:23636514 [GRCh38] Chr16:23647835 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.212-25T>A |
single nucleotide variant |
Familial cancer of breast [RCV001030131] |
Chr16:23636359 [GRCh38] Chr16:23647680 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.212-25_212-24insTA |
insertion |
Familial cancer of breast [RCV001030132] |
Chr16:23636358..23636359 [GRCh38] Chr16:23647679..23647680 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.212-33A>C |
single nucleotide variant |
Familial cancer of breast [RCV001030130] |
Chr16:23636367 [GRCh38] Chr16:23647688 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.212-58A>C |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315615]|Familial cancer of breast [RCV001030129]|Hereditary breast ovarian cancer syndrome [RCV002225300]|Hereditary cancer-predisposing syndrome [RCV000210760]|not provided [RCV000835943]|not specified [RCV001729387] |
Chr16:23636392 [GRCh38] Chr16:23647713 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.212-70T>C |
single nucleotide variant |
Familial cancer of breast [RCV001030128] |
Chr16:23636404 [GRCh38] Chr16:23636404..23636405 [GRCh38] Chr16:23647725 [GRCh37] Chr16:23647725..23647726 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2135C>T (p.Ala712Val) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315616]|Familial cancer of breast [RCV000114512]|Familial cancer of breast [RCV002477269]|Fanconi anemia complementation group N [RCV000405151]|Hereditary cancer-predisposing syndrome [RCV000116080]|Malignant tumor of breast [RCV001358176]|not provided [RCV000759185]|not specified [RCV000417394] |
Chr16:23630019 [GRCh38] Chr16:23641340 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.2145_2146del (p.Asp715fs) |
deletion |
Familial cancer of breast [RCV001030283]|Hereditary cancer-predisposing syndrome [RCV002426653]|PALB2-related disorder [RCV004529920]|not provided [RCV003441741] |
Chr16:23630008..23630009 [GRCh38] Chr16:23641329..23641330 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2200A>T (p.Thr734Ser) |
single nucleotide variant |
Endometrial carcinoma [RCV001358251]|Familial cancer of breast [RCV000114515]|Hereditary cancer-predisposing syndrome [RCV000116081]|Malignant tumor of breast [RCV001356351]|not provided [RCV000586054]|not specified [RCV000855600] |
Chr16:23629954 [GRCh38] Chr16:23641275 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2205A>G (p.Pro735=) |
single nucleotide variant |
Familial cancer of breast [RCV001030285]|Hereditary cancer-predisposing syndrome [RCV004019604] |
Chr16:23629949 [GRCh38] Chr16:23641270 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2256A>G (p.Gly752=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359043]|Familial cancer of breast [RCV001030291]|Hereditary cancer-predisposing syndrome [RCV000130422]|not provided [RCV000759187]|not specified [RCV000212806] |
Chr16:23629898 [GRCh38] Chr16:23641219 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.2275C>A (p.Gln759Lys) |
single nucleotide variant |
Familial cancer of breast [RCV001030295] |
Chr16:23629879 [GRCh38] Chr16:23641200 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.229del (p.Cys77fs) |
deletion |
Breast and/or ovarian cancer [RCV001798297]|Colorectal cancer [RCV002267609]|Familial cancer of breast [RCV000114519]|Hereditary cancer-predisposing syndrome [RCV000772121]|PALB2-related cancer predisposition [RCV005359044]|not provided [RCV000236050] |
Chr16:23636317 [GRCh38] Chr16:23647638 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2301C>A (p.Val767=) |
single nucleotide variant |
Familial cancer of breast [RCV001030296]|Hereditary cancer-predisposing syndrome [RCV002444564] |
Chr16:23629853 [GRCh38] Chr16:23641174 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2323C>T (p.Gln775Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005053908]|Familial cancer of breast [RCV000114521]|Hereditary breast ovarian cancer syndrome [RCV003155914]|Hereditary cancer-predisposing syndrome [RCV000164897]|Malignant tumor of breast [RCV001355683]|not provided [RCV000413982] |
Chr16:23629831 [GRCh38] Chr16:23641152 [GRCh37] Chr16:16p12.2 |
pathogenic|risk factor |
NM_024675.4(PALB2):c.232G>A (p.Val78Ile) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149780]|Familial cancer of breast [RCV000114522]|Hereditary cancer-predisposing syndrome [RCV000116083]|Malignant tumor of breast [RCV001356931]|PALB2-related disorder [RCV004529921]|not provided [RCV000587015]|not specified [RCV000212771] |
Chr16:23636314 [GRCh38] Chr16:23647635 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2365C>T (p.Leu789=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798298]|Familial cancer of breast [RCV001030300]|Hereditary cancer-predisposing syndrome [RCV000160817]|not provided [RCV000588448]|not specified [RCV000212810] |
Chr16:23629789 [GRCh38] Chr16:23641110 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.2386G>T (p.Gly796Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000114524]|Fanconi anemia complementation group N [RCV001781442]|Fanconi anemia complementation group N [RCV003330435]|Hereditary cancer-predisposing syndrome [RCV000129116]|not provided [RCV000236024] |
Chr16:23629768 [GRCh38] Chr16:23641089 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|not provided |
NM_024675.3(PALB2):c.2390delA (p.Gln797Hisfs) |
deletion |
Familial cancer of breast [RCV000114525] |
Chr16:23629764 [GRCh38] Chr16:23641085 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2393_2394insCT (p.Thr799fs) |
insertion |
Fanconi anemia complementation group N [RCV001030304] |
Chr16:23629760..23629761 [GRCh38] Chr16:23641081..23641082 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.23C>T (p.Pro8Leu) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359045]|Familial cancer of breast [RCV000114527]|Hereditary breast ovarian cancer syndrome [RCV002225301]|Hereditary cancer-predisposing syndrome [RCV000160872]|PALB2-related disorder [RCV004529922]|not provided [RCV000589826] |
Chr16:23641135 [GRCh38] Chr16:23652456 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2442G>A (p.Glu814=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492441]|Familial cancer of breast [RCV001030308]|Hereditary cancer-predisposing syndrome [RCV000160818]|Malignant tumor of breast [RCV001354891]|not provided [RCV000590716]|not specified [RCV000212812] |
Chr16:23629712 [GRCh38] Chr16:23641033 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.2469C>A (p.Leu823=) |
single nucleotide variant |
Familial cancer of breast [RCV001030309] |
Chr16:23629685 [GRCh38] Chr16:23641006 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2514+3A>G |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149781]|Familial cancer of breast [RCV000114530]|Familial pancreatic carcinoma [RCV005359046]|Fanconi anemia complementation group N [RCV005016384]|Hereditary cancer-predisposing syndrome [RCV000573333]|not provided [RCV000160843] |
Chr16:23629637 [GRCh38] Chr16:23640958 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2514+71del |
deletion |
Familial cancer of breast [RCV001030315] |
Chr16:23629569 [GRCh38] Chr16:23640890 [GRCh37] Chr16:16p12.2 |
likely benign |
PALB2:c.2515-1G>T |
single nucleotide variant |
Familial cancer of breast [RCV001030317]|Familial cancer of breast [RCV001171466]|Hereditary cancer-predisposing syndrome [RCV002426654]|Pancreatic cancer, susceptibility to, 3 [RCV000001312]|not provided [RCV000133479] |
Chr16:23629276 [GRCh38] Chr16:23640597 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|risk factor |
NM_024675.4(PALB2):c.2515-24A>G |
single nucleotide variant |
not provided [RCV001030316] |
Chr16:23629299 [GRCh38] Chr16:23640620 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2521del (p.Thr841fs) |
deletion |
Familial cancer of breast [RCV003500504]|not provided [RCV001030318] |
Chr16:23629269 [GRCh38] Chr16:23640590 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2559C>T (p.Gly853=) |
single nucleotide variant |
Familial cancer of breast [RCV000114536]|Familial cancer of breast [RCV001171467]|Hereditary cancer-predisposing syndrome [RCV000116088]|not provided [RCV000212813] |
Chr16:23629231 [GRCh38] Chr16:23640552 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.2586+10A>G |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149782]|Endometrial carcinoma [RCV001358400]|Familial cancer of breast [RCV000114537]|Fanconi anemia complementation group N [RCV001118200]|Hereditary cancer-predisposing syndrome [RCV000580770]|not provided [RCV000588544]|not specified [RCV000127295] |
Chr16:23629194 [GRCh38] Chr16:23640515 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.2586+31T>G |
single nucleotide variant |
Familial cancer of breast [RCV001030323] |
Chr16:23629173 [GRCh38] Chr16:23640494 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2586+58C>T |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315617]|Familial cancer of breast [RCV001030324]|Hereditary breast ovarian cancer syndrome [RCV002225302]|not provided [RCV001698580]|not specified [RCV001689641] |
Chr16:23629146 [GRCh38] Chr16:23629146..23629147 [GRCh38] Chr16:23640467 [GRCh37] Chr16:23640467..23640468 [GRCh37] Chr16:16p12.2 |
benign |
NM_024675.4(PALB2):c.2586+81C>T |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315618]|Familial cancer of breast [RCV001030325]|Hereditary breast ovarian cancer syndrome [RCV002225303]|not provided [RCV001566290] |
Chr16:23629123 [GRCh38] Chr16:23640444 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2587-37G>C |
single nucleotide variant |
Familial cancer of breast [RCV001030329] |
Chr16:23626434 [GRCh38] Chr16:23637755 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2587-38C>G |
single nucleotide variant |
Familial cancer of breast [RCV001030328]|not provided [RCV001682801]|not specified [RCV002267852] |
Chr16:23626435 [GRCh38] Chr16:23637756 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2587-59T>C |
single nucleotide variant |
Familial cancer of breast [RCV001030327] |
Chr16:23626456 [GRCh38] Chr16:23637777 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.3(PALB2):c.2587-?_3201+?del (p.Asn863_Met1067del) |
deletion |
Familial cancer of breast [RCV000114544] |
|
pathogenic |
NM_024675.4(PALB2):c.2590C>T (p.Pro864Ser) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149783]|Breast carcinoma [RCV001572628]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315619]|Familial cancer of breast [RCV000114545]|Familial cancer of breast [RCV002490764]|Fanconi anemia complementation group N [RCV000322970]|Hereditary cancer-predisposing syndrome [RCV000116089]|Malignant tumor of breast [RCV001269370]|not provided [RCV000487583]|not specified [RCV000121759] |
Chr16:23626394 [GRCh38] Chr16:23637715 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters|not provided |
NM_024675.4(PALB2):c.2612A>G (p.Asp871Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000114547]|Familial cancer of breast [RCV002490765]|Hereditary cancer-predisposing syndrome [RCV000572146]|Malignant tumor of breast [RCV001356501]|not provided [RCV000522335] |
Chr16:23626372 [GRCh38] Chr16:23637693 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2661C>A (p.Ile887=) |
single nucleotide variant |
Familial cancer of breast [RCV001030339] |
Chr16:23626323 [GRCh38] Chr16:23637644 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2674G>A (p.Glu892Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000114549]|Familial cancer of breast [RCV003483473]|Fanconi anemia complementation group N [RCV001118198]|Fanconi anemia complementation group N [RCV005016385]|Hereditary cancer-predisposing syndrome [RCV000131257]|PALB2-related disorder [RCV004739374]|not provided [RCV000587708]|not specified [RCV000483553] |
Chr16:23626310 [GRCh38] Chr16:23637631 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.2686dup (p.Ser896fs) |
duplication |
Familial cancer of breast [RCV001030340]|Hereditary cancer-predisposing syndrome [RCV000563499]|not provided [RCV000486793] |
Chr16:23626297..23626298 [GRCh38] Chr16:23637618..23637619 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.26T>A (p.Leu9His) |
single nucleotide variant |
Familial cancer of breast [RCV001030104] |
Chr16:23641132 [GRCh38] Chr16:23652453 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2718G>A (p.Trp906Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000114552]|Familial cancer of breast [RCV002498481]|Fanconi anemia complementation group N [RCV005394374]|Hereditary breast ovarian cancer syndrome [RCV004782240]|Hereditary cancer-predisposing syndrome [RCV000562748]|not provided [RCV000255170] |
Chr16:23626266 [GRCh38] Chr16:23637587 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2732C>T (p.Thr911Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000114553]|Hereditary cancer-predisposing syndrome [RCV000454363]|not provided [RCV000589395] |
Chr16:23626252 [GRCh38] Chr16:23637573 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2748+121T>C |
single nucleotide variant |
Familial cancer of breast [RCV001030341] |
Chr16:23626115 [GRCh38] Chr16:23637436 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2749-18C>T |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149784]|Familial cancer of breast [RCV000114555]|Hereditary breast ovarian cancer syndrome [RCV004764763]|Hereditary cancer-predisposing syndrome [RCV000127298]|not provided [RCV000679766]|not specified [RCV000212817] |
Chr16:23624112 [GRCh38] Chr16:23635433 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2752C>T (p.Pro918Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000114556]|Hereditary cancer-predisposing syndrome [RCV000165106]|not provided [RCV000478088]|not specified [RCV001171432] |
Chr16:23624091 [GRCh38] Chr16:23635412 [GRCh37] Chr16:16p12.2 |
benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2761C>T (p.Gln921Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001030342]|Hereditary cancer-predisposing syndrome [RCV003162530] |
Chr16:23624082 [GRCh38] Chr16:23635403 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2773G>C (p.Val925Leu) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798299]|Familial cancer of breast [RCV000114558]|Familial cancer of breast [RCV000764047]|Hereditary cancer-predisposing syndrome [RCV000129279]|not provided [RCV000235847] |
Chr16:23624070 [GRCh38] Chr16:23635391 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2794G>A (p.Val932Met) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149785]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315620]|Familial cancer of breast [RCV000114559]|Familial cancer of breast [RCV002498482]|Familial ovarian cancer [RCV001357367]|Fanconi anemia complementation group N [RCV001118197]|Hereditary cancer-predisposing syndrome [RCV000116090]|Malignant tumor of breast [RCV001356378]|not provided [RCV000514905]|not specified [RCV000121760] |
Chr16:23624049 [GRCh38] Chr16:23635370 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters|not provided |
NM_024675.4(PALB2):c.2816T>G (p.Leu939Trp) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001170349]|Familial cancer of breast [RCV000114561]|Fanconi anemia complementation group N [RCV000306515]|Hereditary breast ovarian cancer syndrome [RCV004760375]|Hereditary cancer-predisposing syndrome [RCV000116092]|Malignant tumor of breast [RCV001356702]|PALB2-related disorder [RCV004528790]|not provided [RCV000586156]|not specified [RCV000417395] |
Chr16:23624027 [GRCh38] Chr16:23635348 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.2823C>A (p.Ile941=) |
single nucleotide variant |
Familial cancer of breast [RCV001030345]|Hereditary cancer-predisposing syndrome [RCV002433601] |
Chr16:23624020 [GRCh38] Chr16:23635341 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2834+12C>T |
single nucleotide variant |
Familial cancer of breast [RCV001030348] |
Chr16:23623997 [GRCh38] Chr16:23635318 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2834+20T>G |
single nucleotide variant |
Familial cancer of breast [RCV001030349] |
Chr16:23623989 [GRCh38] Chr16:23635310 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2834+21_2834+27del |
deletion |
Familial cancer of breast [RCV001030350] |
Chr16:23623982..23623988 [GRCh38] Chr16:23635303..23635309 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2835-1G>C |
single nucleotide variant |
Familial cancer of breast [RCV000114567]|Familial cancer of breast [RCV001171468]|Fanconi anemia complementation group N [RCV005016386]|Hereditary cancer-predisposing syndrome [RCV000220116]|not provided [RCV004589552] |
Chr16:23623131 [GRCh38] Chr16:23634452 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2835-27C>T |
single nucleotide variant |
Familial cancer of breast [RCV001030353]|Hereditary breast ovarian cancer syndrome [RCV002225304]|not provided [RCV004704850]|not specified [RCV002267853] |
Chr16:23623157 [GRCh38] Chr16:23634478 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2837C>G (p.Ala946Gly) |
single nucleotide variant |
Familial cancer of breast [RCV001030354] |
Chr16:23623128 [GRCh38] Chr16:23634449 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2851T>C (p.Ser951Pro) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359047]|Familial cancer of breast [RCV001030355]|Fanconi anemia complementation group N [RCV000397940]|Hereditary cancer-predisposing syndrome [RCV000129725]|not provided [RCV000589520]|not specified [RCV000121763] |
Chr16:23623114 [GRCh38] Chr16:23634435 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters|not provided |
NM_024675.4(PALB2):c.2859T>C (p.Asp953=) |
single nucleotide variant |
Familial cancer of breast [RCV000114571]|Hereditary cancer-predisposing syndrome [RCV000573602]|not provided [RCV001697043]|not specified [RCV005229898] |
Chr16:23623106 [GRCh38] Chr16:23634427 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2865T>A (p.Ser955Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001030356] |
Chr16:23623100 [GRCh38] Chr16:23634421 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2869A>C (p.Lys957Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000114573]|Familial cancer of breast [RCV000764046]|Hereditary cancer-predisposing syndrome [RCV000160848]|not provided [RCV000212818]|not specified [RCV003226198] |
Chr16:23623096 [GRCh38] Chr16:23634417 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2903C>G (p.Ala968Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000114574]|Fanconi anemia complementation group N [RCV005394375]|Hereditary cancer-predisposing syndrome [RCV000131197]|PALB2-related disorder [RCV004545746]|not provided [RCV001704012]|not specified [RCV000215879] |
Chr16:23623062 [GRCh38] Chr16:23634383 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.2920_2921del (p.Lys974fs) |
deletion |
Familial cancer of breast [RCV000114575]|Familial cancer of breast [RCV002477270]|Fanconi anemia complementation group N [RCV001781443]|Hereditary breast ovarian cancer syndrome [RCV000589949]|Hereditary cancer-predisposing syndrome [RCV000132234]|not provided [RCV000133483] |
Chr16:23623044..23623045 [GRCh38] Chr16:23634365..23634366 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2982dup (p.Ala995fs) |
duplication |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005246644]|Familial cancer of breast [RCV000114576]|Hereditary cancer-predisposing syndrome [RCV000213482]|not provided [RCV003229810] |
Chr16:23622982..23622983 [GRCh38] Chr16:23634303..23634304 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.298C>T (p.Leu100Phe) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492442]|Familial cancer of breast [RCV000114577]|Fanconi anemia complementation group N [RCV001119843]|Fanconi anemia complementation group N [RCV001249253]|Hereditary cancer-predisposing syndrome [RCV000116095]|PALB2-related disorder [RCV004528791]|Pancreatic cancer, susceptibility to, 3 [RCV001355228]|not provided [RCV000212772]|not specified [RCV001192907] |
Chr16:23636248 [GRCh38] Chr16:23647569 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.2993G>A (p.Gly998Glu) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315621]|Familial cancer of breast [RCV000114578]|Familial cancer of breast [RCV002498483]|Fanconi anemia complementation group N [RCV000372394]|Hereditary breast ovarian cancer syndrome [RCV002225305]|Hereditary cancer-predisposing syndrome [RCV000127300]|Malignant tumor of breast [RCV001356229]|Ovarian cancer [RCV003153364]|not provided [RCV000755594]|not specified [RCV000121762] |
Chr16:23622972 [GRCh38] Chr16:23634293 [GRCh37] Chr16:16p12.2 |
likely pathogenic|benign|likely benign|conflicting interpretations of pathogenicity|no classifications from unflagged records|not provided |
NM_024675.4(PALB2):c.2996+124C>T |
single nucleotide variant |
Familial cancer of breast [RCV001030362] |
Chr16:23622845 [GRCh38] Chr16:23634166 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2996+17T>C |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149786]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315622]|Familial cancer of breast [RCV000114581]|Familial cancer of breast [RCV002498484]|Hereditary cancer-predisposing syndrome [RCV000127301]|not provided [RCV001529642]|not specified [RCV000212820] |
Chr16:23622952 [GRCh38] Chr16:23634273 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.2996+183del |
deletion |
Familial cancer of breast [RCV001030363]|not provided [RCV001647124] |
Chr16:23622786 [GRCh38] Chr16:23634107 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2996+58T>C |
single nucleotide variant |
Familial cancer of breast [RCV001030361] |
Chr16:23622911 [GRCh38] Chr16:23634232 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2997-624G>C |
single nucleotide variant |
Familial cancer of breast [RCV001030364] |
Chr16:23622102 [GRCh38] Chr16:23633423 [GRCh37] Chr16:16p12.2 |
benign |
NM_024675.4(PALB2):c.3024C>T (p.Pro1008=) |
single nucleotide variant |
Familial cancer of breast [RCV001030366]|Hereditary cancer-predisposing syndrome [RCV000575457]|Malignant tumor of breast [RCV001355003]|not specified [RCV005417963] |
Chr16:23621451 [GRCh38] Chr16:23632772 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3026del (p.Pro1009fs) |
deletion |
Familial cancer of breast [RCV000114586]|Hereditary breast ovarian cancer syndrome [RCV003155915]|Hereditary cancer-predisposing syndrome [RCV000584711]|not provided [RCV000133484] |
Chr16:23621449 [GRCh38] Chr16:23632770 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3048del (p.Phe1016fs) |
deletion |
Familial cancer of breast [RCV000114587]|Familial cancer of breast [RCV002477271]|Hereditary breast ovarian cancer syndrome [RCV001193464]|Hereditary cancer-predisposing syndrome [RCV000129785]|PALB2-related disorder [RCV004739375]|not provided [RCV000412897] |
Chr16:23621427 [GRCh38] Chr16:23632748 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3054G>C (p.Glu1018Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000114588]|Fanconi anemia complementation group N [RCV000286032]|Hereditary breast ovarian cancer syndrome [RCV001030645]|Hereditary cancer-predisposing syndrome [RCV000130354]|Malignant tumor of breast [RCV001356371]|PALB2-related disorder [RCV004529923]|not provided [RCV000858970]|not specified [RCV000212821] |
Chr16:23621421 [GRCh38] Chr16:23632742 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3056T>C (p.Val1019Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000114589]|Hereditary cancer-predisposing syndrome [RCV000131550]|Pancreatic cancer, susceptibility to, 3 [RCV005359048]|not provided [RCV000235226]|not specified [RCV001192771] |
Chr16:23621419 [GRCh38] Chr16:23632740 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3113+131G>T |
single nucleotide variant |
Familial cancer of breast [RCV001030382] |
Chr16:23621231 [GRCh38] Chr16:23632552 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3113G>A (p.Trp1038Ter) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492443]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003389455]|Familial cancer of breast [RCV000114591]|Familial cancer of breast [RCV001171469]|Fanconi anemia complementation group N [RCV001535480]|Fanconi anemia complementation group N [RCV005016387]|Hereditary breast ovarian cancer syndrome [RCV000588093]|Hereditary cancer-predisposing syndrome [RCV000116096]|Inherited breast cancer and ovarian cancer [RCV004584191]|Inherited ovarian cancer (without breast cancer) [RCV004584192]|NICE approved PARP inhibitor treatment [RCV004577322]|PALB2-related disorder [RCV004528792]|not provided [RCV000212822] |
Chr16:23621362 [GRCh38] Chr16:23632683 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|risk factor|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters|not provided |
NM_024675.4(PALB2):c.3114-40T>G |
single nucleotide variant |
Familial cancer of breast [RCV001030387] |
Chr16:23614131 [GRCh38] Chr16:23625452 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3114-42G>T |
single nucleotide variant |
Familial cancer of breast [RCV001030386]|Hereditary cancer-predisposing syndrome [RCV000208880] |
Chr16:23614133 [GRCh38] Chr16:23625454 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3114-51= |
single nucleotide variant |
Familial cancer of breast [RCV001030385]|not provided [RCV001650947]|not specified [RCV001689642] |
Chr16:23614142 [GRCh38] Chr16:23625463 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3116del (p.Asn1039fs) |
deletion |
Breast and/or ovarian cancer [RCV003149787]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005053909]|Familial cancer of breast [RCV000114595]|Familial cancer of breast [RCV002498485]|Fanconi anemia complementation group N [RCV000114596]|Hereditary breast ovarian cancer syndrome [RCV003235042]|Hereditary cancer-predisposing syndrome [RCV000131150]|Malignant tumor of breast [RCV001357097]|PALB2-related disorder [RCV004739376]|not provided [RCV000235691] |
Chr16:23614089 [GRCh38] Chr16:23625410 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|risk factor|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.3128G>C (p.Gly1043Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000114598]|Familial cancer of breast [RCV002483180]|Hereditary cancer-predisposing syndrome [RCV000131630]|not provided [RCV000485289]|not specified [RCV000780560] |
Chr16:23614077 [GRCh38] Chr16:23625398 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3143A>G (p.Lys1048Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001030391]|Hereditary cancer-predisposing syndrome [RCV000772055] |
Chr16:23614062 [GRCh38] Chr16:23625383 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.315G>C (p.Glu105Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000114600]|Familial cancer of breast [RCV002490766]|Hereditary breast ovarian cancer syndrome [RCV005359049]|Hereditary cancer-predisposing syndrome [RCV000116099]|PALB2-related disorder [RCV004529924]|not provided [RCV000212773]|not specified [RCV001174951] |
Chr16:23636231 [GRCh38] Chr16:23647552 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3201+1125T>C |
single nucleotide variant |
Familial cancer of breast [RCV001030397] |
Chr16:23612879 [GRCh38] Chr16:23624200 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3201+112A>G |
single nucleotide variant |
Familial cancer of breast [RCV001030395] |
Chr16:23613892 [GRCh38] Chr16:23625213 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3201+115T>C |
single nucleotide variant |
Familial cancer of breast [RCV001030396] |
Chr16:23613889 [GRCh38] Chr16:23625210 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3201+96G>A |
single nucleotide variant |
Familial cancer of breast [RCV001030394]|Hereditary breast ovarian cancer syndrome [RCV002225306]|not provided [RCV004703236] |
Chr16:23613908 [GRCh38] Chr16:23625229 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3202-1G>C |
single nucleotide variant |
Familial cancer of breast [RCV000114605]|Hereditary cancer-predisposing syndrome [RCV002321588]|not provided [RCV000160851] |
Chr16:23608013 [GRCh38] Chr16:23619334 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3202-45A>G |
single nucleotide variant |
Familial cancer of breast [RCV001030398] |
Chr16:23608057 [GRCh38] Chr16:23619378 [GRCh37] Chr16:16p12.2 |
likely benign |
PALB2:c.3202-?_*297del (p.Gly1068_Ser1186delins45) |
deletion |
Familial cancer of breast [RCV000114607]|Pancreatic cancer 3 [RCV000114608] |
Chr16:23603162..23608012 [GRCh38] Chr16:23614483..23619333 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3249G>C (p.Glu1083Asp) |
single nucleotide variant |
Anaplastic ependymoma [RCV000761171]|Familial cancer of breast [RCV000114609]|Hereditary cancer-predisposing syndrome [RCV000116102]|PALB2-related disorder [RCV004529925]|not provided [RCV000656939]|not specified [RCV000212823] |
Chr16:23607965 [GRCh38] Chr16:23619286 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3251C>T (p.Ser1084Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000114610]|Familial cancer of breast [RCV000764043]|Fanconi anemia complementation group N [RCV001116749]|Hereditary cancer-predisposing syndrome [RCV000160852]|Malignant tumor of breast [RCV001358132]|PALB2-related disorder [RCV004739377]|not provided [RCV000656940]|not specified [RCV003493439] |
Chr16:23607963 [GRCh38] Chr16:23619284 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3252G>A (p.Ser1084=) |
single nucleotide variant |
Familial cancer of breast [RCV001030401]|Familial cancer of breast [RCV002498486]|Hereditary cancer-predisposing syndrome [RCV000162543]|not provided [RCV000588828]|not specified [RCV000506618] |
Chr16:23607962 [GRCh38] Chr16:23619283 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3256C>T (p.Arg1086Ter) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149788]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315406]|Familial cancer of breast [RCV000168017]|Fanconi anemia complementation group N [RCV005003472]|Gastric cancer [RCV003162531]|Hereditary breast ovarian cancer syndrome [RCV001030644]|Hereditary cancer-predisposing syndrome [RCV000160853]|Malignant tumor of breast [RCV002307393]|PALB2-related disorder [RCV004528793]|Pancreatic cancer, susceptibility to, 3 [RCV000114612]|not provided [RCV000212825] |
Chr16:23607958 [GRCh38] Chr16:23619279 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|risk factor|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.3300T>G (p.Thr1100=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315623]|Familial cancer of breast [RCV000114613]|Familial cancer of breast [RCV002498487]|Fanconi anemia complementation group N [RCV000321267]|Hereditary breast ovarian cancer syndrome [RCV002225307]|Hereditary cancer-predisposing syndrome [RCV000162360]|Malignant tumor of breast [RCV001355729]|not provided [RCV000857374]|not specified [RCV000250631] |
Chr16:23607914 [GRCh38] Chr16:23619235 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.3306C>G (p.Ser1102Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000114615]|Fanconi anemia complementation group N [RCV005016388]|Hereditary cancer-predisposing syndrome [RCV000216794]|not specified [RCV002267854] |
Chr16:23607908 [GRCh38] Chr16:23619229 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3307G>A (p.Val1103Met) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359050]|Familial cancer of breast [RCV000114616]|Hereditary breast ovarian cancer syndrome [RCV001030643]|Hereditary cancer-predisposing syndrome [RCV000116103]|PALB2-related disorder [RCV004739378]|not provided [RCV000656941]|not specified [RCV000212827] |
Chr16:23607907 [GRCh38] Chr16:23619228 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3321G>A (p.Leu1107=) |
single nucleotide variant |
Familial cancer of breast [RCV001030409]|Hereditary cancer-predisposing syndrome [RCV001019988] |
Chr16:23607893 [GRCh38] Chr16:23619214 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3323del (p.Tyr1108fs) |
deletion |
Familial cancer of breast [RCV000168157]|Familial cancer of breast [RCV002498488]|Fanconi anemia complementation group N [RCV000114618]|Hereditary breast ovarian cancer syndrome [RCV000590634]|Hereditary cancer-predisposing syndrome [RCV000132282]|Malignant tumor of breast [RCV001356710]|not provided [RCV000235326] |
Chr16:23607891 [GRCh38] Chr16:23619212 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3350+11A>G |
single nucleotide variant |
Familial cancer of breast [RCV001030411]|Fanconi anemia complementation group N [RCV002466432]|not specified [RCV000424366] |
Chr16:23607853 [GRCh38] Chr16:23619174 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3350+16T>G |
single nucleotide variant |
Familial cancer of breast [RCV001030412]|Familial cancer of breast [RCV002498489]|Hereditary cancer-predisposing syndrome [RCV000581930] |
Chr16:23607848 [GRCh38] Chr16:23619169 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3350+4A>G |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315407]|Familial cancer of breast [RCV000114621]|Hereditary cancer-predisposing syndrome [RCV000213830]|Malignant tumor of breast [RCV004798779]|PALB2-related cancer predisposition [RCV005359051]|PALB2-related disorder [RCV004528794]|not provided [RCV000433683] |
Chr16:23607860 [GRCh38] Chr16:23619181 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3356T>C (p.Leu1119Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000114623]|Fanconi anemia complementation group N [RCV005016389]|Hereditary cancer-predisposing syndrome [RCV000574823]|not provided [RCV000481742] |
Chr16:23603664 [GRCh38] Chr16:23614985 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3362del (p.Gly1121fs) |
deletion |
Breast and/or ovarian cancer [RCV001798300]|Familial cancer of breast [RCV000114624]|Hereditary breast ovarian cancer syndrome [RCV001193463]|Hereditary cancer-predisposing syndrome [RCV000130740]|Malignant tumor of breast [RCV001355561]|not provided [RCV000235614] |
Chr16:23603658 [GRCh38] Chr16:23614979 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.3428T>A (p.Leu1143His) |
single nucleotide variant |
Familial cancer of breast [RCV000114625]|Familial cancer of breast [RCV000764041]|Fanconi anemia complementation group N [RCV005394376]|Hereditary cancer-predisposing syndrome [RCV000116104]|PALB2-related disorder [RCV004528795]|bilateral breast cancer [RCV001004833]|not provided [RCV000585950]|not specified [RCV001804169] |
Chr16:23603592 [GRCh38] Chr16:23614913 [GRCh37] Chr16:16p12.2 |
likely pathogenic|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3428T>C (p.Leu1143Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000114626]|Familial cancer of breast [RCV000764040]|Hereditary cancer-predisposing syndrome [RCV001020276] |
Chr16:23603592 [GRCh38] Chr16:23614913 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3433G>C (p.Gly1145Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001030417]|Hereditary cancer-predisposing syndrome [RCV002453423] |
Chr16:23603587 [GRCh38] Chr16:23614908 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.344G>T (p.Gly115Val) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149789]|Familial cancer of breast [RCV000114628]|Hereditary cancer-predisposing syndrome [RCV000165559]|Malignant tumor of breast [RCV001357627]|PALB2-related disorder [RCV004528796]|not provided [RCV000589320] |
Chr16:23636202 [GRCh38] Chr16:23647523 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3483T>C (p.Phe1161=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359052]|Familial cancer of breast [RCV000114629]|Hereditary cancer-predisposing syndrome [RCV000163039]|not provided [RCV001719855] |
Chr16:23603537 [GRCh38] Chr16:23614858 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3495G>A (p.Ser1165=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798301]|Familial cancer of breast [RCV001082966]|Fanconi anemia complementation group N [RCV000384114]|Hereditary cancer-predisposing syndrome [RCV000127303]|Malignant tumor of breast [RCV001355544]|PALB2-related disorder [RCV004739379]|not provided [RCV000586081]|not specified [RCV000212828] |
Chr16:23603525 [GRCh38] Chr16:23614846 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.3497del (p.Gly1166fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV002453424]|not provided [RCV001030419] |
Chr16:23603523 [GRCh38] Chr16:23614844 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3539T>C (p.Ile1180Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000114633]|Hereditary cancer-predisposing syndrome [RCV000569135]|PALB2-related disorder [RCV004739380]|not provided [RCV000479423]|not specified [RCV001824604] |
Chr16:23603481 [GRCh38] Chr16:23614802 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.395del (p.Val132fs) |
deletion |
Familial cancer of breast [RCV000700247]|Fanconi anemia complementation group N [RCV001030150]|Fanconi anemia complementation group N [RCV004776431]|Hereditary cancer-predisposing syndrome [RCV001021525] |
Chr16:23636151 [GRCh38] Chr16:23647472 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.400G>A (p.Asp134Asn) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798302]|Familial cancer of breast [RCV000114637]|Hereditary breast ovarian cancer syndrome [RCV002225308]|Hereditary cancer-predisposing syndrome [RCV000128994]|not provided [RCV000590187]|not specified [RCV000200990] |
Chr16:23636146 [GRCh38] Chr16:23647467 [GRCh37] Chr16:16p12.2 |
likely pathogenic|benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.48+1G>C |
single nucleotide variant |
Familial cancer of breast [RCV001030106]|Hereditary cancer-predisposing syndrome [RCV000213648]|not provided [RCV000236723] |
Chr16:23641109 [GRCh38] Chr16:23652430 [GRCh37] Chr16:16p12.2 |
likely pathogenic|uncertain significance |
NM_024675.4(PALB2):c.48+27G>T |
single nucleotide variant |
Familial cancer of breast [RCV001030107] |
Chr16:23641083 [GRCh38] Chr16:23652404 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.49-173G>T |
single nucleotide variant |
Familial cancer of breast [RCV001030108] |
Chr16:23638302 [GRCh38] Chr16:23649623 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.49-54C>T |
single nucleotide variant |
Familial cancer of breast [RCV001030109]|not provided [RCV004703237] |
Chr16:23638183 [GRCh38] Chr16:23649504 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.503C>A (p.Ser168Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000114642]|Hereditary cancer-predisposing syndrome [RCV000562468]|not provided [RCV003332116] |
Chr16:23636043 [GRCh38] Chr16:23647364 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.505C>A (p.Leu169Ile) |
single nucleotide variant |
Familial cancer of breast [RCV001030154]|Hereditary cancer-predisposing syndrome [RCV002336247] |
Chr16:23636041 [GRCh38] Chr16:23647362 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.3(PALB2):c.508_509delAG (p.Arg170Ilefs) |
deletion |
Familial cancer of breast [RCV000114644] |
Chr16:23636037..23636038 [GRCh38] Chr16:23647358..23647359 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.509_510del (p.Arg170fs) |
deletion |
Breast and/or ovarian cancer [RCV001270995]|Breast carcinoma [RCV001554297]|Breast-ovarian cancer, familial, susceptibility to, 1 [RCV003322596]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004562253]|Carcinoma of pancreas [RCV001391207]|Familial cancer of breast [RCV000114645]|Familial cancer of breast [RCV002505027]|Fanconi anemia complementation group N [RCV003137629]|Hereditary breast ovarian cancer syndrome [RCV003155916]|Hereditary cancer-predisposing syndrome [RCV000130658]|Malignant tumor of breast [RCV001356172]|PALB2-related disorder [RCV004528797]|Pancreatic cancer, susceptibility to, 3 [RCV001258079]|not provided [RCV000212776]|not specified [RCV001000478] |
Chr16:23636036..23636037 [GRCh38] Chr16:23647357..23647358 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.53A>G (p.Lys18Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000114647]|Fanconi anemia complementation group N [RCV000376271]|Hereditary breast ovarian cancer syndrome [RCV002225309]|Hereditary cancer-predisposing syndrome [RCV000129207]|not provided [RCV000440737]|not specified [RCV000121743] |
Chr16:23638125 [GRCh38] Chr16:23649446 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters|not provided |
NM_024675.4(PALB2):c.618T>G (p.Leu206=) |
single nucleotide variant |
Familial cancer of breast [RCV001030161] |
Chr16:23635928 [GRCh38] Chr16:23647249 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.620C>G (p.Pro207Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000114649]|Hereditary cancer-predisposing syndrome [RCV000776330]|not provided [RCV001572249] |
Chr16:23635926 [GRCh38] Chr16:23647247 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.629C>T (p.Pro210Leu) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798303]|Familial cancer of breast [RCV000114650]|Fanconi anemia complementation group N [RCV000306267]|Hereditary breast ovarian cancer syndrome [RCV002225310]|Hereditary cancer-predisposing syndrome [RCV000131969]|Malignant tumor of breast [RCV001358034]|not provided [RCV001705820]|not specified [RCV000121750] |
Chr16:23635917 [GRCh38] Chr16:23647238 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.632A>G (p.Glu211Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000114651]|Hereditary cancer-predisposing syndrome [RCV001025140]|not specified [RCV003493440] |
Chr16:23635914 [GRCh38] Chr16:23647235 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.656A>G (p.Asp219Gly) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359053]|Familial cancer of breast [RCV000114652]|Hereditary cancer [RCV003492444]|Hereditary cancer-predisposing syndrome [RCV000129603]|PALB2-related disorder [RCV004542814]|not provided [RCV000589693]|not specified [RCV000855601] |
Chr16:23635890 [GRCh38] Chr16:23647211 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.697del (p.Val233fs) |
deletion |
Breast and/or ovarian cancer [RCV001270997]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005256561]|Familial cancer of breast [RCV000114653]|Hereditary cancer-predisposing syndrome [RCV000771207]|not provided [RCV000481242] |
Chr16:23635849 [GRCh38] Chr16:23647170 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.721A>G (p.Asn241Asp) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492445]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315624]|Familial cancer of breast [RCV001083216]|Hereditary breast ovarian cancer syndrome [RCV002225311]|Hereditary cancer-predisposing syndrome [RCV000116111]|Malignant tumor of breast [RCV001356373]|not provided [RCV000587175]|not specified [RCV000121748] |
Chr16:23635825 [GRCh38] Chr16:23647146 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters|not provided |
NM_024675.4(PALB2):c.72del (p.Arg26fs) |
deletion |
Familial cancer of breast [RCV000114655]|Fanconi anemia complementation group N [RCV005016390]|Hereditary cancer-predisposing syndrome [RCV000164203]|not provided [RCV001030114] |
Chr16:23638106 [GRCh38] Chr16:23649427 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.751C>T (p.Gln251Ter) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492446]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004813057]|Familial cancer of breast [RCV000114657]|Fanconi anemia complementation group N [RCV004796018]|Hereditary cancer-predisposing syndrome [RCV000210097]|not provided [RCV000413603] |
Chr16:23635795 [GRCh38] Chr16:23647116 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.757_758del (p.Leu253fs) |
microsatellite |
Breast and/or ovarian cancer [RCV003492447]|Breast-ovarian cancer, familial, susceptibility to, 1 [RCV003128230]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005256562]|Familial cancer of breast [RCV000114658]|Familial cancer of breast [RCV002505028]|Fanconi anemia complementation group N [RCV000114659]|Fanconi anemia complementation group N [RCV001535793]|Fanconi anemia complementation group N [RCV004796019]|Hereditary breast ovarian cancer syndrome [RCV004760376]|Hereditary cancer-predisposing syndrome [RCV000116112]|PALB2-related disorder [RCV004739381]|not provided [RCV000212779] |
Chr16:23635788..23635789 [GRCh38] Chr16:23647109..23647110 [GRCh37] Chr16:16p12.2 |
pathogenic|not provided |
NM_024675.4(PALB2):c.758dup (p.Ser254fs) |
duplication |
Familial cancer of breast [RCV000114661]|Familial cancer of breast [RCV002505029]|Hereditary breast ovarian cancer syndrome [RCV001293421]|Hereditary cancer-predisposing syndrome [RCV000129208]|PALB2-related disorder [RCV004542815]|not provided [RCV000212780] |
Chr16:23635787..23635788 [GRCh38] Chr16:23647108..23647109 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.765T>C (p.Asp255=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149790]|Familial cancer of breast [RCV000114662]|Familial cancer of breast [RCV002490768]|Fanconi anemia [RCV000338727]|Hereditary cancer-predisposing syndrome [RCV000215345]|PALB2-related disorder [RCV004529926]|not provided [RCV000590553]|not specified [RCV005229899] |
Chr16:23635781 [GRCh38] Chr16:23647102 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.807T>C (p.Gly269=) |
single nucleotide variant |
Familial cancer of breast [RCV000114663]|Hereditary cancer-predisposing syndrome [RCV000218873]|not provided [RCV001704013] |
Chr16:23635739 [GRCh38] Chr16:23647060 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.814G>A (p.Glu272Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000114664]|Familial cancer of breast [RCV002483181]|Hereditary cancer-predisposing syndrome [RCV000165689]|not provided [RCV003477491]|not specified [RCV004595926] |
Chr16:23635732 [GRCh38] Chr16:23647053 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.832C>G (p.Leu278Val) |
single nucleotide variant |
Familial cancer of breast [RCV001030180] |
Chr16:23635714 [GRCh38] Chr16:23647035 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.83A>G (p.Tyr28Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000114666]|Hereditary cancer-predisposing syndrome [RCV000220533] |
Chr16:23638095 [GRCh38] Chr16:23649416 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.854C>T (p.Ser285Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000114667]|Hereditary cancer-predisposing syndrome [RCV001017979]|not provided [RCV004691752] |
Chr16:23635692 [GRCh38] Chr16:23647013 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.897T>C (p.Ser299=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798304]|Familial cancer of breast [RCV000114668]|Fanconi anemia complementation group N [RCV001118310]|Hereditary cancer-predisposing syndrome [RCV000566337]|not provided [RCV000858848]|not specified [RCV000419649] |
Chr16:23635649 [GRCh38] Chr16:23646970 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.899C>T (p.Thr300Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000114669]|Hereditary cancer-predisposing syndrome [RCV000219489]|Malignant tumor of breast [RCV001354467]|not provided [RCV001284670]|not specified [RCV000121751] |
Chr16:23635647 [GRCh38] Chr16:23646968 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.909C>T (p.Leu303=) |
single nucleotide variant |
Familial cancer of breast [RCV000114670]|Fanconi anemia complementation group N [RCV000300127]|Hereditary cancer-predisposing syndrome [RCV000127304]|Malignant tumor of breast [RCV001358321]|not provided [RCV001531848]|not specified [RCV000212781] |
Chr16:23635637 [GRCh38] Chr16:23646958 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.90G>T (p.Lys30Asn) |
single nucleotide variant |
Familial cancer of breast [RCV001030118] |
Chr16:23638088 [GRCh38] Chr16:23649409 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.925A>G (p.Ile309Val) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315625]|Familial cancer of breast [RCV000114672]|Fanconi anemia complementation group N [RCV000335364]|Hereditary breast ovarian cancer syndrome [RCV002225312]|Hereditary cancer-predisposing syndrome [RCV000129841]|Malignant tumor of breast [RCV001357007]|not provided [RCV000757594]|not specified [RCV000121749] |
Chr16:23635621 [GRCh38] Chr16:23646942 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|not provided |
NM_024675.4(PALB2):c.94C>G (p.Leu32Val) |
single nucleotide variant |
Familial cancer of breast [RCV000114673]|Fanconi anemia complementation group N [RCV001119845]|Fanconi anemia complementation group N [RCV005016391]|Hereditary cancer-predisposing syndrome [RCV000116117]|Malignant tumor of breast [RCV001357251]|PALB2-related disorder [RCV004529927]|not provided [RCV000656932]|not specified [RCV000121744] |
Chr16:23638084 [GRCh38] Chr16:23649405 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.956C>A (p.Ser319Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000114674]|Hereditary cancer-predisposing syndrome [RCV000574080] |
Chr16:23635590 [GRCh38] Chr16:23646911 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.999C>T (p.Thr333=) |
single nucleotide variant |
Familial cancer of breast [RCV000114675]|Hereditary cancer-predisposing syndrome [RCV001525986] |
Chr16:23635547 [GRCh38] Chr16:23646868 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.3(PALB2):c.3201+2109G>C |
single nucleotide variant |
Lung cancer [RCV000099832] |
Chr16:23611895 [GRCh38] Chr16:23623216 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p13.11-12.1(chr16:14954894-28306843)x3 |
copy number gain |
See cases [RCV000051828] |
Chr16:14954894..28306843 [GRCh38] Chr16:15048751..28318164 [GRCh37] Chr16:14956252..28225665 [NCBI36] Chr16:16p13.11-12.1 |
pathogenic |
GRCh38/hg38 16p12.2-11.2(chr16:21463739-29249579)x3 |
copy number gain |
See cases [RCV000051829] |
Chr16:21463739..29249579 [GRCh38] Chr16:21475060..29260900 [GRCh37] Chr16:21382561..29168401 [NCBI36] Chr16:16p12.2-11.2 |
pathogenic |
GRCh38/hg38 16p12.2-11.2(chr16:21602183-29314373)x3 |
copy number gain |
See cases [RCV000051842] |
Chr16:21602183..29314373 [GRCh38] Chr16:21613504..29325694 [GRCh37] Chr16:21521005..29233195 [NCBI36] Chr16:16p12.2-11.2 |
pathogenic |
GRCh38/hg38 16p12.2-11.2(chr16:23047969-30632245)x3 |
copy number gain |
See cases [RCV000052401] |
Chr16:23047969..30632245 [GRCh38] Chr16:23059290..30643566 [GRCh37] Chr16:22966791..30551067 [NCBI36] Chr16:16p12.2-11.2 |
pathogenic |
GRCh38/hg38 16p12.2-12.1(chr16:21600992-28323344)x1 |
copy number loss |
See cases [RCV000052519] |
Chr16:21600992..28323344 [GRCh38] Chr16:21612313..28334665 [GRCh37] Chr16:21519814..28242166 [NCBI36] Chr16:16p12.2-12.1 |
pathogenic |
NM_024675.4(PALB2):c.2057G>A (p.Arg686Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000704434]|Hereditary cancer-predisposing syndrome [RCV000774635]|PALB2-related disorder [RCV004537269]|not provided [RCV001572169]|not specified [RCV003226185] |
Chr16:23630097 [GRCh38] Chr16:23641418 [GRCh37] Chr16:23548919 [NCBI36] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.820dup (p.Thr274fs) |
duplication |
Familial cancer of breast [RCV003451585]|Hereditary breast ovarian cancer syndrome [RCV001030717]|Hereditary cancer-predisposing syndrome [RCV001027286]|not provided [RCV000657281] |
Chr16:23635725..23635726 [GRCh38] Chr16:23647046..23647047 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2619del (p.Ser873fs) |
deletion |
not provided [RCV000657352] |
Chr16:23626365 [GRCh38] Chr16:23637686 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.1845del (p.Asp616fs) |
deletion |
Familial cancer of breast [RCV003607340]|not provided [RCV000657402] |
Chr16:23630309 [GRCh38] Chr16:23641630 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1675_1676delinsTG |
inversion |
Familial cancer of breast [RCV000635816]|Familial cancer of breast [RCV002490784]|Hereditary cancer-predisposing syndrome [RCV000116070]|Malignant tumor of breast [RCV001280657]|PALB2-related disorder [RCV004739404]|Precursor B-cell acute lymphoblastic leukemia [RCV000722029]|not provided [RCV000235193] |
Chr16:23634870..23634871 [GRCh38] Chr16:23646191..23646192 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.3:c.2145_2146delTA |
deletion |
Familial cancer of breast [RCV000114514] |
Chr16:23630008..23630009 [GRCh38] Chr16:23641329..23641330 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1128T>G (p.Ser376Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000204740]|Familial cancer of breast [RCV002483189]|Hereditary cancer-predisposing syndrome [RCV000568625]|not provided [RCV000116062] |
Chr16:23635418 [GRCh38] Chr16:23646739 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1240C>T (p.Arg414Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 1 [RCV004668783]|Familial cancer of breast [RCV000123331]|Fanconi anemia complementation group N [RCV005003478]|Gastric cancer [RCV003162546]|Hereditary breast ovarian cancer syndrome [RCV000588541]|Hereditary cancer-predisposing syndrome [RCV000116064]|Malignant tumor of breast [RCV001354096]|PALB2-related disorder [RCV004529946]|Pancreatic cancer, susceptibility to, 3 [RCV004555854]|not provided [RCV000254674] |
Chr16:23635306 [GRCh38] Chr16:23646627 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1347A>G (p.Lys449=) |
single nucleotide variant |
Familial cancer of breast [RCV001087089]|Hereditary cancer-predisposing syndrome [RCV000116066]|Pancreatic cancer, susceptibility to, 3 [RCV001356241]|not provided [RCV000590184]|not specified [RCV001818286] |
Chr16:23635199 [GRCh38] Chr16:23646520 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.1348A>C (p.Asn450His) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359103]|Familial cancer of breast [RCV000198442]|Familial cancer of breast [RCV000765274]|Hereditary cancer-predisposing syndrome [RCV000116067]|not provided [RCV000212791] |
Chr16:23635198 [GRCh38] Chr16:23646519 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1564C>T (p.Pro522Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000205286]|Hereditary cancer-predisposing syndrome [RCV000563884]|Malignant tumor of breast [RCV001357507]|not provided [RCV000116069]|not specified [RCV001192765] |
Chr16:23634982 [GRCh38] Chr16:23646303 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1697G>A (p.Arg566His) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359104]|Familial cancer of breast [RCV000229982]|Fanconi anemia complementation group N [RCV005016399]|Hereditary cancer-predisposing syndrome [RCV000564017]|PALB2-related disorder [RCV004542828]|not provided [RCV000116071]|not specified [RCV001030254] |
Chr16:23630457 [GRCh38] Chr16:23641778 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1733G>T (p.Ser578Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000474485]|Familial cancer of breast [RCV002483190]|Hereditary cancer-predisposing syndrome [RCV000567502]|not provided [RCV000116074] |
Chr16:23630421 [GRCh38] Chr16:23641742 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.194C>T (p.Pro65Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000168167]|Hereditary cancer-predisposing syndrome [RCV000116075]|Pancreatic cancer, susceptibility to, 3 [RCV001030125]|not provided [RCV000585283]|not specified [RCV000121745] |
Chr16:23637867 [GRCh38] Chr16:23649188 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.1987C>T (p.Arg663Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000410272]|Familial pancreatic carcinoma [RCV005365003]|Hereditary cancer-predisposing syndrome [RCV000116076]|not provided [RCV000212804]|not specified [RCV002509225] |
Chr16:23630167 [GRCh38] Chr16:23641488 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2078A>G (p.His693Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000467228]|Hereditary cancer-predisposing syndrome [RCV000576106]|not provided [RCV000116077] |
Chr16:23630076 [GRCh38] Chr16:23641397 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2117C>G (p.Thr706Ser) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV004019621]|not provided [RCV000116078] |
Chr16:23630037 [GRCh38] Chr16:23641358 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2120del (p.Pro707fs) |
deletion |
Familial cancer of breast [RCV000409069]|Hereditary cancer-predisposing syndrome [RCV000116079]|Malignant tumor of breast [RCV005055585]|Pancreatic cancer, susceptibility to, 3 [RCV001258078]|not provided [RCV000254677] |
Chr16:23630034 [GRCh38] Chr16:23641355 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2230G>A (p.Glu744Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000635763]|Hereditary cancer-predisposing syndrome [RCV000234885]|not provided [RCV000116082]|not specified [RCV002265611] |
Chr16:23629924 [GRCh38] Chr16:23641245 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2379C>T (p.Gly793=) |
single nucleotide variant |
Familial cancer of breast [RCV000200135]|Fanconi anemia complementation group N [RCV000292657]|Hereditary cancer-predisposing syndrome [RCV000116084]|Malignant tumor of breast [RCV001354155]|PALB2-related disorder [RCV004542829]|not provided [RCV000212811]|not specified [RCV000780574] |
Chr16:23629775 [GRCh38] Chr16:23641096 [GRCh37] Chr16:16p12.2 |
likely pathogenic|benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2390_2396del (p.Gln797fs) |
deletion |
Familial cancer of breast [RCV003474718]|Hereditary cancer-predisposing syndrome [RCV000116085]|not provided [RCV000497296] |
Chr16:23629758..23629764 [GRCh38] Chr16:23641079..23641085 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2395A>C (p.Thr799Pro) |
single nucleotide variant |
not provided [RCV000116086] |
Chr16:23629759 [GRCh38] Chr16:23641080 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2509G>A (p.Glu837Lys) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798359]|Familial cancer of breast [RCV000989556]|Fanconi anemia complementation group N [RCV000318539]|Hereditary breast ovarian cancer syndrome [RCV001030647]|Hereditary cancer-predisposing syndrome [RCV000116087]|Malignant tumor of breast [RCV001356207]|PALB2-related disorder [RCV004529947]|not provided [RCV000656936]|not specified [RCV000121758] |
Chr16:23629645 [GRCh38] Chr16:23640966 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.2807T>C (p.Leu936Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001317021]|Hereditary cancer-predisposing syndrome [RCV004943756]|not provided [RCV000116091] |
Chr16:23624036 [GRCh38] Chr16:23635357 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2846G>A (p.Cys949Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000635686]|Fanconi anemia complementation group N [RCV005016400]|Hereditary cancer-predisposing syndrome [RCV001804846]|not provided [RCV000656938]|not specified [RCV000121761] |
Chr16:23623119 [GRCh38] Chr16:23634440 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.2897T>C (p.Ile966Thr) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004760383]|Familial cancer of breast [RCV000204848]|Familial cancer of breast [RCV000764045]|Hereditary cancer-predisposing syndrome [RCV000116094]|Triple-negative breast cancer [RCV000202384]|not provided [RCV000212819]|not specified [RCV002267857] |
Chr16:23623068 [GRCh38] Chr16:23634389 [GRCh37] Chr16:16p12.2 |
likely pathogenic|association|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3125C>G (p.Thr1042Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000706273]|Hereditary cancer-predisposing syndrome [RCV000561324]|not provided [RCV000589774] |
Chr16:23614080 [GRCh38] Chr16:23625401 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3132A>C (p.Gln1044His) |
single nucleotide variant |
Familial cancer of breast [RCV000635880]|Hereditary cancer-predisposing syndrome [RCV000454267]|not provided [RCV000116098] |
Chr16:23614073 [GRCh38] Chr16:23625394 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3175G>A (p.Val1059Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000812526]|Hereditary cancer-predisposing syndrome [RCV001018977]|not provided [RCV000116100] |
Chr16:23614030 [GRCh38] Chr16:23625351 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3229C>G (p.Pro1077Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000821981]|Hereditary cancer-predisposing syndrome [RCV001019319]|not provided [RCV000116101] |
Chr16:23607985 [GRCh38] Chr16:23619306 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3437A>G (p.Gln1146Arg) |
single nucleotide variant |
not provided [RCV000116105] |
Chr16:23603583 [GRCh38] Chr16:23614904 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3456dup (p.Pro1153fs) |
duplication |
Familial cancer of breast [RCV000200796]|Hereditary breast ovarian cancer syndrome [RCV003155917]|Hereditary cancer-predisposing syndrome [RCV000116106]|PALB2-related cancer predisposition [RCV005359105]|PALB2-related disorder [RCV004528808]|not provided [RCV000133488] |
Chr16:23603563..23603564 [GRCh38] Chr16:23614884..23614885 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.353T>C (p.Ile118Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000211074]|Hereditary cancer-predisposing syndrome [RCV000116107]|not provided [RCV000212774]|not specified [RCV002222397] |
Chr16:23636193 [GRCh38] Chr16:23647514 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3549C>A (p.Tyr1183Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 1 [RCV003493446]|Familial cancer of breast [RCV000200012]|Familial cancer of breast [RCV000763376]|Fanconi anemia complementation group N [RCV005394394]|Hereditary breast ovarian cancer syndrome [RCV000587765]|Hereditary cancer-predisposing syndrome [RCV000116108]|PALB2-related disorder [RCV004528809]|not provided [RCV000212831] |
Chr16:23603471 [GRCh38] Chr16:23614792 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.551G>C (p.Ser184Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000559113]|Familial cancer of breast [RCV002498499]|Hereditary cancer-predisposing syndrome [RCV001024216]|not provided [RCV000116109] |
Chr16:23635995 [GRCh38] Chr16:23647316 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.571C>G (p.Pro191Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000211086]|Hereditary cancer-predisposing syndrome [RCV000774642]|not provided [RCV000116110] |
Chr16:23635975 [GRCh38] Chr16:23647296 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.856C>T (p.Pro286Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000410687]|Fanconi anemia complementation group N [RCV005394395]|Hereditary cancer-predisposing syndrome [RCV000567956]|not provided [RCV000766543]|not specified [RCV001174832] |
Chr16:23635690 [GRCh38] Chr16:23647011 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.906CCT[1] (p.Leu304del) |
microsatellite |
Familial cancer of breast [RCV000535050]|Fanconi anemia complementation group N [RCV005394396]|Hereditary cancer-predisposing syndrome [RCV000573937]|not provided [RCV000116114] |
Chr16:23635635..23635637 [GRCh38] Chr16:23646956..23646958 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.928A>G (p.Ser310Gly) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149811]|Familial cancer of breast [RCV000200242]|Hereditary cancer-predisposing syndrome [RCV000116115]|Malignant tumor of breast [RCV001354315]|PALB2-related disorder [RCV004528810]|not provided [RCV000212782]|not specified [RCV001290583] |
Chr16:23635618 [GRCh38] Chr16:23646939 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.949A>C (p.Thr317Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000472765]|Familial cancer of breast [RCV002483191]|Hereditary cancer-predisposing syndrome [RCV000116116]|not provided [RCV000212783] |
Chr16:23635597 [GRCh38] Chr16:23646918 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1188C>T (p.Cys396=) |
single nucleotide variant |
Familial cancer of breast [RCV000123329]|Hereditary cancer-predisposing syndrome [RCV000163124]|not provided [RCV001704046]|not specified [RCV000420289] |
Chr16:23635358 [GRCh38] Chr16:23646679 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.1230T>C (p.Val410=) |
single nucleotide variant |
Familial cancer of breast [RCV000123330]|Hereditary cancer-predisposing syndrome [RCV002362752] |
Chr16:23635316 [GRCh38] Chr16:23646637 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.12T>C (p.Pro4=) |
single nucleotide variant |
Familial cancer of breast [RCV000123332]|Fanconi anemia complementation group N [RCV001121824]|Hereditary cancer-predisposing syndrome [RCV000160826]|not provided [RCV000858740]|not specified [RCV000212765] |
Chr16:23641146 [GRCh38] Chr16:23652467 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.1637T>C (p.Val546Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000123333]|Familial cancer of breast [RCV002492444]|Hereditary cancer-predisposing syndrome [RCV000215046]|PALB2-related disorder [RCV004739425]|not provided [RCV000589758] |
Chr16:23634909 [GRCh38] Chr16:23646230 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2087C>T (p.Thr696Met) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492552]|Familial cancer of breast [RCV000123336]|Fanconi anemia complementation group N [RCV005016426]|Hereditary cancer-predisposing syndrome [RCV000132543]|PALB2-related disorder [RCV004530058]|not provided [RCV001030277] |
Chr16:23630067 [GRCh38] Chr16:23641388 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2167_2168del (p.Met723fs) |
deletion |
Breast neoplasm [RCV000677892]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315410]|Familial cancer of breast [RCV000123337]|Familial cancer of breast [RCV002492445]|Fanconi anemia complementation group N [RCV001336119]|Fanconi anemia complementation group N [RCV004796027]|Gastric cancer [RCV003162563]|Hereditary breast ovarian cancer syndrome [RCV000589589]|Hereditary cancer-predisposing syndrome [RCV000129400]|Malignant tumor of pancreas [RCV000677893]|not provided [RCV000133478] |
Chr16:23629986..23629987 [GRCh38] Chr16:23641307..23641308 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2289G>C (p.Leu763Phe) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798407]|Familial cancer of breast [RCV000123338]|Hereditary cancer-predisposing syndrome [RCV000130052]|Malignant tumor of breast [RCV001357632]|PALB2-related disorder [RCV004528842]|not provided [RCV000587948]|not specified [RCV000212808] |
Chr16:23629865 [GRCh38] Chr16:23641186 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2571G>A (p.Leu857=) |
single nucleotide variant |
Familial cancer of breast [RCV000123339]|Fanconi anemia complementation group N [RCV001535717]|Hereditary cancer-predisposing syndrome [RCV000560973]|not provided [RCV000486288] |
Chr16:23629219 [GRCh38] Chr16:23640540 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.2607C>T (p.Ser869=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149845]|Familial cancer of breast [RCV000123340]|Hereditary cancer-predisposing syndrome [RCV000127296]|PALB2-related disorder [RCV004528843]|not provided [RCV000587582]|not specified [RCV000212814] |
Chr16:23626377 [GRCh38] Chr16:23637698 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.2753C>A (p.Pro918Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000123341]|Hereditary cancer-predisposing syndrome [RCV000220315]|PALB2-related disorder [RCV004739426]|not provided [RCV001546031]|not specified [RCV000507163] |
Chr16:23624090 [GRCh38] Chr16:23635411 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3366C>T (p.Asp1122=) |
single nucleotide variant |
Familial cancer of breast [RCV000123342]|Hereditary cancer-predisposing syndrome [RCV000164965]|PALB2-related disorder [RCV004530059]|not provided [RCV003422008]|not specified [RCV000430555] |
Chr16:23603654 [GRCh38] Chr16:23614975 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.722A>G (p.Asn241Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000123343]|Hereditary cancer-predisposing syndrome [RCV000131587] |
Chr16:23635824 [GRCh38] Chr16:23647145 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.769G>A (p.Gly257Ser) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003492553]|Familial cancer of breast [RCV000123344]|Fanconi anemia complementation group N [RCV005394457]|Hereditary cancer-predisposing syndrome [RCV000165945]|PALB2-related disorder [RCV004530060]|not provided [RCV004589611]|not specified [RCV003226206] |
Chr16:23635777 [GRCh38] Chr16:23647098 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1863T>C (p.Pro621=) |
single nucleotide variant |
Familial cancer of breast [RCV000123334]|Hereditary cancer-predisposing syndrome [RCV000563042]|not specified [RCV000613279] |
Chr16:23630291 [GRCh38] Chr16:23641612 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.2006del (p.Glu669fs) |
deletion |
Familial cancer of breast [RCV001068436]|Hereditary cancer-predisposing syndrome [RCV000160806]|not provided [RCV000497295]|not specified [RCV000121754] |
Chr16:23630148 [GRCh38] Chr16:23641469 [GRCh37] Chr16:16p12.2 |
pathogenic|not provided |
NM_024675.4(PALB2):c.2456A>G (p.Lys819Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000410682]|Hereditary cancer-predisposing syndrome [RCV000129773]|not provided [RCV000657026]|not specified [RCV000121755] |
Chr16:23629698 [GRCh38] Chr16:23641019 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.2258G>A (p.Arg753Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000195647]|Hereditary cancer-predisposing syndrome [RCV000561765]|not provided [RCV000588075]|not specified [RCV000121757] |
Chr16:23629896 [GRCh38] Chr16:23641217 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.1882_1890del (p.Lys628_Cys630del) |
deletion |
Familial cancer of breast [RCV000123335]|Familial cancer of breast [RCV002505071]|Hereditary cancer-predisposing syndrome [RCV000573890]|not provided [RCV001284029]|not specified [RCV000121753] |
Chr16:23630264..23630272 [GRCh38] Chr16:23641585..23641593 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.1054G>C (p.Glu352Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000119209]|Hereditary cancer-predisposing syndrome [RCV000130853]|Pancreatic cancer, susceptibility to, 3 [RCV001356550]|not provided [RCV000858055] |
Chr16:23635492 [GRCh38] Chr16:23646813 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2163A>C (p.Thr721=) |
single nucleotide variant |
Familial cancer of breast [RCV000635963]|Hereditary cancer-predisposing syndrome [RCV000221801]|not provided [RCV001579556]|not specified [RCV000127293] |
Chr16:23629991 [GRCh38] Chr16:23641312 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2742C>T (p.Phe914=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315853]|Familial cancer of breast [RCV000196595]|Familial pancreatic carcinoma [RCV005359186]|Fanconi anemia complementation group N [RCV000357789]|Hereditary cancer-predisposing syndrome [RCV000127297]|not provided [RCV000858526]|not specified [RCV000212816] |
Chr16:23626242 [GRCh38] Chr16:23637563 [GRCh37] Chr16:16p12.2 |
pathogenic|benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.2834+18A>T |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315854]|Familial cancer of breast [RCV000410164]|Hereditary breast ovarian cancer syndrome [RCV002225410]|Hereditary cancer-predisposing syndrome [RCV000580996]|not provided [RCV000679767]|not specified [RCV000127299] |
Chr16:23623991 [GRCh38] Chr16:23635312 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1281T>C (p.Ala427=) |
single nucleotide variant |
Familial cancer of breast [RCV000206142]|Familial cancer of breast [RCV002498627]|Hereditary breast ovarian cancer syndrome [RCV002225411]|Hereditary cancer-predisposing syndrome [RCV000127308]|not provided [RCV001800420]|not specified [RCV000212787] |
Chr16:23635265 [GRCh38] Chr16:23646586 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.1904T>C (p.Val635Ala) |
single nucleotide variant |
not provided [RCV001310325] |
Chr16:23630250 [GRCh38] Chr16:23641571 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1383T>G (p.Ser461Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001889281]|Hereditary cancer-predisposing syndrome [RCV002386668] |
Chr16:23635163 [GRCh38] Chr16:23646484 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2586+6A>G |
single nucleotide variant |
Familial cancer of breast [RCV001303616] |
Chr16:23629198 [GRCh38] Chr16:23640519 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3512del (p.Leu1171fs) |
deletion |
Familial cancer of breast [RCV003219179] |
Chr16:23603508 [GRCh38] Chr16:23614829 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2563del (p.Leu855fs) |
deletion |
Familial cancer of breast [RCV003449834]|not provided [RCV001284197] |
Chr16:23629227 [GRCh38] Chr16:23640548 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2748+1G>C |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315425]|Familial cancer of breast [RCV000409294]|Hereditary cancer-predisposing syndrome [RCV001176291]|not provided [RCV003477909] |
Chr16:23626235 [GRCh38] Chr16:23637556 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3202-1G>A |
single nucleotide variant |
Familial cancer of breast [RCV000409659]|Familial cancer of breast [RCV002481267]|Hereditary cancer-predisposing syndrome [RCV001019201]|not provided [RCV003493565] |
Chr16:23608013 [GRCh38] Chr16:23619334 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1108C>T (p.Gln370Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001030200]|Hereditary cancer-predisposing syndrome [RCV001525190]|not provided [RCV000133472] |
Chr16:23635438 [GRCh38] Chr16:23646759 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.1431del (p.Ser478fs) |
deletion |
Familial cancer of breast [RCV001030225]|not provided [RCV000133473] |
Chr16:23635115 [GRCh38] Chr16:23646436 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.156del (p.Glu53fs) |
deletion |
Familial cancer of breast [RCV000461816]|Hereditary cancer-predisposing syndrome [RCV000566566]|not provided [RCV000133474] |
Chr16:23637905 [GRCh38] Chr16:23649226 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1571C>G (p.Ser524Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000701075]|Hereditary cancer-predisposing syndrome [RCV000454158]|not provided [RCV000133475] |
Chr16:23634975 [GRCh38] Chr16:23646296 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1591_1600del (p.Pro532fs) |
deletion |
Familial cancer of breast [RCV001030237]|Hereditary cancer-predisposing syndrome [RCV004658974]|not provided [RCV000133476] |
Chr16:23634946..23634955 [GRCh38] Chr16:23646267..23646276 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2074C>T (p.Gln692Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001030275]|Hereditary breast ovarian cancer syndrome [RCV003155925]|Hereditary cancer-predisposing syndrome [RCV000562385]|not provided [RCV000133477] |
Chr16:23630080 [GRCh38] Chr16:23641401 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2787_2788del (p.Tyr929_Asn930delinsTer) |
microsatellite |
Familial cancer of breast [RCV001030343]|Hereditary cancer-predisposing syndrome [RCV005401334]|not provided [RCV000133480] |
Chr16:23624055..23624056 [GRCh38] Chr16:23635376..23635377 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2834+1G>T |
single nucleotide variant |
Familial cancer of breast [RCV000411304]|Familial cancer of breast [RCV000763377]|Hereditary cancer-predisposing syndrome [RCV000567638]|not provided [RCV000133481] |
Chr16:23624008 [GRCh38] Chr16:23635329 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.2888del (p.Ser963fs) |
deletion |
Familial cancer of breast [RCV000821314]|Hereditary cancer-predisposing syndrome [RCV002433626]|not provided [RCV000133482] |
Chr16:23623077 [GRCh38] Chr16:23634398 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.3(PALB2):c.2919_2920delAA (p.Lys974Glufs) |
deletion |
not provided [RCV000133483] |
Chr16:23623045..23623046 [GRCh38] Chr16:23634366..23634367 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.3(PALB2):c.3022delC (p.Pro1009Leufs) |
deletion |
not provided [RCV000133484] |
Chr16:23621453 [GRCh38] Chr16:23632774 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3201+1G>C |
single nucleotide variant |
Familial cancer of breast [RCV000230297]|Hereditary cancer-predisposing syndrome [RCV000164723]|not provided [RCV000133485] |
Chr16:23614003 [GRCh38] Chr16:23625324 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance|no classifications from unflagged records |
NM_024675.3(PALB2):c.3423_3426delCTTA (p.Leu1142Phefs) |
deletion |
not provided [RCV000133486] |
Chr16:23603594..23603597 [GRCh38] Chr16:23614915..23614918 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3426dup (p.Leu1143fs) |
duplication |
Familial cancer of breast [RCV000195604]|Hereditary cancer-predisposing syndrome [RCV000454197]|not provided [RCV000133487] |
Chr16:23603593..23603594 [GRCh38] Chr16:23614914..23614915 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3497_3498del (p.Gly1166fs) |
deletion |
Familial cancer of breast [RCV001030420]|not provided [RCV000133489] |
Chr16:23603522..23603523 [GRCh38] Chr16:23614843..23614844 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.3(PALB2):c.3504_3505delCT (p.His1170Phefs) |
deletion |
not provided [RCV000133490] |
Chr16:23603515..23603516 [GRCh38] Chr16:23614836..23614837 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3143del (p.Lys1048fs) |
deletion |
Breast neoplasm [RCV000504602]|Familial cancer of breast [RCV003449391] |
Chr16:23614062 [GRCh38] Chr16:23625383 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.643G>T (p.Glu215Ter) |
single nucleotide variant |
Breast neoplasm [RCV000504603]|Familial cancer of breast [RCV001385716] |
Chr16:23635903 [GRCh38] Chr16:23647224 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2480_2481del (p.Thr827fs) |
microsatellite |
Breast neoplasm [RCV000504613]|Familial cancer of breast [RCV000701403]|Gastric cancer [RCV003159604]|Hereditary cancer-predisposing syndrome [RCV001015644]|not provided [RCV001008183] |
Chr16:23629673..23629674 [GRCh38] Chr16:23640994..23640995 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.451C>T (p.Gln151Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000456418]|Hereditary breast ovarian cancer syndrome [RCV004586565]|Hereditary cancer-predisposing syndrome [RCV000576041]|not provided [RCV000133491] |
Chr16:23636095 [GRCh38] Chr16:23647416 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.48G>A (p.Lys16=) |
single nucleotide variant |
Familial cancer of breast [RCV001030105]|Familial cancer of breast [RCV004796039]|Hereditary cancer-predisposing syndrome [RCV000566830]|not provided [RCV000133492] |
Chr16:23641110 [GRCh38] Chr16:23652431 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.886del (p.Lys295_Met296insTer) |
deletion |
Familial cancer of breast [RCV000822164]|Hereditary cancer-predisposing syndrome [RCV002371980]|not provided [RCV000133493] |
Chr16:23635660 [GRCh38] Chr16:23646981 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.956_962del (p.Ser318_Ser319insTer) |
deletion |
Familial cancer of breast [RCV001030190]|not provided [RCV000133494] |
Chr16:23635584..23635590 [GRCh38] Chr16:23646905..23646911 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2216C>T (p.Pro739Leu) |
single nucleotide variant |
Familial cancer of breast [RCV001871761]|Familial cancer of breast [RCV002486214] |
Chr16:23629938 [GRCh38] Chr16:23641259 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p13.3-11.2(chr16:4644892-29170820)x3 |
copy number gain |
See cases [RCV000133809] |
Chr16:4644892..29170820 [GRCh38] Chr16:4694893..29182141 [GRCh37] Chr16:4634894..29089642 [NCBI36] Chr16:16p13.3-11.2 |
pathogenic |
NM_024675.4(PALB2):c.3201+1G>T |
single nucleotide variant |
Familial cancer of breast [RCV001206798]|Hereditary cancer-predisposing syndrome [RCV000130058] |
Chr16:23614003 [GRCh38] Chr16:23625324 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1037_1041del (p.Lys346fs) |
deletion |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005365022]|Familial cancer of breast [RCV000205410]|Fanconi anemia complementation group N [RCV001781469]|Fanconi anemia complementation group N [RCV004796029]|Hereditary cancer-predisposing syndrome [RCV000130093]|not provided [RCV000133471] |
Chr16:23635505..23635509 [GRCh38] Chr16:23646826..23646830 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1955G>A (p.Ser652Asn) |
single nucleotide variant |
Endometrial carcinoma [RCV001358211]|Familial cancer of breast [RCV000226926]|Fanconi anemia complementation group N [RCV000302799]|Hereditary breast ovarian cancer syndrome [RCV001030649]|Hereditary cancer-predisposing syndrome [RCV000130094]|not provided [RCV000842453]|not specified [RCV001030271] |
Chr16:23630199 [GRCh38] Chr16:23641520 [GRCh37] Chr16:16p12.2 |
likely pathogenic|benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1364A>G (p.Asn455Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000409652]|Fanconi anemia complementation group N [RCV001116859]|Hereditary cancer-predisposing syndrome [RCV000130104]|not provided [RCV000212792] |
Chr16:23635182 [GRCh38] Chr16:23646503 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3044C>T (p.Thr1015Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000689784]|Hereditary cancer-predisposing syndrome [RCV000130130]|not provided [RCV000236113]|not specified [RCV000781686] |
Chr16:23621431 [GRCh38] Chr16:23632752 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2964del (p.Gln988_Val989insTer) |
deletion |
Breast cancer, susceptibility to [RCV000500842]|Familial cancer of breast [RCV000476828]|Familial cancer of breast [RCV002492500]|Hereditary cancer-predisposing syndrome [RCV000130137]|not provided [RCV000481028] |
Chr16:23623001 [GRCh38] Chr16:23634322 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1042C>A (p.Gln348Lys) |
single nucleotide variant |
Chordoma [RCV002266924]|Familial cancer of breast [RCV000232741]|Hereditary cancer-predisposing syndrome [RCV000130172]|PALB2-related disorder [RCV004739441]|not provided [RCV000589687]|not specified [RCV001251061] |
Chr16:23635504 [GRCh38] Chr16:23646825 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1160C>T (p.Ser387Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000540249]|Hereditary cancer-predisposing syndrome [RCV000130177] |
Chr16:23635386 [GRCh38] Chr16:23646707 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2104A>C (p.Ile702Leu) |
single nucleotide variant |
Familial cancer of breast [RCV001857445]|Hereditary cancer-predisposing syndrome [RCV000130218] |
Chr16:23630050 [GRCh38] Chr16:23641371 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3267_3268del (p.Phe1090fs) |
microsatellite |
Familial cancer of breast [RCV000797316]|Hereditary cancer-predisposing syndrome [RCV000130222] |
Chr16:23607946..23607947 [GRCh38] Chr16:23619267..23619268 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.-2C>T |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000130240]|not provided [RCV001357620] |
Chr16:23641159 [GRCh38] Chr16:23652480 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1756G>A (p.Asp586Asn) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798444]|Familial cancer of breast [RCV000411835]|Familial cancer of breast [RCV000764051]|Hereditary cancer-predisposing syndrome [RCV000130326]|not provided [RCV000481375] |
Chr16:23630398 [GRCh38] Chr16:23641719 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3542T>C (p.Phe1181Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001849933]|Hereditary cancer-predisposing syndrome [RCV000130351]|not provided [RCV000235682] |
Chr16:23603478 [GRCh38] Chr16:23614799 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.563C>G (p.Ala188Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000168329]|Hereditary cancer-predisposing syndrome [RCV000130368]|not provided [RCV004791275]|not specified [RCV001818311] |
Chr16:23635983 [GRCh38] Chr16:23647304 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.72G>C (p.Leu24Phe) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000130387]|not provided [RCV004998268] |
Chr16:23638106 [GRCh38] Chr16:23649427 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.424A>T (p.Lys142Ter) |
single nucleotide variant |
Breast cancer, susceptibility to [RCV002251434]|Familial cancer of breast [RCV000476449]|Hereditary cancer-predisposing syndrome [RCV000130421]|Malignant tumor of breast [RCV001357166]|PALB2-related disorder [RCV003387508]|not provided [RCV000412725] |
Chr16:23636122 [GRCh38] Chr16:23647443 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3146T>C (p.Met1049Thr) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003389456]|Familial cancer of breast [RCV000204730]|Familial cancer of breast [RCV002505109]|Fanconi anemia complementation group N [RCV003444205]|Hereditary cancer-predisposing syndrome [RCV000130431]|Malignant tumor of breast [RCV001355887]|PALB2-related disorder [RCV004544294]|not provided [RCV000482622]|not specified [RCV001194140] |
Chr16:23614059 [GRCh38] Chr16:23625380 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3476G>A (p.Trp1159Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003453075]|Hereditary cancer-predisposing syndrome [RCV000130518] |
Chr16:23603544 [GRCh38] Chr16:23614865 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2233A>G (p.Lys745Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000232204]|Hereditary cancer-predisposing syndrome [RCV000130548]|not provided [RCV002247508] |
Chr16:23629921 [GRCh38] Chr16:23641242 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.599del (p.Leu199_Leu200insTer) |
deletion |
Familial cancer of breast [RCV000464043]|Familial cancer of breast [RCV002505111]|Hereditary breast ovarian cancer syndrome [RCV005237567]|Hereditary cancer-predisposing syndrome [RCV000130577]|PALB2-related disorder [RCV004739445]|not provided [RCV000235246] |
Chr16:23635947 [GRCh38] Chr16:23647268 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2521A>G (p.Thr841Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000470365]|Hereditary cancer-predisposing syndrome [RCV000130589] |
Chr16:23629269 [GRCh38] Chr16:23640590 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3449T>G (p.Leu1150Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000211075]|Hereditary cancer-predisposing syndrome [RCV000130657]|PALB2-related disorder [RCV004724828]|not provided [RCV000588260]|not specified [RCV002281957] |
Chr16:23603571 [GRCh38] Chr16:23614892 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1748T>G (p.Leu583Trp) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005365029]|Familial cancer of breast [RCV000198999]|Familial cancer of breast [RCV002483264]|Hereditary cancer-predisposing syndrome [RCV000130719]|not provided [RCV000235282]|not specified [RCV002222405] |
Chr16:23630406 [GRCh38] Chr16:23641727 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3307G>C (p.Val1103Leu) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149901]|Familial cancer of breast [RCV000226292]|Familial cancer of breast [RCV000764042]|Hereditary cancer-predisposing syndrome [RCV000130728]|Ovarian cancer [RCV003153422]|not provided [RCV000483048]|not specified [RCV001194142] |
Chr16:23607907 [GRCh38] Chr16:23619228 [GRCh37] Chr16:16p12.2 |
benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.557A>T (p.Asn186Ile) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315411]|Familial cancer of breast [RCV000197454]|Familial cancer of breast [RCV002478396]|Hereditary cancer-predisposing syndrome [RCV000130756]|not provided [RCV000588642]|not specified [RCV004595933] |
Chr16:23635989 [GRCh38] Chr16:23647310 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3257G>A (p.Arg1086Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000203792]|Fanconi anemia complementation group N [RCV005016447]|Hereditary breast ovarian cancer syndrome [RCV002225436]|Hereditary cancer-predisposing syndrome [RCV000130835]|PALB2-related disorder [RCV004739448]|not provided [RCV000590502]|not specified [RCV000855603] |
Chr16:23607957 [GRCh38] Chr16:23619278 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1189A>T (p.Thr397Ser) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149904]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359248]|Familial cancer of breast [RCV000205533]|Familial ovarian cancer [RCV003447500]|Hereditary cancer-predisposing syndrome [RCV000130855]|Inherited breast cancer and ovarian cancer [RCV004584197]|not provided [RCV000586638]|not specified [RCV002267878] |
Chr16:23635357 [GRCh38] Chr16:23646678 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1127G>C (p.Ser376Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000465244]|Hereditary cancer-predisposing syndrome [RCV000130860]|not provided [RCV003159104] |
Chr16:23635419 [GRCh38] Chr16:23646740 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2947A>T (p.Thr983Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000206313]|Hereditary cancer-predisposing syndrome [RCV000130889]|not provided [RCV000522868] |
Chr16:23623018 [GRCh38] Chr16:23634339 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.734C>T (p.Ala245Val) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315412]|Familial cancer of breast [RCV000200032]|Fanconi anemia complementation group N [RCV005394483]|Hereditary cancer-predisposing syndrome [RCV000130900]|not provided [RCV000483902]|not specified [RCV001030168] |
Chr16:23635812 [GRCh38] Chr16:23647133 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.3492G>T (p.Trp1164Cys) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004551258]|Familial cancer of breast [RCV000412141]|Hereditary cancer-predisposing syndrome [RCV000130901]|not provided [RCV000487310] |
Chr16:23603528 [GRCh38] Chr16:23614849 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.850dup (p.Thr284fs) |
duplication |
Hereditary cancer-predisposing syndrome [RCV000130929] |
Chr16:23635695..23635696 [GRCh38] Chr16:23647016..23647017 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.584T>G (p.Ile195Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000635801]|Hereditary cancer-predisposing syndrome [RCV000130977]|not provided [RCV000212777] |
Chr16:23635962 [GRCh38] Chr16:23647283 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.3(PALB2):c.3286_3289delAACCins8 |
indel |
Hereditary cancer-predisposing syndrome [RCV000131265] |
Chr16:23607925..23607928 [GRCh38] Chr16:23619246..23619249 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.3(PALB2):c.833_834delTAinsAT (p.Leu278His) |
indel |
Neoplastic Syndromes, Hereditary [RCV000131311] |
Chr16:23635712..23635713 [GRCh38] Chr16:23647033..23647034 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1481C>T (p.Thr494Ile) |
single nucleotide variant |
Familial cancer of breast [RCV001045768]|Hereditary cancer-predisposing syndrome [RCV000131338] |
Chr16:23635065 [GRCh38] Chr16:23646386 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2027T>C (p.Ile676Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001084972]|Hereditary breast ovarian cancer syndrome [RCV005359261]|Hereditary cancer-predisposing syndrome [RCV000131362]|not provided [RCV000589092]|not specified [RCV000417393] |
Chr16:23630127 [GRCh38] Chr16:23641448 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.2619T>G (p.Ser873Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000199659]|Familial ovarian cancer [RCV001357530]|Hereditary cancer-predisposing syndrome [RCV000131395]|not provided [RCV001281710]|not specified [RCV000507756] |
Chr16:23626365 [GRCh38] Chr16:23637686 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2257C>T (p.Arg753Ter) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492624]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004597749]|Familial cancer of breast [RCV000466579]|Fanconi anemia complementation group N [RCV001781472]|Gastric cancer [RCV003162588]|Hereditary breast ovarian cancer syndrome [RCV000824730]|Hereditary cancer-predisposing syndrome [RCV000131502]|Malignant tumor of breast [RCV001264577]|PALB2-related disorder [RCV004739453]|not provided [RCV000236519] |
Chr16:23629897 [GRCh38] Chr16:23641218 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.226del (p.Ile76fs) |
deletion |
Familial cancer of breast [RCV000411345]|Familial cancer of breast [RCV002498645]|Hereditary cancer-predisposing syndrome [RCV000131508]|Pancreatic cancer, susceptibility to, 3 [RCV001258080]|not provided [RCV000254673] |
Chr16:23636320 [GRCh38] Chr16:23647641 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.1258C>T (p.Gln420Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000529684]|Hereditary cancer-predisposing syndrome [RCV000131515]|not provided [RCV000657737] |
Chr16:23635288 [GRCh38] Chr16:23646609 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.18G>T (p.Gly6=) |
single nucleotide variant |
Familial cancer of breast [RCV000557471]|Hereditary breast ovarian cancer syndrome [RCV002265620]|Hereditary cancer-predisposing syndrome [RCV000131549]|not provided [RCV000432017] |
Chr16:23641140 [GRCh38] Chr16:23652461 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3320T>C (p.Leu1107Pro) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315413]|Familial cancer of breast [RCV000204289]|Fanconi anemia complementation group N [RCV005394489]|Hereditary cancer-predisposing syndrome [RCV000131597]|not provided [RCV000235261]|not specified [RCV001818326] |
Chr16:23607894 [GRCh38] Chr16:23619215 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.10C>T (p.Pro4Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000205368]|Hereditary cancer-predisposing syndrome [RCV000131600]|not provided [RCV004696852] |
Chr16:23641148 [GRCh38] Chr16:23652469 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.997A>G (p.Thr333Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000531244]|Hereditary cancer-predisposing syndrome [RCV000131627] |
Chr16:23635549 [GRCh38] Chr16:23646870 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3296C>G (p.Thr1099Arg) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359278]|Familial cancer of breast [RCV000410212]|Familial cancer of breast [RCV002478400]|Fanconi anemia complementation group N [RCV001294230]|Hereditary breast ovarian cancer syndrome [RCV005411346]|Hereditary cancer-predisposing syndrome [RCV000131652]|not provided [RCV000657014]|not specified [RCV000235868] |
Chr16:23607918 [GRCh38] Chr16:23619239 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.661_662delinsTA (p.Val221Ter) |
indel |
Familial cancer of breast [RCV000635615]|Hereditary cancer-predisposing syndrome [RCV000131730]|Malignant tumor of breast [RCV001355806]|not provided [RCV000485597] |
Chr16:23635884..23635885 [GRCh38] Chr16:23647205..23647206 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3350+5G>A |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359282]|Familial cancer of breast [RCV000526519]|Fanconi anemia complementation group N [RCV004796031]|Hereditary breast ovarian cancer syndrome [RCV001824643]|Hereditary cancer-predisposing syndrome [RCV000131789]|PALB2-related disorder [RCV004739459]|not provided [RCV004998280] |
Chr16:23607859 [GRCh38] Chr16:23619180 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2931dup (p.Val978fs) |
duplication |
Familial cancer of breast [RCV000195468]|Hereditary cancer-predisposing syndrome [RCV000131794]|not provided [RCV000235842] |
Chr16:23623033..23623034 [GRCh38] Chr16:23634354..23634355 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2557G>A (p.Gly853Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000230627]|Familial cancer of breast [RCV002478401]|Hereditary cancer-predisposing syndrome [RCV000131807]|not provided [RCV000483722]|not specified [RCV001800443] |
Chr16:23629233 [GRCh38] Chr16:23640554 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.560C>T (p.Pro187Leu) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000132065] |
Chr16:23635986 [GRCh38] Chr16:23647307 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1114A>G (p.Ser372Gly) |
single nucleotide variant |
Familial cancer of breast [RCV001232087]|Hereditary cancer-predisposing syndrome [RCV000132072] |
Chr16:23635432 [GRCh38] Chr16:23646753 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.740C>G (p.Thr247Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000211087]|Hereditary cancer-predisposing syndrome [RCV000132073]|not provided [RCV000588870] |
Chr16:23635806 [GRCh38] Chr16:23647127 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2052del (p.Arg686fs) |
deletion |
Familial cancer of breast [RCV000554009]|Familial cancer of breast [RCV001535939]|Hereditary cancer-predisposing syndrome [RCV000132106]|Malignant tumor of breast [RCV001357590]|PALB2-related disorder [RCV004739460]|not provided [RCV000254676] |
Chr16:23630102 [GRCh38] Chr16:23641423 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2608G>A (p.Val870Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000227189]|Hereditary cancer-predisposing syndrome [RCV000132122]|not provided [RCV000656937]|not specified [RCV000212815] |
Chr16:23626376 [GRCh38] Chr16:23637697 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2507_2509del (p.Val836del) |
deletion |
Familial cancer of breast [RCV000465007]|Fanconi anemia [RCV000354505]|Fanconi anemia complementation group N [RCV005016454]|Hereditary cancer-predisposing syndrome [RCV000132137]|not provided [RCV000656935] |
Chr16:23629645..23629647 [GRCh38] Chr16:23640966..23640968 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1552T>C (p.Ser518Pro) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000132235]|not provided [RCV000236344] |
Chr16:23634994 [GRCh38] Chr16:23646315 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2890G>A (p.Gly964Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001307165]|Hereditary cancer-predisposing syndrome [RCV000128945]|not provided [RCV000236207] |
Chr16:23623075 [GRCh38] Chr16:23634396 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3290C>G (p.Pro1097Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000206496]|Hereditary cancer-predisposing syndrome [RCV000129027]|not provided [RCV000588943] |
Chr16:23607924 [GRCh38] Chr16:23619245 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1190C>T (p.Thr397Ile) |
single nucleotide variant |
Familial cancer of breast [RCV003607242]|Hereditary cancer-predisposing syndrome [RCV000129058] |
Chr16:23635356 [GRCh38] Chr16:23646677 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1697G>C (p.Arg566Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000476315]|Fanconi anemia complementation group N [RCV005394468]|Hereditary cancer-predisposing syndrome [RCV000129134]|not provided [RCV001775617] |
Chr16:23630457 [GRCh38] Chr16:23641778 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2401G>A (p.Asp801Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000167989]|Hereditary cancer-predisposing syndrome [RCV000132292]|See cases [RCV002251997]|not provided [RCV001570317] |
Chr16:23629753 [GRCh38] Chr16:23641074 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2716T>C (p.Trp906Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001243537]|Hereditary cancer-predisposing syndrome [RCV000132387]|not provided [RCV001775629] |
Chr16:23626268 [GRCh38] Chr16:23637589 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.292A>G (p.Ile98Val) |
single nucleotide variant |
Familial cancer of breast [RCV000471839]|Hereditary breast ovarian cancer syndrome [RCV002225448]|Hereditary cancer-predisposing syndrome [RCV000132416]|not provided [RCV001753518] |
Chr16:23636254 [GRCh38] Chr16:23647575 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1361C>T (p.Ser454Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000815954]|Fanconi anemia complementation group N [RCV005016458]|Hereditary cancer-predisposing syndrome [RCV000132434]|not provided [RCV000587488] |
Chr16:23635185 [GRCh38] Chr16:23646506 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3507_3508del (p.His1170fs) |
microsatellite |
Breast-ovarian cancer, familial, susceptibility to, 1 [RCV004760387]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005365017]|Familial cancer of breast [RCV000211073]|Fanconi anemia complementation group N [RCV001781465]|Fanconi anemia complementation group N [RCV005016432]|Hereditary breast ovarian cancer syndrome [RCV002225427]|Hereditary cancer-predisposing syndrome [RCV000129272]|PALB2-related disorder [RCV004545747]|not provided [RCV000133490] |
Chr16:23603512..23603513 [GRCh38] Chr16:23614833..23614834 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2705A>T (p.Asp902Val) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000129281] |
Chr16:23626279 [GRCh38] Chr16:23637600 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1328A>G (p.Lys443Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001215760]|Hereditary cancer-predisposing syndrome [RCV000129315] |
Chr16:23635218 [GRCh38] Chr16:23646539 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2852C>T (p.Ser951Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000535908]|Hereditary cancer-predisposing syndrome [RCV000132527]|Malignant tumor of breast [RCV000590893] |
Chr16:23623113 [GRCh38] Chr16:23634434 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2205del (p.Ala736fs) |
deletion |
Familial cancer of breast [RCV001849949]|Hereditary cancer-predisposing syndrome [RCV000132530] |
Chr16:23629949 [GRCh38] Chr16:23641270 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.995T>A (p.Leu332His) |
single nucleotide variant |
Familial cancer of breast [RCV000199494]|Hereditary cancer-predisposing syndrome [RCV000132538]|Malignant tumor of breast [RCV001354291]|not provided [RCV000589127] |
Chr16:23635551 [GRCh38] Chr16:23646872 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2712G>A (p.Trp904Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000799015]|Hereditary cancer-predisposing syndrome [RCV000129390]|not provided [RCV000485246] |
Chr16:23626272 [GRCh38] Chr16:23637593 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2417C>T (p.Pro806Leu) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003149891]|Familial cancer of breast [RCV000204760]|Hereditary cancer-predisposing syndrome [RCV000129403]|Malignant tumor of breast [RCV001355012]|Pancreatic cancer, susceptibility to, 3 [RCV001030305]|not provided [RCV000235688]|not specified [RCV001192769] |
Chr16:23629737 [GRCh38] Chr16:23641058 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.438A>C (p.Arg146Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000410126]|Hereditary cancer-predisposing syndrome [RCV000129467]|not provided [RCV000212775] |
Chr16:23636108 [GRCh38] Chr16:23647429 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2743G>A (p.Ala915Thr) |
single nucleotide variant |
Diffuse midline glioma, H3 K27-altered [RCV003315231]|Familial cancer of breast [RCV000471567]|Hereditary cancer-predisposing syndrome [RCV000129474]|Malignant tumor of breast [RCV001355149]|PALB2-related disorder [RCV004545873]|not provided [RCV000481045] |
Chr16:23626241 [GRCh38] Chr16:23637562 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.1546del (p.Arg516fs) |
deletion |
Familial cancer of breast [RCV000196008]|Hereditary cancer-predisposing syndrome [RCV000129579]|not provided [RCV000506528] |
Chr16:23635000 [GRCh38] Chr16:23646321 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2514+3dup |
duplication |
Familial cancer of breast [RCV000799318]|Hereditary cancer-predisposing syndrome [RCV000129677]|not provided [RCV001849925]|not specified [RCV001800428] |
Chr16:23629636..23629637 [GRCh38] Chr16:23640957..23640958 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.101G>A (p.Arg34His) |
single nucleotide variant |
Familial cancer of breast [RCV000530292]|Familial cancer of breast [RCV002478387]|Fanconi anemia complementation group N [RCV001119844]|Hereditary cancer-predisposing syndrome [RCV000129692]|not provided [RCV001729405]|not specified [RCV000587426] |
Chr16:23638077 [GRCh38] Chr16:23649398 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3508C>T (p.His1170Tyr) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359213]|Familial cancer of breast [RCV000226949]|Hereditary breast ovarian cancer syndrome [RCV004760389]|Hereditary cancer-predisposing syndrome [RCV000129794]|not provided [RCV000212829]|not specified [RCV001818304] |
Chr16:23603512 [GRCh38] Chr16:23614833 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.26delinsCG (p.Leu9fs) |
indel |
Familial cancer of breast [RCV003474754]|Hereditary cancer-predisposing syndrome [RCV000129810] |
Chr16:23641132 [GRCh38] Chr16:23652453 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.654del (p.Asp219fs) |
deletion |
Breast and/or ovarian cancer [RCV001270996]|Familial cancer of breast [RCV000635944]|Hereditary cancer-predisposing syndrome [RCV000129864]|Malignant tumor of breast [RCV001358375]|not provided [RCV005425739] |
Chr16:23635892 [GRCh38] Chr16:23647213 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2568A>C (p.Gln856His) |
single nucleotide variant |
Familial cancer of breast [RCV000476959]|Hereditary cancer-predisposing syndrome [RCV000129881]|not provided [RCV000486393] |
Chr16:23629222 [GRCh38] Chr16:23640543 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2091C>A (p.Gly697=) |
single nucleotide variant |
Familial cancer of breast [RCV000211080]|not specified [RCV000427677] |
Chr16:23630063 [GRCh38] Chr16:23641384 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1931G>A (p.Gly644Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000211083]|Hereditary cancer-predisposing syndrome [RCV003362729] |
Chr16:23630223 [GRCh38] Chr16:23641544 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh38/hg38 16p12.2-11.2(chr16:22634385-29227323)x3 |
copy number gain |
See cases [RCV000135594] |
Chr16:22634385..29227323 [GRCh38] Chr16:22645706..29238644 [GRCh37] Chr16:22553207..29146145 [NCBI36] Chr16:16p12.2-11.2 |
likely pathogenic |
GRCh38/hg38 16p12.2-11.2(chr16:21350622-29202837)x3 |
copy number gain |
See cases [RCV000140235] |
Chr16:21350622..29202837 [GRCh38] Chr16:21361943..29214158 [GRCh37] Chr16:21269444..29121659 [NCBI36] Chr16:16p12.2-11.2 |
likely pathogenic |
NM_024675.4(PALB2):c.1924del (p.Met642fs) |
deletion |
Familial cancer of breast [RCV000410708]|Fanconi anemia complementation group N [RCV005016481]|Hereditary cancer-predisposing syndrome [RCV000160805]|not provided [RCV000212803] |
Chr16:23630230 [GRCh38] Chr16:23641551 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2032del (p.Leu678fs) |
deletion |
Familial cancer of breast [RCV000528815]|Hereditary cancer-predisposing syndrome [RCV000160807]|not provided [RCV000254675] |
Chr16:23630122 [GRCh38] Chr16:23641443 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2154del (p.Arg718fs) |
deletion |
Familial cancer of breast [RCV003453275]|not provided [RCV000160808] |
Chr16:23630000 [GRCh38] Chr16:23641321 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2642_2645dup (p.Cys882fs) |
duplication |
Familial cancer of breast [RCV000465671]|Hereditary cancer-predisposing syndrome [RCV000160809]|Malignant tumor of breast [RCV002271430]|PALB2-related disorder [RCV004724949]|not provided [RCV000497297] |
Chr16:23626338..23626339 [GRCh38] Chr16:23637659..23637660 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2727_2728del (p.Thr911fs) |
deletion |
Familial cancer of breast [RCV000232116]|Familial cancer of breast [RCV002492637]|Gastric cancer [RCV003162679]|Hereditary breast ovarian cancer syndrome [RCV001193416]|Hereditary cancer-predisposing syndrome [RCV000160810]|PALB2-related disorder [RCV004544473]|not provided [RCV000254678] |
Chr16:23626256..23626257 [GRCh38] Chr16:23637577..23637578 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|not provided |
NM_024675.4(PALB2):c.786del (p.Glu263fs) |
deletion |
Familial cancer of breast [RCV001050697]|Hereditary breast ovarian cancer syndrome [RCV001804886]|Hereditary cancer-predisposing syndrome [RCV000574923]|not provided [RCV000160812] |
Chr16:23635760 [GRCh38] Chr16:23647081 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.948del (p.Thr317fs) |
deletion |
Familial cancer of breast [RCV000463598]|Hereditary cancer-predisposing syndrome [RCV000454254]|not provided [RCV000160813] |
Chr16:23635598 [GRCh38] Chr16:23646919 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1059del (p.Lys353fs) |
deletion |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359381]|Familial cancer of breast [RCV000230419]|Familial cancer of breast [RCV002498798]|Hereditary cancer-predisposing syndrome [RCV000575109]|not provided [RCV000160814] |
Chr16:23635487 [GRCh38] Chr16:23646808 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2607C>A (p.Ser869=) |
single nucleotide variant |
Familial cancer of breast [RCV001082563]|Hereditary cancer-predisposing syndrome [RCV000566660]|not provided [RCV000590220]|not specified [RCV000160819] |
Chr16:23626377 [GRCh38] Chr16:23637698 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2748+16G>A |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005235051]|Familial cancer of breast [RCV002053935]|Hereditary cancer-predisposing syndrome [RCV000581066]|not provided [RCV001580104]|not specified [RCV000160820] |
Chr16:23626220 [GRCh38] Chr16:23637541 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3202-8G>A |
single nucleotide variant |
Familial cancer of breast [RCV001081288]|Hereditary cancer-predisposing syndrome [RCV000579984]|not provided [RCV000488296]|not specified [RCV000160821] |
Chr16:23608020 [GRCh38] Chr16:23619341 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3202-8G>T |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798556]|Familial cancer of breast [RCV000476584]|Hereditary breast ovarian cancer syndrome [RCV005359382]|Hereditary cancer-predisposing syndrome [RCV000580700]|not provided [RCV001284321]|not specified [RCV000160822] |
Chr16:23608020 [GRCh38] Chr16:23619341 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.1611G>C (p.Ser537=) |
single nucleotide variant |
Familial cancer of breast [RCV000875722]|Hereditary cancer-predisposing syndrome [RCV002399587]|not specified [RCV000160823] |
Chr16:23634935 [GRCh38] Chr16:23646256 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1641C>T (p.Thr547=) |
single nucleotide variant |
Familial cancer of breast [RCV001083201]|Hereditary cancer-predisposing syndrome [RCV000160824]|not provided [RCV000198904]|not specified [RCV000212799] |
Chr16:23634905 [GRCh38] Chr16:23646226 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters |
NM_024675.4(PALB2):c.-5G>T |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000561746]|not specified [RCV000160825] |
Chr16:23641162 [GRCh38] Chr16:23652483 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1724G>A (p.Trp575Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001238865]|Fanconi anemia complementation group N [RCV001781504]|Hereditary breast ovarian cancer syndrome [RCV003155926]|Hereditary cancer-predisposing syndrome [RCV000771400]|PALB2-related disorder [RCV004724950]|not provided [RCV000160827] |
Chr16:23630430 [GRCh38] Chr16:23641751 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2615T>C (p.Val872Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000462998]|Hereditary cancer-predisposing syndrome [RCV000216057]|Malignant tumor of breast [RCV001356561]|not provided [RCV000160828]|not specified [RCV001420923] |
Chr16:23626369 [GRCh38] Chr16:23637690 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3235G>T (p.Ala1079Ser) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359383]|Familial cancer of breast [RCV000543305]|Hereditary cancer-predisposing syndrome [RCV000564254]|not provided [RCV000160829]|not specified [RCV001797644] |
Chr16:23607979 [GRCh38] Chr16:23619300 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.212-2A>G |
single nucleotide variant |
Familial cancer of breast [RCV000206312]|Familial cancer of breast [RCV002498799]|Fanconi anemia complementation group N [RCV001781505]|Hereditary breast ovarian cancer syndrome [RCV004800300]|Hereditary cancer-predisposing syndrome [RCV000213220]|PALB2-related disorder [RCV004739509]|not provided [RCV000160830] |
Chr16:23636336 [GRCh38] Chr16:23647657 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.364G>T (p.Asp122Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000524596]|Hereditary cancer-predisposing syndrome [RCV001020802]|not provided [RCV000160831] |
Chr16:23636182 [GRCh38] Chr16:23647503 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.397A>G (p.Ser133Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000227552]|Hereditary cancer-predisposing syndrome [RCV000454193]|not provided [RCV000587887] |
Chr16:23636149 [GRCh38] Chr16:23647470 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.968C>A (p.Ala323Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000466032]|Familial cancer of breast [RCV000765278]|Hereditary cancer-predisposing syndrome [RCV000220109]|not provided [RCV000160833] |
Chr16:23635578 [GRCh38] Chr16:23646899 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1407C>G (p.Cys469Trp) |
single nucleotide variant |
Familial cancer of breast [RCV000810010]|Hereditary cancer-predisposing syndrome [RCV000571438]|not provided [RCV000160834] |
Chr16:23635139 [GRCh38] Chr16:23646460 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.43G>T (p.Glu15Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001036521]|Hereditary cancer-predisposing syndrome [RCV000567534]|not provided [RCV000160835] |
Chr16:23641115 [GRCh38] Chr16:23652436 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2020G>A (p.Asp674Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000548729]|Familial cancer of breast [RCV002505195]|Hereditary cancer-predisposing syndrome [RCV000217309]|not provided [RCV000160836] |
Chr16:23630134 [GRCh38] Chr16:23641455 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2106A>G (p.Ile702Met) |
single nucleotide variant |
Familial cancer of breast [RCV000211076]|Hereditary cancer-predisposing syndrome [RCV000160837]|not provided [RCV000212805] |
Chr16:23630048 [GRCh38] Chr16:23641369 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2128A>G (p.Thr710Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000232377]|Familial cancer of breast [RCV002485000]|Hereditary cancer-predisposing syndrome [RCV000569204]|PALB2-related disorder [RCV004535048]|not provided [RCV000160838]|not specified [RCV000780572] |
Chr16:23630026 [GRCh38] Chr16:23641347 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2229T>A (p.Tyr743Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004992040]|Familial cancer of breast [RCV002466252]|Hereditary cancer-predisposing syndrome [RCV002426793]|not provided [RCV000160839] |
Chr16:23629925 [GRCh38] Chr16:23641246 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2329G>A (p.Asp777Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000204167]|Hereditary cancer-predisposing syndrome [RCV000160841]|not provided [RCV000212809] |
Chr16:23629825 [GRCh38] Chr16:23641146 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2353C>T (p.Pro785Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000460019]|Hereditary cancer [RCV004700497]|Hereditary cancer-predisposing syndrome [RCV001015124]|not provided [RCV000160842] |
Chr16:23629801 [GRCh38] Chr16:23641122 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2699C>T (p.Ala900Val) |
single nucleotide variant |
Familial cancer of breast [RCV000555792]|Familial cancer of breast [RCV002485001]|Fanconi anemia complementation group N [RCV005394561]|Hereditary cancer-predisposing syndrome [RCV000216145]|not provided [RCV000160844] |
Chr16:23626285 [GRCh38] Chr16:23637606 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2798G>A (p.Cys933Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000228665]|Hereditary cancer-predisposing syndrome [RCV000571562]|not provided [RCV000160846] |
Chr16:23624045 [GRCh38] Chr16:23635366 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2834+1G>A |
single nucleotide variant |
Familial cancer of breast [RCV000635960]|Familial cancer of breast [RCV002478488]|Hereditary cancer-predisposing syndrome [RCV001016726]|Malignant tumor of breast [RCV001268941]|not provided [RCV000160847] |
Chr16:23624008 [GRCh38] Chr16:23635329 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2922G>T (p.Lys974Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000205333]|Hereditary cancer-predisposing syndrome [RCV000566246]|Malignant tumor of breast [RCV001355089]|not provided [RCV000160849]|not specified [RCV002267894] |
Chr16:23623043 [GRCh38] Chr16:23634364 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3191A>G (p.Tyr1064Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000467780]|Hereditary cancer-predisposing syndrome [RCV000774624]|not provided [RCV000160850] |
Chr16:23614014 [GRCh38] Chr16:23625335 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3278T>C (p.Ile1093Thr) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003483530]|Familial cancer of breast [RCV000197231]|Hereditary cancer-predisposing syndrome [RCV000223658]|Malignant tumor of breast [RCV001357444]|not provided [RCV000160854] |
Chr16:23607936 [GRCh38] Chr16:23619257 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|likely benign|uncertain significance |
NM_024675.4(PALB2):c.3404G>A (p.Gly1135Glu) |
single nucleotide variant |
Carcinoma of colon [RCV001030415]|Familial cancer of breast [RCV000232726]|Familial cancer of breast [RCV002492638]|Hereditary cancer-predisposing syndrome [RCV000570480]|not provided [RCV000589198]|not specified [RCV000855602] |
Chr16:23603616 [GRCh38] Chr16:23614937 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3452T>A (p.Leu1151His) |
single nucleotide variant |
Familial cancer of breast [RCV000799466]|Hereditary cancer-predisposing syndrome [RCV003162680]|not provided [RCV000160856] |
Chr16:23603568 [GRCh38] Chr16:23614889 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3474T>A (p.His1158Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000464364]|Hereditary cancer-predisposing syndrome [RCV000576122]|not provided [RCV000160857] |
Chr16:23603546 [GRCh38] Chr16:23614867 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.109-2A>G |
single nucleotide variant |
Familial cancer of breast [RCV000803061]|Fanconi anemia complementation group N [RCV005016482]|Hereditary cancer-predisposing syndrome [RCV000572657]|not provided [RCV000160858] |
Chr16:23637954 [GRCh38] Chr16:23649275 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.161A>G (p.Glu54Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000463943]|Hereditary cancer-predisposing syndrome [RCV000160859]|not provided [RCV000212769]|not specified [RCV000780564] |
Chr16:23637900 [GRCh38] Chr16:23649221 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.187C>T (p.Leu63Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000469950]|Familial cancer of breast [RCV000765279]|Hereditary cancer-predisposing syndrome [RCV000576103]|not provided [RCV000160860] |
Chr16:23637874 [GRCh38] Chr16:23649195 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.208T>C (p.Ser70Pro) |
single nucleotide variant |
Familial cancer of breast [RCV001234988]|Hereditary cancer-predisposing syndrome [RCV003298193]|not provided [RCV000160861] |
Chr16:23637853 [GRCh38] Chr16:23649174 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.262C>G (p.Leu88Val) |
single nucleotide variant |
Familial cancer of breast [RCV000701072]|Hereditary cancer-predisposing syndrome [RCV001016091]|not provided [RCV000160862] |
Chr16:23636284 [GRCh38] Chr16:23647605 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.521A>G (p.Lys174Arg) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359384]|Familial cancer of breast [RCV000557614]|Hereditary cancer-predisposing syndrome [RCV000774644]|not provided [RCV000160863] |
Chr16:23636025 [GRCh38] Chr16:23647346 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.535C>G (p.Gln179Glu) |
single nucleotide variant |
Familial cancer of breast [RCV001850272]|not provided [RCV000160864]|not specified [RCV003321524] |
Chr16:23636011 [GRCh38] Chr16:23647332 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.587G>A (p.Arg196Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000228567]|Hereditary cancer-predisposing syndrome [RCV000216462]|PALB2-related disorder [RCV004535049]|not provided [RCV000160865] |
Chr16:23635959 [GRCh38] Chr16:23647280 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.688G>T (p.Glu230Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000471920]|Hereditary cancer-predisposing syndrome [RCV000561729]|not provided [RCV000160866] |
Chr16:23635858 [GRCh38] Chr16:23647179 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1156A>G (p.Thr386Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000528086]|Familial cancer of breast [RCV002492639]|Hereditary cancer-predisposing syndrome [RCV000773131]|not provided [RCV000160867] |
Chr16:23635390 [GRCh38] Chr16:23646711 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1400G>A (p.Gly467Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000549785]|Hereditary cancer-predisposing syndrome [RCV000160868]|not provided [RCV000212793] |
Chr16:23635146 [GRCh38] Chr16:23646467 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1471G>C (p.Ala491Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000635626]|Familial cancer of breast [RCV002485002]|Hereditary cancer-predisposing syndrome [RCV000216241]|PALB2-related disorder [RCV004535050]|not provided [RCV000160869] |
Chr16:23635075 [GRCh38] Chr16:23646396 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1492G>T (p.Asp498Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000197379]|Fanconi anemia complementation group N [RCV000368837]|Hereditary breast ovarian cancer syndrome [RCV001030650]|Hereditary cancer-predisposing syndrome [RCV000160870]|Malignant tumor of breast [RCV001356483]|not provided [RCV000858743]|not specified [RCV000200991] |
Chr16:23635054 [GRCh38] Chr16:23646375 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters |
NM_024675.4(PALB2):c.1610C>T (p.Ser537Leu) |
single nucleotide variant |
Carcinoma of colon [RCV001030240]|Familial cancer of breast [RCV000168207]|Fanconi anemia complementation group N [RCV001121722]|Hereditary cancer-predisposing syndrome [RCV000220923]|PALB2-related disorder [RCV004535051]|not provided [RCV000160871] |
Chr16:23634936 [GRCh38] Chr16:23646257 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.37G>A (p.Glu13Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000197594]|Familial cancer of breast [RCV002478489]|Hereditary cancer-predisposing syndrome [RCV000160873]|not provided [RCV000235192] |
Chr16:23641121 [GRCh38] Chr16:23652442 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.3:c.833_834ATdelTAinsAT |
insertion |
Hereditary cancer-predisposing syndrome [RCV000160815] |
Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.372C>T (p.Thr124=) |
single nucleotide variant |
Familial cancer of breast [RCV000537604]|Fanconi anemia complementation group N [RCV005396470]|Hereditary cancer-predisposing syndrome [RCV000164424]|PALB2-related disorder [RCV004535099]|not specified [RCV002271436] |
Chr16:23636174 [GRCh38] Chr16:23647495 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1846G>C (p.Asp616His) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003989339]|Familial cancer of breast [RCV000635889]|Familial cancer of breast [RCV002492657]|Hereditary cancer-predisposing syndrome [RCV000164427]|not provided [RCV000483250]|not specified [RCV001269117] |
Chr16:23630308 [GRCh38] Chr16:23641629 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1222T>G (p.Tyr408Asp) |
single nucleotide variant |
Familial cancer of breast [RCV001362967]|Hereditary cancer-predisposing syndrome [RCV000164451]|not provided [RCV001030205] |
Chr16:23635324 [GRCh38] Chr16:23646645 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.109C>A (p.Arg37Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000234405]|Hereditary cancer-predisposing syndrome [RCV000164472]|PALB2-related disorder [RCV004724955]|not provided [RCV000656933]|not specified [RCV000481543] |
Chr16:23637952 [GRCh38] Chr16:23649273 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2271A>G (p.Thr757=) |
single nucleotide variant |
Familial cancer of breast [RCV000934630]|Fanconi anemia complementation group N [RCV005396473]|Hereditary cancer-predisposing syndrome [RCV000164529] |
Chr16:23629883 [GRCh38] Chr16:23641204 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2228A>T (p.Tyr743Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000698708]|Hereditary cancer-predisposing syndrome [RCV000164551] |
Chr16:23629926 [GRCh38] Chr16:23641247 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1408A>G (p.Thr470Ala) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359480]|Familial cancer of breast [RCV000525404]|Hereditary cancer-predisposing syndrome [RCV000164567]|Inherited breast cancer and ovarian cancer [RCV005237616]|not provided [RCV000480806]|not specified [RCV002265643] |
Chr16:23635138 [GRCh38] Chr16:23646459 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3228_3244dup (p.Ser1082fs) |
duplication |
Familial cancer of breast [RCV003454398]|Hereditary cancer-predisposing syndrome [RCV000164597] |
Chr16:23607969..23607970 [GRCh38] Chr16:23619290..23619291 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.40A>G (p.Lys14Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000693912]|Hereditary cancer-predisposing syndrome [RCV000164630]|not provided [RCV001565871] |
Chr16:23641118 [GRCh38] Chr16:23652439 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2208C>A (p.Ala736=) |
single nucleotide variant |
Familial cancer of breast [RCV000204026]|Hereditary cancer-predisposing syndrome [RCV000164661]|not provided [RCV001800485]|not specified [RCV000417789] |
Chr16:23629946 [GRCh38] Chr16:23641267 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.100C>T (p.Arg34Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000199940]|Hereditary cancer-predisposing syndrome [RCV000164663]|Inherited breast cancer and ovarian cancer [RCV004808602]|not provided [RCV000236984]|not specified [RCV002222417] |
Chr16:23638078 [GRCh38] Chr16:23649399 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1097A>G (p.Asn366Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000204324]|Hereditary cancer-predisposing syndrome [RCV000164773]|PALB2-related disorder [RCV004535105]|not provided [RCV005054172] |
Chr16:23635449 [GRCh38] Chr16:23646770 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.169T>A (p.Cys57Ser) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000164803] |
Chr16:23637892 [GRCh38] Chr16:23649213 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.950C>T (p.Thr317Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000200449]|Hereditary cancer-predisposing syndrome [RCV000164806]|Malignant tumor of breast [RCV001357471]|not provided [RCV000766544] |
Chr16:23635596 [GRCh38] Chr16:23646917 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3451C>T (p.Leu1151Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000816063]|Familial cancer of breast [RCV002485036]|Hereditary cancer-predisposing syndrome [RCV000166777]|not provided [RCV000587507] |
Chr16:23603569 [GRCh38] Chr16:23614890 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1510G>A (p.Val504Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000816945]|Hereditary cancer-predisposing syndrome [RCV000166778] |
Chr16:23635036 [GRCh38] Chr16:23646357 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1545A>G (p.Lys515=) |
single nucleotide variant |
Familial cancer of breast [RCV000545596]|Hereditary cancer-predisposing syndrome [RCV000166787]|not specified [RCV000606738] |
Chr16:23635001 [GRCh38] Chr16:23646322 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3204G>A (p.Gly1068=) |
single nucleotide variant |
Familial cancer of breast [RCV000636006]|Hereditary cancer-predisposing syndrome [RCV000166794]|PALB2-related disorder [RCV004539562]|not provided [RCV001579700]|not specified [RCV000602197] |
Chr16:23608010 [GRCh38] Chr16:23619331 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3004_3007del (p.Glu1002fs) |
deletion |
Familial cancer of breast [RCV000635888]|Fanconi anemia complementation group N [RCV002243834]|Hereditary breast ovarian cancer syndrome [RCV004782275]|Hereditary cancer-predisposing syndrome [RCV000166810] |
Chr16:23621468..23621471 [GRCh38] Chr16:23632789..23632792 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1379A>G (p.Gln460Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000989572]|Fanconi anemia complementation group N [RCV000289282]|Fanconi anemia complementation group N [RCV005396492]|Hereditary breast ovarian cancer syndrome [RCV001030716]|Hereditary cancer-predisposing syndrome [RCV000166836]|PALB2-related disorder [RCV004739541]|not provided [RCV000483813]|not specified [RCV000780567] |
Chr16:23635167 [GRCh38] Chr16:23646488 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1123C>A (p.Leu375Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000198293]|Hereditary cancer-predisposing syndrome [RCV000166837]|PALB2-related disorder [RCV004545875]|not provided [RCV000236203]|not specified [RCV001420780] |
Chr16:23635423 [GRCh38] Chr16:23646744 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_024675.4(PALB2):c.1095G>A (p.Arg365=) |
single nucleotide variant |
Familial cancer of breast [RCV000934638]|Hereditary cancer-predisposing syndrome [RCV000166857]|Malignant tumor of breast [RCV001357372]|not specified [RCV000605029] |
Chr16:23635451 [GRCh38] Chr16:23646772 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1659C>G (p.His553Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000547924]|Hereditary cancer-predisposing syndrome [RCV000166875]|not specified [RCV001201201] |
Chr16:23634887 [GRCh38] Chr16:23646208 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3545T>C (p.Val1182Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000548591]|Hereditary cancer-predisposing syndrome [RCV000166908] |
Chr16:23603475 [GRCh38] Chr16:23614796 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1093A>G (p.Arg365Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000205169]|Familial cancer of breast [RCV002485020]|Hereditary cancer-predisposing syndrome [RCV000164864]|not provided [RCV000486708] |
Chr16:23635453 [GRCh38] Chr16:23646774 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1684G>A (p.Gly562Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000686970]|Hereditary cancer-predisposing syndrome [RCV000164956] |
Chr16:23634862 [GRCh38] Chr16:23646183 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3367G>A (p.Val1123Met) |
single nucleotide variant |
Familial cancer of breast [RCV000211079]|Familial cancer of breast [RCV002485022]|Hereditary cancer-predisposing syndrome [RCV000164958]|not provided [RCV000479580] |
Chr16:23603653 [GRCh38] Chr16:23614974 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.788A>G (p.Glu263Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000233981]|Fanconi anemia complementation group N [RCV005016493]|Hereditary cancer-predisposing syndrome [RCV000164996]|not provided [RCV000485489] |
Chr16:23635758 [GRCh38] Chr16:23647079 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.503C>T (p.Ser168Leu) |
single nucleotide variant |
Familial cancer of breast [RCV001035722]|Hereditary cancer-predisposing syndrome [RCV000166977]|not provided [RCV000759191] |
Chr16:23636043 [GRCh38] Chr16:23647364 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2831T>A (p.Ile944Asn) |
single nucleotide variant |
Familial cancer of breast [RCV003162715]|Hereditary cancer-predisposing syndrome [RCV000166978] |
Chr16:23624012 [GRCh38] Chr16:23635333 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2508C>G (p.Val836=) |
single nucleotide variant |
Familial cancer of breast [RCV000410515]|Hereditary cancer-predisposing syndrome [RCV000166988]|PALB2-related disorder [RCV004535131]|not provided [RCV001706089]|not specified [RCV001818395] |
Chr16:23629646 [GRCh38] Chr16:23640967 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2356C>T (p.His786Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000226421]|Familial cancer of breast [RCV002505215]|Fanconi anemia complementation group N [RCV003129793]|Hereditary cancer-predisposing syndrome [RCV000166996]|not provided [RCV001566992]|not specified [RCV003321534] |
Chr16:23629798 [GRCh38] Chr16:23641119 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.36G>A (p.Glu12=) |
single nucleotide variant |
Familial cancer of breast [RCV000476001]|Hereditary cancer-predisposing syndrome [RCV000165018]|not provided [RCV004998329] |
Chr16:23641122 [GRCh38] Chr16:23652443 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.9G>A (p.Glu3=) |
single nucleotide variant |
Familial cancer of breast [RCV000204176]|Hereditary cancer-predisposing syndrome [RCV000165076]|not provided [RCV001721067]|not specified [RCV000418049] |
Chr16:23641149 [GRCh38] Chr16:23652470 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2474G>C (p.Arg825Thr) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005359498]|Endometrial carcinoma [RCV001256975]|Familial cancer of breast [RCV001086620]|Hereditary cancer-predisposing syndrome [RCV000165079]|not provided [RCV000236812]|not specified [RCV000780569] |
Chr16:23629680 [GRCh38] Chr16:23641001 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1594C>T (p.Pro532Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000819569]|Hereditary cancer-predisposing syndrome [RCV000165089]|not specified [RCV003398840] |
Chr16:23634952 [GRCh38] Chr16:23646273 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2782G>A (p.Val928Met) |
single nucleotide variant |
Familial cancer of breast [RCV002516474]|Hereditary cancer-predisposing syndrome [RCV000165137] |
Chr16:23624061 [GRCh38] Chr16:23635382 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.900A>G (p.Thr300=) |
single nucleotide variant |
Familial cancer of breast [RCV000205195]|Familial cancer of breast [RCV002485038]|Hereditary cancer-predisposing syndrome [RCV000167125]|PALB2-related disorder [RCV004535134]|not provided [RCV001721087] |
Chr16:23635646 [GRCh38] Chr16:23646967 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1451T>A (p.Leu484Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001310142]|Generalized hypopigmentation [RCV000414940]|Hereditary breast ovarian cancer syndrome [RCV000587378]|Hereditary cancer-predisposing syndrome [RCV000167136]|Malignant tumor of breast [RCV001356904]|not provided [RCV001543564] |
Chr16:23635095 [GRCh38] Chr16:23646416 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1708G>A (p.Glu570Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000410345]|Hereditary cancer-predisposing syndrome [RCV000167185] |
Chr16:23630446 [GRCh38] Chr16:23641767 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1273G>A (p.Val425Met) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003491915]|Familial cancer of breast [RCV000205365]|Hereditary breast ovarian cancer syndrome [RCV004689644]|Hereditary cancer-predisposing syndrome [RCV000167189]|Malignant tumor of breast [RCV001358598]|PALB2-related disorder [RCV004539565]|not provided [RCV000236471]|not specified [RCV001030212] |
Chr16:23635273 [GRCh38] Chr16:23646594 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1930G>T (p.Gly644Ter) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000165251] |
Chr16:23630224 [GRCh38] Chr16:23641545 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1209G>A (p.Leu403=) |
single nucleotide variant |
Familial cancer of breast [RCV001083443]|Hereditary cancer-predisposing syndrome [RCV000165272]|not provided [RCV000467675]|not specified [RCV000440263] |
Chr16:23635337 [GRCh38] Chr16:23646658 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1715C>T (p.Ser572Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000411877]|Hereditary cancer-predisposing syndrome [RCV000165275] |
Chr16:23630439 [GRCh38] Chr16:23641760 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3426_3429del (p.Leu1142fs) |
microsatellite |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003991017]|Familial cancer of breast [RCV000540873]|Hereditary cancer-predisposing syndrome [RCV000165289]|not provided [RCV000133486] |
Chr16:23603591..23603594 [GRCh38] Chr16:23614912..23614915 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.2662A>T (p.Ile888Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000456550]|Hereditary cancer-predisposing syndrome [RCV000165291]|not provided [RCV002284368] |
Chr16:23626322 [GRCh38] Chr16:23637643 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2453T>C (p.Phe818Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000476189]|Hereditary cancer [RCV005235052]|Hereditary cancer-predisposing syndrome [RCV000162394]|not provided [RCV004589674] |
Chr16:23629701 [GRCh38] Chr16:23641022 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1623G>A (p.Arg541=) |
single nucleotide variant |
Familial cancer of breast [RCV000204373]|Hereditary cancer-predisposing syndrome [RCV000162458]|not provided [RCV000759896]|not specified [RCV001192768] |
Chr16:23634923 [GRCh38] Chr16:23646244 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.2253T>C (p.Ala751=) |
single nucleotide variant |
Familial cancer of breast [RCV000465740]|Hereditary cancer-predisposing syndrome [RCV000162576]|not provided [RCV001711322] |
Chr16:23629901 [GRCh38] Chr16:23641222 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1257C>T (p.Cys419=) |
single nucleotide variant |
Familial cancer of breast [RCV000942401]|Hereditary cancer-predisposing syndrome [RCV000162584] |
Chr16:23635289 [GRCh38] Chr16:23646610 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1599T>C (p.Thr533=) |
single nucleotide variant |
Familial cancer of breast [RCV000232866]|Familial pancreatic carcinoma [RCV005359395]|Fanconi anemia complementation group N [RCV001121723]|Hereditary cancer-predisposing syndrome [RCV000162589]|PALB2-related disorder [RCV004544477]|not provided [RCV001704155]|not specified [RCV001818362] |
Chr16:23634947 [GRCh38] Chr16:23646268 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.824C>T (p.Thr275Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000663229]|Hereditary cancer-predisposing syndrome [RCV000165341]|Malignant tumor of breast [RCV001355748]|not provided [RCV001824291] |
Chr16:23635722 [GRCh38] Chr16:23647043 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2277A>G (p.Gln759=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003150021]|Familial cancer of breast [RCV000472744]|Fanconi anemia complementation group N [RCV001119745]|Hereditary cancer-predisposing syndrome [RCV000165372]|PALB2-related disorder [RCV004535111]|not specified [RCV000614133] |
Chr16:23629877 [GRCh38] Chr16:23641198 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2067G>A (p.Ser689=) |
single nucleotide variant |
Carcinoma of colon [RCV001356268]|Familial cancer of breast [RCV000197495]|Fanconi anemia complementation group N [RCV001119747]|Hereditary cancer-predisposing syndrome [RCV000165391]|PALB2-related disorder [RCV004535112]|not provided [RCV001284030]|not specified [RCV000420216] |
Chr16:23630087 [GRCh38] Chr16:23641408 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.980G>A (p.Cys327Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000460541]|Hereditary cancer-predisposing syndrome [RCV000165411]|not provided [RCV001836740] |
Chr16:23635566 [GRCh38] Chr16:23646887 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3418T>G (p.Trp1140Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000195510]|Familial cancer of breast [RCV002478497]|Hereditary cancer-predisposing syndrome [RCV000162652]|Malignant tumor of breast [RCV001358491]|not provided [RCV000236626] |
Chr16:23603602 [GRCh38] Chr16:23614923 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3525A>G (p.Gln1175=) |
single nucleotide variant |
Familial cancer of breast [RCV000470645]|Hereditary cancer-predisposing syndrome [RCV000162726]|PALB2-related disorder [RCV004544483] |
Chr16:23603495 [GRCh38] Chr16:23614816 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.2082A>G (p.Thr694=) |
single nucleotide variant |
Familial cancer of breast [RCV000205968]|Fanconi anemia complementation group N [RCV005394574]|Hereditary cancer-predisposing syndrome [RCV000162752]|PALB2-related disorder [RCV004535058]|not provided [RCV000759184]|not specified [RCV000507922] |
Chr16:23630072 [GRCh38] Chr16:23641393 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3287A>G (p.Asn1096Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001030403]|Hereditary cancer-predisposing syndrome [RCV000162754] |
Chr16:23607927 [GRCh38] Chr16:23619248 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3203G>C (p.Gly1068Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000463764]|Hereditary cancer-predisposing syndrome [RCV000165472] |
Chr16:23608011 [GRCh38] Chr16:23619332 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3351-5A>C |
single nucleotide variant |
Familial cancer of breast [RCV000526871]|Hereditary cancer-predisposing syndrome [RCV000165540] |
Chr16:23603674 [GRCh38] Chr16:23614995 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2810G>A (p.Gly937Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000206821]|Familial pancreatic carcinoma [RCV005359513]|Hereditary cancer-predisposing syndrome [RCV000165549] |
Chr16:23624033 [GRCh38] Chr16:23635354 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2748+1G>T |
single nucleotide variant |
Familial cancer of breast [RCV000635768]|Hereditary breast ovarian cancer syndrome [RCV003155927]|Hereditary cancer-predisposing syndrome [RCV000165555]|not provided [RCV000487378] |
Chr16:23626235 [GRCh38] Chr16:23637556 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.210A>C (p.Ser70=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000165562] |
Chr16:23637851 [GRCh38] Chr16:23649172 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2418G>A (p.Pro806=) |
single nucleotide variant |
Familial cancer of breast [RCV000233118]|Hereditary cancer-predisposing syndrome [RCV000162786]|not provided [RCV001721029]|not specified [RCV000426070] |
Chr16:23629736 [GRCh38] Chr16:23641057 [GRCh37] Chr16:16p12.2 |
likely pathogenic|benign|likely benign |
NM_024675.4(PALB2):c.2244A>G (p.Thr748=) |
single nucleotide variant |
Familial cancer of breast [RCV000211088]|Hereditary cancer-predisposing syndrome [RCV000163058]|not provided [RCV000759186]|not specified [RCV000600407] |
Chr16:23629910 [GRCh38] Chr16:23641231 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2601C>T (p.Ser867=) |
single nucleotide variant |
Familial cancer of breast [RCV005425750]|Hereditary cancer-predisposing syndrome [RCV000163108] |
Chr16:23626383 [GRCh38] Chr16:23637704 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2986G>T (p.Glu996Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000227242]|Hereditary cancer-predisposing syndrome [RCV000167226]|Malignant tumor of breast [RCV002271440]|not provided [RCV000485825] |
Chr16:23622979 [GRCh38] Chr16:23634300 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.423G>A (p.Gln141=) |
single nucleotide variant |
Familial cancer of breast [RCV000409495]|Hereditary cancer-predisposing syndrome [RCV000165612]|PALB2-related disorder [RCV004535115]|not provided [RCV001721073]|not specified [RCV004782271] |
Chr16:23636123 [GRCh38] Chr16:23647444 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1662A>G (p.Glu554=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003491900]|Familial cancer of breast [RCV000462332]|Hereditary cancer-predisposing syndrome [RCV000165629]|not provided [RCV001567936] |
Chr16:23634884 [GRCh38] Chr16:23646205 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.3433G>A (p.Gly1145Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000798287]|Hereditary cancer-predisposing syndrome [RCV000165631]|not provided [RCV004998336] |
Chr16:23603587 [GRCh38] Chr16:23614908 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1454C>T (p.Thr485Ile) |
single nucleotide variant |
Carcinoma of colon [RCV001030228]|Familial cancer of breast [RCV000205126]|Hereditary cancer-predisposing syndrome [RCV000165637]|not specified [RCV000507136] |
Chr16:23635092 [GRCh38] Chr16:23646413 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.495C>T (p.Gly165=) |
single nucleotide variant |
Bile duct cancer [RCV001357741]|Familial cancer of breast [RCV000532734]|Fanconi anemia complementation group N [RCV001119841]|Hereditary cancer-predisposing syndrome [RCV000165654]|not provided [RCV000679773]|not specified [RCV000444952] |
Chr16:23636051 [GRCh38] Chr16:23647372 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1505A>G (p.Lys502Arg) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000165659] |
Chr16:23635041 [GRCh38] Chr16:23646362 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2955T>G (p.Ser985=) |
single nucleotide variant |
Familial cancer of breast [RCV000200287]|Hereditary breast ovarian cancer syndrome [RCV005359417]|Hereditary cancer-predisposing syndrome [RCV000163267]|not provided [RCV003477589]|not specified [RCV000612434] |
Chr16:23623010 [GRCh38] Chr16:23634331 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.940C>T (p.Gln314Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000463323]|Hereditary breast ovarian cancer syndrome [RCV000586368]|Hereditary cancer-predisposing syndrome [RCV000167296]|not provided [RCV000523563] |
Chr16:23635606 [GRCh38] Chr16:23646927 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.339A>C (p.Pro113=) |
single nucleotide variant |
Familial cancer of breast [RCV000921954]|Hereditary cancer-predisposing syndrome [RCV000167306]|PALB2-related disorder [RCV004539567]|not provided [RCV001636704]|not specified [RCV000781691] |
Chr16:23636207 [GRCh38] Chr16:23647528 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.2382G>A (p.Arg794=) |
single nucleotide variant |
Familial cancer of breast [RCV002053993]|Hereditary cancer-predisposing syndrome [RCV000167317] |
Chr16:23629772 [GRCh38] Chr16:23641093 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.637G>C (p.Val213Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000635925]|Familial cancer of breast [RCV002485041]|Hereditary cancer-predisposing syndrome [RCV000167372]|not specified [RCV001193467] |
Chr16:23635909 [GRCh38] Chr16:23647230 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1433C>T (p.Ser478Phe) |
single nucleotide variant |
Familial cancer of breast [RCV001350067]|Hereditary cancer-predisposing syndrome [RCV000167376]|not specified [RCV001778766] |
Chr16:23635113 [GRCh38] Chr16:23646434 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2902G>A (p.Ala968Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001850325]|Hereditary cancer-predisposing syndrome [RCV000165827] |
Chr16:23623063 [GRCh38] Chr16:23634384 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.9G>T (p.Glu3Asp) |
single nucleotide variant |
Familial cancer of breast [RCV001036481]|Hereditary cancer-predisposing syndrome [RCV000165831]|not provided [RCV001564218]|not specified [RCV001194141] |
Chr16:23641149 [GRCh38] Chr16:23652470 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.538G>A (p.Glu180Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000700154]|Hereditary cancer-predisposing syndrome [RCV000165834]|not provided [RCV004777609] |
Chr16:23636008 [GRCh38] Chr16:23647329 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2311A>G (p.Ser771Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000411000]|Hereditary cancer-predisposing syndrome [RCV000165876]|not specified [RCV001824655] |
Chr16:23629843 [GRCh38] Chr16:23641164 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1030A>G (p.Asn344Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000230594]|Hereditary cancer-predisposing syndrome [RCV000165880]|not provided [RCV004692776] |
Chr16:23635516 [GRCh38] Chr16:23646837 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3282G>A (p.Val1094=) |
single nucleotide variant |
Familial cancer of breast [RCV000411397]|Hereditary cancer-predisposing syndrome [RCV000163456]|not provided [RCV001721045] |
Chr16:23607932 [GRCh38] Chr16:23619253 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3069A>G (p.Gln1023=) |
single nucleotide variant |
Familial cancer of breast [RCV000931143]|Hereditary cancer-predisposing syndrome [RCV000163477] |
Chr16:23621406 [GRCh38] Chr16:23632727 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2130G>A (p.Thr710=) |
single nucleotide variant |
Familial cancer of breast [RCV000635758]|Hereditary cancer-predisposing syndrome [RCV000163496]|not provided [RCV000486987]|not specified [RCV000781696] |
Chr16:23630024 [GRCh38] Chr16:23641345 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2747_2748+4del |
deletion |
Familial cancer of breast [RCV000552616]|Fanconi anemia complementation group N [RCV005396496]|Hereditary cancer-predisposing syndrome [RCV000167394]|not provided [RCV000708616] |
Chr16:23626232..23626237 [GRCh38] Chr16:23637553..23637558 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1766C>T (p.Thr589Met) |
single nucleotide variant |
Carcinoma of colon [RCV001030258]|Familial cancer of breast [RCV000474329]|Hereditary cancer-predisposing syndrome [RCV000167418]|Malignant tumor of breast [RCV001357624]|PALB2-related disorder [RCV004739545]|not provided [RCV000479496]|not specified [RCV001175052] |
Chr16:23630388 [GRCh38] Chr16:23641709 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1881G>A (p.Val627=) |
single nucleotide variant |
Familial cancer of breast [RCV001087589]|Hereditary cancer-predisposing syndrome [RCV000167465]|Pancreatic cancer, susceptibility to, 3 [RCV005365097]|not provided [RCV000636028]|not specified [RCV000608586] |
Chr16:23630273 [GRCh38] Chr16:23641594 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3114-5C>T |
single nucleotide variant |
Familial cancer of breast [RCV000934763]|Hereditary cancer-predisposing syndrome [RCV000167480]|not provided [RCV001775654] |
Chr16:23614096 [GRCh38] Chr16:23625417 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1958G>A (p.Cys653Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000456974]|Hereditary cancer-predisposing syndrome [RCV000167483] |
Chr16:23630196 [GRCh38] Chr16:23641517 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2985A>T (p.Ala995=) |
single nucleotide variant |
Familial cancer of breast [RCV001430096]|Familial cancer of breast [RCV002492665]|Hereditary cancer-predisposing syndrome [RCV000165948]|not provided [RCV000924813] |
Chr16:23622980 [GRCh38] Chr16:23634301 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1691A>G (p.Lys564Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000197146]|Hereditary cancer-predisposing syndrome [RCV000165968]|not provided [RCV001030253] |
Chr16:23630463 [GRCh38] Chr16:23641784 [GRCh37] Chr16:16p12.2 |
pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2649A>G (p.Lys883=) |
single nucleotide variant |
Familial cancer of breast [RCV000636025]|Hereditary cancer-predisposing syndrome [RCV000166006] |
Chr16:23626335 [GRCh38] Chr16:23637656 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1252A>G (p.Asn418Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000228629]|Fanconi anemia complementation group N [RCV005016498]|Hereditary cancer-predisposing syndrome [RCV000166018]|not provided [RCV001775647] |
Chr16:23635294 [GRCh38] Chr16:23646615 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2913C>A (p.Gly971=) |
single nucleotide variant |
Familial cancer of breast [RCV001445382]|Hereditary cancer-predisposing syndrome [RCV000163520] |
Chr16:23623052 [GRCh38] Chr16:23634373 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.312T>C (p.Pro104=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003150001]|Familial cancer of breast [RCV001082844]|Hereditary cancer-predisposing syndrome [RCV000163526]|not provided [RCV000679769]|not specified [RCV000421791] |
Chr16:23636234 [GRCh38] Chr16:23647555 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1033T>C (p.Leu345=) |
single nucleotide variant |
Familial cancer of breast [RCV000472210]|Hereditary cancer-predisposing syndrome [RCV000163534]|not provided [RCV001571618]|not specified [RCV001030194] |
Chr16:23635513 [GRCh38] Chr16:23646834 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.843T>C (p.Ile281=) |
single nucleotide variant |
Familial cancer of breast [RCV002516452]|Hereditary cancer-predisposing syndrome [RCV000163567] |
Chr16:23635703 [GRCh38] Chr16:23647024 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.768C>T (p.Ser256=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003150004]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005235060]|Familial cancer of breast [RCV000206372]|Hereditary cancer-predisposing syndrome [RCV000163571]|Malignant tumor of breast [RCV001354332]|PALB2-related disorder [RCV004535077]|not provided [RCV000587304]|not specified [RCV001818368] |
Chr16:23635778 [GRCh38] Chr16:23647099 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1272C>T (p.Ala424=) |
single nucleotide variant |
Familial cancer of breast [RCV000410129]|Familial cancer of breast [RCV002478498]|Hereditary cancer-predisposing syndrome [RCV000163630]|not provided [RCV001281734]|not specified [RCV000430438] |
Chr16:23635274 [GRCh38] Chr16:23646595 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1014A>G (p.Pro338=) |
single nucleotide variant |
Familial cancer of breast [RCV001496214]|Hereditary cancer-predisposing syndrome [RCV000163646] |
Chr16:23635532 [GRCh38] Chr16:23646853 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3297G>A (p.Thr1099=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003316004]|Familial cancer of breast [RCV000199114]|Familial cancer of breast [RCV002498809]|Familial ovarian cancer [RCV003447509]|Hereditary cancer-predisposing syndrome [RCV000163669]|PALB2-related disorder [RCV004539536]|not provided [RCV001704173]|not specified [RCV000436143] |
Chr16:23607917 [GRCh38] Chr16:23619238 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.2336C>G (p.Ser779Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000457524]|Hereditary breast ovarian cancer syndrome [RCV003226227]|Hereditary cancer-predisposing syndrome [RCV000166057]|PALB2-related disorder [RCV004528915]|not provided [RCV000480723] |
Chr16:23629818 [GRCh38] Chr16:23641139 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1539A>T (p.Thr513=) |
single nucleotide variant |
Familial cancer of breast [RCV002516494]|Hereditary cancer-predisposing syndrome [RCV000166064] |
Chr16:23635007 [GRCh38] Chr16:23646328 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1272C>G (p.Ala424=) |
single nucleotide variant |
Familial cancer of breast [RCV001473404]|Hereditary cancer-predisposing syndrome [RCV000166069]|not specified [RCV000442090] |
Chr16:23635274 [GRCh38] Chr16:23646595 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2134G>C (p.Ala712Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000459199]|Familial cancer of breast [RCV002485027]|Hereditary cancer-predisposing syndrome [RCV000166087] |
Chr16:23630020 [GRCh38] Chr16:23641341 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1395G>A (p.Met465Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000635660]|Hereditary cancer-predisposing syndrome [RCV000166131] |
Chr16:23635151 [GRCh38] Chr16:23646472 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2701C>G (p.Leu901Val) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000166144] |
Chr16:23626283 [GRCh38] Chr16:23637604 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.739A>G (p.Thr247Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000459460]|Familial cancer of breast [RCV002485029]|Hereditary cancer-predisposing syndrome [RCV000166174] |
Chr16:23635807 [GRCh38] Chr16:23647128 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1755T>C (p.Asp585=) |
single nucleotide variant |
Familial cancer of breast [RCV000980044]|Hereditary cancer-predisposing syndrome [RCV000166184]|not specified [RCV000609583] |
Chr16:23630399 [GRCh38] Chr16:23641720 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1291_1292del (p.His432fs) |
microsatellite |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005256573]|Familial cancer of breast [RCV000635659]|Hereditary cancer-predisposing syndrome [RCV000166194]|not provided [RCV000657306] |
Chr16:23635254..23635255 [GRCh38] Chr16:23646575..23646576 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1748T>C (p.Leu583Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000464125]|Fanconi anemia complementation group N [RCV005016500]|Hereditary cancer-predisposing syndrome [RCV000166198]|not provided [RCV000996241]|not specified [RCV005230014] |
Chr16:23630406 [GRCh38] Chr16:23641727 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.957T>C (p.Ser319=) |
single nucleotide variant |
Familial cancer of breast [RCV002516497]|Hereditary cancer-predisposing syndrome [RCV000166224] |
Chr16:23635589 [GRCh38] Chr16:23646910 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.142A>G (p.Ile48Val) |
single nucleotide variant |
Familial cancer of breast [RCV000200742]|Hereditary cancer-predisposing syndrome [RCV000166309]|not provided [RCV000213155] |
Chr16:23637919 [GRCh38] Chr16:23649240 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2881C>T (p.Leu961=) |
single nucleotide variant |
Familial cancer of breast [RCV001082547]|Familial cancer of breast [RCV002498824]|Fanconi anemia complementation group N [RCV000314489]|Fanconi anemia complementation group N [RCV005396488]|Hereditary cancer-predisposing syndrome [RCV000166333]|not provided [RCV000586278]|not specified [RCV000440818] |
Chr16:23623084 [GRCh38] Chr16:23634405 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1481C>A (p.Thr494Asn) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000166342] |
Chr16:23635065 [GRCh38] Chr16:23646386 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1311A>G (p.Lys437=) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798577]|Familial cancer of breast [RCV000409601]|Fanconi anemia complementation group N [RCV005394596]|Hereditary cancer-predisposing syndrome [RCV000163802]|PALB2-related disorder [RCV004535084]|not provided [RCV001284668]|not specified [RCV000780558] |
Chr16:23635235 [GRCh38] Chr16:23646556 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.405T>C (p.Pro135=) |
single nucleotide variant |
Familial cancer of breast [RCV000525958]|Hereditary cancer-predisposing syndrome [RCV000163924]|not provided [RCV001357587]|not specified [RCV000433802] |
Chr16:23636141 [GRCh38] Chr16:23647462 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3201+2dup |
duplication |
Familial cancer of breast [RCV001046380]|Hereditary cancer-predisposing syndrome [RCV000166354]|not provided [RCV001557148] |
Chr16:23614001..23614002 [GRCh38] Chr16:23625322..23625323 [GRCh37] Chr16:16p12.2 |
likely pathogenic|uncertain significance |
NM_024675.4(PALB2):c.1526G>A (p.Gly509Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000458684]|Familial cancer of breast [RCV000765273]|Hereditary cancer-predisposing syndrome [RCV000166375]|not specified [RCV002228767] |
Chr16:23635020 [GRCh38] Chr16:23646341 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1026C>G (p.Asn342Lys) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000166424] |
Chr16:23635520 [GRCh38] Chr16:23646841 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1790T>G (p.Met597Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000168192]|Hereditary cancer-predisposing syndrome [RCV000166427]|not provided [RCV001775650] |
Chr16:23630364 [GRCh38] Chr16:23641685 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.829G>A (p.Asp277Asn) |
single nucleotide variant |
Carcinoma of colon [RCV001030179]|Familial cancer of breast [RCV000477600]|Fanconi anemia complementation group N [RCV001336120]|Hereditary cancer-predisposing syndrome [RCV000166462]|not provided [RCV000235601] |
Chr16:23635717 [GRCh38] Chr16:23647038 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1914_1929del (p.Phe638fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000166469] |
Chr16:23630225..23630240 [GRCh38] Chr16:23641546..23641561 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.49-2A>T |
single nucleotide variant |
Familial cancer of breast [RCV000198571]|Hereditary cancer-predisposing syndrome [RCV000166471]|not provided [RCV004719727] |
Chr16:23638131 [GRCh38] Chr16:23649452 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.813T>A (p.Ser271Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000556676]|Hereditary cancer-predisposing syndrome [RCV000166472]|not provided [RCV001555224]|not specified [RCV001193465] |
Chr16:23635733 [GRCh38] Chr16:23647054 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.843_845del (p.Arg282del) |
deletion |
Familial cancer of breast [RCV000476802]|Hereditary cancer-predisposing syndrome [RCV000166474]|not provided [RCV003237755] |
Chr16:23635701..23635703 [GRCh38] Chr16:23647022..23647024 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2882T>C (p.Leu961Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000196629]|Hereditary cancer-predisposing syndrome [RCV000166475] |
Chr16:23623083 [GRCh38] Chr16:23634404 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2228A>G (p.Tyr743Cys) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003150010]|Familial cancer of breast [RCV000197626]|Familial pancreatic carcinoma [RCV005359455]|Fanconi anemia complementation group N [RCV000296163]|Hereditary breast ovarian cancer syndrome [RCV001030648]|Hereditary cancer-predisposing syndrome [RCV000164010]|not provided [RCV000255110]|not specified [RCV000781684] |
Chr16:23629926 [GRCh38] Chr16:23641247 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2569T>C (p.Leu857=) |
single nucleotide variant |
Familial cancer of breast [RCV001490279]|Hereditary cancer-predisposing syndrome [RCV000164027] |
Chr16:23629221 [GRCh38] Chr16:23640542 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2337A>C (p.Ser779=) |
single nucleotide variant |
Familial cancer of breast [RCV000211059]|Hereditary cancer-predisposing syndrome [RCV000164043] |
Chr16:23629817 [GRCh38] Chr16:23641138 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.195G>A (p.Pro65=) |
single nucleotide variant |
Familial cancer of breast [RCV000204765]|Familial cancer of breast [RCV002505204]|Hereditary cancer-predisposing syndrome [RCV000164062]|PALB2-related disorder [RCV004535090]|not provided [RCV000759183]|not specified [RCV000438495] |
Chr16:23637866 [GRCh38] Chr16:23649187 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2792T>G (p.Leu931Arg) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003389046]|Familial cancer of breast [RCV000408812]|Hereditary cancer-predisposing syndrome [RCV000166492]|Malignant tumor of breast [RCV001354782]|not provided [RCV000483646]|not specified [RCV002298494] |
Chr16:23624051 [GRCh38] Chr16:23635372 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2597G>A (p.Gly866Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000635797]|Hereditary cancer-predisposing syndrome [RCV000166501]|not provided [RCV005414475] |
Chr16:23626387 [GRCh38] Chr16:23637708 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2344C>T (p.Pro782Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000470017]|Familial cancer of breast [RCV002492670]|Hereditary cancer-predisposing syndrome [RCV000166543]|Malignant tumor of breast [RCV001355915]|not provided [RCV000478256]|not specified [RCV003479039] |
Chr16:23629810 [GRCh38] Chr16:23641131 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.993A>G (p.Glu331=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005235075]|Familial cancer of breast [RCV000411791]|Fanconi anemia complementation group N [RCV005396490]|Hereditary cancer-predisposing syndrome [RCV000166544] |
Chr16:23635553 [GRCh38] Chr16:23646874 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1852G>A (p.Asp618Asn) |
single nucleotide variant |
Familial cancer of breast [RCV001246033]|Hereditary cancer-predisposing syndrome [RCV000166567] |
Chr16:23630302 [GRCh38] Chr16:23641623 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.101G>T (p.Arg34Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000456690]|Familial cancer of breast [RCV002498826]|Hereditary cancer-predisposing syndrome [RCV000166587]|not provided [RCV000520497] |
Chr16:23638077 [GRCh38] Chr16:23649398 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3520G>A (p.Gly1174Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000469459]|Hereditary cancer-predisposing syndrome [RCV000166607] |
Chr16:23603500 [GRCh38] Chr16:23614821 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3244A>G (p.Ser1082Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000232382]|Familial cancer of breast [RCV002505212]|Hereditary cancer-predisposing syndrome [RCV000166614]|not provided [RCV004998351] |
Chr16:23607970 [GRCh38] Chr16:23619291 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1616_1617dup (p.Asn540fs) |
duplication |
Familial cancer of breast [RCV000815197]|Familial cancer of breast [RCV003483548]|Hereditary cancer-predisposing syndrome [RCV000166617]|PALB2-related disorder [RCV004724960] |
Chr16:23634928..23634929 [GRCh38] Chr16:23646249..23646250 [GRCh37] Chr16:16p12.2 |
pathogenic|not provided |
NM_024675.4(PALB2):c.1920A>T (p.Ser640=) |
single nucleotide variant |
Familial cancer of breast [RCV000474783]|Hereditary cancer-predisposing syndrome [RCV000164122]|not specified [RCV001527022] |
Chr16:23630234 [GRCh38] Chr16:23641555 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.84C>T (p.Tyr28=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003316018]|Familial cancer of breast [RCV000195762]|Hereditary cancer-predisposing syndrome [RCV000164145]|not provided [RCV000679774]|not specified [RCV000428315] |
Chr16:23638094 [GRCh38] Chr16:23649415 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.2100A>T (p.Ser700=) |
single nucleotide variant |
Familial cancer of breast [RCV000200038]|Fanconi anemia complementation group N [RCV000347505]|Hereditary cancer-predisposing syndrome [RCV000164155]|PALB2-related disorder [RCV004539543]|not provided [RCV001358505]|not specified [RCV000611803] |
Chr16:23630054 [GRCh38] Chr16:23641375 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1647_1648del (p.His549fs) |
microsatellite |
Familial cancer of breast [RCV004589745]|Hereditary cancer-predisposing syndrome [RCV000164237] |
Chr16:23634898..23634899 [GRCh38] Chr16:23646219..23646220 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2524_2535delinsTCAGA (p.Ala842fs) |
indel |
Familial cancer of breast [RCV003162710]|Hereditary cancer-predisposing syndrome [RCV000166663] |
Chr16:23629255..23629266 [GRCh38] Chr16:23640576..23640587 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1085_1086del (p.Leu362fs) |
deletion |
Familial cancer of breast [RCV000688589]|Hereditary cancer-predisposing syndrome [RCV000166687] |
Chr16:23635460..23635461 [GRCh38] Chr16:23646781..23646782 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.610T>G (p.Ser204Ala) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000166705] |
Chr16:23635936 [GRCh38] Chr16:23647257 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.242A>G (p.Lys81Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001246886]|Hereditary cancer-predisposing syndrome [RCV000166745] |
Chr16:23636304 [GRCh38] Chr16:23647625 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.266A>G (p.Asp89Gly) |
single nucleotide variant |
Familial cancer of breast [RCV002517613]|Hereditary cancer-predisposing syndrome [RCV000164258] |
Chr16:23636280 [GRCh38] Chr16:23647601 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1421G>A (p.Ser474Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000693357]|Hereditary cancer-predisposing syndrome [RCV000164284]|not provided [RCV000235242] |
Chr16:23635125 [GRCh38] Chr16:23646446 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1692A>G (p.Lys564=) |
single nucleotide variant |
Familial cancer of breast [RCV001436402]|Hereditary cancer-predisposing syndrome [RCV000164335]|not specified [RCV000418479] |
Chr16:23630462 [GRCh38] Chr16:23641783 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2478C>T (p.Asn826=) |
single nucleotide variant |
Familial cancer of breast [RCV000206600]|Hereditary cancer-predisposing syndrome [RCV000164395]|PALB2-related disorder [RCV004535097]|not specified [RCV000435545] |
Chr16:23629676 [GRCh38] Chr16:23640997 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.3244_3245del (p.Glu1081_Ser1082insTer) |
microsatellite |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004992136]|Familial cancer of breast [RCV000470633]|Hereditary breast ovarian cancer syndrome [RCV001778875]|Hereditary cancer-predisposing syndrome [RCV000568838]|PALB2-related disorder [RCV004535238]|not provided [RCV000254912] |
Chr16:23607969..23607970 [GRCh38] Chr16:23619290..23619291 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1496T>A (p.Leu499Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001390098]|not provided [RCV000254924] |
Chr16:23635050 [GRCh38] Chr16:23646371 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3234T>A (p.Cys1078Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001855013]|Hereditary cancer-predisposing syndrome [RCV001525205]|not provided [RCV000254975] |
Chr16:23607980 [GRCh38] Chr16:23619301 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2368C>T (p.Gln790Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000552634]|Fanconi anemia [RCV000509375]|Hereditary breast ovarian cancer syndrome [RCV003155937]|Hereditary cancer-predisposing syndrome [RCV000454204]|not provided [RCV000255054] |
Chr16:23629786 [GRCh38] Chr16:23641107 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|not provided |
NM_024675.4(PALB2):c.2996+1G>T |
single nucleotide variant |
Familial cancer of breast [RCV001379452]|Hereditary cancer-predisposing syndrome [RCV001017834]|not provided [RCV000255151] |
Chr16:23622968 [GRCh38] Chr16:23634289 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.1424C>G (p.Ser475Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001066196]|Hereditary cancer-predisposing syndrome [RCV002392782]|not provided [RCV000255228] |
Chr16:23635122 [GRCh38] Chr16:23646443 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2597del (p.Gly866fs) |
deletion |
Familial cancer of breast [RCV000168153] |
Chr16:23626387 [GRCh38] Chr16:23637708 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1659C>A (p.His553Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000168288]|Hereditary cancer-predisposing syndrome [RCV000582233]|not provided [RCV000519942] |
Chr16:23634887 [GRCh38] Chr16:23646208 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2671T>A (p.Cys891Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000168304]|Hereditary cancer-predisposing syndrome [RCV002426800] |
Chr16:23626313 [GRCh38] Chr16:23637634 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.3(PALB2):c.2587-?_*(1_?)del |
deletion |
Familial cancer of breast [RCV000168323] |
Chr16:23603458..23626397 [GRCh38] Chr16:23614779..23637718 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1241G>A (p.Arg414Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000168333]|Familial pancreatic carcinoma [RCV005365098]|Hereditary cancer-predisposing syndrome [RCV000561279]|PALB2-related disorder [RCV004739549]|not provided [RCV000478331]|not specified [RCV001818405] |
Chr16:23635305 [GRCh38] Chr16:23646626 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1487A>G (p.Asp496Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000168368]|Hereditary cancer-predisposing syndrome [RCV000575875]|not provided [RCV003228909] |
Chr16:23635059 [GRCh38] Chr16:23646380 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_23603458)_(23603669_?)del |
deletion |
Familial cancer of breast [RCV000168419] |
Chr16:23603458..23603669 [GRCh38] Chr16:23614779..23614990 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1115G>C (p.Ser372Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000168425]|Familial cancer of breast [RCV000765277]|Hereditary cancer-predisposing syndrome [RCV000774638] |
Chr16:23635431 [GRCh38] Chr16:23646752 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2896A>G (p.Ile966Val) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315417]|Familial cancer of breast [RCV000168443]|Familial cancer of breast [RCV002492681]|Fanconi anemia complementation group N [RCV000282581]|Hereditary cancer-predisposing syndrome [RCV000220514]|not provided [RCV000483896]|not specified [RCV003114319] |
Chr16:23623069 [GRCh38] Chr16:23634390 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.3:c.3495T>G |
single nucleotide variant |
Familial cancer of breast [RCV000211056] |
Chr16:23603525 [GRCh38] Chr16:23614846 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2755G>A (p.Val919Ile) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003150103]|Chordoma [RCV002266935]|Familial cancer of breast [RCV000211057]|Fanconi anemia complementation group N [RCV005016571]|Hereditary cancer-predisposing syndrome [RCV000454132]|not provided [RCV000478723]|not specified [RCV002465567] |
Chr16:23624088 [GRCh38] Chr16:23635409 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3366C>A (p.Asp1122Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000211062] |
Chr16:23603654 [GRCh38] Chr16:23614975 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2606C>G (p.Ser869Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000211067]|Hereditary cancer-predisposing syndrome [RCV000574296]|not provided [RCV000484494] |
Chr16:23626378 [GRCh38] Chr16:23637699 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1194G>T (p.Val398=) |
single nucleotide variant |
Familial cancer of breast [RCV000211072]|Hereditary cancer-predisposing syndrome [RCV002336588]|not provided [RCV004998437] |
Chr16:23635352 [GRCh38] Chr16:23646673 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.1478C>T (p.Pro493Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000211081]|Hereditary cancer-predisposing syndrome [RCV000217376]|Pilocytic astrocytoma [RCV000761143]|not provided [RCV001582721] |
Chr16:23635068 [GRCh38] Chr16:23646389 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2328C>T (p.Phe776=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003316170]|Familial cancer of breast [RCV000211085]|Hereditary cancer-predisposing syndrome [RCV000223186]|not provided [RCV001723789]|not specified [RCV000442137] |
Chr16:23629826 [GRCh38] Chr16:23641147 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1947_1966dup (p.Pro656fs) |
duplication |
Familial cancer of breast [RCV000211063] |
Chr16:23630187..23630188 [GRCh38] Chr16:23641508..23641509 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.522_523del (p.Arg175fs) |
deletion |
Familial cancer of breast [RCV000211064] |
Chr16:23636023..23636024 [GRCh38] Chr16:23647344..23647345 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.1085T>C (p.Leu362Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000211066] |
Chr16:23635461 [GRCh38] Chr16:23646782 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2484C>T (p.Cys828=) |
single nucleotide variant |
Familial cancer of breast [RCV000211068]|Hereditary cancer-predisposing syndrome [RCV002426987]|not specified [RCV001030310] |
Chr16:23629670 [GRCh38] Chr16:23640991 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3294G>A (p.Lys1098=) |
single nucleotide variant |
Familial cancer of breast [RCV000211069] |
Chr16:23607920 [GRCh38] Chr16:23619241 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2597G>T (p.Gly866Val) |
single nucleotide variant |
Familial cancer of breast [RCV000167868]|Hereditary cancer-predisposing syndrome [RCV000579819] |
Chr16:23626387 [GRCh38] Chr16:23637708 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.85A>G (p.Ser29Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000167900]|Hereditary cancer-predisposing syndrome [RCV000217631]|not provided [RCV002262763] |
Chr16:23638093 [GRCh38] Chr16:23649414 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.3(PALB2):c.3114-?_3350+?del |
deletion |
Familial cancer of breast [RCV000167940] |
Chr16:23607864..23614091 [GRCh38] Chr16:23619185..23625412 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.1316G>T (p.Gly439Val) |
single nucleotide variant |
Familial cancer of breast [RCV000167944]|Familial cancer of breast [RCV000765276]|Hereditary cancer-predisposing syndrome [RCV000565232]|not provided [RCV000588409]|not specified [RCV001818401] |
Chr16:23635230 [GRCh38] Chr16:23646551 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1096A>G (p.Asn366Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000167975]|Hereditary cancer-predisposing syndrome [RCV000774639]|Inherited breast cancer and ovarian cancer [RCV004808606] |
Chr16:23635450 [GRCh38] Chr16:23646771 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3106G>C (p.Val1036Leu) |
single nucleotide variant |
Carcinoma of colon [RCV001030381]|Familial cancer of breast [RCV000168000]|Familial cancer of breast [RCV002485044]|Hereditary cancer-predisposing syndrome [RCV000216674]|not provided [RCV000479177]|not specified [RCV001731498] |
Chr16:23621369 [GRCh38] Chr16:23632690 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2835-1G>A |
single nucleotide variant |
Familial cancer of breast [RCV000168057]|Hereditary cancer-predisposing syndrome [RCV000454148]|PALB2-related disorder [RCV004528920]|not provided [RCV000255033] |
Chr16:23623131 [GRCh38] Chr16:23634452 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2920_2923del (p.Lys974fs) |
deletion |
Familial cancer of breast [RCV000168075] |
Chr16:23623042..23623045 [GRCh38] Chr16:23634363..23634366 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1966_1967insAGAGGAAGCTGTATTTTTC (p.Pro656fs) |
insertion |
Familial cancer of breast [RCV000168094]|Hereditary cancer-predisposing syndrome [RCV000564048] |
Chr16:23630187..23630188 [GRCh38] Chr16:23641508..23641509 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.301G>C (p.Asp101His) |
single nucleotide variant |
Familial cancer of breast [RCV001234794]|Hereditary cancer-predisposing syndrome [RCV001018073]|not provided [RCV000178364] |
Chr16:23636245 [GRCh38] Chr16:23647566 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2505C>T (p.Ser835=) |
single nucleotide variant |
Familial cancer of breast [RCV001085109]|Hereditary cancer-predisposing syndrome [RCV000575425]|Malignant tumor of breast [RCV001354928]|not provided [RCV000724499]|not specified [RCV003321538] |
Chr16:23629649 [GRCh38] Chr16:23640970 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2140G>A (p.Asp714Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000195423]|Familial pancreatic carcinoma [RCV005361157]|Hereditary cancer-predisposing syndrome [RCV000562225]|not provided [RCV003223619] |
Chr16:23630014 [GRCh38] Chr16:23641335 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3538A>G (p.Ile1180Val) |
single nucleotide variant |
Familial cancer of breast [RCV000195715]|Familial cancer of breast [RCV002492923]|Fanconi anemia complementation group N [RCV005396619]|Hereditary cancer-predisposing syndrome [RCV000216876]|not provided [RCV000478251]|not specified [RCV001251265] |
Chr16:23603482 [GRCh38] Chr16:23614803 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1792C>T (p.Leu598=) |
single nucleotide variant |
Familial cancer of breast [RCV000195746]|Hereditary cancer-predisposing syndrome [RCV000581753]|not provided [RCV001722110]|not specified [RCV000445227] |
Chr16:23630362 [GRCh38] Chr16:23641683 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.2506G>T (p.Val836Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000195841]|Hereditary cancer-predisposing syndrome [RCV000584448]|not provided [RCV001030312] |
Chr16:23629648 [GRCh38] Chr16:23640969 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3260G>A (p.Ser1087Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000196033]|Hereditary cancer-predisposing syndrome [RCV001019497] |
Chr16:23607954 [GRCh38] Chr16:23619275 [GRCh37] Chr16:16p12.2 |
pathogenic|likely benign|uncertain significance |
NM_024675.4(PALB2):c.2178T>C (p.Pro726=) |
single nucleotide variant |
Familial cancer of breast [RCV000196097]|Hereditary cancer-predisposing syndrome [RCV000568234]|not provided [RCV000841381] |
Chr16:23629976 [GRCh38] Chr16:23641297 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.511T>A (p.Leu171Met) |
single nucleotide variant |
Familial cancer of breast [RCV000196309] |
Chr16:23636035 [GRCh38] Chr16:23647356 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.3(PALB2):c.3114-?_3201+?dup88 |
duplication |
Familial cancer of breast [RCV000196349] |
Chr16:23614004..23614091 [GRCh38] Chr16:23625325..23625412 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.753G>C (p.Gln251His) |
single nucleotide variant |
Familial cancer of breast [RCV000196503] |
Chr16:23635793 [GRCh38] Chr16:23647114 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2640C>T (p.Ala880=) |
single nucleotide variant |
Familial cancer of breast [RCV000196557]|Fanconi anemia complementation group N [RCV005396609]|Hereditary cancer-predisposing syndrome [RCV000575506] |
Chr16:23626344 [GRCh38] Chr16:23637665 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.929G>A (p.Ser310Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000196709]|Hereditary cancer-predisposing syndrome [RCV000570793]|PALB2-related disorder [RCV004739590]|not provided [RCV000480147]|not specified [RCV004689672] |
Chr16:23635617 [GRCh38] Chr16:23646938 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3103A>G (p.Ile1035Val) |
single nucleotide variant |
Chordoma [RCV002266931]|Familial cancer of breast [RCV000196785]|Hereditary cancer-predisposing syndrome [RCV000220160]|not provided [RCV001797063] |
Chr16:23621372 [GRCh38] Chr16:23632693 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.351T>C (p.Pro117=) |
single nucleotide variant |
Familial cancer of breast [RCV001083303]|Hereditary cancer-predisposing syndrome [RCV000566532]|not provided [RCV000679772]|not specified [RCV003323450] |
Chr16:23636195 [GRCh38] Chr16:23647516 [GRCh37] Chr16:16p12.2 |
pathogenic|benign|likely benign |
NM_024675.4(PALB2):c.985C>G (p.Leu329Val) |
single nucleotide variant |
Familial cancer of breast [RCV000196873]|not provided [RCV001030192] |
Chr16:23635561 [GRCh38] Chr16:23646882 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3202-9C>T |
single nucleotide variant |
Familial cancer of breast [RCV000196913]|Hereditary cancer-predisposing syndrome [RCV000579396]|Pancreatic cancer, susceptibility to, 3 [RCV001354308]|not provided [RCV001711353]|not specified [RCV001818478] |
Chr16:23608021 [GRCh38] Chr16:23619342 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.3247G>A (p.Glu1083Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000196986]|Familial cancer of breast [RCV000764044]|Hereditary cancer-predisposing syndrome [RCV000574156]|See cases [RCV002252054]|not provided [RCV000480697]|not specified [RCV001194139] |
Chr16:23607967 [GRCh38] Chr16:23619288 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2996+9del |
deletion |
Familial cancer of breast [RCV000197031]|Hereditary cancer-predisposing syndrome [RCV000580718]|Malignant tumor of breast [RCV001354543]|PALB2-related disorder [RCV004739585]|not provided [RCV003477663]|not specified [RCV000478607] |
Chr16:23622960 [GRCh38] Chr16:23634281 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2176C>T (p.Pro726Ser) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005361158]|Familial cancer of breast [RCV000197340]|Hereditary cancer-predisposing syndrome [RCV000569353]|not provided [RCV001775663] |
Chr16:23629978 [GRCh38] Chr16:23641299 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2360C>T (p.Thr787Ile) |
single nucleotide variant |
Carcinoma of colon [RCV001030299]|Familial cancer of breast [RCV000197564]|Hereditary cancer-predisposing syndrome [RCV000216753]|not provided [RCV000236931]|not specified [RCV004586620] |
Chr16:23629794 [GRCh38] Chr16:23641115 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2543A>G (p.Asp848Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000197723] |
Chr16:23629247 [GRCh38] Chr16:23640568 [GRCh37] Chr16:16p12.2 |
likely pathogenic|uncertain significance |
NM_024675.4(PALB2):c.1839G>A (p.Gln613=) |
single nucleotide variant |
Familial cancer of breast [RCV000197939]|Familial pancreatic carcinoma [RCV005365125]|Hereditary cancer-predisposing syndrome [RCV000214157]|not specified [RCV000615484] |
Chr16:23630315 [GRCh38] Chr16:23641636 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2515-1G>C |
single nucleotide variant |
Familial cancer of breast [RCV000198016]|Hereditary cancer-predisposing syndrome [RCV000580827]|not provided [RCV000985889] |
Chr16:23629276 [GRCh38] Chr16:23640597 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.3448C>T (p.Leu1150Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000198123]|Hereditary cancer-predisposing syndrome [RCV000776376]|not provided [RCV001284322] |
Chr16:23603572 [GRCh38] Chr16:23614893 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.841A>T (p.Ile281Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000198379]|Fanconi anemia complementation group N [RCV005396620]|Hereditary cancer-predisposing syndrome [RCV000454145]|not provided [RCV003114361] |
Chr16:23635705 [GRCh38] Chr16:23647026 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2935A>C (p.Ser979Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000198507] |
Chr16:23623030 [GRCh38] Chr16:23634351 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2763G>C (p.Gln921His) |
single nucleotide variant |
Familial cancer of breast [RCV000198606] |
Chr16:23624080 [GRCh38] Chr16:23635401 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2997-9T>C |
single nucleotide variant |
Familial cancer of breast [RCV001450160]|Hereditary cancer-predisposing syndrome [RCV001525968]|not specified [RCV001194136] |
Chr16:23621487 [GRCh38] Chr16:23632808 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3172T>G (p.Ser1058Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000198725]|Hereditary cancer-predisposing syndrome [RCV002321799] |
Chr16:23614033 [GRCh38] Chr16:23625354 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2748+9del |
deletion |
Familial cancer of breast [RCV000198769] |
Chr16:23626227 [GRCh38] Chr16:23637548 [GRCh37] Chr16:16p12.2 |
likely pathogenic|likely benign |
NM_024675.4(PALB2):c.735G>A (p.Ala245=) |
single nucleotide variant |
Familial cancer of breast [RCV001087862]|Familial cancer of breast [RCV002478701]|Hereditary cancer-predisposing syndrome [RCV000214366]|not provided [RCV000841727] |
Chr16:23635811 [GRCh38] Chr16:23647132 [GRCh37] Chr16:16p12.2 |
likely pathogenic|benign|likely benign |
NM_024675.4(PALB2):c.2470dup (p.Cys824fs) |
duplication |
Breast-ovarian cancer, familial, susceptibility to, 1 [RCV003224869]|Familial cancer of breast [RCV000199043]|Hereditary cancer-predisposing syndrome [RCV000215206]|Malignant tumor of breast [RCV005237703]|not provided [RCV001268661] |
Chr16:23629683..23629684 [GRCh38] Chr16:23641004..23641005 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1093A>C (p.Arg365=) |
single nucleotide variant |
Familial cancer of breast [RCV000199103]|Hereditary cancer-predisposing syndrome [RCV000571694]|not specified [RCV000419084] |
Chr16:23635453 [GRCh38] Chr16:23646774 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3473A>G (p.His1158Arg) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798672]|Familial cancer of breast [RCV000199321]|Hereditary cancer-predisposing syndrome [RCV000217762]|PALB2-related disorder [RCV004739589]|not provided [RCV004998415] |
Chr16:23603547 [GRCh38] Chr16:23614868 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1848T>C (p.Asp616=) |
single nucleotide variant |
Familial cancer of breast [RCV001482291]|Hereditary cancer-predisposing syndrome [RCV004943768] |
Chr16:23630306 [GRCh38] Chr16:23641627 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.3(PALB2):c.2587-?_2748+?del |
deletion |
Familial cancer of breast [RCV000199582]|Hereditary cancer-predisposing syndrome [RCV000210086] |
Chr16:23626236..23626397 [GRCh38] Chr16:23637557..23637718 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.380A>G (p.His127Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000199860]|Hereditary cancer-predisposing syndrome [RCV001804936]|not provided [RCV001030147] |
Chr16:23636166 [GRCh38] Chr16:23647487 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.3(PALB2):c.3114-?_3201+?del |
deletion |
Familial cancer of breast [RCV000199868] |
Chr16:23614004..23614091 [GRCh38] Chr16:23625325..23625412 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2229T>C (p.Tyr743=) |
single nucleotide variant |
Familial cancer of breast [RCV000199909]|Hereditary cancer-predisposing syndrome [RCV000219447] |
Chr16:23629925 [GRCh38] Chr16:23641246 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.212-10del |
deletion |
Familial cancer of breast [RCV001084305]|Hereditary cancer-predisposing syndrome [RCV000580912]|PALB2-related cancer predisposition [RCV005365122]|not provided [RCV000587569]|not specified [RCV001818473] |
Chr16:23636344 [GRCh38] Chr16:23647665 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3209T>C (p.Leu1070Pro) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003150089]|Familial cancer of breast [RCV000200608]|Familial cancer of breast [RCV002503787]|Hereditary cancer-predisposing syndrome [RCV000568710]|not provided [RCV004719744] |
Chr16:23608005 [GRCh38] Chr16:23619326 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1337A>T (p.Asp446Val) |
single nucleotide variant |
Familial cancer of breast [RCV000200861]|Familial cancer of breast [RCV002492922]|Hereditary cancer-predisposing syndrome [RCV000562823]|PALB2-related disorder [RCV004530198]|Retinoblastoma [RCV000761148]|not provided [RCV000255070]|not specified [RCV001194137] |
Chr16:23635209 [GRCh38] Chr16:23646530 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2514+1G>C |
single nucleotide variant |
Familial cancer of breast [RCV001229856]|Hereditary cancer-predisposing syndrome [RCV002429197]|not provided [RCV000255296] |
Chr16:23629639 [GRCh38] Chr16:23640960 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.33_36dup (p.Glu13Ter) |
duplication |
Hereditary cancer-predisposing syndrome [RCV001180726] |
Chr16:23641121..23641122 [GRCh38] Chr16:23652442..23652443 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1580G>A (p.Cys527Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV005091329]|Hereditary cancer-predisposing syndrome [RCV000561219] |
Chr16:23634966 [GRCh38] Chr16:23646287 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.406A>T (p.Ser136Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000542390]|Hereditary cancer-predisposing syndrome [RCV001021800]|not specified [RCV004525963] |
Chr16:23636140 [GRCh38] Chr16:23647461 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1242A>C (p.Arg414=) |
single nucleotide variant |
Familial cancer of breast [RCV000211070]|Hereditary cancer-predisposing syndrome [RCV000569226]|Malignant tumor of breast [RCV001356016]|not provided [RCV001705186] |
Chr16:23635304 [GRCh38] Chr16:23646625 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3073G>A (p.Ala1025Thr) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003491950]|Familial cancer of breast [RCV000202108]|Fanconi anemia complementation group N [RCV001116750]|Fanconi anemia complementation group N [RCV005396622]|Hereditary cancer-predisposing syndrome [RCV000213208]|not provided [RCV000479987]|not specified [RCV001174762] |
Chr16:23621402 [GRCh38] Chr16:23632723 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2756T>G (p.Val919Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000258956] |
Chr16:23624087 [GRCh38] Chr16:23635408 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1178A>G (p.Lys393Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000204310]|Familial cancer of breast [RCV002494523]|Hereditary cancer-predisposing syndrome [RCV001010149]|not provided [RCV004767150]|not specified [RCV003488460] |
Chr16:23635368 [GRCh38] Chr16:23646689 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_23603458)_(23614091_?)del |
deletion |
Familial cancer of breast [RCV000204353] |
Chr16:23603458..23614091 [GRCh38] Chr16:23614779..23625412 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.860dup (p.Ser288fs) |
duplication |
Familial cancer of breast [RCV000204478]|Hereditary cancer-predisposing syndrome [RCV001018084]|not provided [RCV002510818] |
Chr16:23635685..23635686 [GRCh38] Chr16:23647006..23647007 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.93dup (p.Leu32fs) |
duplication |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004597760]|Familial cancer of breast [RCV000204530]|Familial cancer of breast [RCV002485348]|Hereditary cancer-predisposing syndrome [RCV000223136]|PALB2-related cancer predisposition [RCV005361189]|Pancreatic cancer, susceptibility to, 3 [RCV002288830]|not provided [RCV000236141] |
Chr16:23638084..23638085 [GRCh38] Chr16:23649405..23649406 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
GRCh37/hg19 16p13.3-11.2(chr16:102839-28327676)x3 |
copy number gain |
See cases [RCV000203445] |
Chr16:102839..28327676 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic |
NM_024675.4(PALB2):c.398G>T (p.Ser133Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000204748]|Fanconi anemia complementation group N [RCV005016566]|Hereditary cancer-predisposing syndrome [RCV000575642]|Pancreatic cancer, susceptibility to, 3 [RCV005361185] |
Chr16:23636148 [GRCh38] Chr16:23647469 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2031T>C (p.Val677=) |
single nucleotide variant |
Familial cancer of breast [RCV000204811]|Hereditary cancer-predisposing syndrome [RCV000567205]|PALB2-related disorder [RCV004530246]|not provided [RCV001815251]|not specified [RCV000604788] |
Chr16:23630123 [GRCh38] Chr16:23641444 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1457A>T (p.Lys486Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000205091]|Hereditary cancer-predisposing syndrome [RCV002390544]|not provided [RCV001030229]|not specified [RCV000780561] |
Chr16:23635089 [GRCh38] Chr16:23646410 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2899A>C (p.Lys967Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000205092] |
Chr16:23623066 [GRCh38] Chr16:23634387 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.393G>C (p.Arg131Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000205247] |
Chr16:23636153 [GRCh38] Chr16:23647474 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.508A>G (p.Arg170Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000205323]|Hereditary cancer-predisposing syndrome [RCV000215139]|not provided [RCV000484020]|not specified [RCV003114369] |
Chr16:23636038 [GRCh38] Chr16:23647359 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.3(PALB2):c.3202-?_*(1_?)del |
deletion |
Hereditary cancer-predisposing syndrome [RCV000210201] |
Chr16:23603458..23608012 [GRCh38] Chr16:23614779..23619333 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1758T>C (p.Asp586=) |
single nucleotide variant |
Familial cancer of breast [RCV001448243]|Hereditary cancer-predisposing syndrome [RCV001013048]|not specified [RCV003155124] |
Chr16:23630396 [GRCh38] Chr16:23641717 [GRCh37] Chr16:16p12.2 |
risk factor|benign|likely benign |
NM_024675.4(PALB2):c.541G>C (p.Glu181Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000205547]|Familial cancer of breast [RCV002485341]|Hereditary cancer-predisposing syndrome [RCV000774643] |
Chr16:23636005 [GRCh38] Chr16:23647326 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2469C>G (p.Leu823=) |
single nucleotide variant |
Familial cancer of breast [RCV000205616]|Hereditary cancer-predisposing syndrome [RCV000570985]|PALB2-related disorder [RCV004530233]|not provided [RCV001355858]|not specified [RCV000440482] |
Chr16:23629685 [GRCh38] Chr16:23641006 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.3103A>T (p.Ile1035Phe) |
single nucleotide variant |
Carcinoma of colon [RCV001030379]|Familial cancer of breast [RCV000205673]|Familial cancer of breast [RCV002485342]|Hereditary cancer-predisposing syndrome [RCV000565112]|not provided [RCV003153483] |
Chr16:23621372 [GRCh38] Chr16:23632693 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1563C>G (p.Thr521=) |
single nucleotide variant |
Familial cancer of breast [RCV000205681]|Hereditary cancer-predisposing syndrome [RCV000563388] |
Chr16:23634983 [GRCh38] Chr16:23646304 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.149A>C (p.Lys50Thr) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003491955]|Familial cancer of breast [RCV000205692]|Hereditary cancer-predisposing syndrome [RCV000221595]|Malignant tumor of breast [RCV001357513]|not provided [RCV000656934]|not specified [RCV000236334] |
Chr16:23637912 [GRCh38] Chr16:23649233 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3373G>T (p.Asp1125Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000205701]|Hereditary cancer-predisposing syndrome [RCV000220052]|PALB2-related disorder [RCV004541293]|not provided [RCV001559044] |
Chr16:23603647 [GRCh38] Chr16:23614968 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3310G>A (p.Gly1104Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000205794]|Hereditary cancer-predisposing syndrome [RCV000565663]|not provided [RCV000237061] |
Chr16:23607904 [GRCh38] Chr16:23619225 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2834+2T>G |
single nucleotide variant |
Familial cancer of breast [RCV000205865] |
Chr16:23624007 [GRCh38] Chr16:23635328 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3331C>G (p.Pro1111Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000205952]|Familial cancer of breast [RCV002478727]|Hereditary breast ovarian cancer syndrome [RCV004764779]|Hereditary cancer-predisposing syndrome [RCV000222857]|not provided [RCV000587389]|not specified [RCV001800527] |
Chr16:23607883 [GRCh38] Chr16:23619204 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3059A>G (p.Gln1020Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000206051]|Hereditary cancer-predisposing syndrome [RCV001018358] |
Chr16:23621416 [GRCh38] Chr16:23632737 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1794G>A (p.Leu598=) |
single nucleotide variant |
Familial cancer of breast [RCV000206106]|Familial cancer of breast [RCV002500643]|Hereditary cancer-predisposing syndrome [RCV000219903]|PALB2-related disorder [RCV004541287]|not provided [RCV001705169]|not specified [RCV000418143] |
Chr16:23630360 [GRCh38] Chr16:23641681 [GRCh37] Chr16:16p12.2 |
pathogenic|benign|likely benign |
NM_024675.4(PALB2):c.554A>G (p.Lys185Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000206508]|Hereditary cancer-predisposing syndrome [RCV002345740]|not provided [RCV004772866] |
Chr16:23635992 [GRCh38] Chr16:23647313 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.660T>C (p.Ser220=) |
single nucleotide variant |
Familial cancer of breast [RCV000203679]|Hereditary cancer-predisposing syndrome [RCV000570942]|Malignant tumor of breast [RCV001354997]|not provided [RCV003477705]|not specified [RCV000601651] |
Chr16:23635886 [GRCh38] Chr16:23647207 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.3271C>T (p.Gln1091Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004692825]|Familial cancer of breast [RCV000206656]|not provided [RCV000708617] |
Chr16:23607943 [GRCh38] Chr16:23619264 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3286_3289delinsGTTAATGA (p.Asn1096fs) |
indel |
Familial cancer of breast [RCV000206761]|Hereditary breast ovarian cancer syndrome [RCV000586640]|Hereditary cancer-predisposing syndrome [RCV000217334]|not provided [RCV000507665] |
Chr16:23607925..23607928 [GRCh38] Chr16:23619246..23619249 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.761C>A (p.Ser254Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000206812]|Hereditary cancer-predisposing syndrome [RCV002390551] |
Chr16:23635785 [GRCh38] Chr16:23647106 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.226A>G (p.Ile76Val) |
single nucleotide variant |
Carcinoma of colon [RCV001030134]|Familial cancer of breast [RCV000203860]|Fanconi anemia complementation group N [RCV005016565]|Hereditary cancer-predisposing syndrome [RCV000223229]|not provided [RCV000590079]|not specified [RCV001526861] |
Chr16:23636320 [GRCh38] Chr16:23647641 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2561A>G (p.Asn854Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000203889]|Hereditary cancer-predisposing syndrome [RCV000573572]|not provided [RCV000679765] |
Chr16:23629229 [GRCh38] Chr16:23640550 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1647C>A (p.His549Gln) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798683]|Familial cancer of breast [RCV000203956]|Fanconi anemia complementation group N [RCV005396646]|Hereditary cancer-predisposing syndrome [RCV000219639]|not provided [RCV000766620]|not specified [RCV000479905] |
Chr16:23634899 [GRCh38] Chr16:23646220 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.109C>T (p.Arg37Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000204029]|Hereditary cancer-predisposing syndrome [RCV000561601]|PALB2-related disorder [RCV004530229]|not provided [RCV000485666]|not specified [RCV002247634] |
Chr16:23637952 [GRCh38] Chr16:23649273 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1805A>T (p.Gln602Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000204088] |
Chr16:23630349 [GRCh38] Chr16:23641670 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3350+1G>A |
single nucleotide variant |
Familial cancer of breast [RCV000204129] |
Chr16:23607863 [GRCh38] Chr16:23619184 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1042C>T (p.Gln348Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000409735]|Hereditary breast ovarian cancer syndrome [RCV000416712]|Hereditary cancer-predisposing syndrome [RCV000568484]|Malignant tumor of breast [RCV001358472]|not provided [RCV000255651] |
Chr16:23635504 [GRCh38] Chr16:23646825 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2505C>A (p.Ser835=) |
single nucleotide variant |
Familial cancer of breast [RCV000542987]|Hereditary cancer-predisposing syndrome [RCV003302806] |
Chr16:23629649 [GRCh38] Chr16:23640970 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1650del (p.Lys550fs) |
deletion |
Familial cancer of breast [RCV003500524]|not provided [RCV000255534] |
Chr16:23634896 [GRCh38] Chr16:23646217 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.487_488del (p.Val163fs) |
microsatellite |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003389468]|Familial cancer of breast [RCV000799725]|Hereditary cancer-predisposing syndrome [RCV000454359]|Pancreatic cancer, susceptibility to, 3 [RCV002272200]|not provided [RCV000255562] |
Chr16:23636058..23636059 [GRCh38] Chr16:23647379..23647380 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3295_3301del (p.Thr1099fs) |
deletion |
not provided [RCV000255569] |
Chr16:23607913..23607919 [GRCh38] Chr16:23619234..23619240 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.3311G>A (p.Gly1104Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000557463]|Hereditary cancer-predisposing syndrome [RCV000561557] |
Chr16:23607903 [GRCh38] Chr16:23619224 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2719del (p.Glu907fs) |
deletion |
Familial cancer of breast [RCV000811566]|Hereditary cancer-predisposing syndrome [RCV000561628]|not provided [RCV004596270] |
Chr16:23626265 [GRCh38] Chr16:23637586 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1440del (p.Lys480fs) |
deletion |
Familial cancer of breast [RCV000689768]|Hereditary cancer-predisposing syndrome [RCV000561471] |
Chr16:23635106 [GRCh38] Chr16:23646427 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2177C>T (p.Pro726Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000544352]|Hereditary cancer-predisposing syndrome [RCV002431575] |
Chr16:23629977 [GRCh38] Chr16:23641298 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.210A>G (p.Ser70=) |
single nucleotide variant |
Familial cancer of breast [RCV000690592]|Hereditary cancer-predisposing syndrome [RCV000561518] |
Chr16:23637851 [GRCh38] Chr16:23649172 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1471G>A (p.Ala491Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000555891]|Hereditary cancer-predisposing syndrome [RCV000563308]|not provided [RCV001545090] |
Chr16:23635075 [GRCh38] Chr16:23646396 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2784G>A (p.Val928=) |
single nucleotide variant |
Familial cancer of breast [RCV002490997]|Familial cancer of breast [RCV002528334]|Hereditary cancer-predisposing syndrome [RCV001016600]|not provided [RCV000547116] |
Chr16:23624059 [GRCh38] Chr16:23635380 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.2515-3C>T |
single nucleotide variant |
Familial cancer of breast [RCV000543762]|Hereditary cancer-predisposing syndrome [RCV001015746]|not provided [RCV001775854] |
Chr16:23629278 [GRCh38] Chr16:23640599 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.899C>G (p.Thr300Arg) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000562506] |
Chr16:23635647 [GRCh38] Chr16:23646968 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.823A>C (p.Thr275Pro) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000562515] |
Chr16:23635723 [GRCh38] Chr16:23647044 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.371C>A (p.Thr124Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000688473]|Hereditary cancer-predisposing syndrome [RCV000573383]|not provided [RCV000522653] |
Chr16:23636175 [GRCh38] Chr16:23647496 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1498T>C (p.Ser500Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000207336]|Familial cancer of breast [RCV002478746]|Hereditary cancer-predisposing syndrome [RCV001524375]|not provided [RCV003477707] |
Chr16:23635048 [GRCh38] Chr16:23646369 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1991T>C (p.Met664Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000547344]|Hereditary cancer-predisposing syndrome [RCV001013948] |
Chr16:23630163 [GRCh38] Chr16:23641484 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3399T>C (p.Thr1133=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000563145] |
Chr16:23603621 [GRCh38] Chr16:23614942 [GRCh37] Chr16:16p12.2 |
likely benign |
GRCh37/hg19 16p12.3-11.2(chr16:19590412-29814175)x3 |
copy number gain |
Breast ductal adenocarcinoma [RCV000207226] |
Chr16:19590412..29814175 [GRCh37] Chr16:16p12.3-11.2 |
uncertain significance |
NM_024675.4(PALB2):c.2542G>C (p.Asp848His) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000579592] |
Chr16:23629248 [GRCh38] Chr16:23640569 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p13.3-11.2(chr16:1279324-31926800)x3 |
copy number gain |
Breast ductal adenocarcinoma [RCV000207053] |
Chr16:1279324..31926800 [GRCh37] Chr16:16p13.3-11.2 |
uncertain significance |
NM_024675.4(PALB2):c.2500C>T (p.His834Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV001853887]|Hereditary cancer-predisposing syndrome [RCV000579392] |
Chr16:23629654 [GRCh38] Chr16:23640975 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1919C>G (p.Ser640Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003453539]|Hereditary cancer-predisposing syndrome [RCV002406678]|not provided [RCV000756460] |
Chr16:23630235 [GRCh38] Chr16:23641556 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.964_975dup (p.Glu322_Ile325dup) |
duplication |
Familial cancer of breast [RCV000411049]|Hereditary cancer-predisposing syndrome [RCV000219474] |
Chr16:23635570..23635571 [GRCh38] Chr16:23646891..23646892 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1035A>C (p.Leu345Phe) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000219505] |
Chr16:23635511 [GRCh38] Chr16:23646832 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.34GAG[1] (p.Glu13del) |
microsatellite |
Familial cancer of breast [RCV000817877]|Hereditary cancer-predisposing syndrome [RCV000219523]|Infiltrating duct carcinoma of breast [RCV000677894]|not provided [RCV000985894]|not specified [RCV001175516] |
Chr16:23641119..23641121 [GRCh38] Chr16:23652440..23652442 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.48+2T>G |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000221819] |
Chr16:23641108 [GRCh38] Chr16:23652429 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.2257C>A (p.Arg753=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000221875] |
Chr16:23629897 [GRCh38] Chr16:23641218 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2971G>T (p.Val991Phe) |
single nucleotide variant |
Carcinoma of colon [RCV001030360]|Familial cancer of breast [RCV000459925]|Hereditary cancer-predisposing syndrome [RCV000221881]|not provided [RCV000481851]|not specified [RCV001527008] |
Chr16:23622994 [GRCh38] Chr16:23634315 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2917A>G (p.Thr973Ala) |
single nucleotide variant |
Familial cancer of breast [RCV002518234]|Hereditary cancer-predisposing syndrome [RCV000221884] |
Chr16:23623048 [GRCh38] Chr16:23634369 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2481A>T (p.Thr827=) |
single nucleotide variant |
Familial cancer of breast [RCV000554218]|Hereditary cancer-predisposing syndrome [RCV000221910]|not specified [RCV000427990] |
Chr16:23629673 [GRCh38] Chr16:23640994 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.115C>T (p.Gln39Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000551161]|Hereditary cancer-predisposing syndrome [RCV000223492] |
Chr16:23637946 [GRCh38] Chr16:23649267 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2108T>G (p.Leu703Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001221815]|Hereditary cancer-predisposing syndrome [RCV000223583] |
Chr16:23630046 [GRCh38] Chr16:23641367 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2787T>C (p.Tyr929=) |
single nucleotide variant |
Familial cancer of breast [RCV001483979]|Hereditary cancer-predisposing syndrome [RCV000215323] |
Chr16:23624056 [GRCh38] Chr16:23635377 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1960A>G (p.Ile654Val) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005361351]|Familial cancer of breast [RCV000468846]|Hereditary cancer-predisposing syndrome [RCV000215342]|not provided [RCV001030272]|not specified [RCV004689684] |
Chr16:23630194 [GRCh38] Chr16:23641515 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.170G>T (p.Cys57Phe) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000215387] |
Chr16:23637891 [GRCh38] Chr16:23649212 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.500_513del (p.Asp167fs) |
deletion |
Familial cancer of breast [RCV001383290]|Hereditary cancer-predisposing syndrome [RCV000217069] |
Chr16:23636033..23636046 [GRCh38] Chr16:23647354..23647367 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2470del (p.Cys824fs) |
deletion |
Familial cancer of breast [RCV000686532]|Gastric cancer [RCV003165554]|Hereditary cancer-predisposing syndrome [RCV000217072]|not provided [RCV001800544] |
Chr16:23629684 [GRCh38] Chr16:23641005 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3350G>A (p.Arg1117Lys) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315422]|Familial cancer of breast [RCV000533846]|Hereditary breast ovarian cancer syndrome [RCV002277578]|Hereditary cancer-predisposing syndrome [RCV000217139]|not provided [RCV004998471]|not specified [RCV002271470] |
Chr16:23607864 [GRCh38] Chr16:23619185 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2488del (p.Glu830fs) |
deletion |
Breast and/or ovarian cancer [RCV003150120]|Familial cancer of breast [RCV000635786]|Fanconi anemia complementation group N [RCV001782706]|Hereditary breast ovarian cancer syndrome [RCV004017527]|Hereditary cancer-predisposing syndrome [RCV000217161]|not provided [RCV000478191] |
Chr16:23629666 [GRCh38] Chr16:23640987 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3027del (p.Glu1010fs) |
deletion |
Familial cancer of breast [RCV000689332]|Hereditary cancer-predisposing syndrome [RCV000217162] |
Chr16:23621448 [GRCh38] Chr16:23632769 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3377A>C (p.His1126Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000469669]|Hereditary cancer-predisposing syndrome [RCV000217197] |
Chr16:23603643 [GRCh38] Chr16:23614964 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3306C>T (p.Ser1102=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003316205]|Familial cancer of breast [RCV000465602]|Hereditary cancer-predisposing syndrome [RCV000219653]|not provided [RCV003417784]|not specified [RCV001030407] |
Chr16:23607908 [GRCh38] Chr16:23619229 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1573G>T (p.Asp525Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV001857775]|Hereditary cancer-predisposing syndrome [RCV000219759] |
Chr16:23634973 [GRCh38] Chr16:23646294 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3471A>T (p.Gln1157His) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000219777] |
Chr16:23603549 [GRCh38] Chr16:23614870 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2142_2143insTAA (p.Asp715Ter) |
insertion |
Hereditary cancer-predisposing syndrome [RCV000222029] |
Chr16:23630011..23630012 [GRCh38] Chr16:23641332..23641333 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.229T>C (p.Cys77Arg) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005361343]|Familial cancer of breast [RCV000472473]|Hereditary cancer-predisposing syndrome [RCV000222033]|not provided [RCV000485885]|not specified [RCV001818541] |
Chr16:23636317 [GRCh38] Chr16:23647638 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.3(PALB2):c.2966_2967insCAACAAGT (p.Glu990Asnfs) |
insertion |
Familial cancer of breast [RCV000211065] |
Chr16:23622998..23622999 [GRCh38] Chr16:23634319..23634320 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.577dup (p.Thr193fs) |
duplication |
Familial cancer of breast [RCV000211071] |
Chr16:23635968..23635969 [GRCh38] Chr16:23647289..23647290 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.693dup (p.Gly232fs) |
duplication |
Familial cancer of breast [RCV000211082]|Hereditary cancer-predisposing syndrome [RCV004020583] |
Chr16:23635852..23635853 [GRCh38] Chr16:23647173..23647174 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2586G>C (p.Lys862Asn) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003150118]|Familial cancer of breast [RCV000635942]|Hereditary cancer-predisposing syndrome [RCV000217255] |
Chr16:23629204 [GRCh38] Chr16:23640525 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3396_3405del (p.Thr1133fs) |
deletion |
Familial cancer of breast [RCV000812433]|Hereditary cancer-predisposing syndrome [RCV000217312]|not provided [RCV003477763] |
Chr16:23603615..23603624 [GRCh38] Chr16:23614936..23614945 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1638C>T (p.Val546=) |
single nucleotide variant |
Familial cancer of breast [RCV001504109]|Hereditary cancer-predisposing syndrome [RCV000217329]|not specified [RCV000607543] |
Chr16:23634908 [GRCh38] Chr16:23646229 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1378C>T (p.Gln460Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001853499]|Hereditary cancer-predisposing syndrome [RCV000222117] |
Chr16:23635168 [GRCh38] Chr16:23646489 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1830A>G (p.Thr610=) |
single nucleotide variant |
Familial cancer of breast [RCV001457806]|Hereditary cancer-predisposing syndrome [RCV000222133]|not specified [RCV001192767] |
Chr16:23630324 [GRCh38] Chr16:23641645 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2630G>A (p.Trp877Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001064019]|Hereditary cancer-predisposing syndrome [RCV000213186] |
Chr16:23626354 [GRCh38] Chr16:23637675 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2981T>C (p.Phe994Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000556582]|Hereditary cancer-predisposing syndrome [RCV000213191] |
Chr16:23622984 [GRCh38] Chr16:23634305 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.35A>C (p.Glu12Ala) |
single nucleotide variant |
Familial cancer of breast [RCV001204816]|Hereditary cancer-predisposing syndrome [RCV000213226] |
Chr16:23641123 [GRCh38] Chr16:23652444 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2274C>T (p.Pro758=) |
single nucleotide variant |
Familial cancer of breast [RCV001429014]|Hereditary cancer-predisposing syndrome [RCV000213308]|not provided [RCV001705226] |
Chr16:23629880 [GRCh38] Chr16:23641201 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2835G>A (p.Arg945=) |
single nucleotide variant |
Familial cancer of breast [RCV001320081]|Hereditary cancer-predisposing syndrome [RCV000217381]|not provided [RCV000483812] |
Chr16:23623130 [GRCh38] Chr16:23634451 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2849C>T (p.Ser950Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000691866]|Fanconi anemia complementation group N [RCV001118196]|Hereditary cancer-predisposing syndrome [RCV000217386]|not specified [RCV001818529] |
Chr16:23623116 [GRCh38] Chr16:23634437 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1216del (p.Ala406fs) |
deletion |
Familial cancer of breast [RCV001389702]|Hereditary cancer-predisposing syndrome [RCV000219937]|PALB2-related cancer predisposition [RCV005361316] |
Chr16:23635330 [GRCh38] Chr16:23646651 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3219C>G (p.Val1073=) |
single nucleotide variant |
Familial cancer of breast [RCV000932681]|Hereditary cancer-predisposing syndrome [RCV000219952]|not specified [RCV000422048] |
Chr16:23607995 [GRCh38] Chr16:23619316 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.308G>A (p.Gly103Glu) |
single nucleotide variant |
Familial cancer of breast [RCV001854715]|Hereditary cancer-predisposing syndrome [RCV000222248] |
Chr16:23636238 [GRCh38] Chr16:23647559 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3114G>A (p.Trp1038Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001070907]|Hereditary cancer-predisposing syndrome [RCV000222262]|not provided [RCV001030388] |
Chr16:23614091 [GRCh38] Chr16:23625412 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3078G>A (p.Leu1026=) |
single nucleotide variant |
Familial cancer of breast [RCV001450512]|Hereditary cancer-predisposing syndrome [RCV000562358] |
Chr16:23621397 [GRCh38] Chr16:23632718 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2978C>T (p.Thr993Met) |
single nucleotide variant |
Familial cancer of breast [RCV000544190]|Familial cancer of breast [RCV002478799]|Fanconi anemia complementation group N [RCV005396720]|Hereditary cancer-predisposing syndrome [RCV000213330]|not provided [RCV000236936]|not specified [RCV002267960] |
Chr16:23622987 [GRCh38] Chr16:23634308 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2512C>G (p.Gln838Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000635607]|Familial cancer of breast [RCV002478788]|Hereditary cancer-predisposing syndrome [RCV000213341]|not provided [RCV003223625] |
Chr16:23629642 [GRCh38] Chr16:23640963 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1085T>G (p.Leu362Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000810294]|Hereditary cancer-predisposing syndrome [RCV000213354] |
Chr16:23635461 [GRCh38] Chr16:23646782 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1925T>C (p.Met642Thr) |
single nucleotide variant |
Familial cancer of breast [RCV003607268]|Hereditary cancer-predisposing syndrome [RCV000213359] |
Chr16:23630229 [GRCh38] Chr16:23641550 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3096G>C (p.Met1032Ile) |
single nucleotide variant |
Familial cancer of breast [RCV001216363]|Hereditary cancer-predisposing syndrome [RCV000217483] |
Chr16:23621379 [GRCh38] Chr16:23632700 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1425_1426insT (p.Arg476Ter) |
insertion |
Familial cancer of breast [RCV003454635]|Hereditary cancer-predisposing syndrome [RCV000217519]|not provided [RCV001284669] |
Chr16:23635120..23635121 [GRCh38] Chr16:23646441..23646442 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2199T>C (p.Thr733=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000217553] |
Chr16:23629955 [GRCh38] Chr16:23641276 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.831C>T (p.Asp277=) |
single nucleotide variant |
Familial cancer of breast [RCV000226682]|Hereditary cancer-predisposing syndrome [RCV000217566]|PALB2-related disorder [RCV004532779]|not provided [RCV000615411]|not specified [RCV001824692] |
Chr16:23635715 [GRCh38] Chr16:23647036 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2167A>T (p.Met723Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000467128]|Fanconi anemia complementation group N [RCV005016605]|Hereditary cancer-predisposing syndrome [RCV000217611]|not provided [RCV003153509] |
Chr16:23629987 [GRCh38] Chr16:23641308 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1415A>G (p.Gln472Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001037656]|Fanconi anemia complementation group N [RCV001116858]|Hereditary cancer-predisposing syndrome [RCV000219983] |
Chr16:23635131 [GRCh38] Chr16:23646452 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.707dup (p.Leu237fs) |
duplication |
Familial cancer of breast [RCV000685002]|Hereditary cancer-predisposing syndrome [RCV000219994]|not provided [RCV000344893] |
Chr16:23635838..23635839 [GRCh38] Chr16:23647159..23647160 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3089C>T (p.Thr1030Ile) |
single nucleotide variant |
Familial cancer of breast [RCV001222271]|Hereditary breast ovarian cancer syndrome [RCV000675186]|Hereditary cancer-predisposing syndrome [RCV000220028]|not provided [RCV000236606] |
Chr16:23621386 [GRCh38] Chr16:23632707 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.194C>G (p.Pro65Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000558261]|Hereditary cancer-predisposing syndrome [RCV000213510] |
Chr16:23637867 [GRCh38] Chr16:23649188 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2690T>G (p.Leu897Arg) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000213587] |
Chr16:23626294 [GRCh38] Chr16:23637615 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.38A>G (p.Glu13Gly) |
single nucleotide variant |
Familial cancer of breast [RCV005090076]|Hereditary cancer-predisposing syndrome [RCV000213589] |
Chr16:23641120 [GRCh38] Chr16:23652441 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.658del (p.Ser220fs) |
deletion |
Familial cancer of breast [RCV000810472]|Hereditary cancer-predisposing syndrome [RCV000217719]|not provided [RCV000657496] |
Chr16:23635888 [GRCh38] Chr16:23647209 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1020T>C (p.Asn340=) |
single nucleotide variant |
Familial cancer of breast [RCV000475868]|Hereditary cancer-predisposing syndrome [RCV000220055]|PALB2-related disorder [RCV004541354] |
Chr16:23635526 [GRCh38] Chr16:23646847 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1660G>A (p.Glu554Lys) |
single nucleotide variant |
Familial cancer of breast [RCV001053537]|Hereditary cancer-predisposing syndrome [RCV000565852]|not provided [RCV001584375]|not specified [RCV005231088] |
Chr16:23634886 [GRCh38] Chr16:23646207 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2288_2291del (p.His762_Leu763insTer) |
deletion |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004558531]|Familial cancer of breast [RCV000467619]|Hereditary cancer-predisposing syndrome [RCV000213608]|Pancreatic cancer, susceptibility to, 3 [RCV001357568]|not provided [RCV000235354] |
Chr16:23629863..23629866 [GRCh38] Chr16:23641184..23641187 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.2628T>G (p.Phe876Leu) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000213757] |
Chr16:23626356 [GRCh38] Chr16:23637677 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.826C>T (p.His276Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000544750]|Hereditary cancer-predisposing syndrome [RCV000215431] |
Chr16:23635720 [GRCh38] Chr16:23647041 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2096C>G (p.Ser699Cys) |
single nucleotide variant |
Familial cancer of breast [RCV001053807]|Familial cancer of breast [RCV002485422]|Hereditary cancer-predisposing syndrome [RCV000215445] |
Chr16:23630058 [GRCh38] Chr16:23641379 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.27C>G (p.Leu9=) |
single nucleotide variant |
Familial cancer of breast [RCV001409240]|Hereditary cancer-predisposing syndrome [RCV000215451]|not specified [RCV000420697] |
Chr16:23641131 [GRCh38] Chr16:23652452 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3412G>A (p.Ala1138Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000686283]|Fanconi anemia complementation group N [RCV005016592]|Hereditary cancer-predisposing syndrome [RCV000215508]|not provided [RCV000759188] |
Chr16:23603608 [GRCh38] Chr16:23614929 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3475T>C (p.Trp1159Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000822894]|Hereditary cancer-predisposing syndrome [RCV000217867]|not provided [RCV000483996]|not specified [RCV002267968] |
Chr16:23603545 [GRCh38] Chr16:23614866 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1732A>G (p.Ser578Gly) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005361246]|Familial cancer of breast [RCV000464403]|Hereditary cancer-predisposing syndrome [RCV000217898]|Pancreatic cancer, susceptibility to, 3 [RCV001030256]|not provided [RCV000985887] |
Chr16:23630422 [GRCh38] Chr16:23641743 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1767G>A (p.Thr589=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005365148]|Familial cancer of breast [RCV000457514]|Fanconi anemia complementation group N [RCV001121719]|Hereditary cancer-predisposing syndrome [RCV000217926]|PALB2-related disorder [RCV004532777]|not provided [RCV002478785]|not specified [RCV000436798] |
Chr16:23630387 [GRCh38] Chr16:23641708 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.844A>G (p.Arg282Gly) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003491976]|Familial cancer of breast [RCV000462094]|Hereditary cancer-predisposing syndrome [RCV000220267]|not provided [RCV000759905] |
Chr16:23635702 [GRCh38] Chr16:23647023 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.955T>C (p.Ser319Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000542010] |
Chr16:23635591 [GRCh38] Chr16:23646912 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2506G>C (p.Val836Leu) |
single nucleotide variant |
B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) [RCV000761094]|Familial cancer of breast [RCV000687946]|Familial cancer of breast [RCV002494591]|Hereditary cancer-predisposing syndrome [RCV000215537] |
Chr16:23629648 [GRCh38] Chr16:23640969 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3392T>C (p.Ile1131Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000229527]|Fanconi anemia complementation group N [RCV005396705]|Hereditary cancer-predisposing syndrome [RCV000215576]|not provided [RCV000590765] |
Chr16:23603628 [GRCh38] Chr16:23614949 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.140C>A (p.Ser47Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV003765422]|Hereditary cancer-predisposing syndrome [RCV000215607] |
Chr16:23637921 [GRCh38] Chr16:23649242 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.583A>G (p.Ile195Val) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005365161]|Familial cancer of breast [RCV001234307]|Fanconi anemia complementation group N [RCV005016591]|Hereditary cancer-predisposing syndrome [RCV000215618]|not provided [RCV001030160] |
Chr16:23635963 [GRCh38] Chr16:23647284 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3095T>G (p.Met1032Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000696228]|Hereditary cancer-predisposing syndrome [RCV000215619]|Malignant tumor of breast [RCV001357160] |
Chr16:23621380 [GRCh38] Chr16:23632701 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3358G>T (p.Glu1120Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003454620]|Hereditary cancer-predisposing syndrome [RCV000215626] |
Chr16:23603662 [GRCh38] Chr16:23614983 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.773G>A (p.Ser258Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000635854]|Hereditary cancer-predisposing syndrome [RCV000215658]|not provided [RCV002485415] |
Chr16:23635773 [GRCh38] Chr16:23647094 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2032C>T (p.Leu678=) |
single nucleotide variant |
Familial cancer of breast [RCV001086211]|Familial cancer of breast [RCV002485421]|Hereditary cancer-predisposing syndrome [RCV000215668]|not provided [RCV000842681] |
Chr16:23630122 [GRCh38] Chr16:23641443 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.15C>T (p.Pro5=) |
single nucleotide variant |
Familial cancer of breast [RCV000876409]|Hereditary cancer-predisposing syndrome [RCV000217958]|not provided [RCV001610533] |
Chr16:23641143 [GRCh38] Chr16:23652464 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2674G>T (p.Glu892Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001045962]|Hereditary cancer-predisposing syndrome [RCV000217992]|Inherited breast cancer and ovarian cancer [RCV005237756] |
Chr16:23626310 [GRCh38] Chr16:23637631 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1072C>T (p.Pro358Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000466160]|Familial cancer of breast [RCV002494599]|Hereditary cancer-predisposing syndrome [RCV000220349]|not provided [RCV000235363] |
Chr16:23635474 [GRCh38] Chr16:23646795 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2635del (p.Arg879fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000215674] |
Chr16:23626349 [GRCh38] Chr16:23637670 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1392G>A (p.Arg464=) |
single nucleotide variant |
Familial cancer of breast [RCV001467864]|Hereditary cancer-predisposing syndrome [RCV000215687] |
Chr16:23635154 [GRCh38] Chr16:23646475 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1456A>G (p.Lys486Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000811638]|Hereditary cancer-predisposing syndrome [RCV000215703]|not provided [RCV001570464] |
Chr16:23635090 [GRCh38] Chr16:23646411 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.693A>T (p.Lys231Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000474743]|Hereditary cancer-predisposing syndrome [RCV000215723]|not provided [RCV003226913] |
Chr16:23635853 [GRCh38] Chr16:23647174 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3544G>C (p.Val1182Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000802184]|Hereditary cancer-predisposing syndrome [RCV000215738] |
Chr16:23603476 [GRCh38] Chr16:23614797 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2448C>G (p.Phe816Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000635843]|Hereditary cancer-predisposing syndrome [RCV000215749]|not specified [RCV002247661] |
Chr16:23629706 [GRCh38] Chr16:23641027 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.2112T>A (p.Leu704=) |
single nucleotide variant |
Familial cancer of breast [RCV000466956]|Hereditary cancer-predisposing syndrome [RCV000215772]|not provided [RCV001574258] |
Chr16:23630042 [GRCh38] Chr16:23641363 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.39G>A (p.Glu13=) |
single nucleotide variant |
Familial cancer of breast [RCV001444465]|Hereditary cancer-predisposing syndrome [RCV000218102] |
Chr16:23641119 [GRCh38] Chr16:23652440 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.263T>C (p.Leu88Pro) |
single nucleotide variant |
Familial cancer of breast [RCV003765434]|Hereditary cancer-predisposing syndrome [RCV000222343] |
Chr16:23636283 [GRCh38] Chr16:23647604 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1704A>C (p.Gln568His) |
single nucleotide variant |
Familial cancer of breast [RCV000458896]|Hereditary cancer-predisposing syndrome [RCV000222348] |
Chr16:23630450 [GRCh38] Chr16:23641771 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.712A>G (p.Arg238Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000692131]|Familial cancer of breast [RCV002485431]|Hereditary cancer-predisposing syndrome [RCV000214112]|not provided [RCV001566064] |
Chr16:23635834 [GRCh38] Chr16:23647155 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1694G>A (p.Ser565Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000536671]|Hereditary cancer-predisposing syndrome [RCV000214165]|not provided [RCV001753674]|not specified [RCV004526647] |
Chr16:23630460 [GRCh38] Chr16:23641781 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3261C>T (p.Ser1087=) |
single nucleotide variant |
Familial cancer of breast [RCV005420828]|Hereditary cancer-predisposing syndrome [RCV000214201] |
Chr16:23607953 [GRCh38] Chr16:23619274 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3113+5G>C |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005416112]|Familial cancer of breast [RCV000231026]|Fanconi anemia complementation group N [RCV005016593]|Hereditary cancer-predisposing syndrome [RCV000214215]|not provided [RCV000255512] |
Chr16:23621357 [GRCh38] Chr16:23632678 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1944T>C (p.Leu648=) |
single nucleotide variant |
Familial cancer of breast [RCV000457327]|Hereditary cancer-predisposing syndrome [RCV000215925] |
Chr16:23630210 [GRCh38] Chr16:23641531 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3246_3247del (p.Ser1082fs) |
deletion |
Familial cancer of breast [RCV003454610]|Hereditary cancer-predisposing syndrome [RCV000215931] |
Chr16:23607967..23607968 [GRCh38] Chr16:23619288..23619289 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2413G>T (p.Val805Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000697289]|Hereditary cancer-predisposing syndrome [RCV000218274]|not provided [RCV003328568] |
Chr16:23629741 [GRCh38] Chr16:23641062 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1670T>C (p.Phe557Ser) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000218299] |
Chr16:23634876 [GRCh38] Chr16:23646197 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2609T>C (p.Val870Ala) |
single nucleotide variant |
Familial cancer of breast [RCV001219607]|Hereditary cancer-predisposing syndrome [RCV000218350]|not provided [RCV000480874] |
Chr16:23626375 [GRCh38] Chr16:23637696 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2273C>G (p.Pro758Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000526650]|Familial cancer of breast [RCV002485417]|Hereditary cancer-predisposing syndrome [RCV000218372]|not provided [RCV001762473] |
Chr16:23629881 [GRCh38] Chr16:23641202 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1079A>G (p.Asp360Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000459883]|Familial cancer of breast [RCV002500734]|Hereditary cancer-predisposing syndrome [RCV000220824]|not provided [RCV000679759] |
Chr16:23635467 [GRCh38] Chr16:23646788 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3488A>T (p.Lys1163Ile) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000214233] |
Chr16:23603532 [GRCh38] Chr16:23614853 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3374_3395del (p.Asp1125fs) |
deletion |
Familial cancer of breast [RCV001384358]|Hereditary cancer-predisposing syndrome [RCV000214247]|not provided [RCV000657478] |
Chr16:23603625..23603646 [GRCh38] Chr16:23614946..23614967 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.870G>A (p.Glu290=) |
single nucleotide variant |
Familial cancer of breast [RCV005425827]|Hereditary cancer-predisposing syndrome [RCV000214277] |
Chr16:23635676 [GRCh38] Chr16:23646997 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2147A>G (p.Asn716Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000458608]|Hereditary cancer-predisposing syndrome [RCV000214302]|PALB2-related disorder [RCV004532798]|Papillary thyroid carcinoma [RCV000761167]|not provided [RCV001567281]|not specified [RCV002271471] |
Chr16:23630007 [GRCh38] Chr16:23641328 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2919A>G (p.Thr973=) |
single nucleotide variant |
Familial cancer of breast [RCV001470201]|Hereditary cancer-predisposing syndrome [RCV000216000] |
Chr16:23623046 [GRCh38] Chr16:23634367 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2667T>A (p.Thr889=) |
single nucleotide variant |
Familial cancer of breast [RCV005090094]|Fanconi anemia complementation group N [RCV001118199]|Hereditary cancer-predisposing syndrome [RCV000216116] |
Chr16:23626317 [GRCh38] Chr16:23637638 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.3111T>C (p.Ile1037=) |
single nucleotide variant |
Familial cancer of breast [RCV001403855]|Hereditary cancer-predisposing syndrome [RCV000218393] |
Chr16:23621364 [GRCh38] Chr16:23632685 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1052C>A (p.Thr351Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000531194]|Fanconi anemia complementation group N [RCV005016578]|Hereditary cancer-predisposing syndrome [RCV000218423] |
Chr16:23635494 [GRCh38] Chr16:23646815 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1952G>A (p.Gly651Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000635716]|Hereditary cancer-predisposing syndrome [RCV000218442] |
Chr16:23630202 [GRCh38] Chr16:23641523 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2076G>C (p.Gln692His) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000218446] |
Chr16:23630078 [GRCh38] Chr16:23641399 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2411_2412del (p.Ser804fs) |
microsatellite |
Familial cancer of breast [RCV000229872]|Fanconi anemia complementation group N [RCV001782707]|Hereditary breast ovarian cancer syndrome [RCV002307453]|Hereditary cancer-predisposing syndrome [RCV000218515]|PALB2-related disorder [RCV005250039]|not provided [RCV000236720] |
Chr16:23629742..23629743 [GRCh38] Chr16:23641063..23641064 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.1515C>T (p.Ala505=) |
single nucleotide variant |
Familial cancer of breast [RCV001499661]|Hereditary cancer-predisposing syndrome [RCV000220867] |
Chr16:23635031 [GRCh38] Chr16:23646352 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3494C>T (p.Ser1165Leu) |
single nucleotide variant |
Chordoma [RCV002266936]|Familial cancer of breast [RCV000535759]|Familial cancer of breast [RCV002478804]|Fanconi anemia complementation group N [RCV001121621]|Hereditary cancer-predisposing syndrome [RCV000220953]|not provided [RCV000485944] |
Chr16:23603526 [GRCh38] Chr16:23614847 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2296_2297del (p.Val767fs) |
deletion |
Familial cancer of breast [RCV000468711]|Hereditary cancer-predisposing syndrome [RCV000220967]|not provided [RCV000236917] |
Chr16:23629857..23629858 [GRCh38] Chr16:23641178..23641179 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2053A>G (p.Lys685Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000704180]|Hereditary cancer-predisposing syndrome [RCV000222569]|not specified [RCV003488479] |
Chr16:23630101 [GRCh38] Chr16:23641422 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3165C>A (p.Tyr1055Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001857756]|Hereditary cancer-predisposing syndrome [RCV000222632]|not provided [RCV004998440] |
Chr16:23614040 [GRCh38] Chr16:23625361 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1982C>G (p.Pro661Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000559033]|Familial cancer of breast [RCV002485425]|Familial pancreatic carcinoma [RCV005361321]|Hereditary cancer-predisposing syndrome [RCV000222668]|not provided [RCV005252824]|not specified [RCV001582753] |
Chr16:23630172 [GRCh38] Chr16:23641493 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3114-522T>C |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000209151] |
Chr16:23614613 [GRCh38] Chr16:23625934 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1702C>A (p.Gln568Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000818865]|Familial cancer of breast [RCV002494593]|Hereditary cancer-predisposing syndrome [RCV000214422]|PALB2-related disorder [RCV004541351]|not specified [RCV004701288] |
Chr16:23630452 [GRCh38] Chr16:23641773 [GRCh37] Chr16:16p12.2 |
pathogenic|uncertain significance |
NM_024675.4(PALB2):c.2811A>C (p.Gly937=) |
single nucleotide variant |
Familial cancer of breast [RCV001478867]|Hereditary cancer-predisposing syndrome [RCV000214425] |
Chr16:23624032 [GRCh38] Chr16:23635353 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.663A>G (p.Val221=) |
single nucleotide variant |
Familial cancer of breast [RCV005090106]|Hereditary cancer-predisposing syndrome [RCV000216157] |
Chr16:23635883 [GRCh38] Chr16:23647204 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2873A>C (p.Gln958Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000635913]|Hereditary cancer-predisposing syndrome [RCV000216200] |
Chr16:23623092 [GRCh38] Chr16:23634413 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.135G>A (p.Lys45=) |
single nucleotide variant |
Familial cancer of breast [RCV001500992]|Hereditary cancer-predisposing syndrome [RCV000216258]|not specified [RCV000445169] |
Chr16:23637926 [GRCh38] Chr16:23649247 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1139G>C (p.Ser380Thr) |
single nucleotide variant |
Familial cancer of breast [RCV005090109]|Hereditary cancer-predisposing syndrome [RCV000218548]|not provided [RCV000479465] |
Chr16:23635407 [GRCh38] Chr16:23646728 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3225T>A (p.Ser1075Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000466966]|Familial cancer of breast [RCV002500726]|Fanconi anemia complementation group N [RCV005396711]|Hereditary cancer-predisposing syndrome [RCV000218610] |
Chr16:23607989 [GRCh38] Chr16:23619310 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1346A>T (p.Lys449Ile) |
single nucleotide variant |
Familial cancer of breast [RCV005090091]|Hereditary cancer-predisposing syndrome [RCV000218614] |
Chr16:23635200 [GRCh38] Chr16:23646521 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1238C>A (p.Thr413Lys) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000218626] |
Chr16:23635308 [GRCh38] Chr16:23646629 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.48+4C>T |
single nucleotide variant |
Familial cancer of breast [RCV000635739]|Hereditary cancer-predisposing syndrome [RCV000218641] |
Chr16:23641106 [GRCh38] Chr16:23652427 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1814C>T (p.Ser605Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000794879]|Hereditary cancer-predisposing syndrome [RCV000218680]|not provided [RCV004767171] |
Chr16:23630340 [GRCh38] Chr16:23641661 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1206del (p.Leu403fs) |
deletion |
Familial cancer of breast [RCV001030203]|Gastric cancer [RCV003165555]|Hereditary cancer-predisposing syndrome [RCV000218688] |
Chr16:23635340 [GRCh38] Chr16:23646661 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2325dup (p.Phe776fs) |
duplication |
Breast and/or ovarian cancer [RCV001798719]|Familial cancer of breast [RCV000468481]|Hereditary cancer-predisposing syndrome [RCV000218689]|PALB2-related cancer predisposition [RCV005365163]|PALB2-related disorder [RCV004532801]|not provided [RCV000236131] |
Chr16:23629828..23629829 [GRCh38] Chr16:23641149..23641150 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2504C>T (p.Ser835Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000797707]|Hereditary cancer-predisposing syndrome [RCV000221085] |
Chr16:23629650 [GRCh38] Chr16:23640971 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.578C>T (p.Thr193Ile) |
single nucleotide variant |
Familial cancer of breast [RCV002519710]|Hereditary cancer-predisposing syndrome [RCV000222826]|not provided [RCV001030159] |
Chr16:23635968 [GRCh38] Chr16:23647289 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.48+398A>G |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000209187] |
Chr16:23640712 [GRCh38] Chr16:23652033 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1684+1290C>T |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000209482] |
Chr16:23633572 [GRCh38] Chr16:23644893 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2996+3A>G |
single nucleotide variant |
Familial cancer of breast [RCV003114389]|Hereditary cancer-predisposing syndrome [RCV000214540]|Malignant tumor of breast [RCV001356342]|not provided [RCV001797070] |
Chr16:23622966 [GRCh38] Chr16:23634287 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1263G>A (p.Arg421=) |
single nucleotide variant |
Familial cancer of breast [RCV001493688]|Hereditary cancer-predisposing syndrome [RCV000214557] |
Chr16:23635283 [GRCh38] Chr16:23646604 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2156del (p.Pro719fs) |
deletion |
Familial cancer of breast [RCV000663079]|Hereditary cancer-predisposing syndrome [RCV000216333] |
Chr16:23629998 [GRCh38] Chr16:23641319 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.908T>C (p.Leu303Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000822728]|Hereditary cancer-predisposing syndrome [RCV000216402]|not provided [RCV001284671] |
Chr16:23635638 [GRCh38] Chr16:23646959 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.595C>T (p.Leu199Phe) |
single nucleotide variant |
Familial cancer of breast [RCV003765443]|Hereditary cancer-predisposing syndrome [RCV000216403] |
Chr16:23635951 [GRCh38] Chr16:23647272 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3027T>C (p.Pro1009=) |
single nucleotide variant |
Familial cancer of breast [RCV001397966]|Hereditary cancer-predisposing syndrome [RCV000216427]|not specified [RCV000616466] |
Chr16:23621448 [GRCh38] Chr16:23632769 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3201+3A>C |
single nucleotide variant |
Familial cancer of breast [RCV001853618]|Hereditary cancer-predisposing syndrome [RCV000216437] |
Chr16:23614001 [GRCh38] Chr16:23625322 [GRCh37] Chr16:16p12.2 |
likely pathogenic|uncertain significance |
NM_024675.4(PALB2):c.2482_2504delinsAAGGTACAAT (p.Cys828fs) |
indel |
Hereditary cancer-predisposing syndrome [RCV000216440] |
Chr16:23629650..23629672 [GRCh38] Chr16:23640971..23640993 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3210C>G (p.Leu1070=) |
single nucleotide variant |
Familial cancer of breast [RCV001493013]|Hereditary cancer-predisposing syndrome [RCV000218741]|not provided [RCV000228470] |
Chr16:23608004 [GRCh38] Chr16:23619325 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.35del (p.Glu12fs) |
deletion |
Familial cancer of breast [RCV000803336]|Hereditary cancer-predisposing syndrome [RCV000218745] |
Chr16:23641123 [GRCh38] Chr16:23652444 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1804C>G (p.Gln602Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000538187]|Hereditary cancer-predisposing syndrome [RCV000218759] |
Chr16:23630350 [GRCh38] Chr16:23641671 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1918T>G (p.Ser640Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000635882]|Familial cancer of breast [RCV002478798]|Hereditary cancer-predisposing syndrome [RCV000221223]|not specified [RCV002509316] |
Chr16:23630236 [GRCh38] Chr16:23641557 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2325A>C (p.Gln775His) |
single nucleotide variant |
Familial cancer of breast [RCV000231589]|Hereditary cancer-predisposing syndrome [RCV000221269]|not specified [RCV002267954] |
Chr16:23629829 [GRCh38] Chr16:23641150 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.745_749del (p.Pro249fs) |
deletion |
Gastric cancer [RCV003165565]|Hereditary cancer-predisposing syndrome [RCV000222919] |
Chr16:23635797..23635801 [GRCh38] Chr16:23647118..23647122 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2515-39A>G |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000209505] |
Chr16:23629314 [GRCh38] Chr16:23640635 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3232T>A (p.Cys1078Ser) |
single nucleotide variant |
Carcinoma of colon [RCV001030400]|Familial cancer of breast [RCV000530258]|Hereditary cancer-predisposing syndrome [RCV000214649]|not provided [RCV001788088]|not specified [RCV003230458] |
Chr16:23607982 [GRCh38] Chr16:23619303 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2167A>G (p.Met723Val) |
single nucleotide variant |
Familial cancer of breast [RCV001350792]|Hereditary cancer-predisposing syndrome [RCV000214669] |
Chr16:23629987 [GRCh38] Chr16:23641308 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3061G>A (p.Gly1021Arg) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001798715]|Familial cancer of breast [RCV000558947]|Hereditary cancer-predisposing syndrome [RCV000214675]|not provided [RCV003328567]|not specified [RCV002265691] |
Chr16:23621414 [GRCh38] Chr16:23632735 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.71T>C (p.Leu24Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000474579]|Hereditary cancer-predisposing syndrome [RCV000214682] |
Chr16:23638107 [GRCh38] Chr16:23649428 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2280del (p.Ala761fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000214754] |
Chr16:23629874 [GRCh38] Chr16:23641195 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.330A>G (p.Gly110=) |
single nucleotide variant |
Familial cancer of breast [RCV000544506]|Hereditary cancer-predisposing syndrome [RCV000214791]|not specified [RCV003321555] |
Chr16:23636216 [GRCh38] Chr16:23647537 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.466_467del (p.Ile156fs) |
deletion |
Familial cancer of breast [RCV001045091]|Hereditary cancer-predisposing syndrome [RCV000214798]|not provided [RCV001091642] |
Chr16:23636079..23636080 [GRCh38] Chr16:23647400..23647401 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1744T>C (p.Ser582Pro) |
single nucleotide variant |
Familial cancer of breast [RCV001316625]|Hereditary cancer-predisposing syndrome [RCV000214800] |
Chr16:23630410 [GRCh38] Chr16:23641731 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.512T>G (p.Leu171Trp) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000214801] |
Chr16:23636034 [GRCh38] Chr16:23647355 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2437A>G (p.Ile813Val) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000216460] |
Chr16:23629717 [GRCh38] Chr16:23641038 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1157C>G (p.Thr386Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000635788]|Hereditary cancer-predisposing syndrome [RCV000216492]|not provided [RCV003477772] |
Chr16:23635389 [GRCh38] Chr16:23646710 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3417T>G (p.Ile1139Met) |
single nucleotide variant |
Familial cancer of breast [RCV000635692]|Hereditary cancer-predisposing syndrome [RCV000216504]|not provided [RCV005055762] |
Chr16:23603603 [GRCh38] Chr16:23614924 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1902A>G (p.Pro634=) |
single nucleotide variant |
Familial cancer of breast [RCV001439585]|Hereditary cancer-predisposing syndrome [RCV000216555] |
Chr16:23630252 [GRCh38] Chr16:23641573 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1588C>T (p.Leu530Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000635734]|Hereditary cancer-predisposing syndrome [RCV000218879] |
Chr16:23634958 [GRCh38] Chr16:23646279 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.908T>A (p.Leu303His) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000218945] |
Chr16:23635638 [GRCh38] Chr16:23646959 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.347T>A (p.Leu116Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000709748]|Hereditary cancer-predisposing syndrome [RCV000223009]|not provided [RCV003227721] |
Chr16:23636199 [GRCh38] Chr16:23647520 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2217T>C (p.Pro739=) |
single nucleotide variant |
Familial cancer of breast [RCV001459451]|Hereditary cancer-predisposing syndrome [RCV000223061]|not specified [RCV000430420] |
Chr16:23629937 [GRCh38] Chr16:23641258 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3204G>T (p.Gly1068=) |
single nucleotide variant |
Familial cancer of breast [RCV000878248]|Familial cancer of breast [RCV002500737]|Hereditary cancer-predisposing syndrome [RCV000223144] |
Chr16:23608010 [GRCh38] Chr16:23619331 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3350+1313G>A |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000209812] |
Chr16:23606551 [GRCh38] Chr16:23617872 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1163del (p.Pro388fs) |
deletion |
Familial cancer of breast [RCV005090043]|Hereditary cancer-predisposing syndrome [RCV000210113] |
Chr16:23635383 [GRCh38] Chr16:23646704 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3186del (p.Ala1063fs) |
deletion |
Familial cancer of breast [RCV002517428]|Hereditary cancer-predisposing syndrome [RCV000210123] |
Chr16:23614019 [GRCh38] Chr16:23625340 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2391del (p.Gln797fs) |
deletion |
Familial cancer of breast [RCV000114525]|Hereditary cancer-predisposing syndrome [RCV000210140] |
Chr16:23629763 [GRCh38] Chr16:23641084 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.1919C>A (p.Ser640Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000545701]|Fanconi anemia complementation group N [RCV005016586]|Hereditary cancer-predisposing syndrome [RCV000214899]|not provided [RCV000479396] |
Chr16:23630235 [GRCh38] Chr16:23641556 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.619C>T (p.Pro207Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001370562]|Hereditary cancer-predisposing syndrome [RCV000214926] |
Chr16:23635927 [GRCh38] Chr16:23647248 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2904T>C (p.Ala968=) |
single nucleotide variant |
Familial cancer of breast [RCV002054968]|Hereditary cancer-predisposing syndrome [RCV000216640] |
Chr16:23623061 [GRCh38] Chr16:23634382 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1847A>G (p.Asp616Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000700347]|Hereditary cancer-predisposing syndrome [RCV000216725]|PALB2-related disorder [RCV004545877]|not provided [RCV000235495] |
Chr16:23630307 [GRCh38] Chr16:23641628 [GRCh37] Chr16:16p12.2 |
uncertain significance|not provided |
NM_024675.4(PALB2):c.3453C>G (p.Leu1151=) |
single nucleotide variant |
Familial cancer of breast [RCV000635993]|Hereditary cancer-predisposing syndrome [RCV000219007] |
Chr16:23603567 [GRCh38] Chr16:23614888 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1653T>C (p.Tyr551=) |
single nucleotide variant |
Familial cancer of breast [RCV001494527]|Hereditary cancer-predisposing syndrome [RCV000219143] |
Chr16:23634893 [GRCh38] Chr16:23646214 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.157GAA[1] (p.Glu54del) |
microsatellite |
Familial cancer of breast [RCV001300672]|Hereditary cancer-predisposing syndrome [RCV000221452] |
Chr16:23637899..23637901 [GRCh38] Chr16:23649220..23649222 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.459G>A (p.Arg153=) |
single nucleotide variant |
Familial cancer of breast [RCV003607262]|Hereditary cancer-predisposing syndrome [RCV000221463]|not specified [RCV000603082] |
Chr16:23636087 [GRCh38] Chr16:23647408 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.59A>T (p.Lys20Ile) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000221475] |
Chr16:23638119 [GRCh38] Chr16:23649440 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.947C>T (p.Pro316Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000687299]|Hereditary cancer-predisposing syndrome [RCV000221523]|not provided [RCV005230110] |
Chr16:23635599 [GRCh38] Chr16:23646920 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1918T>A (p.Ser640Thr) |
single nucleotide variant |
Fanconi anemia complementation group N [RCV003133189]|Hereditary cancer-predisposing syndrome [RCV000221530] |
Chr16:23630236 [GRCh38] Chr16:23641557 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2117C>T (p.Thr706Ile) |
single nucleotide variant |
Familial cancer of breast [RCV001070685]|Hereditary cancer-predisposing syndrome [RCV000223246] |
Chr16:23630037 [GRCh38] Chr16:23641358 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2514+136T>C |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000209821]|not provided [RCV000836094] |
Chr16:23629504 [GRCh38] Chr16:23640825 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2506G>A (p.Val836Ile) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005361295]|Familial cancer of breast [RCV000457210]|Fanconi anemia complementation group N [RCV005016588]|Hereditary cancer-predisposing syndrome [RCV000214970]|not provided [RCV000586837]|not specified [RCV001420721] |
Chr16:23629648 [GRCh38] Chr16:23640969 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1540G>A (p.Gly514Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000989570]|Familial cancer of breast [RCV001027798]|Familial cancer of breast [RCV003224228]|Hereditary cancer-predisposing syndrome [RCV000214985]|not provided [RCV000589880] |
Chr16:23635006 [GRCh38] Chr16:23646327 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.154G>A (p.Val52Ile) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000215013]|not provided [RCV000482119] |
Chr16:23637907 [GRCh38] Chr16:23649228 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1771C>G (p.Pro591Ala) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000215112] |
Chr16:23630383 [GRCh38] Chr16:23641704 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1251C>T (p.Ser417=) |
single nucleotide variant |
Familial cancer of breast [RCV002054966]|Hereditary cancer-predisposing syndrome [RCV000216771] |
Chr16:23635295 [GRCh38] Chr16:23646616 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2850C>T (p.Ser950=) |
single nucleotide variant |
Familial cancer of breast [RCV001426135]|Hereditary cancer-predisposing syndrome [RCV000216811] |
Chr16:23623115 [GRCh38] Chr16:23634436 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2965G>A (p.Val989Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000233398]|Hereditary cancer-predisposing syndrome [RCV000216882]|not provided [RCV001775679] |
Chr16:23623000 [GRCh38] Chr16:23634321 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2693G>A (p.Trp898Ter) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003491974]|Familial cancer of breast [RCV002518293]|Hereditary cancer-predisposing syndrome [RCV000216899]|not provided [RCV000478895] |
Chr16:23626291 [GRCh38] Chr16:23637612 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2482T>C (p.Cys828Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000530385]|Hereditary cancer-predisposing syndrome [RCV000216908]|not specified [RCV001175042] |
Chr16:23629672 [GRCh38] Chr16:23640993 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3035C>G (p.Thr1012Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001294420]|Hereditary cancer-predisposing syndrome [RCV000219169] |
Chr16:23621440 [GRCh38] Chr16:23632761 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2815T>G (p.Leu939Val) |
single nucleotide variant |
Familial cancer of breast [RCV001323873]|Hereditary cancer-predisposing syndrome [RCV000219174] |
Chr16:23624028 [GRCh38] Chr16:23635349 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3276C>T (p.Leu1092=) |
single nucleotide variant |
Familial cancer of breast [RCV000876137]|Hereditary cancer-predisposing syndrome [RCV000219218]|PALB2-related disorder [RCV004532774]|not specified [RCV002267953] |
Chr16:23607938 [GRCh38] Chr16:23619259 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.338C>G (p.Pro113Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000552379]|Hereditary cancer-predisposing syndrome [RCV000219266] |
Chr16:23636208 [GRCh38] Chr16:23647529 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3473_3476dup (p.Trp1159Ter) |
duplication |
Hereditary cancer-predisposing syndrome [RCV000219269] |
Chr16:23603543..23603544 [GRCh38] Chr16:23614864..23614865 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.878G>A (p.Gly293Asp) |
single nucleotide variant |
Familial cancer of breast [RCV001207077]|Hereditary cancer-predisposing syndrome [RCV000219309]|not provided [RCV002285286]|not specified [RCV003330591] |
Chr16:23635668 [GRCh38] Chr16:23646989 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.22C>G (p.Pro8Ala) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000221638] |
Chr16:23641136 [GRCh38] Chr16:23652457 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2673C>T (p.Cys891=) |
single nucleotide variant |
Familial cancer of breast [RCV000228269]|Hereditary cancer-predisposing syndrome [RCV000223322]|PALB2-related disorder [RCV004532783]|not provided [RCV001722181]|not specified [RCV000599763] |
Chr16:23626311 [GRCh38] Chr16:23637632 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2760dup (p.Gln921fs) |
duplication |
Familial cancer of breast [RCV003454646]|Hereditary cancer-predisposing syndrome [RCV000223425] |
Chr16:23624082..23624083 [GRCh38] Chr16:23635403..23635404 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2739C>G (p.His913Gln) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000223456] |
Chr16:23626245 [GRCh38] Chr16:23637566 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2580G>T (p.Glu860Asp) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005357695]|Familial cancer of breast [RCV000704755]|Hereditary cancer-predisposing syndrome [RCV000562114] |
Chr16:23629210 [GRCh38] Chr16:23640531 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2750T>C (p.Val917Ala) |
single nucleotide variant |
Carcinoma of colon [RCV001358536]|Familial cancer of breast [RCV000533162]|Hereditary cancer-predisposing syndrome [RCV000215127] |
Chr16:23624093 [GRCh38] Chr16:23635414 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.902A>G (p.Asp301Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000461086]|Hereditary cancer-predisposing syndrome [RCV000215213]|Pancreatic cancer, susceptibility to, 3 [RCV001354911]|not provided [RCV000478906]|not specified [RCV004800343] |
Chr16:23635644 [GRCh38] Chr16:23646965 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.*4A>G |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000216933] |
Chr16:23603455 [GRCh38] Chr16:23614776 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.29G>T (p.Ser10Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000635910]|Familial cancer of breast [RCV002500733]|Hereditary cancer-predisposing syndrome [RCV000217002]|not provided [RCV000759904]|not specified [RCV001358719] |
Chr16:23641129 [GRCh38] Chr16:23652450 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3041T>C (p.Leu1014Pro) |
single nucleotide variant |
Familial cancer of breast [RCV002515654]|Hereditary cancer-predisposing syndrome [RCV000217010]|not specified [RCV001420922] |
Chr16:23621434 [GRCh38] Chr16:23632755 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2403C>G (p.Asp801Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000635714]|Hereditary cancer-predisposing syndrome [RCV000217062]|not provided [RCV001589150]|not specified [RCV002247653] |
Chr16:23629751 [GRCh38] Chr16:23641072 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.541G>T (p.Glu181Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001060848]|Hereditary breast ovarian cancer syndrome [RCV005237732]|Hereditary cancer-predisposing syndrome [RCV000219378] |
Chr16:23636005 [GRCh38] Chr16:23647326 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2968G>T (p.Glu990Ter) |
single nucleotide variant |
Breast neoplasm [RCV000504617]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005361290]|Familial cancer of breast [RCV000635907]|Fanconi anemia complementation group N [RCV004796114]|Hereditary cancer-predisposing syndrome [RCV000219424]|not provided [RCV000657700] |
Chr16:23622997 [GRCh38] Chr16:23634318 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.474G>A (p.Gln158=) |
single nucleotide variant |
Familial cancer of breast [RCV001470966]|Hereditary cancer-predisposing syndrome [RCV002338758] |
Chr16:23636072 [GRCh38] Chr16:23647393 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.212-3C>T |
single nucleotide variant |
Familial cancer of breast [RCV000228404]|Hereditary cancer-predisposing syndrome [RCV000569563] |
Chr16:23636337 [GRCh38] Chr16:23647658 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1422T>G (p.Ser474Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000228498] |
Chr16:23635124 [GRCh38] Chr16:23646445 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2T>C (p.Met1Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000230496]|Hereditary cancer-predisposing syndrome [RCV002436040] |
Chr16:23641156 [GRCh38] Chr16:23652477 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|uncertain significance |
NM_024675.4(PALB2):c.3328C>G (p.Leu1110Val) |
single nucleotide variant |
Familial cancer of breast [RCV000228942]|Hereditary cancer-predisposing syndrome [RCV001019995]|not specified [RCV003323472] |
Chr16:23607886 [GRCh38] Chr16:23619207 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2840T>C (p.Leu947Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000229185]|Fanconi anemia complementation group N [RCV005003582]|Hereditary cancer-predisposing syndrome [RCV000564890]|Inherited breast cancer and ovarian cancer [RCV005055099]|not provided [RCV000587839]|not specified [RCV005238770] |
Chr16:23623125 [GRCh38] Chr16:23634446 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.907C>G (p.Leu303Val) |
single nucleotide variant |
Familial cancer of breast [RCV000231531] |
Chr16:23635639 [GRCh38] Chr16:23646960 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_23603162)_(23603669_?)del |
deletion |
Familial cancer of breast [RCV000231706] |
Chr16:23603162..23603669 [GRCh38] Chr16:23614483..23614990 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2964A>G (p.Gln988=) |
single nucleotide variant |
Familial cancer of breast [RCV000229549]|Hereditary cancer-predisposing syndrome [RCV000563128]|PALB2-related disorder [RCV004725117]|not provided [RCV000759903]|not specified [RCV001192741] |
Chr16:23623001 [GRCh38] Chr16:23634322 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1468C>G (p.Pro490Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000230011]|Hereditary cancer-predisposing syndrome [RCV000580968]|not provided [RCV003151762]|not specified [RCV000781690] |
Chr16:23635078 [GRCh38] Chr16:23646399 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2508C>T (p.Val836=) |
single nucleotide variant |
Familial cancer of breast [RCV000230223]|Hereditary cancer-predisposing syndrome [RCV000567967]|PALB2-related disorder [RCV004541456]|not specified [RCV001030313] |
Chr16:23629646 [GRCh38] Chr16:23640967 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2881C>A (p.Leu961Met) |
single nucleotide variant |
Familial cancer of breast [RCV000232469]|Hereditary cancer-predisposing syndrome [RCV000563083]|not provided [RCV003480566] |
Chr16:23623084 [GRCh38] Chr16:23634405 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2067G>T (p.Ser689=) |
single nucleotide variant |
Familial cancer of breast [RCV000230721]|Hereditary cancer-predisposing syndrome [RCV000564587]|not provided [RCV001711642] |
Chr16:23630087 [GRCh38] Chr16:23641408 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.48+7G>C |
single nucleotide variant |
Familial cancer of breast [RCV000230746]|Hereditary cancer-predisposing syndrome [RCV000580140]|PALB2-related disorder [RCV004541457]|not provided [RCV000586925]|not specified [RCV000433452] |
Chr16:23641103 [GRCh38] Chr16:23652424 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3553T>C (p.Tyr1185His) |
single nucleotide variant |
Familial cancer of breast [RCV000230845]|Hereditary cancer-predisposing syndrome [RCV001178373] |
Chr16:23603467 [GRCh38] Chr16:23614788 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.3(PALB2):c.-200_*297dup4058 |
duplication |
Familial cancer of breast [RCV000232927] |
Chr16:23603162..23641357 [GRCh38] Chr16:23614483..23652678 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1226A>G (p.Tyr409Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000230943]|Hereditary cancer [RCV003492015]|Hereditary cancer-predisposing syndrome [RCV000709387]|not provided [RCV000985884] |
Chr16:23635320 [GRCh38] Chr16:23646641 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2624T>C (p.Met875Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000231157]|Hereditary cancer-predisposing syndrome [RCV004649110]|not specified [RCV000780566] |
Chr16:23626360 [GRCh38] Chr16:23637681 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1463G>T (p.Ser488Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000226177]|Familial cancer of breast [RCV002487087]|Hereditary cancer-predisposing syndrome [RCV000564692]|not provided [RCV000589383] |
Chr16:23635083 [GRCh38] Chr16:23646404 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.288A>C (p.Thr96=) |
single nucleotide variant |
Familial cancer of breast [RCV000226308]|Hereditary cancer-predisposing syndrome [RCV000567712]|not specified [RCV000439616] |
Chr16:23636258 [GRCh38] Chr16:23647579 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2928G>A (p.Arg976=) |
single nucleotide variant |
Familial cancer of breast [RCV001464805]|Hereditary cancer-predisposing syndrome [RCV005384685]|not specified [RCV000607008] |
Chr16:23623037 [GRCh38] Chr16:23634358 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2801_2803dup (p.Val934dup) |
duplication |
Familial cancer of breast [RCV000231506] |
Chr16:23624039..23624040 [GRCh38] Chr16:23635360..23635361 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.7G>T (p.Glu3Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000231797]|Hereditary cancer-predisposing syndrome [RCV000582525]|not provided [RCV000657770] |
Chr16:23641151 [GRCh38] Chr16:23652472 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1369G>T (p.Glu457Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000231944] |
Chr16:23635177 [GRCh38] Chr16:23646498 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2836G>T (p.Ala946Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000226341]|Hereditary cancer-predisposing syndrome [RCV000574799]|not provided [RCV001800599] |
Chr16:23623129 [GRCh38] Chr16:23634450 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3420G>A (p.Trp1140Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000226507]|Hereditary cancer-predisposing syndrome [RCV004020882] |
Chr16:23603600 [GRCh38] Chr16:23614921 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.991G>C (p.Glu331Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000226576]|Hereditary cancer-predisposing syndrome [RCV000568702]|not provided [RCV004777638] |
Chr16:23635555 [GRCh38] Chr16:23646876 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1374T>C (p.Thr458=) |
single nucleotide variant |
Familial cancer of breast [RCV001416070]|Hereditary cancer-predisposing syndrome [RCV001011251] |
Chr16:23635172 [GRCh38] Chr16:23646493 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1455T>G (p.Thr485=) |
single nucleotide variant |
Familial cancer of breast [RCV000232336]|Familial cancer of breast [RCV002500814]|Hereditary cancer-predisposing syndrome [RCV000574541]|not provided [RCV001697592]|not specified [RCV000438747] |
Chr16:23635091 [GRCh38] Chr16:23646412 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2427A>C (p.Thr809=) |
single nucleotide variant |
Familial cancer of breast [RCV001079062]|Hereditary cancer-predisposing syndrome [RCV000569833]|not provided [RCV000840886] |
Chr16:23629727 [GRCh38] Chr16:23641048 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3154G>A (p.Asp1052Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000233764]|Hereditary cancer-predisposing syndrome [RCV001188179] |
Chr16:23614051 [GRCh38] Chr16:23625372 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2201C>A (p.Thr734Asn) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005361461]|Familial cancer of breast [RCV000233965]|Familial cancer of breast [RCV002487088]|Fanconi anemia complementation group N [RCV001119746]|Hereditary cancer-predisposing syndrome [RCV000569446]|PALB2-related disorder [RCV004739637]|not provided [RCV001566044]|not specified [RCV001820767] |
Chr16:23629953 [GRCh38] Chr16:23641274 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2058G>T (p.Arg686Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000234183]|Hereditary cancer-predisposing syndrome [RCV000776230]|not provided [RCV000481768] |
Chr16:23630096 [GRCh38] Chr16:23641417 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.365A>G (p.Asp122Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000232654]|Hereditary cancer-predisposing syndrome [RCV001189069]|not provided [RCV004721317] |
Chr16:23636181 [GRCh38] Chr16:23647502 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.170G>A (p.Cys57Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000232697]|Hereditary cancer-predisposing syndrome [RCV001184078] |
Chr16:23637891 [GRCh38] Chr16:23649212 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2594C>G (p.Ser865Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000234617]|Hereditary cancer-predisposing syndrome [RCV003352808] |
Chr16:23626390 [GRCh38] Chr16:23637711 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1910C>T (p.Pro637Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000233232]|Hereditary cancer-predisposing syndrome [RCV001013662]|not provided [RCV003324737] |
Chr16:23630244 [GRCh38] Chr16:23641565 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1753G>A (p.Asp585Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000227668]|Hereditary cancer-predisposing syndrome [RCV000773064]|not provided [RCV002277593] |
Chr16:23630401 [GRCh38] Chr16:23641722 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1057A>G (p.Lys353Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000227723] |
Chr16:23635489 [GRCh38] Chr16:23646810 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2509G>T (p.Glu837Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000227927]|Hereditary breast ovarian cancer syndrome [RCV001193462]|Hereditary cancer-predisposing syndrome [RCV000454198]|Pancreatic cancer, susceptibility to, 3 [RCV001030314]|not provided [RCV000235331] |
Chr16:23629645 [GRCh38] Chr16:23640966 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.517G>A (p.Gly173Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000234668]|Hereditary cancer-predisposing syndrome [RCV000573091] |
Chr16:23636029 [GRCh38] Chr16:23647350 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2792T>C (p.Leu931Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000233853]|Hereditary cancer-predisposing syndrome [RCV000579478]|not provided [RCV003325474]|not specified [RCV001174956] |
Chr16:23624051 [GRCh38] Chr16:23635372 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2066C>T (p.Ser689Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000228021]|Hereditary cancer-predisposing syndrome [RCV000774634]|PALB2-related disorder [RCV004541455]|not provided [RCV001030274] |
Chr16:23630088 [GRCh38] Chr16:23641409 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1160C>G (p.Ser387Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000228108]|Hereditary cancer-predisposing syndrome [RCV000572350] |
Chr16:23635386 [GRCh38] Chr16:23646707 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2282C>T (p.Ala761Val) |
single nucleotide variant |
Familial cancer of breast [RCV000226043] |
Chr16:23629872 [GRCh38] Chr16:23641193 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2653C>A (p.Pro885Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000234440]|Familial cancer of breast [RCV002494662]|Hereditary cancer-predisposing syndrome [RCV000573285]|not provided [RCV004772882]|not specified [RCV000781692] |
Chr16:23626331 [GRCh38] Chr16:23637652 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3179G>C (p.Cys1060Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000228718] |
Chr16:23614026 [GRCh38] Chr16:23625347 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.871G>A (p.Ala291Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000228762]|Hereditary cancer-predisposing syndrome [RCV000772149]|not specified [RCV003387816] |
Chr16:23635675 [GRCh38] Chr16:23646996 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.79G>T (p.Glu27Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000228882]|Familial cancer of breast [RCV002500815]|Fanconi anemia complementation group N [RCV003485568]|Hereditary cancer-predisposing syndrome [RCV000454231]|Lung cancer [RCV002282082]|Malignant tumor of breast [RCV001175093]|PALB2-related disorder [RCV004532964]|not provided [RCV000255635] |
Chr16:23638099 [GRCh38] Chr16:23649420 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3355C>T (p.Leu1119=) |
single nucleotide variant |
Familial cancer of breast [RCV001438030] |
Chr16:23603665 [GRCh38] Chr16:23614986 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2079del (p.His693fs) |
deletion |
Familial cancer of breast [RCV000234710] |
Chr16:23630075 [GRCh38] Chr16:23641396 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1809A>G (p.Leu603=) |
single nucleotide variant |
Familial cancer of breast [RCV000229237]|Hereditary cancer-predisposing syndrome [RCV001013257] |
Chr16:23630345 [GRCh38] Chr16:23641666 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2377G>A (p.Gly793Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000229269]|Hereditary cancer-predisposing syndrome [RCV000570086]|not specified [RCV002247680] |
Chr16:23629777 [GRCh38] Chr16:23641098 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1861C>A (p.Pro621Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000989565]|Hereditary cancer-predisposing syndrome [RCV000454184]|not provided [RCV000235273]|not specified [RCV001192764] |
Chr16:23630293 [GRCh38] Chr16:23641614 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.12dup (p.Pro5fs) |
duplication |
Familial cancer of breast [RCV000686286]|Hereditary breast ovarian cancer syndrome [RCV004525908]|Hereditary cancer-predisposing syndrome [RCV001010853]|not provided [RCV000235308] |
Chr16:23641145..23641146 [GRCh38] Chr16:23652466..23652467 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2435C>T (p.Pro812Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000635929]|Familial cancer of breast [RCV002494681]|Hereditary cancer-predisposing syndrome [RCV000575251]|Malignant tumor of breast [RCV001357974]|not provided [RCV000235316]|not specified [RCV003330604] |
Chr16:23629719 [GRCh38] Chr16:23641040 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3201+5_3201+8del |
microsatellite |
Familial cancer of breast [RCV005090193]|Hereditary cancer-predisposing syndrome [RCV001019200]|not provided [RCV000235324] |
Chr16:23613996..23613999 [GRCh38] Chr16:23625317..23625320 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1714del (p.Ser572fs) |
deletion |
Familial cancer of breast [RCV003454718]|not provided [RCV000235421] |
Chr16:23630440 [GRCh38] Chr16:23641761 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2053A>C (p.Lys685Gln) |
single nucleotide variant |
Familial cancer of breast [RCV001854851]|Hereditary cancer-predisposing syndrome [RCV000566295]|not provided [RCV000235440] |
Chr16:23630101 [GRCh38] Chr16:23641422 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1467_1468del (p.Pro490fs) |
microsatellite |
Familial cancer of breast [RCV001854854]|not provided [RCV000235468] |
Chr16:23635078..23635079 [GRCh38] Chr16:23646399..23646400 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3014T>C (p.Phe1005Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000635611]|Hereditary cancer-predisposing syndrome [RCV000565406]|not provided [RCV000235539] |
Chr16:23621461 [GRCh38] Chr16:23632782 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3239_3240del (p.Lys1080fs) |
deletion |
Familial cancer of breast [RCV000464814]|Hereditary cancer-predisposing syndrome [RCV000575894]|not provided [RCV000235489] |
Chr16:23607974..23607975 [GRCh38] Chr16:23619295..23619296 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2444C>T (p.Ser815Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000695288]|Hereditary cancer-predisposing syndrome [RCV000572013]|not provided [RCV000235600] |
Chr16:23629710 [GRCh38] Chr16:23641031 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1570_1571del (p.Ser524fs) |
deletion |
not specified [RCV000235607] |
Chr16:23634975..23634976 [GRCh38] Chr16:23646296..23646297 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3047T>G (p.Phe1016Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000635899]|Fanconi anemia complementation group N [RCV005016646]|Hereditary cancer-predisposing syndrome [RCV000563250]|not provided [RCV000235618] |
Chr16:23621428 [GRCh38] Chr16:23632749 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2860G>T (p.Glu954Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001854860]|not provided [RCV000235480] |
Chr16:23623105 [GRCh38] Chr16:23634426 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.616C>T (p.Leu206Phe) |
single nucleotide variant |
Familial cancer of breast [RCV001854875]|Hereditary cancer-predisposing syndrome [RCV004943825]|not provided [RCV000235659] |
Chr16:23635930 [GRCh38] Chr16:23647251 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.155T>C (p.Val52Ala) |
single nucleotide variant |
Breast neoplasm [RCV000417330]|Familial cancer of breast [RCV000462987]|Hereditary cancer-predisposing syndrome [RCV000568339]|not provided [RCV000235666] |
Chr16:23637906 [GRCh38] Chr16:23649227 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2342G>A (p.Ser781Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000695049]|Hereditary cancer-predisposing syndrome [RCV001180224]|Malignant tumor of breast [RCV001355456]|not provided [RCV000235686] |
Chr16:23629812 [GRCh38] Chr16:23641133 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2267_2283dup (p.His762fs) |
duplication |
Familial cancer of breast [RCV000461617]|Fanconi anemia complementation group N [RCV003485569]|Hereditary cancer-predisposing syndrome [RCV000454296]|not provided [RCV000235770] |
Chr16:23629870..23629871 [GRCh38] Chr16:23641191..23641192 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3436C>A (p.Gln1146Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000553351]|Hereditary cancer-predisposing syndrome [RCV001020303]|not provided [RCV000235777]|not specified [RCV000780559] |
Chr16:23603584 [GRCh38] Chr16:23614905 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.398G>A (p.Ser133Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000691656]|Hereditary cancer-predisposing syndrome [RCV000570939]|not provided [RCV000235826]|not specified [RCV000780568] |
Chr16:23636148 [GRCh38] Chr16:23647469 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1189A>G (p.Thr397Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000635934]|not provided [RCV000235843]|not specified [RCV003987476] |
Chr16:23635357 [GRCh38] Chr16:23646678 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1538del (p.Thr513fs) |
deletion |
Familial cancer of breast [RCV000465796]|Hereditary cancer-predisposing syndrome [RCV004649111]|not provided [RCV000235884] |
Chr16:23635008 [GRCh38] Chr16:23646329 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3491G>A (p.Trp1164Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000477362]|Hereditary cancer-predisposing syndrome [RCV000454361]|not provided [RCV000235914] |
Chr16:23603529 [GRCh38] Chr16:23614850 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1256G>T (p.Cys419Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000686671]|Hereditary cancer-predisposing syndrome [RCV002258864]|not provided [RCV000759893] |
Chr16:23635290 [GRCh38] Chr16:23646611 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2148T>A (p.Asn716Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000464776]|Familial cancer of breast [RCV002479940]|Hereditary cancer-predisposing syndrome [RCV000574979]|not provided [RCV000236038] |
Chr16:23630006 [GRCh38] Chr16:23641327 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3492G>A (p.Trp1164Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000662671]|Hereditary cancer-predisposing syndrome [RCV001020433]|not provided [RCV000235984] |
Chr16:23603528 [GRCh38] Chr16:23614849 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1655A>G (p.Gln552Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000535862]|Hereditary cancer-predisposing syndrome [RCV000565356]|not provided [RCV000235973] |
Chr16:23634891 [GRCh38] Chr16:23646212 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2197A>G (p.Thr733Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000470751]|Familial cancer of breast [RCV002487097]|Hereditary cancer-predisposing syndrome [RCV000571493]|not provided [RCV000236085]|not specified [RCV005230178] |
Chr16:23629957 [GRCh38] Chr16:23641278 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2961dup (p.Gln988fs) |
duplication |
not provided [RCV000236132] |
Chr16:23623003..23623004 [GRCh38] Chr16:23634324..23634325 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3436C>G (p.Gln1146Glu) |
single nucleotide variant |
Familial cancer of breast [RCV001854872]|Hereditary cancer-predisposing syndrome [RCV001183519]|not provided [RCV000236192] |
Chr16:23603584 [GRCh38] Chr16:23614905 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1727G>A (p.Ser576Asn) |
single nucleotide variant |
Familial cancer of breast [RCV001317387]|Hereditary cancer-predisposing syndrome [RCV000772053]|not provided [RCV000236534] |
Chr16:23630427 [GRCh38] Chr16:23641748 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2066C>A (p.Ser689Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003454716]|Hereditary cancer-predisposing syndrome [RCV002418041]|not provided [RCV000236381] |
Chr16:23630088 [GRCh38] Chr16:23641409 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2996+5G>T |
single nucleotide variant |
Familial cancer of breast [RCV000468560]|Hereditary cancer-predisposing syndrome [RCV000562437]|PALB2-related disorder [RCV004541468]|not provided [RCV000587970]|not specified [RCV005238783] |
Chr16:23622964 [GRCh38] Chr16:23634285 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2204C>T (p.Pro735Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000537105]|Hereditary cancer-predisposing syndrome [RCV000566819]|not provided [RCV000236741]|not specified [RCV001171430] |
Chr16:23629950 [GRCh38] Chr16:23641271 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1294C>T (p.His432Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV003607277]|not provided [RCV000236572] |
Chr16:23635252 [GRCh38] Chr16:23646573 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.668T>C (p.Ile223Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000635688]|Hereditary cancer-predisposing syndrome [RCV000572381]|not provided [RCV000236902]|not specified [RCV001193466] |
Chr16:23635878 [GRCh38] Chr16:23647199 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.205C>T (p.His69Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000823428]|Familial cancer of breast [RCV002494677]|Hereditary cancer-predisposing syndrome [RCV000575557]|not provided [RCV000236918]|not specified [RCV000781688] |
Chr16:23637856 [GRCh38] Chr16:23649177 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1A>G (p.Met1Val) |
single nucleotide variant |
Familial cancer of breast [RCV000696235]|Hereditary cancer-predisposing syndrome [RCV002418043]|not provided [RCV000237093] |
Chr16:23641157 [GRCh38] Chr16:23652478 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.472C>T (p.Gln158Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001382726]|not provided [RCV000237059] |
Chr16:23636074 [GRCh38] Chr16:23647395 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.931A>G (p.Lys311Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000528073]|Hereditary cancer-predisposing syndrome [RCV000564202]|not provided [RCV001584261] |
Chr16:23635615 [GRCh38] Chr16:23646936 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1046del (p.Asn349fs) |
deletion |
Familial cancer of breast [RCV000555459]|Hereditary cancer-predisposing syndrome [RCV000563951]|not provided [RCV001268549] |
Chr16:23635500 [GRCh38] Chr16:23646821 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.-36G>A |
single nucleotide variant |
not specified [RCV000605099] |
Chr16:23641193 [GRCh38] Chr16:23652514 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.-39G>T |
single nucleotide variant |
not specified [RCV000599848] |
Chr16:23641196 [GRCh38] Chr16:23652517 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.195G>T (p.Pro65=) |
single nucleotide variant |
Familial cancer of breast [RCV005427135]|Hereditary cancer-predisposing syndrome [RCV005384785]|not specified [RCV000606724] |
Chr16:23637866 [GRCh38] Chr16:23649187 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.640A>C (p.Thr214Pro) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000562571] |
Chr16:23635906 [GRCh38] Chr16:23647227 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.814G>T (p.Glu272Ter) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000562700] |
Chr16:23635732 [GRCh38] Chr16:23647053 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2802A>G (p.Val934=) |
single nucleotide variant |
Familial cancer of breast [RCV001495851]|Hereditary cancer-predisposing syndrome [RCV000562803]|not provided [RCV000759901] |
Chr16:23624041 [GRCh38] Chr16:23635362 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2635A>G (p.Arg879Gly) |
single nucleotide variant |
Familial cancer of breast [RCV001853732]|Hereditary cancer-predisposing syndrome [RCV000563383] |
Chr16:23626349 [GRCh38] Chr16:23637670 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.447G>T (p.Lys149Asn) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000563281] |
Chr16:23636099 [GRCh38] Chr16:23647420 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1285A>C (p.Ile429Leu) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005357648]|Hereditary cancer-predisposing syndrome [RCV000563315]|not provided [RCV005000246] |
Chr16:23635261 [GRCh38] Chr16:23646582 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.948C>T (p.Pro316=) |
single nucleotide variant |
Familial cancer of breast [RCV000524878]|Hereditary cancer-predisposing syndrome [RCV003159787] |
Chr16:23635598 [GRCh38] Chr16:23646919 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2748+1G>A |
single nucleotide variant |
Familial cancer of breast [RCV001234382]|Fanconi anemia complementation group N [RCV005018988]|Hereditary cancer-predisposing syndrome [RCV000563623]|not provided [RCV000985891] |
Chr16:23626235 [GRCh38] Chr16:23637556 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3506C>G (p.Ser1169Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000543689]|Hereditary cancer-predisposing syndrome [RCV000563642] |
Chr16:23603514 [GRCh38] Chr16:23614835 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.560C>A (p.Pro187His) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003448324]|Familial cancer of breast [RCV000635903]|Hereditary cancer [RCV003492103]|Hereditary cancer-predisposing syndrome [RCV000563795]|not provided [RCV002476221] |
Chr16:23635986 [GRCh38] Chr16:23647307 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2719G>A (p.Glu907Lys) |
single nucleotide variant |
Familial cancer of breast [RCV001853728]|Hereditary cancer-predisposing syndrome [RCV000563796]|not specified [RCV003994023] |
Chr16:23626265 [GRCh38] Chr16:23637586 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1334A>C (p.Lys445Thr) |
single nucleotide variant |
Familial cancer of breast [RCV002295302]|Hereditary cancer-predisposing syndrome [RCV000564662] |
Chr16:23635212 [GRCh38] Chr16:23646533 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3211T>C (p.Phe1071Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000541418]|Hereditary cancer-predisposing syndrome [RCV000566217] |
Chr16:23608003 [GRCh38] Chr16:23619324 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.675A>G (p.Pro225=) |
single nucleotide variant |
Familial cancer of breast [RCV001473695]|Hereditary cancer-predisposing syndrome [RCV000573904] |
Chr16:23635871 [GRCh38] Chr16:23647192 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2297C>T (p.Ser766Leu) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000564510] |
Chr16:23629857 [GRCh38] Chr16:23641178 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.153A>T (p.Thr51=) |
single nucleotide variant |
not specified [RCV000603815] |
Chr16:23637908 [GRCh38] Chr16:23649229 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2997-18A>C |
single nucleotide variant |
Familial cancer of breast [RCV002529472]|Hereditary cancer-predisposing syndrome [RCV001175783]|not specified [RCV000604879] |
Chr16:23621496 [GRCh38] Chr16:23632817 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3517G>A (p.Ala1173Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000635665]|Hereditary cancer-predisposing syndrome [RCV000566111] |
Chr16:23603503 [GRCh38] Chr16:23614824 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1266A>G (p.Lys422=) |
single nucleotide variant |
Familial cancer of breast [RCV001475264]|Hereditary cancer-predisposing syndrome [RCV000566243] |
Chr16:23635280 [GRCh38] Chr16:23646601 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.544del (p.Ile182fs) |
deletion |
Familial cancer of breast [RCV001218112]|Hereditary cancer-predisposing syndrome [RCV002347972]|not provided [RCV000255783] |
Chr16:23636002 [GRCh38] Chr16:23647323 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3041_3042del (p.Leu1014fs) |
deletion |
not provided [RCV000255792] |
Chr16:23621433..23621434 [GRCh38] Chr16:23632754..23632755 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.3114-1G>A |
single nucleotide variant |
Familial cancer of breast [RCV000551424]|Hereditary cancer-predisposing syndrome [RCV000569707]|Pancreatic cancer, susceptibility to, 3 [RCV005361500]|not provided [RCV000255848] |
Chr16:23614092 [GRCh38] Chr16:23625413 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.178C>T (p.Gln60Ter) |
single nucleotide variant |
Familial cancer of breast [RCV002518769]|Hereditary cancer-predisposing syndrome [RCV001013160]|not provided [RCV000255924] |
Chr16:23637883 [GRCh38] Chr16:23649204 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2937T>C (p.Ser979=) |
single nucleotide variant |
Familial cancer of breast [RCV005056219]|Hereditary cancer-predisposing syndrome [RCV000566489] |
Chr16:23623028 [GRCh38] Chr16:23634349 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.421C>T (p.Gln141Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003454783]|not provided [RCV000256010] |
Chr16:23636125 [GRCh38] Chr16:23647446 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1048del (p.Gln350fs) |
deletion |
not provided [RCV000256061] |
Chr16:23635498 [GRCh38] Chr16:23646819 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.3017del (p.Phe1005_Leu1006insTer) |
deletion |
Familial cancer of breast [RCV000576650]|Hereditary cancer-predisposing syndrome [RCV001018066]|Malignant tumor of breast [RCV003492021]|not provided [RCV000256067] |
Chr16:23621458 [GRCh38] Chr16:23632779 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2835-2A>C |
single nucleotide variant |
Familial cancer of breast [RCV003454780]|not provided [RCV000256178] |
Chr16:23623132 [GRCh38] Chr16:23634453 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2370A>G (p.Gln790=) |
single nucleotide variant |
Familial cancer of breast [RCV000528789] |
Chr16:23629784 [GRCh38] Chr16:23641105 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2764A>G (p.Ile922Val) |
single nucleotide variant |
Familial cancer of breast [RCV000799150]|Hereditary cancer-predisposing syndrome [RCV000567694] |
Chr16:23624079 [GRCh38] Chr16:23635400 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1953A>G (p.Gly651=) |
single nucleotide variant |
Familial cancer of breast [RCV003767128]|Hereditary cancer-predisposing syndrome [RCV000566643] |
Chr16:23630201 [GRCh38] Chr16:23641522 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.6C>T (p.Asp2=) |
single nucleotide variant |
Familial cancer of breast [RCV001399255]|Hereditary cancer-predisposing syndrome [RCV002367812] |
Chr16:23641152 [GRCh38] Chr16:23652473 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1429del (p.Thr477fs) |
deletion |
Familial cancer of breast [RCV001853733]|Hereditary cancer-predisposing syndrome [RCV000567168] |
Chr16:23635117 [GRCh38] Chr16:23646438 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1937_1938dup (p.His647fs) |
microsatellite |
Familial cancer of breast [RCV001380465]|not provided [RCV000515715] |
Chr16:23630215..23630216 [GRCh38] Chr16:23641536..23641537 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1169C>A (p.Ser390Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000529031] |
Chr16:23635377 [GRCh38] Chr16:23646698 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.3(PALB2):c.3202-?_3350+?del |
deletion |
Familial cancer of breast [RCV000239995] |
|
pathogenic |
NM_024675.4(PALB2):c.1377C>A (p.Asp459Glu) |
single nucleotide variant |
Familial cancer of breast [RCV001218569]|Hereditary cancer-predisposing syndrome [RCV000564673] |
Chr16:23635169 [GRCh38] Chr16:23646490 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1141C>T (p.Leu381Phe) |
single nucleotide variant |
Familial cancer of breast [RCV001239808]|Hereditary cancer-predisposing syndrome [RCV000566800] |
Chr16:23635405 [GRCh38] Chr16:23646726 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.3(PALB2):c.1685-?_2748+?dup |
duplication |
Familial cancer of breast [RCV000240558] |
|
likely pathogenic |
NM_024675.4(PALB2):c.113C>G (p.Ala38Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000547522]|Fanconi anemia complementation group N [RCV000328650]|Hereditary cancer-predisposing syndrome [RCV000271163]|not specified [RCV005407049] |
Chr16:23637948 [GRCh38] Chr16:23649269 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.601dup (p.Ser201fs) |
duplication |
Breast-ovarian cancer, familial, susceptibility to, 1 [RCV003992255]|Familial cancer of breast [RCV000576582]|Hereditary cancer-predisposing syndrome [RCV000454239]|not provided [RCV000275856] |
Chr16:23635944..23635945 [GRCh38] Chr16:23647265..23647266 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2029del (p.Val677fs) |
deletion |
not provided [RCV000391283] |
Chr16:23630125 [GRCh38] Chr16:23641446 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.-149G>A |
single nucleotide variant |
Fanconi anemia complementation group N [RCV000278764]|Hereditary cancer-predisposing syndrome [RCV000336126] |
Chr16:23641306 [GRCh38] Chr16:23652627 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2428C>T (p.Pro810Ser) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV004944016]|not provided [RCV000586718] |
Chr16:23629726 [GRCh38] Chr16:23641047 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.413A>C (p.Glu138Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000814273]|not provided [RCV000586801] |
Chr16:23636133 [GRCh38] Chr16:23647454 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2222G>T (p.Gly741Val) |
single nucleotide variant |
Familial cancer of breast [RCV000705027]|Hereditary cancer-predisposing syndrome [RCV000568439] |
Chr16:23629932 [GRCh38] Chr16:23641253 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.74A>G (p.Lys25Arg) |
single nucleotide variant |
not specified [RCV001269179] |
Chr16:23638104 [GRCh38] Chr16:23649425 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1193_1194del (p.Val398fs) |
deletion |
Breast and/or ovarian cancer [RCV001270992] |
Chr16:23635352..23635353 [GRCh38] Chr16:23646673..23646674 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.375A>G (p.Gln125=) |
single nucleotide variant |
Familial cancer of breast [RCV001482322]|Hereditary cancer-predisposing syndrome [RCV000574083] |
Chr16:23636171 [GRCh38] Chr16:23647492 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.585A>T (p.Ile195=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005357567]|Familial cancer of breast [RCV000547695]|Hereditary cancer-predisposing syndrome [RCV000570015]|not provided [RCV001722467] |
Chr16:23635961 [GRCh38] Chr16:23647282 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.810_828del (p.Ser270fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000564818] |
Chr16:23635718..23635736 [GRCh38] Chr16:23647039..23647057 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1803G>C (p.Lys601Asn) |
single nucleotide variant |
Familial cancer of breast [RCV001213794]|Hereditary cancer-predisposing syndrome [RCV000567899] |
Chr16:23630351 [GRCh38] Chr16:23641672 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1042_1044del (p.Gln348del) |
deletion |
not provided [RCV000722832] |
Chr16:23635502..23635504 [GRCh38] Chr16:23646823..23646825 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1434T>C (p.Ser478=) |
single nucleotide variant |
Familial cancer of breast [RCV005422298]|Hereditary cancer-predisposing syndrome [RCV003311308] |
Chr16:23635112 [GRCh38] Chr16:23646433 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2959C>A (p.Gln987Lys) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003311312] |
Chr16:23623006 [GRCh38] Chr16:23634327 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1539A>G (p.Thr513=) |
single nucleotide variant |
Familial cancer of breast [RCV005422299]|Hereditary cancer-predisposing syndrome [RCV003311313] |
Chr16:23635007 [GRCh38] Chr16:23646328 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2425A>T (p.Thr809Ser) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000567979] |
Chr16:23629729 [GRCh38] Chr16:23641050 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1458A>G (p.Lys486=) |
single nucleotide variant |
Familial cancer of breast [RCV000526724]|Hereditary cancer-predisposing syndrome [RCV004943959]|not provided [RCV000985885] |
Chr16:23635088 [GRCh38] Chr16:23646409 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.3(PALB2):c.1724dup (p.Ser576Glufs) |
duplication |
Familial cancer of breast [RCV003449257]|Hereditary cancer-predisposing syndrome [RCV002404276]|not provided [RCV000487876] |
Chr16:23630428..23630429 [GRCh38] Chr16:23641749..23641750 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2788A>T (p.Asn930Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000559528]|Familial pancreatic carcinoma [RCV005357566]|Hereditary cancer-predisposing syndrome [RCV000565362]|not provided [RCV001571859]|not specified [RCV001174763] |
Chr16:23624055 [GRCh38] Chr16:23635376 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3279T>C (p.Ile1093=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000565346] |
Chr16:23607935 [GRCh38] Chr16:23619256 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2245G>T (p.Glu749Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001242094]|Hereditary cancer-predisposing syndrome [RCV000568921]|Pancreatic cancer, susceptibility to, 3 [RCV003338667] |
Chr16:23629909 [GRCh38] Chr16:23641230 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1061C>G (p.Ser354Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000532399]|Hereditary cancer-predisposing syndrome [RCV005384759] |
Chr16:23635485 [GRCh38] Chr16:23646806 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1263_1265dup (p.Lys422dup) |
duplication |
Familial cancer of breast [RCV001343804]|not provided [RCV000722439] |
Chr16:23635280..23635281 [GRCh38] Chr16:23646601..23646602 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.793A>G (p.Ile265Val) |
single nucleotide variant |
Familial cancer of breast [RCV000531817]|Hereditary cancer-predisposing syndrome [RCV000773072] |
Chr16:23635753 [GRCh38] Chr16:23647074 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2982T>A (p.Phe994Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000532634] |
Chr16:23622983 [GRCh38] Chr16:23634304 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2818del (p.Glu940fs) |
deletion |
Familial cancer of breast [RCV000532811] |
Chr16:23624025 [GRCh38] Chr16:23635346 [GRCh37] Chr16:16p12.2 |
pathogenic |
NC_000016.9:g.(?_23614482)_(23614991_23619184)del |
deletion |
Malignant tumor of breast [RCV002281805] |
Chr16:23614482..23614991 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.2949C>G (p.Thr983=) |
single nucleotide variant |
Familial cancer of breast [RCV000921181]|Hereditary cancer-predisposing syndrome [RCV000568585]|PALB2-related disorder [RCV004740333] |
Chr16:23623016 [GRCh38] Chr16:23634337 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1828A>C (p.Thr610Pro) |
single nucleotide variant |
Familial cancer of breast [RCV004569129]|Hereditary cancer-predisposing syndrome [RCV000568145] |
Chr16:23630326 [GRCh38] Chr16:23641647 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.228_229del (p.Ile76fs) |
microsatellite |
Familial cancer of breast [RCV000709750]|Hereditary breast ovarian cancer syndrome [RCV000585929]|Hereditary cancer-predisposing syndrome [RCV003584668]|not provided [RCV003493679] |
Chr16:23636317..23636318 [GRCh38] Chr16:23647638..23647639 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1192G>A (p.Val398Met) |
single nucleotide variant |
Familial cancer of breast [RCV000553689]|Hereditary cancer-predisposing syndrome [RCV000771520]|not provided [RCV001030202] |
Chr16:23635354 [GRCh38] Chr16:23646675 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.893T>C (p.Val298Ala) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000568197] |
Chr16:23635653 [GRCh38] Chr16:23646974 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2235A>G (p.Lys745=) |
single nucleotide variant |
Familial cancer of breast [RCV000636022]|Hereditary cancer-predisposing syndrome [RCV000774632]|not specified [RCV000603362] |
Chr16:23629919 [GRCh38] Chr16:23641240 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3350+4A>C |
single nucleotide variant |
Familial cancer of breast [RCV000701534]|Hereditary cancer-predisposing syndrome [RCV000565846] |
Chr16:23607860 [GRCh38] Chr16:23619181 [GRCh37] Chr16:16p12.2 |
likely pathogenic|uncertain significance |
NM_024675.4(PALB2):c.28A>G (p.Ser10Gly) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003311296] |
Chr16:23641130 [GRCh38] Chr16:23652451 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3240del (p.Glu1081fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV003311298] |
Chr16:23607974 [GRCh38] Chr16:23619295 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.3445G>T (p.Ala1149Ser) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003311300] |
Chr16:23603575 [GRCh38] Chr16:23614896 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1568C>T (p.Ala523Val) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003311310]|not provided [RCV004765796] |
Chr16:23634978 [GRCh38] Chr16:23646299 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2001A>T (p.Glu667Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000528052]|Hereditary cancer-predisposing syndrome [RCV001014050] |
Chr16:23630153 [GRCh38] Chr16:23641474 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1601C>T (p.Ser534Phe) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000566158]|not provided [RCV001030238] |
Chr16:23634945 [GRCh38] Chr16:23646266 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1429A>G (p.Thr477Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000550600]|Fanconi anemia complementation group N [RCV005018922] |
Chr16:23635117 [GRCh38] Chr16:23646438 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1155A>G (p.Ala385=) |
single nucleotide variant |
Familial cancer of breast [RCV002060420]|Hereditary cancer-predisposing syndrome [RCV000566394] |
Chr16:23635391 [GRCh38] Chr16:23646712 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1974A>C (p.Glu658Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000551035]|Hereditary cancer-predisposing syndrome [RCV003362833] |
Chr16:23630180 [GRCh38] Chr16:23641501 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.621A>G (p.Pro207=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000566509] |
Chr16:23635925 [GRCh38] Chr16:23647246 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1470C>G (p.Pro490=) |
single nucleotide variant |
Familial cancer of breast [RCV000636033]|Hereditary cancer-predisposing syndrome [RCV000567276] |
Chr16:23635076 [GRCh38] Chr16:23646397 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.108+4A>G |
single nucleotide variant |
Familial cancer of breast [RCV001247245]|Hereditary cancer-predisposing syndrome [RCV000567444]|not provided [RCV000586750] |
Chr16:23638066 [GRCh38] Chr16:23649387 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.514_517del (p.Ser172fs) |
deletion |
Familial cancer of breast [RCV000552754]|Hereditary cancer-predisposing syndrome [RCV001189642]|Malignant tumor of breast [RCV001293572] |
Chr16:23636029..23636032 [GRCh38] Chr16:23647350..23647353 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.901_907del (p.Asp301fs) |
deletion |
Familial cancer of breast [RCV001030187]|Hereditary cancer-predisposing syndrome [RCV000568077]|not provided [RCV000657183] |
Chr16:23635639..23635645 [GRCh38] Chr16:23646960..23646966 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.733G>C (p.Ala245Pro) |
single nucleotide variant |
Familial cancer of breast [RCV001065218]|Fanconi anemia complementation group N [RCV000369199]|Hereditary cancer-predisposing syndrome [RCV000312211] |
Chr16:23635813 [GRCh38] Chr16:23647134 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1130A>C (p.Gln377Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000635851]|Familial cancer of breast [RCV002476263]|Hereditary cancer-predisposing syndrome [RCV000579536]|not specified [RCV001821698] |
Chr16:23635416 [GRCh38] Chr16:23646737 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2641G>A (p.Gly881Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000549911]|Hereditary cancer-predisposing syndrome [RCV000572967]|Pancreatic cancer, susceptibility to, 3 [RCV001030336]|not provided [RCV004592565]|not specified [RCV005407704] |
Chr16:23626343 [GRCh38] Chr16:23637664 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.109C>G (p.Arg37Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000550350]|Hereditary cancer-predisposing syndrome [RCV000567015] |
Chr16:23637952 [GRCh38] Chr16:23649273 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.851C>T (p.Thr284Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000550650]|Hereditary cancer-predisposing syndrome [RCV000575766] |
Chr16:23635695 [GRCh38] Chr16:23647016 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2858A>G (p.Asp953Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000814534]|Hereditary cancer-predisposing syndrome [RCV000564938]|not provided [RCV003478226] |
Chr16:23623107 [GRCh38] Chr16:23634428 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1064del (p.Ser354_Leu355insTer) |
deletion |
Familial cancer of breast [RCV003451241]|Hereditary cancer-predisposing syndrome [RCV000564999] |
Chr16:23635482 [GRCh38] Chr16:23646803 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2602T>G (p.Cys868Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000549136] |
Chr16:23626382 [GRCh38] Chr16:23637703 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2906T>C (p.Val969Ala) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000565275] |
Chr16:23623059 [GRCh38] Chr16:23634380 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.432A>G (p.Pro144=) |
single nucleotide variant |
Familial cancer of breast [RCV000920342]|Hereditary cancer-predisposing syndrome [RCV000565285] |
Chr16:23636114 [GRCh38] Chr16:23647435 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1133C>T (p.Pro378Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000526864]|Hereditary cancer-predisposing syndrome [RCV002448657]|not provided [RCV002293450] |
Chr16:23635413 [GRCh38] Chr16:23646734 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.-49C>A |
single nucleotide variant |
not specified [RCV000606303] |
Chr16:23641206 [GRCh38] Chr16:23652527 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2249T>C (p.Val750Ala) |
single nucleotide variant |
Familial cancer of breast [RCV001337540]|Hereditary cancer-predisposing syndrome [RCV000582136]|not provided [RCV003237955] |
Chr16:23629905 [GRCh38] Chr16:23641226 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2515-7T>G |
single nucleotide variant |
Familial cancer of breast [RCV002530804]|Hereditary cancer-predisposing syndrome [RCV000582208] |
Chr16:23629282 [GRCh38] Chr16:23640603 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1371A>C (p.Glu457Asp) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000583925] |
Chr16:23635175 [GRCh38] Chr16:23646496 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2607dup (p.Val870fs) |
duplication |
Familial cancer of breast [RCV000699553]|Hereditary cancer-predisposing syndrome [RCV000583934] |
Chr16:23626376..23626377 [GRCh38] Chr16:23637697..23637698 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1704A>G (p.Gln568=) |
single nucleotide variant |
Familial cancer of breast [RCV003607332]|Hereditary cancer-predisposing syndrome [RCV000583986] |
Chr16:23630450 [GRCh38] Chr16:23641771 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2996+14T>G |
single nucleotide variant |
Familial cancer of breast [RCV002061896]|Fanconi anemia complementation group N [RCV001116751]|Hereditary cancer-predisposing syndrome [RCV000583916]|PALB2-related cancer predisposition [RCV005357760] |
Chr16:23622955 [GRCh38] Chr16:23634276 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1800A>C (p.Leu600Phe) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000579773] |
Chr16:23630354 [GRCh38] Chr16:23641675 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3203G>A (p.Gly1068Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000635679]|Hereditary cancer-predisposing syndrome [RCV000579885] |
Chr16:23608011 [GRCh38] Chr16:23619332 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1595C>T (p.Pro532Leu) |
single nucleotide variant |
Familial cancer of breast [RCV001853886]|Hereditary cancer-predisposing syndrome [RCV000580022]|not provided [RCV001755967] |
Chr16:23634951 [GRCh38] Chr16:23646272 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.110G>T (p.Arg37Leu) |
single nucleotide variant |
Familial cancer of breast [RCV002529107]|Hereditary cancer-predisposing syndrome [RCV000580072] |
Chr16:23637951 [GRCh38] Chr16:23649272 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1765A>G (p.Thr589Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000550043]|Hereditary cancer-predisposing syndrome [RCV001013028]|not provided [RCV003478137] |
Chr16:23630389 [GRCh38] Chr16:23641710 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1175A>G (p.Glu392Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000807416]|Hereditary cancer-predisposing syndrome [RCV000582248] |
Chr16:23635371 [GRCh38] Chr16:23646692 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2877A>G (p.Val959=) |
single nucleotide variant |
Familial cancer of breast [RCV001396964]|Hereditary cancer-predisposing syndrome [RCV000582271] |
Chr16:23623088 [GRCh38] Chr16:23634409 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1619dup (p.Asn540fs) |
duplication |
Familial cancer of breast [RCV001235208]|Hereditary cancer-predisposing syndrome [RCV000582329] |
Chr16:23634926..23634927 [GRCh38] Chr16:23646247..23646248 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1914del (p.Phe638fs) |
deletion |
Familial cancer of breast [RCV001236410]|Hereditary cancer-predisposing syndrome [RCV000582393] |
Chr16:23630240 [GRCh38] Chr16:23641561 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3297G>C (p.Thr1099=) |
single nucleotide variant |
Familial cancer of breast [RCV001410494]|Hereditary cancer-predisposing syndrome [RCV000584055]|not provided [RCV000975645] |
Chr16:23607917 [GRCh38] Chr16:23619238 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.211+19C>T |
single nucleotide variant |
Familial cancer of breast [RCV002061893]|Hereditary cancer-predisposing syndrome [RCV000584004]|not specified [RCV000607662] |
Chr16:23637831 [GRCh38] Chr16:23649152 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.109-18T>C |
single nucleotide variant |
Familial cancer of breast [RCV002530803]|Hereditary cancer-predisposing syndrome [RCV000584110] |
Chr16:23637970 [GRCh38] Chr16:23649291 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2437A>C (p.Ile813Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000699252]|Hereditary cancer-predisposing syndrome [RCV000584188]|not provided [RCV001567582] |
Chr16:23629717 [GRCh38] Chr16:23641038 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.109-12T>A |
single nucleotide variant |
Familial cancer of breast [RCV000794723]|Fanconi anemia complementation group N [RCV003133384]|Hereditary cancer-predisposing syndrome [RCV000579887]|PALB2-related cancer predisposition [RCV005357727]|not provided [RCV001030120] |
Chr16:23637964 [GRCh38] Chr16:23649285 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|uncertain significance|no classifications from unflagged records |
NM_024675.4(PALB2):c.3379T>C (p.Cys1127Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000701458]|Fanconi anemia complementation group N [RCV005019004]|Hereditary breast ovarian cancer syndrome [RCV005367434]|Hereditary cancer-predisposing syndrome [RCV000579960]|Ovarian cancer [RCV003153752]|not provided [RCV001030414] |
Chr16:23603641 [GRCh38] Chr16:23614962 [GRCh37] Chr16:16p12.2 |
benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.676A>G (p.Thr226Ala) |
single nucleotide variant |
Familial cancer of breast [RCV001853888]|Hereditary cancer-predisposing syndrome [RCV000580295]|not specified [RCV002248794] |
Chr16:23635870 [GRCh38] Chr16:23647191 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1546dup (p.Arg516fs) |
duplication |
Familial cancer of breast [RCV001225187]|Hereditary cancer-predisposing syndrome [RCV000582395] |
Chr16:23634999..23635000 [GRCh38] Chr16:23646320..23646321 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2961A>G (p.Gln987=) |
single nucleotide variant |
Familial cancer of breast [RCV000989553]|Hereditary cancer-predisposing syndrome [RCV000582550] |
Chr16:23623004 [GRCh38] Chr16:23634325 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.1276dup (p.Glu426fs) |
duplication |
Hereditary cancer-predisposing syndrome [RCV000582558] |
Chr16:23635269..23635270 [GRCh38] Chr16:23646590..23646591 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2563C>G (p.Leu855Val) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000582572] |
Chr16:23629227 [GRCh38] Chr16:23640548 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1206T>C (p.Leu402=) |
single nucleotide variant |
Familial cancer of breast [RCV005427102]|Hereditary cancer-predisposing syndrome [RCV000584330] |
Chr16:23635340 [GRCh38] Chr16:23646661 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1538C>T (p.Thr513Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000635783]|Hereditary cancer-predisposing syndrome [RCV000580586]|not provided [RCV001030236] |
Chr16:23635008 [GRCh38] Chr16:23646329 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2905G>A (p.Val969Met) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000580616] |
Chr16:23623060 [GRCh38] Chr16:23634381 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2236G>A (p.Ala746Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001373028]|Hereditary cancer-predisposing syndrome [RCV000580654] |
Chr16:23629918 [GRCh38] Chr16:23641239 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.97G>A (p.Ala33Thr) |
single nucleotide variant |
Familial cancer of breast [RCV002530755]|Hereditary cancer-predisposing syndrome [RCV000580732] |
Chr16:23638081 [GRCh38] Chr16:23649402 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3273G>C (p.Gln1091His) |
single nucleotide variant |
Familial cancer of breast [RCV001853934]|Hereditary cancer-predisposing syndrome [RCV000582608] |
Chr16:23607941 [GRCh38] Chr16:23619262 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2587-10A>T |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000582482] |
Chr16:23626407 [GRCh38] Chr16:23637728 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2047C>T (p.His683Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000805561]|Hereditary cancer-predisposing syndrome [RCV000582645] |
Chr16:23630107 [GRCh38] Chr16:23641428 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2415C>T (p.Val805=) |
single nucleotide variant |
Familial cancer of breast [RCV002529273]|Hereditary cancer-predisposing syndrome [RCV000582689] |
Chr16:23629739 [GRCh38] Chr16:23641060 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1685-7T>G |
single nucleotide variant |
Familial cancer of breast [RCV000663169]|Hereditary cancer-predisposing syndrome [RCV000582581]|not specified [RCV004767419] |
Chr16:23630476 [GRCh38] Chr16:23641797 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1041A>G (p.Glu347=) |
single nucleotide variant |
Familial cancer of breast [RCV005422780]|Hereditary cancer-predisposing syndrome [RCV000582730] |
Chr16:23635505 [GRCh38] Chr16:23646826 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2748+15C>T |
single nucleotide variant |
Familial cancer of breast [RCV002061894]|Hereditary cancer-predisposing syndrome [RCV000584236]|Malignant tumor of breast [RCV001355879]|not provided [RCV001597179] |
Chr16:23626221 [GRCh38] Chr16:23637542 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.3226C>T (p.His1076Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV001860094]|Hereditary cancer-predisposing syndrome [RCV000584241]|not provided [RCV000586520] |
Chr16:23607988 [GRCh38] Chr16:23619309 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1148T>C (p.Leu383Pro) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000584423] |
Chr16:23635398 [GRCh38] Chr16:23646719 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.546del (p.Ser183fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000584485] |
Chr16:23636000 [GRCh38] Chr16:23647321 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1004A>G (p.Asn335Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000554257]|Hereditary cancer-predisposing syndrome [RCV000777235]|not provided [RCV004719858] |
Chr16:23635542 [GRCh38] Chr16:23646863 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1620C>T (p.Asn540=) |
single nucleotide variant |
Familial cancer of breast [RCV002526792]|Hereditary cancer-predisposing syndrome [RCV000568574] |
Chr16:23634926 [GRCh38] Chr16:23646247 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1965T>C (p.Phe655=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000566541] |
Chr16:23630189 [GRCh38] Chr16:23641510 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3500C>G (p.Thr1167Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001860052]|Hereditary cancer-predisposing syndrome [RCV000580938] |
Chr16:23603520 [GRCh38] Chr16:23614841 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1684+11A>G |
single nucleotide variant |
Familial cancer of breast [RCV001860051]|Fanconi anemia complementation group N [RCV001121720]|Hereditary cancer-predisposing syndrome [RCV000580824] |
Chr16:23634851 [GRCh38] Chr16:23646172 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2817G>C (p.Leu939Phe) |
single nucleotide variant |
Familial cancer of breast [RCV003607325]|Hereditary cancer-predisposing syndrome [RCV000580854] |
Chr16:23624026 [GRCh38] Chr16:23635347 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1940A>T (p.His647Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000695699]|Hereditary cancer-predisposing syndrome [RCV000582747]|not provided [RCV001755976]|not specified [RCV002282244] |
Chr16:23630214 [GRCh38] Chr16:23641535 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.108+12G>A |
single nucleotide variant |
Familial cancer of breast [RCV002065103]|Hereditary cancer-predisposing syndrome [RCV000582676]|not specified [RCV000616557] |
Chr16:23638058 [GRCh38] Chr16:23649379 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.3231C>T (p.Pro1077=) |
single nucleotide variant |
Familial cancer of breast [RCV001418183]|Hereditary cancer-predisposing syndrome [RCV000582683] |
Chr16:23607983 [GRCh38] Chr16:23619304 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1413A>G (p.Gly471=) |
single nucleotide variant |
Familial cancer of breast [RCV005427103]|Hereditary cancer-predisposing syndrome [RCV000582788] |
Chr16:23635133 [GRCh38] Chr16:23646454 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1004A>T (p.Asn335Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000808097]|Hereditary cancer-predisposing syndrome [RCV000582813]|not provided [RCV001755975] |
Chr16:23635542 [GRCh38] Chr16:23646863 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2673C>A (p.Cys891Ter) |
single nucleotide variant |
Familial cancer of breast [RCV002529275]|Hereditary cancer-predisposing syndrome [RCV000582849] |
Chr16:23626311 [GRCh38] Chr16:23637632 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1368G>A (p.Glu456=) |
single nucleotide variant |
Familial cancer of breast [RCV001058296]|Hereditary cancer-predisposing syndrome [RCV000582872] |
Chr16:23635178 [GRCh38] Chr16:23646499 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.212-18C>T |
single nucleotide variant |
Familial cancer of breast [RCV002529272]|Hereditary cancer-predisposing syndrome [RCV000584371] |
Chr16:23636352 [GRCh38] Chr16:23647673 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1112A>T (p.Glu371Val) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000584501] |
Chr16:23635434 [GRCh38] Chr16:23646755 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3067C>T (p.Gln1023Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000803999]|Hereditary breast ovarian cancer syndrome [RCV001269180]|Hereditary cancer-predisposing syndrome [RCV000584638] |
Chr16:23621408 [GRCh38] Chr16:23632729 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1857T>C (p.Phe619=) |
single nucleotide variant |
Familial cancer of breast [RCV003607333]|Hereditary cancer-predisposing syndrome [RCV001525793]|not specified [RCV000588740] |
Chr16:23630297 [GRCh38] Chr16:23641618 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.2920A>G (p.Lys974Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000817606]|Familial cancer of breast [RCV002491131]|Hereditary cancer-predisposing syndrome [RCV000568691]|not provided [RCV003128630] |
Chr16:23623045 [GRCh38] Chr16:23634366 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.48+6G>A |
single nucleotide variant |
Familial cancer of breast [RCV000532373] |
Chr16:23641104 [GRCh38] Chr16:23652425 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.133A>C (p.Lys45Gln) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000568945] |
Chr16:23637928 [GRCh38] Chr16:23649249 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1772C>A (p.Pro591Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000809631]|Hereditary cancer-predisposing syndrome [RCV000581038] |
Chr16:23630382 [GRCh38] Chr16:23641703 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3107T>C (p.Val1036Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000635728]|Hereditary cancer-predisposing syndrome [RCV000581074]|not specified [RCV001824836] |
Chr16:23621368 [GRCh38] Chr16:23632689 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.29_30delinsTT |
indel |
Hereditary cancer-predisposing syndrome [RCV000581179] |
Chr16:23641128..23641129 [GRCh38] Chr16:23652449..23652450 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1140_1143del (p.Ser380fs) |
deletion |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005367439]|Familial cancer of breast [RCV000635928]|Familial cancer of breast [RCV002476266]|Hereditary cancer-predisposing syndrome [RCV000582948]|not provided [RCV001030201]|not specified [RCV001800805] |
Chr16:23635403..23635406 [GRCh38] Chr16:23646724..23646727 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2796G>A (p.Val932=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000583029] |
Chr16:23624047 [GRCh38] Chr16:23635368 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3350+2C>G |
single nucleotide variant |
Familial cancer of breast [RCV001361268]|Hereditary cancer-predisposing syndrome [RCV000582943] |
Chr16:23607862 [GRCh38] Chr16:23619183 [GRCh37] Chr16:16p12.2 |
likely pathogenic|uncertain significance |
NM_024675.4(PALB2):c.2466G>T (p.Gln822His) |
single nucleotide variant |
Familial cancer of breast [RCV000805353]|Hereditary cancer-predisposing syndrome [RCV000583057]|not specified [RCV002248800] |
Chr16:23629688 [GRCh38] Chr16:23641009 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.338C>T (p.Pro113Leu) |
single nucleotide variant |
Familial cancer of breast [RCV003159984]|Hereditary cancer-predisposing syndrome [RCV000584695] |
Chr16:23636208 [GRCh38] Chr16:23647529 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_001407299.1(PALB2):c.3113+7271del |
deletion |
Familial cancer of breast [RCV000816456] |
Chr16:23614091 [GRCh38] Chr16:23625412 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3228del (p.Cys1078fs) |
deletion |
Familial cancer of breast [RCV003451308]|Hereditary cancer-predisposing syndrome [RCV000581225] |
Chr16:23607986 [GRCh38] Chr16:23619307 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2847T>C (p.Cys949=) |
single nucleotide variant |
Familial cancer of breast [RCV000869694]|Hereditary cancer-predisposing syndrome [RCV000581254] |
Chr16:23623118 [GRCh38] Chr16:23634439 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1940A>G (p.His647Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001853932]|Hereditary cancer-predisposing syndrome [RCV000581258] |
Chr16:23630214 [GRCh38] Chr16:23641535 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3166C>T (p.Gln1056Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001038568]|Gastric cancer [RCV003159983]|Hereditary cancer-predisposing syndrome [RCV000581301]|not provided [RCV005256644] |
Chr16:23614039 [GRCh38] Chr16:23625360 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.48+5C>T |
single nucleotide variant |
Familial cancer of breast [RCV001246045]|Hereditary cancer-predisposing syndrome [RCV000583006]|PALB2-related disorder [RCV004543293] |
Chr16:23641105 [GRCh38] Chr16:23652426 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.476A>G (p.Glu159Gly) |
single nucleotide variant |
Familial cancer of breast [RCV001034983]|Hereditary cancer-predisposing syndrome [RCV000583113]|not specified [RCV000781697] |
Chr16:23636070 [GRCh38] Chr16:23647391 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1437_1438del (p.Lys480fs) |
deletion |
Familial cancer of breast [RCV002529271]|Hereditary cancer-predisposing syndrome [RCV000583187] |
Chr16:23635108..23635109 [GRCh38] Chr16:23646429..23646430 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1811T>C (p.Leu604Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000555346] |
Chr16:23630343 [GRCh38] Chr16:23641664 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.759A>G (p.Leu253=) |
single nucleotide variant |
Familial cancer of breast [RCV000555349]|Hereditary cancer-predisposing syndrome [RCV000774641] |
Chr16:23635787 [GRCh38] Chr16:23647108 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3553T>G (p.Tyr1185Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000635895]|Hereditary cancer-predisposing syndrome [RCV002456292]|not specified [RCV000590060] |
Chr16:23603467 [GRCh38] Chr16:23614788 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2606C>A (p.Ser869Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV001216427]|Hereditary cancer-predisposing syndrome [RCV000567216] |
Chr16:23626378 [GRCh38] Chr16:23637699 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1518A>G (p.Gln506=) |
single nucleotide variant |
Familial cancer of breast [RCV000552151]|Hereditary cancer-predisposing syndrome [RCV002395343] |
Chr16:23635028 [GRCh38] Chr16:23646349 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1032_1033dup (p.Leu345fs) |
duplication |
Familial cancer of breast [RCV000709749]|Hereditary cancer-predisposing syndrome [RCV000581296]|not provided [RCV003328606] |
Chr16:23635512..23635513 [GRCh38] Chr16:23646833..23646834 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2298A>G (p.Ser766=) |
single nucleotide variant |
Familial cancer of breast [RCV001464845]|Hereditary cancer-predisposing syndrome [RCV000581427] |
Chr16:23629856 [GRCh38] Chr16:23641177 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1800A>G (p.Leu600=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000583241] |
Chr16:23630354 [GRCh38] Chr16:23641675 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.303T>G (p.Asp101Glu) |
single nucleotide variant |
Fanconi anemia complementation group N [RCV003133386]|Fanconi anemia complementation group N [RCV005019008]|Hereditary cancer-predisposing syndrome [RCV000583166]|not specified [RCV001800806] |
Chr16:23636243 [GRCh38] Chr16:23647564 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1500T>G (p.Ser500=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000583094] |
Chr16:23635046 [GRCh38] Chr16:23646367 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1059A>G (p.Lys353=) |
single nucleotide variant |
Familial cancer of breast [RCV005427142]|not specified [RCV000604323] |
Chr16:23635487 [GRCh38] Chr16:23646808 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.-1G>T |
single nucleotide variant |
not provided [RCV000590615] |
Chr16:23641158 [GRCh38] Chr16:23652479 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1227T>C (p.Tyr409=) |
single nucleotide variant |
Familial cancer of breast [RCV001451262]|Hereditary cancer-predisposing syndrome [RCV000581501]|not provided [RCV000759892]|not specified [RCV000600139] |
Chr16:23635319 [GRCh38] Chr16:23646640 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2949C>T (p.Thr983=) |
single nucleotide variant |
Familial cancer of breast [RCV002061895]|Hereditary cancer-predisposing syndrome [RCV000581503] |
Chr16:23623016 [GRCh38] Chr16:23634337 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3113+17G>T |
single nucleotide variant |
Familial cancer of breast [RCV001853933]|Hereditary cancer-predisposing syndrome [RCV000581411]|not specified [RCV000609993] |
Chr16:23621345 [GRCh38] Chr16:23632666 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.1301A>C (p.Asp434Ala) |
single nucleotide variant |
Familial cancer of breast [RCV001345251]|Hereditary cancer-predisposing syndrome [RCV000581417] |
Chr16:23635245 [GRCh38] Chr16:23646566 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2835-15T>G |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000583396] |
Chr16:23623145 [GRCh38] Chr16:23634466 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2464C>T (p.Gln822Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003451307]|Hereditary cancer-predisposing syndrome [RCV000581596]|not provided [RCV002268211] |
Chr16:23629690 [GRCh38] Chr16:23641011 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1685-20G>A |
single nucleotide variant |
Familial cancer of breast [RCV002061892]|Hereditary cancer-predisposing syndrome [RCV000581547] |
Chr16:23630489 [GRCh38] Chr16:23641810 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2556A>G (p.Pro852=) |
single nucleotide variant |
Familial cancer of breast [RCV001429565]|Hereditary cancer-predisposing syndrome [RCV000581550] |
Chr16:23629234 [GRCh38] Chr16:23640555 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1468C>T (p.Pro490Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001030232]|Hereditary cancer-predisposing syndrome [RCV000581576] |
Chr16:23635078 [GRCh38] Chr16:23646399 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1435C>A (p.Gln479Lys) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000581702] |
Chr16:23635111 [GRCh38] Chr16:23646432 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.36G>C (p.Glu12Asp) |
single nucleotide variant |
Familial cancer of breast [RCV001308779]|Hereditary cancer-predisposing syndrome [RCV000581707] |
Chr16:23641122 [GRCh38] Chr16:23652443 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.-10C>T |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000583508]|PALB2-related cancer predisposition [RCV005357758]|not provided [RCV001712601] |
Chr16:23641167 [GRCh38] Chr16:23652488 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.1012C>G (p.Pro338Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000805488]|Hereditary cancer-predisposing syndrome [RCV000583434] |
Chr16:23635534 [GRCh38] Chr16:23646855 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3155A>T (p.Asp1052Val) |
single nucleotide variant |
Familial cancer of breast [RCV000821809]|Hereditary cancer-predisposing syndrome [RCV000583445] |
Chr16:23614050 [GRCh38] Chr16:23625371 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3324C>A (p.Tyr1108Ter) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003362812]|not provided [RCV000523756] |
Chr16:23607890 [GRCh38] Chr16:23619211 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.3116A>C (p.Asn1039Thr) |
single nucleotide variant |
Familial cancer of breast [RCV003766947]|not provided [RCV000523781] |
Chr16:23614089 [GRCh38] Chr16:23625410 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2715G>A (p.Gln905=) |
single nucleotide variant |
Familial cancer of breast [RCV000635990]|Hereditary cancer-predisposing syndrome [RCV000581737]|not specified [RCV003117354] |
Chr16:23626269 [GRCh38] Chr16:23637590 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2749-1G>T |
single nucleotide variant |
Familial cancer of breast [RCV000824261]|Hereditary cancer-predisposing syndrome [RCV000581632] |
Chr16:23624095 [GRCh38] Chr16:23635416 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.987A>G (p.Leu329=) |
single nucleotide variant |
Familial cancer of breast [RCV002065104]|Hereditary cancer-predisposing syndrome [RCV000581755] |
Chr16:23635559 [GRCh38] Chr16:23646880 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1401C>T (p.Gly467=) |
single nucleotide variant |
Familial cancer of breast [RCV000698902]|Hereditary cancer-predisposing syndrome [RCV000581781] |
Chr16:23635145 [GRCh38] Chr16:23646466 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.262C>T (p.Leu88Phe) |
single nucleotide variant |
Familial cancer of breast [RCV001215064]|Hereditary cancer-predisposing syndrome [RCV000581810] |
Chr16:23636284 [GRCh38] Chr16:23647605 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.667del (p.Ile223fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000583625] |
Chr16:23635879 [GRCh38] Chr16:23647200 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2257_2259del (p.Arg753del) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000583634] |
Chr16:23629895..23629897 [GRCh38] Chr16:23641216..23641218 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.337C>G (p.Pro113Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000635912]|Hereditary cancer-predisposing syndrome [RCV000583654]|not provided [RCV001779019]|not specified [RCV000781694] |
Chr16:23636209 [GRCh38] Chr16:23647530 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2517T>G (p.Thr839=) |
single nucleotide variant |
Familial cancer of breast [RCV005427104]|Hereditary cancer-predisposing syndrome [RCV000583662] |
Chr16:23629273 [GRCh38] Chr16:23640594 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2586+11T>C |
single nucleotide variant |
Familial cancer of breast [RCV002529274]|Hereditary cancer-predisposing syndrome [RCV000583590] |
Chr16:23629193 [GRCh38] Chr16:23640514 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.594C>T (p.His198=) |
single nucleotide variant |
Familial cancer of breast [RCV002061897]|Hereditary cancer-predisposing syndrome [RCV000583703] |
Chr16:23635952 [GRCh38] Chr16:23647273 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1190_1191del (p.Thr397fs) |
microsatellite |
Hereditary cancer-predisposing syndrome [RCV000583714] |
Chr16:23635355..23635356 [GRCh38] Chr16:23646676..23646677 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3439T>C (p.Cys1147Arg) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000569188] |
Chr16:23603581 [GRCh38] Chr16:23614902 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1843C>G (p.Pro615Ala) |
single nucleotide variant |
Familial cancer of breast [RCV001339383]|Hereditary cancer-predisposing syndrome [RCV000569198]|not provided [RCV001284028] |
Chr16:23630311 [GRCh38] Chr16:23641632 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2514+10A>G |
single nucleotide variant |
Familial cancer of breast [RCV001399807]|Hereditary cancer-predisposing syndrome [RCV000583772]|not specified [RCV002248801] |
Chr16:23629630 [GRCh38] Chr16:23640951 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2898A>T (p.Ile966=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000583719] |
Chr16:23623067 [GRCh38] Chr16:23634388 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.363A>G (p.Thr121=) |
single nucleotide variant |
Familial cancer of breast [RCV001088396]|Hereditary cancer-predisposing syndrome [RCV000583847]|not provided [RCV000967620] |
Chr16:23636183 [GRCh38] Chr16:23647504 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.211+1G>A |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005357759]|Familial cancer of breast [RCV000989582]|Hereditary cancer-predisposing syndrome [RCV000581906]|not provided [RCV002466544] |
Chr16:23637849 [GRCh38] Chr16:23649170 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.109-7C>T |
single nucleotide variant |
Familial cancer of breast [RCV001438248]|Hereditary cancer-predisposing syndrome [RCV000581970] |
Chr16:23637959 [GRCh38] Chr16:23649280 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.48+20G>A |
single nucleotide variant |
Familial cancer of breast [RCV001860095]|Hereditary cancer-predisposing syndrome [RCV000581991] |
Chr16:23641090 [GRCh38] Chr16:23652411 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1843C>A (p.Pro615Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000800019]|Hereditary cancer-predisposing syndrome [RCV000582084] |
Chr16:23630311 [GRCh38] Chr16:23641632 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3427C>G (p.Leu1143Val) |
single nucleotide variant |
Familial cancer of breast [RCV000806205]|Hereditary cancer-predisposing syndrome [RCV002332648] |
Chr16:23603593 [GRCh38] Chr16:23614914 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1883A>C (p.Lys628Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000706639]|Hereditary cancer-predisposing syndrome [RCV000570203]|not provided [RCV001584379]|not specified [RCV004800473] |
Chr16:23630271 [GRCh38] Chr16:23641592 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.615A>G (p.Glu205=) |
single nucleotide variant |
Familial cancer of breast [RCV000559401]|Fanconi anemia complementation group N [RCV005398793]|Hereditary cancer-predisposing syndrome [RCV000581161] |
Chr16:23635931 [GRCh38] Chr16:23647252 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2194_2200del (p.Gly732fs) |
deletion |
Familial cancer of breast [RCV003451271]|Hereditary cancer-predisposing syndrome [RCV000571878] |
Chr16:23629954..23629960 [GRCh38] Chr16:23641275..23641281 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1494C>T (p.Asp498=) |
single nucleotide variant |
Familial cancer of breast [RCV005427027]|Hereditary cancer-predisposing syndrome [RCV000571892] |
Chr16:23635052 [GRCh38] Chr16:23646373 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1972del (p.Glu658fs) |
deletion |
Familial cancer of breast [RCV001858207]|Gastric cancer [RCV003159963]|Hereditary cancer-predisposing syndrome [RCV000571927] |
Chr16:23630182 [GRCh38] Chr16:23641503 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3201+20G>T |
single nucleotide variant |
Familial cancer of breast [RCV000410732]|not specified [RCV000434620] |
Chr16:23613984 [GRCh38] Chr16:23625305 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.2576C>A (p.Ser859Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000410429]|Hereditary cancer-predisposing syndrome [RCV000454290] |
Chr16:23629214 [GRCh38] Chr16:23640535 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2748+13C>G |
single nucleotide variant |
Familial cancer of breast [RCV000411264]|Hereditary cancer-predisposing syndrome [RCV000580542]|not specified [RCV000417961] |
Chr16:23626223 [GRCh38] Chr16:23637544 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3256del (p.Arg1086fs) |
deletion |
Familial cancer of breast [RCV000410678]|Hereditary cancer-predisposing syndrome [RCV000565546]|not provided [RCV004760484] |
Chr16:23607958 [GRCh38] Chr16:23619279 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3G>A (p.Met1Ile) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004698787]|Familial cancer of breast [RCV000410696]|Hereditary cancer-predisposing syndrome [RCV000567207]|not provided [RCV000505935] |
Chr16:23641155 [GRCh38] Chr16:23652476 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3351-5A>G |
single nucleotide variant |
Familial cancer of breast [RCV000930568]|Hereditary cancer-predisposing syndrome [RCV000570221]|not provided [RCV001696960] |
Chr16:23603674 [GRCh38] Chr16:23614995 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2160_2161insG (p.Thr721fs) |
insertion |
Familial cancer of breast [RCV003451273]|Hereditary cancer-predisposing syndrome [RCV000570259] |
Chr16:23629993..23629994 [GRCh38] Chr16:23641314..23641315 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3432_3433delinsAT (p.Gly1145Cys) |
indel |
Familial cancer of breast [RCV000635629]|Hereditary cancer-predisposing syndrome [RCV000570300] |
Chr16:23603587..23603588 [GRCh38] Chr16:23614908..23614909 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.623A>T (p.Asp208Val) |
single nucleotide variant |
Familial cancer of breast [RCV000635613]|Hereditary cancer-predisposing syndrome [RCV000571974]|not provided [RCV001726249] |
Chr16:23635923 [GRCh38] Chr16:23647244 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.437GAA[1] (p.Arg147del) |
microsatellite |
Familial cancer of breast [RCV000410910]|Hereditary cancer-predisposing syndrome [RCV000569782]|not provided [RCV000482861] |
Chr16:23636104..23636106 [GRCh38] Chr16:23647425..23647427 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1139G>A (p.Ser380Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000534767]|Hereditary cancer-predisposing syndrome [RCV001189378] |
Chr16:23635407 [GRCh38] Chr16:23646728 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1214C>G (p.Pro405Arg) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000572154]|not provided [RCV001030204] |
Chr16:23635332 [GRCh38] Chr16:23646653 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2357A>G (p.His786Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000539995]|Hereditary cancer-predisposing syndrome [RCV000774631]|not provided [RCV005000154] |
Chr16:23629797 [GRCh38] Chr16:23641118 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1507G>C (p.Ala503Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000540105]|Hereditary cancer-predisposing syndrome [RCV000579884]|not provided [RCV001755821] |
Chr16:23635039 [GRCh38] Chr16:23646360 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1684+10G>T |
single nucleotide variant |
Familial cancer of breast [RCV000411082] |
Chr16:23634852 [GRCh38] Chr16:23646173 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1838del (p.Gln613fs) |
deletion |
Familial cancer of breast [RCV000411169]|Hereditary cancer-predisposing syndrome [RCV002411276] |
Chr16:23630316 [GRCh38] Chr16:23641637 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1653del (p.Gln552fs) |
deletion |
Familial cancer of breast [RCV003451260]|Hereditary cancer-predisposing syndrome [RCV000570673] |
Chr16:23634893 [GRCh38] Chr16:23646214 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.844_847del (p.Arg282fs) |
deletion |
Familial cancer of breast [RCV001221268]|Hereditary cancer-predisposing syndrome [RCV000573235]|Malignant tumor of breast [RCV004701661]|not provided [RCV000657358] |
Chr16:23635699..23635702 [GRCh38] Chr16:23647020..23647023 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1869G>A (p.Lys623=) |
single nucleotide variant |
Familial cancer of breast [RCV000539532]|Hereditary cancer-predisposing syndrome [RCV000583471] |
Chr16:23630285 [GRCh38] Chr16:23641606 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.485G>A (p.Cys162Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000540257] |
Chr16:23636061 [GRCh38] Chr16:23647382 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3404G>C (p.Gly1135Ala) |
single nucleotide variant |
Familial cancer of breast [RCV004569236]|Hereditary cancer-predisposing syndrome [RCV000574784]|not provided [RCV004696950] |
Chr16:23603616 [GRCh38] Chr16:23614937 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3351-10A>G |
single nucleotide variant |
Familial cancer of breast [RCV000411335]|not provided [RCV001796024] |
Chr16:23603679 [GRCh38] Chr16:23615000 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2628T>C (p.Phe876=) |
single nucleotide variant |
Familial cancer of breast [RCV000537832]|Hereditary cancer-predisposing syndrome [RCV001186967] |
Chr16:23626356 [GRCh38] Chr16:23637677 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.132T>G (p.Ile44Met) |
single nucleotide variant |
Familial cancer of breast [RCV000560340]|Hereditary cancer-predisposing syndrome [RCV000580130]|not specified [RCV000590410] |
Chr16:23637929 [GRCh38] Chr16:23649250 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1530A>C (p.Arg510Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001215642]|Familial cancer of breast [RCV002476240]|Hereditary cancer-predisposing syndrome [RCV000572434] |
Chr16:23635016 [GRCh38] Chr16:23646337 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1661A>G (p.Glu554Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000560464] |
Chr16:23634885 [GRCh38] Chr16:23646206 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2915del (p.Leu972fs) |
deletion |
Familial cancer of breast [RCV000539206]|Hereditary cancer-predisposing syndrome [RCV002438336] |
Chr16:23623050 [GRCh38] Chr16:23634371 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.938G>T (p.Gly313Val) |
single nucleotide variant |
Familial cancer of breast [RCV003607313]|Hereditary cancer-predisposing syndrome [RCV000573571] |
Chr16:23635608 [GRCh38] Chr16:23646929 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.111T>C (p.Arg37=) |
single nucleotide variant |
Familial cancer of breast [RCV000635973]|Hereditary cancer-predisposing syndrome [RCV000574002] |
Chr16:23637950 [GRCh38] Chr16:23649271 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1327A>T (p.Lys443Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000814465]|Hereditary cancer-predisposing syndrome [RCV000574863] |
Chr16:23635219 [GRCh38] Chr16:23646540 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2995G>A (p.Gly999Arg) |
single nucleotide variant |
Familial cancer of breast [RCV002528151]|Hereditary cancer-predisposing syndrome [RCV000569420] |
Chr16:23622970 [GRCh38] Chr16:23634291 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2219_2220del (p.Gln740fs) |
deletion |
Familial cancer of breast [RCV001388884]|Hereditary cancer-predisposing syndrome [RCV000570851]|not provided [RCV005000319] |
Chr16:23629934..23629935 [GRCh38] Chr16:23641255..23641256 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2513A>G (p.Gln838Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000703973]|Hereditary cancer-predisposing syndrome [RCV000572503]|not provided [RCV004592702] |
Chr16:23629641 [GRCh38] Chr16:23640962 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3302T>G (p.Leu1101Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000560521] |
Chr16:23607912 [GRCh38] Chr16:23619233 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3317T>C (p.Met1106Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000538048]|Hereditary cancer-predisposing syndrome [RCV001190818]|not provided [RCV001541422] |
Chr16:23607897 [GRCh38] Chr16:23619218 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2734T>G (p.Trp912Gly) |
single nucleotide variant |
Familial cancer of breast [RCV003219178]|not specified [RCV003321982] |
Chr16:23626250 [GRCh38] Chr16:23637571 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3375T>C (p.Asp1125=) |
single nucleotide variant |
Familial cancer of breast [RCV005422209]|Hereditary cancer-predisposing syndrome [RCV000574150] |
Chr16:23603645 [GRCh38] Chr16:23614966 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.724T>G (p.Phe242Val) |
single nucleotide variant |
Familial cancer of breast [RCV000538178]|Hereditary cancer-predisposing syndrome [RCV001026201] |
Chr16:23635822 [GRCh38] Chr16:23647143 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2821A>G (p.Ile941Val) |
single nucleotide variant |
Familial cancer of breast [RCV000534984]|Fanconi anemia complementation group N [RCV005004225]|Hereditary cancer-predisposing syndrome [RCV000572648]|not provided [RCV000759902] |
Chr16:23624022 [GRCh38] Chr16:23635343 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3425del (p.Leu1142fs) |
deletion |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315424]|Familial cancer of breast [RCV000412323]|Hereditary cancer-predisposing syndrome [RCV002450948] |
Chr16:23603595 [GRCh38] Chr16:23614916 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.43G>A (p.Glu15Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000635761]|Hereditary cancer-predisposing syndrome [RCV000571125]|not provided [RCV004800469] |
Chr16:23641115 [GRCh38] Chr16:23652436 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NC_000016.10:g.(?_23603453)_(23614097_?)del |
deletion |
Familial cancer of breast [RCV000541898] |
Chr16:23603453..23614097 [GRCh38] Chr16:23614774..23625418 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.233T>C (p.Val78Ala) |
single nucleotide variant |
Familial cancer of breast [RCV001044744]|Hereditary cancer-predisposing syndrome [RCV000575076] |
Chr16:23636313 [GRCh38] Chr16:23647634 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1708G>C (p.Glu570Gln) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005367382]|Familial cancer of breast [RCV000542001]|Hereditary cancer-predisposing syndrome [RCV004943960]|PALB2-related disorder [RCV004722886] |
Chr16:23630446 [GRCh38] Chr16:23641767 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1698T>C (p.Arg566=) |
single nucleotide variant |
Familial cancer of breast [RCV000636002]|Hereditary cancer-predisposing syndrome [RCV000571358]|PALB2-related disorder [RCV004530619]|not provided [RCV001755959] |
Chr16:23630456 [GRCh38] Chr16:23641777 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2660T>G (p.Ile887Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001221245]|Hereditary cancer-predisposing syndrome [RCV000571382]|PALB2-related disorder [RCV004722939]|Pancreatic cancer, susceptibility to, 3 [RCV001030338] |
Chr16:23626324 [GRCh38] Chr16:23637645 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1784A>G (p.Asp595Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000812280]|Hereditary cancer-predisposing syndrome [RCV000571419] |
Chr16:23630370 [GRCh38] Chr16:23641691 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.102C>T (p.Arg34=) |
single nucleotide variant |
Familial cancer of breast [RCV000538446]|Hereditary cancer-predisposing syndrome [RCV001009749] |
Chr16:23638076 [GRCh38] Chr16:23649397 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.850A>G (p.Thr284Ala) |
single nucleotide variant |
Familial cancer of breast [RCV003607310]|Hereditary cancer-predisposing syndrome [RCV000575140]|not provided [RCV001030183] |
Chr16:23635696 [GRCh38] Chr16:23647017 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.212-24TA[4] |
microsatellite |
Familial cancer of breast [RCV000410697]|Familial cancer of breast [RCV002502438]|Hereditary cancer-predisposing syndrome [RCV000583383]|not provided [RCV000679763] |
Chr16:23636352..23636353 [GRCh38] Chr16:23647673..23647674 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2467C>T (p.Leu823Phe) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000571473] |
Chr16:23629687 [GRCh38] Chr16:23641008 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2596G>T (p.Gly866Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000536489]|Hereditary cancer-predisposing syndrome [RCV001187392]|not provided [RCV000759899]|not specified [RCV004596242] |
Chr16:23626388 [GRCh38] Chr16:23637709 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.430C>G (p.Pro144Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000696043]|Hereditary cancer-predisposing syndrome [RCV000574433] |
Chr16:23636116 [GRCh38] Chr16:23647437 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2749-2A>C |
single nucleotide variant |
Familial cancer of breast [RCV001858134]|Hereditary cancer-predisposing syndrome [RCV000574502] |
Chr16:23624096 [GRCh38] Chr16:23635417 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.2910T>G (p.Leu970=) |
single nucleotide variant |
Familial cancer of breast [RCV005091320]|Hereditary cancer-predisposing syndrome [RCV000560926] |
Chr16:23623055 [GRCh38] Chr16:23634376 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1633G>A (p.Glu545Lys) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000560954] |
Chr16:23634913 [GRCh38] Chr16:23646234 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2512C>T (p.Gln838Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001053672]|Hereditary breast ovarian cancer syndrome [RCV001553686]|Hereditary cancer-predisposing syndrome [RCV000561038] |
Chr16:23629642 [GRCh38] Chr16:23640963 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2928G>T (p.Arg976Ser) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003444569]|Familial cancer of breast [RCV000556190]|Hereditary cancer-predisposing syndrome [RCV000777238]|not provided [RCV002298647] |
Chr16:23623037 [GRCh38] Chr16:23634358 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3194C>G (p.Ser1065Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000635916]|Hereditary cancer-predisposing syndrome [RCV000569766] |
Chr16:23614011 [GRCh38] Chr16:23625332 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2473A>G (p.Arg825Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000764048]|Familial cancer of breast [RCV001861653]|Hereditary cancer-predisposing syndrome [RCV000454362] |
Chr16:23629681 [GRCh38] Chr16:23641002 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
GRCh37/hg19 16p12.3-11.2(chr16:19424115-30142220)x3 |
copy number gain |
See cases [RCV000449403] |
Chr16:19424115..30142220 [GRCh37] Chr16:16p12.3-11.2 |
pathogenic |
NM_024675.4(PALB2):c.1557C>T (p.Ala519=) |
single nucleotide variant |
Familial cancer of breast [RCV000553079]|Hereditary cancer-predisposing syndrome [RCV000454128] |
Chr16:23634989 [GRCh38] Chr16:23646310 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1186dup (p.Cys396fs) |
duplication |
Familial cancer of breast [RCV000685167]|Hereditary cancer-predisposing syndrome [RCV000454134]|not provided [RCV000985883] |
Chr16:23635359..23635360 [GRCh38] Chr16:23646680..23646681 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.956C>T (p.Ser319Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000792997]|Hereditary cancer-predisposing syndrome [RCV000454136] |
Chr16:23635590 [GRCh38] Chr16:23646911 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2974_2975dup (p.Met992fs) |
duplication |
Familial cancer of breast [RCV000635661]|Hereditary cancer-predisposing syndrome [RCV000454143] |
Chr16:23622989..23622990 [GRCh38] Chr16:23634310..23634311 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.976dup (p.Ser326fs) |
duplication |
Familial cancer of breast [RCV000635689]|Hereditary cancer-predisposing syndrome [RCV000454170] |
Chr16:23635569..23635570 [GRCh38] Chr16:23646890..23646891 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1350_1355del (p.450NL[1]) |
deletion |
Familial cancer of breast [RCV000706688]|Hereditary cancer-predisposing syndrome [RCV000454172] |
Chr16:23635191..23635196 [GRCh38] Chr16:23646512..23646517 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.931A>T (p.Lys311Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003476020]|Hereditary cancer-predisposing syndrome [RCV000454180] |
Chr16:23635615 [GRCh38] Chr16:23646936 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2850del (p.Ser951fs) |
deletion |
Familial cancer of breast [RCV001383427]|Hereditary cancer-predisposing syndrome [RCV000454187]|not provided [RCV001284198] |
Chr16:23623115 [GRCh38] Chr16:23634436 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3202-2A>C |
single nucleotide variant |
Familial cancer of breast [RCV000576715]|Hereditary cancer-predisposing syndrome [RCV000454196] |
Chr16:23608014 [GRCh38] Chr16:23619335 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2748+2T>C |
single nucleotide variant |
Familial cancer of breast [RCV003449105]|Hereditary cancer-predisposing syndrome [RCV000454214] |
Chr16:23626234 [GRCh38] Chr16:23637555 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.1114dup (p.Ser372fs) |
duplication |
Familial cancer of breast [RCV000534137]|Hereditary cancer-predisposing syndrome [RCV000454221]|not provided [RCV000657345] |
Chr16:23635431..23635432 [GRCh38] Chr16:23646752..23646753 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1047_1050del (p.Asn349fs) |
deletion |
Familial cancer of breast [RCV003449103]|Hereditary cancer-predisposing syndrome [RCV000454229] |
Chr16:23635496..23635499 [GRCh38] Chr16:23646817..23646820 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2832del (p.Arg945fs) |
deletion |
Familial cancer of breast [RCV001861654]|Fanconi anemia complementation group N [RCV001782911]|Hereditary cancer-predisposing syndrome [RCV000454241]|not provided [RCV001030346] |
Chr16:23624011 [GRCh38] Chr16:23635332 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1591_1592del (p.Leu531fs) |
deletion |
Familial cancer of breast [RCV003449104]|Hereditary cancer-predisposing syndrome [RCV000454252] |
Chr16:23634954..23634955 [GRCh38] Chr16:23646275..23646276 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2930T>C (p.Leu977Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000635859]|Hereditary cancer-predisposing syndrome [RCV000454273] |
Chr16:23623035 [GRCh38] Chr16:23634356 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2092del (p.Leu698fs) |
deletion |
Familial cancer of breast [RCV000687337]|Hereditary cancer-predisposing syndrome [RCV000454277]|not provided [RCV001008879] |
Chr16:23630062 [GRCh38] Chr16:23641383 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3464C>G (p.Ser1155Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000529716]|Hereditary cancer-predisposing syndrome [RCV000454280]|not provided [RCV000480681] |
Chr16:23603556 [GRCh38] Chr16:23614877 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.48+1del |
deletion |
Hereditary cancer-predisposing syndrome [RCV000454282] |
Chr16:23641109 [GRCh38] Chr16:23652430 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.106C>T (p.Gln36Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000763378]|Familial cancer of breast [RCV001380280]|Hereditary cancer-predisposing syndrome [RCV000454301]|not provided [RCV000657579] |
Chr16:23638072 [GRCh38] Chr16:23649393 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3311del (p.Gly1104fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000454312]|not provided [RCV000484224] |
Chr16:23607903 [GRCh38] Chr16:23619224 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2343C>A (p.Ser781Arg) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000454316] |
Chr16:23629811 [GRCh38] Chr16:23641132 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2103C>T (p.Ser701=) |
single nucleotide variant |
Familial cancer of breast [RCV000554777]|Hereditary cancer-predisposing syndrome [RCV000454317]|not provided [RCV001721487] |
Chr16:23630051 [GRCh38] Chr16:23641372 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1817_1818del (p.Phe606fs) |
deletion |
Familial cancer of breast [RCV002526374]|Hereditary cancer-predisposing syndrome [RCV000454322] |
Chr16:23630336..23630337 [GRCh38] Chr16:23641657..23641658 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.759del (p.Ser254fs) |
deletion |
Familial cancer of breast [RCV000458746]|Hereditary cancer-predisposing syndrome [RCV000454341] |
Chr16:23635787 [GRCh38] Chr16:23647108 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.2765T>A (p.Ile922Lys) |
single nucleotide variant |
Familial cancer of breast [RCV001327843]|Hereditary cancer-predisposing syndrome [RCV000454350]|not provided [RCV001800671] |
Chr16:23624078 [GRCh38] Chr16:23635399 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.108+1G>A |
single nucleotide variant |
Familial cancer of breast [RCV000466548]|Hereditary cancer-predisposing syndrome [RCV000454354]|Pancreatic cancer, susceptibility to, 3 [RCV001258109]|not provided [RCV000484652] |
Chr16:23638069 [GRCh38] Chr16:23649390 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1039G>T (p.Glu347Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315427]|Familial cancer of breast [RCV003239290]|Hereditary cancer-predisposing syndrome [RCV000454356] |
Chr16:23635507 [GRCh38] Chr16:23646828 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 |
copy number gain |
See cases [RCV000446684] |
Chr16:69193..90274381 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p12.2(chr16:23567993-23666408)x1 |
copy number loss |
See cases [RCV000447156] |
Chr16:23567993..23666408 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.78G>A (p.Arg26=) |
single nucleotide variant |
Familial cancer of breast [RCV000456431]|Hereditary cancer-predisposing syndrome [RCV000563892]|not provided [RCV001720025]|not specified [RCV004596178] |
Chr16:23638100 [GRCh38] Chr16:23649421 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1989C>T (p.Arg663=) |
single nucleotide variant |
Familial cancer of breast [RCV001215378]|Hereditary cancer-predisposing syndrome [RCV002418294]|not specified [RCV000427597] |
Chr16:23630165 [GRCh38] Chr16:23641486 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.109-4C>G |
single nucleotide variant |
Familial cancer of breast [RCV001396725]|Hereditary cancer-predisposing syndrome [RCV003168693]|not specified [RCV000431241] |
Chr16:23637956 [GRCh38] Chr16:23649277 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2043A>G (p.Lys681=) |
single nucleotide variant |
Familial cancer of breast [RCV002522695]|Hereditary cancer-predisposing syndrome [RCV004022520]|not specified [RCV000431270] |
Chr16:23630111 [GRCh38] Chr16:23641432 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1110G>A (p.Gln370=) |
single nucleotide variant |
Familial cancer of breast [RCV001431166]|Hereditary cancer-predisposing syndrome [RCV001017332]|not provided [RCV001357517] |
Chr16:23635436 [GRCh38] Chr16:23646757 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.3351-9T>C |
single nucleotide variant |
Familial cancer of breast [RCV002522659]|not specified [RCV000437964] |
Chr16:23603678 [GRCh38] Chr16:23614999 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.48+19G>A |
single nucleotide variant |
Familial cancer of breast [RCV002063502]|Hereditary cancer-predisposing syndrome [RCV000579460]|not specified [RCV000441483] |
Chr16:23641091 [GRCh38] Chr16:23652412 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1166T>C (p.Leu389Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000697985]|Hereditary cancer-predisposing syndrome [RCV001017499] |
Chr16:23635380 [GRCh38] Chr16:23646701 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2587-5G>A |
single nucleotide variant |
Familial cancer of breast [RCV000474454]|Hereditary cancer-predisposing syndrome [RCV003168660]|not specified [RCV000427652] |
Chr16:23626402 [GRCh38] Chr16:23637723 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.212-7T>C |
single nucleotide variant |
Familial cancer of breast [RCV000560076]|Hereditary cancer-predisposing syndrome [RCV001178270]|not specified [RCV000427697] |
Chr16:23636341 [GRCh38] Chr16:23647662 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.48+19G>C |
single nucleotide variant |
Familial cancer of breast [RCV002063655]|not specified [RCV000431523] |
Chr16:23641091 [GRCh38] Chr16:23652412 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3220C>T (p.Leu1074=) |
single nucleotide variant |
Familial cancer of breast [RCV001466865]|Hereditary cancer-predisposing syndrome [RCV000562360]|not specified [RCV000431540] |
Chr16:23607994 [GRCh38] Chr16:23619315 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3113+11C>T |
single nucleotide variant |
Familial cancer of breast [RCV002058921]|Hereditary cancer-predisposing syndrome [RCV000775909]|not specified [RCV000434599] |
Chr16:23621351 [GRCh38] Chr16:23632672 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3201+10G>A |
single nucleotide variant |
Familial cancer of breast [RCV000474901]|Hereditary cancer-predisposing syndrome [RCV000582777]|not provided [RCV005230341]|not specified [RCV000431630] |
Chr16:23613994 [GRCh38] Chr16:23625315 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3054G>A (p.Glu1018=) |
single nucleotide variant |
Familial cancer of breast [RCV001409459]|Hereditary cancer-predisposing syndrome [RCV002446687]|not specified [RCV000434836] |
Chr16:23621421 [GRCh38] Chr16:23632742 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2655A>G (p.Pro885=) |
single nucleotide variant |
Familial cancer of breast [RCV001423949]|Hereditary cancer-predisposing syndrome [RCV000775917]|not provided [RCV001698367] |
Chr16:23626329 [GRCh38] Chr16:23637650 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2587-16G>A |
single nucleotide variant |
Familial cancer of breast [RCV005421762]|not specified [RCV000438335] |
Chr16:23626413 [GRCh38] Chr16:23637734 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.903T>C (p.Asp301=) |
single nucleotide variant |
Familial cancer of breast [RCV001451954]|Hereditary cancer-predisposing syndrome [RCV003298435]|not specified [RCV000438352] |
Chr16:23635643 [GRCh38] Chr16:23646964 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.832C>T (p.Leu278=) |
single nucleotide variant |
Familial cancer of breast [RCV001430081]|Hereditary cancer-predisposing syndrome [RCV002436308]|not specified [RCV000424718] |
Chr16:23635714 [GRCh38] Chr16:23647035 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3113+12C>A |
single nucleotide variant |
PALB2-related cancer predisposition [RCV005365292]|not specified [RCV000442520] |
Chr16:23621350 [GRCh38] Chr16:23632671 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2834+15A>G |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003316526]|Familial cancer of breast [RCV002061456]|Hereditary breast ovarian cancer syndrome [RCV002225612]|Hereditary cancer-predisposing syndrome [RCV000580268]|not provided [RCV001810892]|not specified [RCV000418834] |
Chr16:23623994 [GRCh38] Chr16:23635315 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3099C>T (p.Asn1033=) |
single nucleotide variant |
Familial cancer of breast [RCV000460475]|Hereditary cancer-predisposing syndrome [RCV000568402]|not specified [RCV000442675] |
Chr16:23621376 [GRCh38] Chr16:23632697 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2992G>A (p.Gly998Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001046244]|Hereditary cancer-predisposing syndrome [RCV000775926]|not specified [RCV000442850] |
Chr16:23622973 [GRCh38] Chr16:23634294 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1448C>G (p.Ser483Ter) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV001525971]|not provided [RCV000421638] |
Chr16:23635098 [GRCh38] Chr16:23646419 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2220A>G (p.Gln740=) |
single nucleotide variant |
not specified [RCV000425244] |
Chr16:23629934 [GRCh38] Chr16:23641255 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1812G>A (p.Leu604=) |
single nucleotide variant |
Familial cancer of breast [RCV001396100]|Hereditary cancer-predisposing syndrome [RCV001013278]|not specified [RCV000432191] |
Chr16:23630342 [GRCh38] Chr16:23641663 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.249C>T (p.His83=) |
single nucleotide variant |
Familial cancer of breast [RCV001438952]|Hereditary cancer-predisposing syndrome [RCV001015757]|PALB2-related disorder [RCV004539881]|not provided [RCV001726173]|not specified [RCV000435762] |
Chr16:23636297 [GRCh38] Chr16:23647618 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2319T>G (p.Thr773=) |
single nucleotide variant |
Familial cancer of breast [RCV003500537]|Hereditary cancer-predisposing syndrome [RCV001015170]|not specified [RCV000439306] |
Chr16:23629835 [GRCh38] Chr16:23641156 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1684+4A>C |
single nucleotide variant |
not specified [RCV000443024] |
Chr16:23634858 [GRCh38] Chr16:23646179 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1685-14T>A |
single nucleotide variant |
Familial cancer of breast [RCV000663142]|Hereditary cancer-predisposing syndrome [RCV003584602]|PALB2-related cancer predisposition [RCV005355771]|not specified [RCV000443095] |
Chr16:23630483 [GRCh38] Chr16:23641804 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.1438A>T (p.Lys480Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001390153]|Hereditary cancer-predisposing syndrome [RCV005384711]|not provided [RCV000424678] |
Chr16:23635108 [GRCh38] Chr16:23646429 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2880A>G (p.Leu960=) |
single nucleotide variant |
Familial cancer of breast [RCV001475906]|not specified [RCV000429088] |
Chr16:23623085 [GRCh38] Chr16:23634406 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3432C>G (p.Leu1144=) |
single nucleotide variant |
Familial cancer of breast [RCV001470539]|Hereditary cancer-predisposing syndrome [RCV000564530]|not provided [RCV000872091] |
Chr16:23603588 [GRCh38] Chr16:23614909 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.297A>G (p.Thr99=) |
single nucleotide variant |
Familial cancer of breast [RCV000943674]|Hereditary cancer-predisposing syndrome [RCV001017753]|not specified [RCV000436028] |
Chr16:23636249 [GRCh38] Chr16:23647570 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2835-11A>G |
single nucleotide variant |
Familial cancer of breast [RCV002062437]|Hereditary cancer-predisposing syndrome [RCV000582354]|PALB2-related cancer predisposition [RCV005355739]|not provided [RCV001712372]|not specified [RCV005230337] |
Chr16:23623141 [GRCh38] Chr16:23634462 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2993G>C (p.Gly998Ala) |
single nucleotide variant |
Familial cancer of breast [RCV001038066]|Hereditary cancer-predisposing syndrome [RCV000775893]|not specified [RCV000425596] |
Chr16:23622972 [GRCh38] Chr16:23634293 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1497G>A (p.Leu499=) |
single nucleotide variant |
Familial cancer of breast [RCV000868026]|Fanconi anemia complementation group N [RCV005398560]|Hereditary cancer-predisposing syndrome [RCV000563978]|not provided [RCV001712401] |
Chr16:23635049 [GRCh38] Chr16:23646370 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.211+14A>G |
single nucleotide variant |
Familial cancer of breast [RCV002061455]|not specified [RCV000429399] |
Chr16:23637836 [GRCh38] Chr16:23649157 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2514+18T>G |
single nucleotide variant |
Familial cancer of breast [RCV002062411]|Hereditary cancer-predisposing syndrome [RCV001180017]|not specified [RCV000439754] |
Chr16:23629622 [GRCh38] Chr16:23640943 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2391A>G (p.Gln797=) |
single nucleotide variant |
Familial cancer of breast [RCV002063480]|Hereditary cancer-predisposing syndrome [RCV002451033]|not specified [RCV000422395] |
Chr16:23629763 [GRCh38] Chr16:23641084 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.66A>G (p.Ala22=) |
single nucleotide variant |
Familial cancer of breast [RCV001456862]|Fanconi anemia complementation group N [RCV001119846]|Hereditary cancer-predisposing syndrome [RCV000569467]|not provided [RCV000923663] |
Chr16:23638112 [GRCh38] Chr16:23649433 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.201A>G (p.Leu67=) |
single nucleotide variant |
Familial cancer of breast [RCV002061454]|Hereditary cancer-predisposing syndrome [RCV000580577]|not specified [RCV000422637] |
Chr16:23637860 [GRCh38] Chr16:23649181 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1611G>A (p.Ser537=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005355718]|Familial cancer of breast [RCV000989569]|Fanconi anemia complementation group N [RCV001121721]|Hereditary cancer-predisposing syndrome [RCV000572139]|not provided [RCV001703482]|not specified [RCV005407090] |
Chr16:23634935 [GRCh38] Chr16:23646256 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1685-1G>C |
single nucleotide variant |
Familial cancer of breast [RCV001055212]|Hereditary cancer-predisposing syndrome [RCV002411312]|not provided [RCV000431972] |
Chr16:23630470 [GRCh38] Chr16:23641791 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.48+16G>A |
single nucleotide variant |
Familial cancer of breast [RCV001861582]|not specified [RCV000436803] |
Chr16:23641094 [GRCh38] Chr16:23652415 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1123C>T (p.Leu375=) |
single nucleotide variant |
Familial cancer of breast [RCV000937924]|Hereditary cancer-predisposing syndrome [RCV001009925]|not specified [RCV000444135] |
Chr16:23635423 [GRCh38] Chr16:23646744 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1659C>T (p.His553=) |
single nucleotide variant |
Familial cancer of breast [RCV000636042]|Hereditary cancer-predisposing syndrome [RCV000568745]|not specified [RCV000444145] |
Chr16:23634887 [GRCh38] Chr16:23646208 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1684+10G>A |
single nucleotide variant |
Familial cancer of breast [RCV001426448]|Hereditary cancer-predisposing syndrome [RCV000580107]|not specified [RCV000423010] |
Chr16:23634852 [GRCh38] Chr16:23646173 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1974A>G (p.Glu658=) |
single nucleotide variant |
Familial cancer of breast [RCV003607284]|Hereditary cancer-predisposing syndrome [RCV004022396]|not specified [RCV000433512] |
Chr16:23630180 [GRCh38] Chr16:23641501 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.462A>G (p.Thr154=) |
single nucleotide variant |
Familial cancer of breast [RCV000874635]|Hereditary cancer-predisposing syndrome [RCV000569273]|not specified [RCV000436997] |
Chr16:23636084 [GRCh38] Chr16:23647405 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2034A>G (p.Leu678=) |
single nucleotide variant |
Familial cancer of breast [RCV000472557]|Hereditary cancer-predisposing syndrome [RCV000572092]|PALB2-related disorder [RCV004739720]|not provided [RCV001703483] |
Chr16:23630120 [GRCh38] Chr16:23641441 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1971G>A (p.Glu657=) |
single nucleotide variant |
Familial cancer of breast [RCV002059668]|not specified [RCV000444352] |
Chr16:23630183 [GRCh38] Chr16:23641504 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1424C>A (p.Ser475Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003449055]|Hereditary cancer-predisposing syndrome [RCV005384712]|not provided [RCV000436797] |
Chr16:23635122 [GRCh38] Chr16:23646443 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3474T>C (p.His1158=) |
single nucleotide variant |
Familial cancer of breast [RCV000461054]|Hereditary cancer-predisposing syndrome [RCV000567371]|not specified [RCV000423165] |
Chr16:23603546 [GRCh38] Chr16:23614867 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.429G>T (p.Leu143=) |
single nucleotide variant |
Familial cancer of breast [RCV000636040]|Hereditary cancer-predisposing syndrome [RCV002328982]|not specified [RCV000423198] |
Chr16:23636117 [GRCh38] Chr16:23647438 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2652G>A (p.Glu884=) |
single nucleotide variant |
Familial cancer of breast [RCV003607285]|Hereditary cancer-predisposing syndrome [RCV004943840]|not specified [RCV000433849] |
Chr16:23626332 [GRCh38] Chr16:23637653 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2901A>G (p.Lys967=) |
single nucleotide variant |
Familial cancer of breast [RCV000939681]|Hereditary cancer-predisposing syndrome [RCV002436339]|not provided [RCV001704506] |
Chr16:23623064 [GRCh38] Chr16:23634385 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.49-4C>T |
single nucleotide variant |
Familial cancer of breast [RCV001409521]|Hereditary cancer-predisposing syndrome [RCV002339057]|not specified [RCV000427040] |
Chr16:23638133 [GRCh38] Chr16:23649454 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1746C>T (p.Ser582=) |
single nucleotide variant |
Familial cancer of breast [RCV001490679]|Hereditary cancer-predisposing syndrome [RCV000775902]|not provided [RCV003477918]|not specified [RCV000430741] |
Chr16:23630408 [GRCh38] Chr16:23641729 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.309G>A (p.Gly103=) |
single nucleotide variant |
Familial cancer of breast [RCV001421853]|Hereditary cancer-predisposing syndrome [RCV002323618]|not specified [RCV000430777] |
Chr16:23636237 [GRCh38] Chr16:23647558 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3419G>C (p.Trp1140Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000459022]|Hereditary cancer-predisposing syndrome [RCV001020256]|not provided [RCV004999469] |
Chr16:23603601 [GRCh38] Chr16:23614922 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.695del (p.Gly232fs) |
deletion |
Familial cancer of breast [RCV000462844]|Hereditary cancer-predisposing syndrome [RCV001177042]|Inherited prostate cancer [RCV004584215]|Malignant tumor of breast [RCV001355700]|Pancreatic cancer, susceptibility to, 3 [RCV004796185] |
Chr16:23635851 [GRCh38] Chr16:23647172 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1492G>A (p.Asp498Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000466463]|Familial cancer of breast [RCV002496776]|Hereditary cancer-predisposing syndrome [RCV000572623] |
Chr16:23635054 [GRCh38] Chr16:23646375 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1383T>A (p.Ser461Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000470251]|Familial cancer of breast [RCV002481444]|Hereditary cancer-predisposing syndrome [RCV000568070]|not provided [RCV000679760]|not specified [RCV000781681] |
Chr16:23635163 [GRCh38] Chr16:23646484 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_23621362)_(23641357_?)del |
deletion |
Familial cancer of breast [RCV000240082] |
Chr16:23621362..23641357 [GRCh38] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.20A>G (p.Lys7Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000702590]|Hereditary cancer-predisposing syndrome [RCV000571040]|PALB2-related disorder [RCV004527591]|not provided [RCV000483460]|not specified [RCV003226305] |
Chr16:23641138 [GRCh38] Chr16:23652459 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.45A>G (p.Glu15=) |
single nucleotide variant |
Familial cancer of breast [RCV001085519]|Familial pancreatic carcinoma [RCV005355905]|Hereditary cancer-predisposing syndrome [RCV003168912]|not provided [RCV000828254] |
Chr16:23641113 [GRCh38] Chr16:23652434 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1435C>T (p.Gln479Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000463150]|Hereditary cancer-predisposing syndrome [RCV001011563] |
Chr16:23635111 [GRCh38] Chr16:23646432 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3262C>G (p.Pro1088Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000466711] |
Chr16:23607952 [GRCh38] Chr16:23619273 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.177T>C (p.Ser59=) |
single nucleotide variant |
Familial cancer of breast [RCV001413033] |
Chr16:23637884 [GRCh38] Chr16:23649205 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.294C>G (p.Ile98Met) |
single nucleotide variant |
Familial cancer of breast [RCV000470493]|Fanconi anemia complementation group N [RCV005398627]|Hereditary cancer-predisposing syndrome [RCV003362793] |
Chr16:23636252 [GRCh38] Chr16:23647573 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2514+8C>T |
single nucleotide variant |
Familial cancer of breast [RCV000470502]|Hereditary cancer-predisposing syndrome [RCV004017633]|PALB2-related disorder [RCV004740248] |
Chr16:23629632 [GRCh38] Chr16:23640953 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.619C>A (p.Pro207Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000474143] |
Chr16:23635927 [GRCh38] Chr16:23647248 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2877A>T (p.Val959=) |
single nucleotide variant |
Familial cancer of breast [RCV001409446]|Hereditary cancer-predisposing syndrome [RCV002436504]|not specified [RCV000605173] |
Chr16:23623088 [GRCh38] Chr16:23634409 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.892G>C (p.Val298Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000474350] |
Chr16:23635654 [GRCh38] Chr16:23646975 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1537A>G (p.Thr513Ala) |
single nucleotide variant |
Carcinoma of colon [RCV001030235]|Familial cancer of breast [RCV000474363]|Familial cancer of breast [RCV002480416]|Hereditary cancer-predisposing syndrome [RCV000575626]|not provided [RCV000587874] |
Chr16:23635009 [GRCh38] Chr16:23646330 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2730T>A (p.Tyr910Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000459119]|Familial cancer of breast [RCV002489062]|Hereditary cancer-predisposing syndrome [RCV000568217]|not provided [RCV000657580] |
Chr16:23626254 [GRCh38] Chr16:23637575 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1225T>C (p.Tyr409His) |
single nucleotide variant |
Familial cancer of breast [RCV001306440]|Hereditary cancer-predisposing syndrome [RCV001010425]|not provided [RCV000479502] |
Chr16:23635321 [GRCh38] Chr16:23646642 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3286A>G (p.Asn1096Asp) |
single nucleotide variant |
Familial cancer of breast [RCV001070851]|Hereditary cancer-predisposing syndrome [RCV002446939]|not provided [RCV000483673] |
Chr16:23607928 [GRCh38] Chr16:23619249 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3432C>T (p.Leu1144=) |
single nucleotide variant |
Familial cancer of breast [RCV001084275]|Familial cancer of breast [RCV002496833]|Hereditary breast ovarian cancer syndrome [RCV005355904]|Hereditary cancer-predisposing syndrome [RCV000569983]|PALB2-related disorder [RCV004541491]|not provided [RCV000459418]|not specified [RCV001805092] |
Chr16:23603588 [GRCh38] Chr16:23614909 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NC_000016.10:g.(?_23603162)_(23641357_?)del |
deletion |
Familial cancer of breast [RCV000459483] |
Chr16:23603162..23641357 [GRCh38] Chr16:23614483..23652678 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1217C>T (p.Ala406Val) |
single nucleotide variant |
Familial cancer of breast [RCV000463216]|Familial cancer of breast [RCV002481447]|Hereditary cancer-predisposing syndrome [RCV000569051]|not provided [RCV001561387] |
Chr16:23635329 [GRCh38] Chr16:23646650 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1503G>A (p.Arg501=) |
single nucleotide variant |
Familial cancer of breast [RCV000463328]|Hereditary cancer-predisposing syndrome [RCV000562135] |
Chr16:23635043 [GRCh38] Chr16:23646364 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.635C>G (p.Pro212Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000466962]|Hereditary cancer-predisposing syndrome [RCV003278818] |
Chr16:23635911 [GRCh38] Chr16:23647232 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_23621362)_(23623130_?)del |
deletion |
Familial cancer of breast [RCV000467057] |
Chr16:23621362..23623130 [GRCh38] Chr16:23632683..23634451 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.2586+8G>A |
single nucleotide variant |
Familial cancer of breast [RCV001412130]|Hereditary cancer-predisposing syndrome [RCV001188077] |
Chr16:23629196 [GRCh38] Chr16:23640517 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3151A>G (p.Ile1051Val) |
single nucleotide variant |
Familial cancer of breast [RCV000470811] |
Chr16:23614054 [GRCh38] Chr16:23625375 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.858T>C (p.Pro286=) |
single nucleotide variant |
Familial cancer of breast [RCV001465296]|Hereditary cancer-predisposing syndrome [RCV001192342] |
Chr16:23635688 [GRCh38] Chr16:23647009 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2834+3A>G |
single nucleotide variant |
Familial cancer of breast [RCV000474406]|Hereditary cancer-predisposing syndrome [RCV001016728] |
Chr16:23624006 [GRCh38] Chr16:23635327 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1929T>C (p.Phe643=) |
single nucleotide variant |
Familial cancer of breast [RCV001087451]|Hereditary cancer-predisposing syndrome [RCV000563422]|not provided [RCV000833205] |
Chr16:23630225 [GRCh38] Chr16:23641546 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.3(PALB2):c.*146A>G |
single nucleotide variant |
Familial cancer of breast [RCV000466324] |
Chr16:23603313 [GRCh38] Chr16:23614634 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2793C>T (p.Leu931=) |
single nucleotide variant |
Familial cancer of breast [RCV000466413]|Fanconi anemia complementation group N [RCV005398660]|Hereditary cancer-predisposing syndrome [RCV000570321] |
Chr16:23624050 [GRCh38] Chr16:23635371 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.548del (p.Ser183fs) |
deletion |
Familial cancer of breast [RCV000546704]|not provided [RCV000482031] |
Chr16:23635998 [GRCh38] Chr16:23647319 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1184C>T (p.Ser395Phe) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005355963]|not provided [RCV000479732] |
Chr16:23635362 [GRCh38] Chr16:23646683 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2014G>A (p.Glu672Lys) |
single nucleotide variant |
Familial cancer of breast [RCV001068443]|not provided [RCV000479952] |
Chr16:23630140 [GRCh38] Chr16:23641461 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1694G>T (p.Ser565Ile) |
single nucleotide variant |
Fanconi anemia complementation group N [RCV005018803]|not provided [RCV000479988]|not specified [RCV005230941] |
Chr16:23630460 [GRCh38] Chr16:23641781 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2836G>A (p.Ala946Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001305631]|Hereditary cancer-predisposing syndrome [RCV004943923]|not provided [RCV000484044] |
Chr16:23623129 [GRCh38] Chr16:23634450 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1399G>C (p.Gly467Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000459652]|Hereditary cancer-predisposing syndrome [RCV002393137] |
Chr16:23635147 [GRCh38] Chr16:23646468 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2129C>T (p.Thr710Met) |
single nucleotide variant |
Familial cancer of breast [RCV000459728]|Familial cancer of breast [RCV002481449]|Hereditary cancer-predisposing syndrome [RCV000573568]|PALB2-related disorder [RCV004740237]|not provided [RCV001030280]|not specified [RCV000780575] |
Chr16:23630025 [GRCh38] Chr16:23641346 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3508C>A (p.His1170Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000459786]|Hereditary cancer-predisposing syndrome [RCV001192088] |
Chr16:23603512 [GRCh38] Chr16:23614833 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2725C>G (p.Leu909Val) |
single nucleotide variant |
Familial cancer of breast [RCV000463483]|Hereditary cancer-predisposing syndrome [RCV000572861] |
Chr16:23626259 [GRCh38] Chr16:23637580 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1405T>C (p.Cys469Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000467308]|Hereditary cancer-predisposing syndrome [RCV000565804]|not specified [RCV002509391] |
Chr16:23635141 [GRCh38] Chr16:23646462 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.355del (p.Gln119fs) |
deletion |
Familial cancer of breast [RCV000470952]|Hereditary cancer-predisposing syndrome [RCV000777931] |
Chr16:23636191 [GRCh38] Chr16:23647512 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2936del (p.Ser979fs) |
deletion |
Familial cancer of breast [RCV000471018]|Hereditary cancer-predisposing syndrome [RCV001017569] |
Chr16:23623029 [GRCh38] Chr16:23634350 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.510A>C (p.Arg170Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000474642]|Fanconi anemia complementation group N [RCV001294231]|Hereditary cancer-predisposing syndrome [RCV000571001]|not provided [RCV003477982] |
Chr16:23636036 [GRCh38] Chr16:23647357 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1742T>C (p.Leu581Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000474723]|Hereditary cancer-predisposing syndrome [RCV000561355]|not provided [RCV001584161] |
Chr16:23630412 [GRCh38] Chr16:23641733 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1910C>G (p.Pro637Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000474810]|Hereditary cancer-predisposing syndrome [RCV005384724] |
Chr16:23630244 [GRCh38] Chr16:23641565 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3325T>C (p.Cys1109Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000470766]|Familial cancer of breast [RCV002496778]|Hereditary cancer-predisposing syndrome [RCV000568208] |
Chr16:23607889 [GRCh38] Chr16:23619210 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1843C>T (p.Pro615Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000474289]|Hereditary cancer-predisposing syndrome [RCV001188083]|Malignant tumor of breast [RCV001358009] |
Chr16:23630311 [GRCh38] Chr16:23641632 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.163C>T (p.Gln55Ter) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003168945]|not provided [RCV000482275] |
Chr16:23637898 [GRCh38] Chr16:23649219 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1179A>G (p.Lys393=) |
single nucleotide variant |
Familial cancer of breast [RCV001396731]|Hereditary cancer-predisposing syndrome [RCV000567685]|not provided [RCV000480231] |
Chr16:23635367 [GRCh38] Chr16:23646688 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.3220C>G (p.Leu1074Val) |
single nucleotide variant |
Familial cancer of breast [RCV000541767]|Familial cancer of breast [RCV002475937]|Hereditary cancer-predisposing syndrome [RCV000571325]|not provided [RCV000679770] |
Chr16:23607994 [GRCh38] Chr16:23619315 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2514+20_2514+21del |
microsatellite |
Familial cancer of breast [RCV000663326]|Hereditary cancer-predisposing syndrome [RCV001179077]|not specified [RCV000484369] |
Chr16:23629619..23629620 [GRCh38] Chr16:23640940..23640941 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1593_1594delinsAA (p.Pro532Thr) |
indel |
Familial cancer of breast [RCV000456200] |
Chr16:23634952..23634953 [GRCh38] Chr16:23646273..23646274 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2434C>T (p.Pro812Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000459994]|Hereditary cancer-predisposing syndrome [RCV001015523] |
Chr16:23629720 [GRCh38] Chr16:23641041 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1614T>C (p.Ile538=) |
single nucleotide variant |
Familial cancer of breast [RCV001451567]|not specified [RCV004596220] |
Chr16:23634932 [GRCh38] Chr16:23646253 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1742del (p.Leu581fs) |
deletion |
Familial cancer of breast [RCV000474845]|Hereditary cancer-predisposing syndrome [RCV004649163] |
Chr16:23630412 [GRCh38] Chr16:23641733 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2272C>A (p.Pro758Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001030294]|Hereditary cancer-predisposing syndrome [RCV000582044]|not provided [RCV000480440] |
Chr16:23629882 [GRCh38] Chr16:23641203 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3106_3108del (p.Val1036del) |
deletion |
Hereditary cancer-predisposing syndrome [RCV002323836]|not provided [RCV000480444] |
Chr16:23621367..23621369 [GRCh38] Chr16:23632688..23632690 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1357C>T (p.Leu453Phe) |
single nucleotide variant |
Familial cancer of breast [RCV001061052]|Hereditary cancer-predisposing syndrome [RCV002383912]|not provided [RCV000484400] |
Chr16:23635189 [GRCh38] Chr16:23646510 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2875G>T (p.Val959Leu) |
single nucleotide variant |
Familial cancer of breast [RCV001865437]|Hereditary cancer-predisposing syndrome [RCV000562675]|not provided [RCV000484497] |
Chr16:23623090 [GRCh38] Chr16:23634411 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2804C>T (p.Ala935Val) |
single nucleotide variant |
Familial cancer of breast [RCV000456370]|not provided [RCV001797089] |
Chr16:23624039 [GRCh38] Chr16:23635360 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1671_1674del (p.Ile558fs) |
microsatellite |
Colonic neoplasm [RCV001653830]|Familial cancer of breast [RCV000456465]|Gastric cancer [RCV003168820]|Hereditary cancer-predisposing syndrome [RCV000709384]|not provided [RCV001800680] |
Chr16:23634872..23634875 [GRCh38] Chr16:23646193..23646196 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3391A>G (p.Ile1131Val) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005355850]|Familial cancer of breast [RCV000456527]|Hereditary cancer-predisposing syndrome [RCV000771464]|not provided [RCV000589068]|not specified [RCV004596198] |
Chr16:23603629 [GRCh38] Chr16:23614950 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2799T>C (p.Cys933=) |
single nucleotide variant |
Familial cancer of breast [RCV000456575]|Hereditary cancer-predisposing syndrome [RCV000774625]|not specified [RCV000607558] |
Chr16:23624044 [GRCh38] Chr16:23635365 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.764A>G (p.Asp255Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000460160]|Hereditary cancer-predisposing syndrome [RCV000771521]|not provided [RCV003477983]|not specified [RCV001824789] |
Chr16:23635782 [GRCh38] Chr16:23647103 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1623G>T (p.Arg541Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000463842]|Hereditary cancer-predisposing syndrome [RCV000573051] |
Chr16:23634923 [GRCh38] Chr16:23646244 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1137G>A (p.Lys379=) |
single nucleotide variant |
Familial cancer of breast [RCV001486591]|not specified [RCV000588160] |
Chr16:23635409 [GRCh38] Chr16:23646730 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2835-7G>A |
single nucleotide variant |
Familial cancer of breast [RCV000471397] |
Chr16:23623137 [GRCh38] Chr16:23634458 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3099C>A (p.Asn1033Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000476692]|Hereditary cancer-predisposing syndrome [RCV001018602] |
Chr16:23621376 [GRCh38] Chr16:23632697 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1067_1068insTA (p.Lys356fs) |
insertion |
Familial cancer of breast [RCV001851211]|not provided [RCV000483358] |
Chr16:23635478..23635479 [GRCh38] Chr16:23646799..23646800 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3421G>A (p.Asp1141Asn) |
single nucleotide variant |
Familial cancer of breast [RCV002525917]|Hereditary cancer-predisposing syndrome [RCV004943925]|not provided [RCV000480747] |
Chr16:23603599 [GRCh38] Chr16:23614920 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3246T>A (p.Ser1082Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001851221]|not provided [RCV000480789] |
Chr16:23607968 [GRCh38] Chr16:23619289 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2614G>A (p.Val872Met) |
single nucleotide variant |
Familial cancer of breast [RCV000696384]|Hereditary cancer-predisposing syndrome [RCV004659056]|not provided [RCV000484695] |
Chr16:23626370 [GRCh38] Chr16:23637691 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1303G>A (p.Val435Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000635753]|Hereditary cancer-predisposing syndrome [RCV001010868]|not provided [RCV000484772] |
Chr16:23635243 [GRCh38] Chr16:23646564 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1600T>G (p.Ser534Ala) |
single nucleotide variant |
Chordoma [RCV002266967]|Familial cancer of breast [RCV000689372]|Hereditary cancer-predisposing syndrome [RCV001012375]|not provided [RCV000484915] |
Chr16:23634946 [GRCh38] Chr16:23646267 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1399G>A (p.Gly467Ser) |
single nucleotide variant |
Carcinoma of colon [RCV001030223]|Familial cancer of breast [RCV001220144]|Hereditary cancer-predisposing syndrome [RCV001011366]|not provided [RCV000484965] |
Chr16:23635147 [GRCh38] Chr16:23646468 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2946G>T (p.Gly982=) |
single nucleotide variant |
Familial cancer of breast [RCV000456647]|Hereditary cancer-predisposing syndrome [RCV001525952] |
Chr16:23623019 [GRCh38] Chr16:23634340 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NC_000016.10:g.(?_23624009)_(23624094_?)del |
deletion |
Familial cancer of breast [RCV000460399] |
Chr16:23624009..23624094 [GRCh38] Chr16:23635330..23635415 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2623A>T (p.Met875Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000460422] |
Chr16:23626361 [GRCh38] Chr16:23637682 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2912G>T (p.Gly971Val) |
single nucleotide variant |
Familial cancer of breast [RCV000460458]|Hereditary cancer-predisposing syndrome [RCV000572113] |
Chr16:23623053 [GRCh38] Chr16:23634374 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2587-2A>C |
single nucleotide variant |
Familial cancer of breast [RCV000460478]|Hereditary cancer-predisposing syndrome [RCV002429521] |
Chr16:23626399 [GRCh38] Chr16:23637720 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.25C>T (p.Leu9Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000464168]|Familial pancreatic carcinoma [RCV005355848]|Hereditary breast ovarian cancer syndrome [RCV001030718]|Hereditary cancer-predisposing syndrome [RCV000566603]|not provided [RCV001030103]|not specified [RCV002282156] |
Chr16:23641133 [GRCh38] Chr16:23652454 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2587-10A>G |
single nucleotide variant |
Familial cancer of breast [RCV000467868] |
Chr16:23626407 [GRCh38] Chr16:23637728 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2303G>C (p.Cys768Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000471672]|Hereditary cancer-predisposing syndrome [RCV001015017] |
Chr16:23629851 [GRCh38] Chr16:23641172 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1006A>G (p.Asn336Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000471766]|Hereditary cancer-predisposing syndrome [RCV003168822] |
Chr16:23635540 [GRCh38] Chr16:23646861 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2720A>G (p.Glu907Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000460671]|Hereditary cancer-predisposing syndrome [RCV000565070]|Pancreatic cancer, susceptibility to, 3 [RCV001357370]|not provided [RCV000485757] |
Chr16:23626264 [GRCh38] Chr16:23637585 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.470C>T (p.Ser157Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000460958]|Hereditary cancer-predisposing syndrome [RCV000581614]|not provided [RCV000481171] |
Chr16:23636076 [GRCh38] Chr16:23647397 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1696C>T (p.Arg566Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000461240]|Familial cancer of breast [RCV002481446]|Hereditary cancer-predisposing syndrome [RCV000563652]|not provided [RCV000586825] |
Chr16:23630458 [GRCh38] Chr16:23641779 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.709C>A (p.Leu237Ile) |
single nucleotide variant |
not provided [RCV000480879] |
Chr16:23635837 [GRCh38] Chr16:23647158 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2515-21_2515-19del |
microsatellite |
Familial cancer of breast [RCV001865450]|Hereditary cancer-predisposing syndrome [RCV000584337]|not specified [RCV000484998] |
Chr16:23629294..23629296 [GRCh38] Chr16:23640615..23640617 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.2514G>A (p.Gln838=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003352885]|not provided [RCV000485000] |
Chr16:23629640 [GRCh38] Chr16:23640961 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.295A>C (p.Thr99Pro) |
single nucleotide variant |
not provided [RCV000485016] |
Chr16:23636251 [GRCh38] Chr16:23647572 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.47A>G (p.Lys16Arg) |
single nucleotide variant |
Familial cancer of breast [RCV003766700]|Hereditary cancer-predisposing syndrome [RCV000584562]|not provided [RCV000485171] |
Chr16:23641111 [GRCh38] Chr16:23652432 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.119_120delinsTT (p.Arg40Ile) |
indel |
Familial cancer of breast [RCV003607292]|Hereditary cancer-predisposing syndrome [RCV004943917]|not specified [RCV000485222] |
Chr16:23637941..23637942 [GRCh38] Chr16:23649262..23649263 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1212T>G (p.Phe404Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000456832]|Hereditary cancer-predisposing syndrome [RCV000572809]|PALB2-related disorder [RCV004529597]|not provided [RCV001584162] |
Chr16:23635334 [GRCh38] Chr16:23646655 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1213C>G (p.Pro405Ala) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492059]|Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005355849]|Familial cancer of breast [RCV000456874]|Hereditary cancer-predisposing syndrome [RCV000561159]|Ovarian cancer [RCV003153632]|PALB2-related disorder [RCV004529596] |
Chr16:23635333 [GRCh38] Chr16:23646654 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance|no classifications from unflagged records |
NM_024675.4(PALB2):c.34G>A (p.Glu12Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000456981]|Hereditary cancer-predisposing syndrome [RCV001020463] |
Chr16:23641124 [GRCh38] Chr16:23652445 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2375C>G (p.Ser792Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000457054]|Fanconi anemia complementation group N [RCV001813781]|Hereditary cancer-predisposing syndrome [RCV004649161] |
Chr16:23629779 [GRCh38] Chr16:23641100 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2263T>C (p.Cys755Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000464317]|Familial cancer of breast [RCV002489063]|Hereditary cancer-predisposing syndrome [RCV000562621]|not provided [RCV004591325] |
Chr16:23629891 [GRCh38] Chr16:23641212 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1084C>G (p.Leu362Val) |
single nucleotide variant |
Familial cancer of breast [RCV000475695]|Hereditary cancer-predisposing syndrome [RCV000572723] |
Chr16:23635462 [GRCh38] Chr16:23646783 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1923A>G (p.Lys641=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003316618]|Familial cancer of breast [RCV000989563]|Hereditary cancer-predisposing syndrome [RCV000570008]|PALB2-related disorder [RCV004740249]|not provided [RCV001721538]|not specified [RCV003987551] |
Chr16:23630231 [GRCh38] Chr16:23641552 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3546A>G (p.Val1182=) |
single nucleotide variant |
Familial cancer of breast [RCV000475777]|Hereditary cancer-predisposing syndrome [RCV000579709] |
Chr16:23603474 [GRCh38] Chr16:23614795 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1343G>A (p.Ser448Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000464002]|Hereditary cancer-predisposing syndrome [RCV000564122]|not provided [RCV000486431] |
Chr16:23635203 [GRCh38] Chr16:23646524 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2188A>G (p.Ile730Val) |
single nucleotide variant |
Familial cancer of breast [RCV000468216]|Hereditary cancer-predisposing syndrome [RCV000563382]|Malignant tumor of breast [RCV001354437]|not provided [RCV000479293]|not specified [RCV001199879] |
Chr16:23629966 [GRCh38] Chr16:23641287 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3054G>T (p.Glu1018Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000694700]|Hereditary cancer-predisposing syndrome [RCV000561822]|Pancreatic cancer, susceptibility to, 3 [RCV001030372]|not provided [RCV000481068]|not specified [RCV002268123] |
Chr16:23621421 [GRCh38] Chr16:23632742 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.769G>C (p.Gly257Arg) |
single nucleotide variant |
Familial cancer of breast [RCV003607293]|Hereditary cancer-predisposing syndrome [RCV002402401]|not provided [RCV000485497] |
Chr16:23635777 [GRCh38] Chr16:23647098 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.235T>C (p.Tyr79His) |
single nucleotide variant |
Familial cancer of breast [RCV000457264]|Hereditary cancer-predisposing syndrome [RCV000774959] |
Chr16:23636311 [GRCh38] Chr16:23647632 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2056del (p.Arg686fs) |
deletion |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV004796186]|Familial cancer of breast [RCV000460802] |
Chr16:23630098 [GRCh38] Chr16:23641419 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1761T>C (p.Ala587=) |
single nucleotide variant |
Familial cancer of breast [RCV000460868] |
Chr16:23630393 [GRCh38] Chr16:23641714 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.673C>T (p.Pro225Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000464707]|Hereditary cancer-predisposing syndrome [RCV000775813] |
Chr16:23635873 [GRCh38] Chr16:23647194 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2842T>A (p.Phe948Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000468342] |
Chr16:23623123 [GRCh38] Chr16:23634444 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1752T>C (p.Asp584=) |
single nucleotide variant |
Familial cancer of breast [RCV000468528]|Hereditary cancer-predisposing syndrome [RCV000562132] |
Chr16:23630402 [GRCh38] Chr16:23641723 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3484G>A (p.Val1162Met) |
single nucleotide variant |
Familial cancer of breast [RCV000476087]|Hereditary cancer-predisposing syndrome [RCV000565094]|not provided [RCV003441880] |
Chr16:23603536 [GRCh38] Chr16:23614857 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3296C>T (p.Thr1099Met) |
single nucleotide variant |
Familial cancer of breast [RCV000472486]|Familial cancer of breast [RCV002481448]|Hereditary breast ovarian cancer syndrome [RCV005090913]|Hereditary cancer-predisposing syndrome [RCV000567781]|PALB2-related disorder [RCV004533195]|not provided [RCV000487381]|not specified [RCV003493583] |
Chr16:23607918 [GRCh38] Chr16:23619239 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.127A>G (p.Lys43Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000474623]|Familial cancer of breast [RCV002481445]|Hereditary cancer-predisposing syndrome [RCV000580520]|not provided [RCV000485071] |
Chr16:23637934 [GRCh38] Chr16:23649255 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1751ATG[4] (p.Asp586dup) |
microsatellite |
Familial cancer of breast [RCV001245580]|Hereditary cancer-predisposing syndrome [RCV000564754]|Ovarian neoplasm [RCV000474774]|not provided [RCV000486630] |
Chr16:23630394..23630395 [GRCh38] Chr16:23641715..23641716 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3035C>T (p.Thr1012Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000475841]|Fanconi anemia complementation group N [RCV005018786]|Hereditary cancer-predisposing syndrome [RCV000575045]|not provided [RCV000479556] |
Chr16:23621440 [GRCh38] Chr16:23632761 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.206A>T (p.His69Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000476673]|Fanconi anemia complementation group N [RCV005018787]|Hereditary cancer-predisposing syndrome [RCV000569594]|not provided [RCV000485056] |
Chr16:23637855 [GRCh38] Chr16:23649176 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1490A>C (p.Asn497Thr) |
single nucleotide variant |
Familial cancer of breast [RCV005093884]|Hereditary cancer-predisposing syndrome [RCV001183874] |
Chr16:23635056 [GRCh38] Chr16:23646377 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2915T>C (p.Leu972Pro) |
single nucleotide variant |
Familial cancer of breast [RCV001856853]|Fanconi anemia complementation group N [RCV005429022]|Hereditary cancer-predisposing syndrome [RCV002436545]|not provided [RCV000481355] |
Chr16:23623050 [GRCh38] Chr16:23634371 [GRCh37] Chr16:16p12.2 |
uncertain significance|not provided |
NM_024675.4(PALB2):c.3025C>T (p.Pro1009Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000534054]|Familial cancer of breast [RCV002489151]|Hereditary cancer-predisposing syndrome [RCV000571996]|PALB2-related disorder [RCV004527587]|Pancreatic cancer, susceptibility to, 3 [RCV001030367]|not provided [RCV000481367] |
Chr16:23621450 [GRCh38] Chr16:23632771 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2411C>T (p.Ser804Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000635655]|Familial cancer of breast [RCV002475930]|Hereditary cancer-predisposing syndrome [RCV000581656]|not provided [RCV000481392] |
Chr16:23629743 [GRCh38] Chr16:23641064 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2606C>T (p.Ser869Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000688490]|Fanconi anemia complementation group N [RCV005018807]|Hereditary cancer-predisposing syndrome [RCV000580078]|not provided [RCV000481486] |
Chr16:23626378 [GRCh38] Chr16:23637699 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.752A>G (p.Gln251Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001371804]|Hereditary cancer-predisposing syndrome [RCV001026527]|not provided [RCV000481499] |
Chr16:23635794 [GRCh38] Chr16:23647115 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2340C>T (p.Gly780=) |
single nucleotide variant |
Familial cancer of breast [RCV000814645]|Hereditary cancer-predisposing syndrome [RCV004943920]|not provided [RCV000485867] |
Chr16:23629814 [GRCh38] Chr16:23641135 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2940C>T (p.Ser980=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005355903]|Familial cancer of breast [RCV000461224]|Hereditary cancer-predisposing syndrome [RCV000580627]|not provided [RCV001712437] |
Chr16:23623025 [GRCh38] Chr16:23634346 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.2749-1G>C |
single nucleotide variant |
Familial cancer of breast [RCV000461242]|not provided [RCV002509392] |
Chr16:23624095 [GRCh38] Chr16:23635416 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2424A>C (p.Gly808=) |
single nucleotide variant |
Familial cancer of breast [RCV001405471]|Familial cancer of breast [RCV002489126]|Hereditary cancer-predisposing syndrome [RCV000568058] |
Chr16:23629730 [GRCh38] Chr16:23641051 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.727A>C (p.Thr243Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000464943]|Hereditary cancer-predisposing syndrome [RCV000567643]|not provided [RCV001848813] |
Chr16:23635819 [GRCh38] Chr16:23647140 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3152T>C (p.Ile1051Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000468630]|Hereditary cancer-predisposing syndrome [RCV002323732] |
Chr16:23614053 [GRCh38] Chr16:23625374 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.9:g.(?_23646183)_(23652678_?)dup |
duplication |
Familial cancer of breast [RCV000468677] |
Chr16:23634862..23641357 [GRCh38] Chr16:23646183..23652678 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1366G>T (p.Glu456Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000472293] |
Chr16:23635180 [GRCh38] Chr16:23646501 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.757C>G (p.Leu253Val) |
single nucleotide variant |
Familial cancer of breast [RCV000472302]|Hereditary cancer-predisposing syndrome [RCV002393138] |
Chr16:23635789 [GRCh38] Chr16:23647110 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.552del (p.Ser184fs) |
deletion |
Familial cancer of breast [RCV000476239]|Hereditary cancer-predisposing syndrome [RCV003362794] |
Chr16:23635994 [GRCh38] Chr16:23647315 [GRCh37] Chr16:16p12.2 |
pathogenic |
NC_000016.10:g.(?_23626236)_(23630469_?)del |
deletion |
Familial cancer of breast [RCV000476325] |
Chr16:23626236..23630469 [GRCh38] Chr16:23637557..23641790 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1052C>G (p.Thr351Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000706974]|Hereditary cancer-predisposing syndrome [RCV002402385]|not provided [RCV000481668] |
Chr16:23635494 [GRCh38] Chr16:23646815 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1491T>G (p.Asn497Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000635954]|Hereditary cancer-predisposing syndrome [RCV001011852]|not provided [RCV000486048] |
Chr16:23635055 [GRCh38] Chr16:23646376 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NC_000016.10:g.(?_23621362)_(23626397_?)del |
deletion |
Familial cancer of breast [RCV000457552] |
Chr16:23621362..23626397 [GRCh38] Chr16:23632683..23637718 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.243G>C (p.Lys81Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000457618] |
Chr16:23636303 [GRCh38] Chr16:23647624 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3256C>G (p.Arg1086Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000461441]|Hereditary breast ovarian cancer syndrome [RCV005355852]|Hereditary cancer-predisposing syndrome [RCV000773077]|not provided [RCV003319358]|not specified [RCV003321613] |
Chr16:23607958 [GRCh38] Chr16:23619279 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.284dup (p.Thr96fs) |
duplication |
Familial cancer of breast [RCV000461492] |
Chr16:23636261..23636262 [GRCh38] Chr16:23647582..23647583 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3264_3266dup (p.Val1089dup) |
duplication |
Familial cancer of breast [RCV000465048]|Hereditary cancer-predisposing syndrome [RCV000580782] |
Chr16:23607947..23607948 [GRCh38] Chr16:23619268..23619269 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2711G>A (p.Trp904Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005355847]|Familial cancer of breast [RCV000465081]|Hereditary cancer-predisposing syndrome [RCV000566729]|not provided [RCV000522916] |
Chr16:23626273 [GRCh38] Chr16:23637594 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3114-3A>G |
single nucleotide variant |
Familial cancer of breast [RCV000465211]|Hereditary cancer-predisposing syndrome [RCV000775815]|not provided [RCV002480417] |
Chr16:23614094 [GRCh38] Chr16:23625415 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3064A>G (p.Met1022Val) |
single nucleotide variant |
Familial cancer of breast [RCV000465224] |
Chr16:23621411 [GRCh38] Chr16:23632732 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2835-3T>C |
single nucleotide variant |
Familial cancer of breast [RCV000468775]|Hereditary cancer-predisposing syndrome [RCV001016565]|not specified [RCV004596199] |
Chr16:23623133 [GRCh38] Chr16:23634454 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.880A>G (p.Lys294Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000468876]|Hereditary cancer-predisposing syndrome [RCV000574047]|not provided [RCV002223850] |
Chr16:23635666 [GRCh38] Chr16:23646987 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2502T>C (p.His834=) |
single nucleotide variant |
Familial cancer of breast [RCV001394414] |
Chr16:23629652 [GRCh38] Chr16:23640973 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3023C>T (p.Pro1008Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000468963]|Hereditary cancer-predisposing syndrome [RCV000561044] |
Chr16:23621452 [GRCh38] Chr16:23632773 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2507T>A (p.Val836Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000472505] |
Chr16:23629647 [GRCh38] Chr16:23640968 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.853T>C (p.Ser285Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000472686]|not provided [RCV001030184] |
Chr16:23635693 [GRCh38] Chr16:23647014 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1734T>C (p.Ser578=) |
single nucleotide variant |
Familial cancer of breast [RCV000476348]|Hereditary cancer-predisposing syndrome [RCV000569080] |
Chr16:23630420 [GRCh38] Chr16:23641741 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.444G>C (p.Lys148Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000476400]|Hereditary cancer-predisposing syndrome [RCV000775931] |
Chr16:23636102 [GRCh38] Chr16:23647423 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1048C>T (p.Gln350Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000476491]|Hereditary cancer-predisposing syndrome [RCV002402280]|not provided [RCV000520926] |
Chr16:23635498 [GRCh38] Chr16:23646819 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2389C>A (p.Gln797Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000476517]|Hereditary cancer-predisposing syndrome [RCV000567346]|not provided [RCV003318580] |
Chr16:23629765 [GRCh38] Chr16:23641086 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.886dup (p.Met296fs) |
duplication |
Familial cancer of breast [RCV000476540]|Gastric cancer [RCV003168821]|Hereditary cancer-predisposing syndrome [RCV000570661]|not provided [RCV001591095] |
Chr16:23635659..23635660 [GRCh38] Chr16:23646980..23646981 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1465del (p.Ser489fs) |
deletion |
Familial cancer of breast [RCV003449168]|not provided [RCV000485530] |
Chr16:23635081 [GRCh38] Chr16:23646402 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2335T>G (p.Ser779Ala) |
single nucleotide variant |
Familial cancer of breast [RCV001295395]|not provided [RCV000482102] |
Chr16:23629819 [GRCh38] Chr16:23641140 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2326T>C (p.Phe776Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000662841]|Hereditary cancer-predisposing syndrome [RCV001015195]|not provided [RCV000486202] |
Chr16:23629828 [GRCh38] Chr16:23641149 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3047T>C (p.Phe1016Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001316103]|Hereditary cancer-predisposing syndrome [RCV000572600]|not provided [RCV000486222] |
Chr16:23621428 [GRCh38] Chr16:23632749 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1462A>G (p.Ser488Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000685721]|Hereditary cancer-predisposing syndrome [RCV000571809]|not provided [RCV000486346] |
Chr16:23635084 [GRCh38] Chr16:23646405 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1119G>A (p.Glu373=) |
single nucleotide variant |
Familial cancer of breast [RCV000635978]|Hereditary cancer-predisposing syndrome [RCV000568342]|not specified [RCV001805193] |
Chr16:23635427 [GRCh38] Chr16:23646748 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1424dup (p.Arg476fs) |
duplication |
Familial cancer of breast [RCV000461710]|Hereditary breast ovarian cancer syndrome [RCV003155944]|Hereditary cancer-predisposing syndrome [RCV000709386]|not provided [RCV000657445] |
Chr16:23635121..23635122 [GRCh38] Chr16:23646442..23646443 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.789A>T (p.Glu263Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000461747]|Hereditary cancer-predisposing syndrome [RCV002418405] |
Chr16:23635757 [GRCh38] Chr16:23647078 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2791C>T (p.Leu931Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000465386] |
Chr16:23624052 [GRCh38] Chr16:23635373 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.304G>A (p.Val102Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000465446]|Hereditary cancer-predisposing syndrome [RCV000562562]|not provided [RCV003332178] |
Chr16:23636242 [GRCh38] Chr16:23647563 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.269A>G (p.Glu90Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000465489] |
Chr16:23636277 [GRCh38] Chr16:23647598 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2231A>G (p.Glu744Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000469209]|Familial cancer of breast [RCV002496777]|Hereditary cancer-predisposing syndrome [RCV003298495] |
Chr16:23629923 [GRCh38] Chr16:23641244 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.953_954del (p.Ser318fs) |
deletion |
Familial cancer of breast [RCV000472709]|Hereditary cancer-predisposing syndrome [RCV000775927] |
Chr16:23635592..23635593 [GRCh38] Chr16:23646913..23646914 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2581T>G (p.Leu861Val) |
single nucleotide variant |
Familial cancer of breast [RCV000472859]|Hereditary cancer-predisposing syndrome [RCV004649162] |
Chr16:23629209 [GRCh38] Chr16:23640530 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.602G>A (p.Ser201Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000476599]|Hereditary cancer-predisposing syndrome [RCV004943900] |
Chr16:23635944 [GRCh38] Chr16:23647265 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2878del (p.Leu960fs) |
deletion |
Familial cancer of breast [RCV000524943]|Familial cancer of breast [RCV002496872]|Hereditary cancer-predisposing syndrome [RCV000568432]|not provided [RCV000485849] |
Chr16:23623087 [GRCh38] Chr16:23634408 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2021A>T (p.Asp674Val) |
single nucleotide variant |
Familial cancer of breast [RCV001851157]|Hereditary cancer-predisposing syndrome [RCV005384731]|not provided [RCV000482211] |
Chr16:23630133 [GRCh38] Chr16:23641454 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.108+9A>G |
single nucleotide variant |
Familial cancer of breast [RCV001495481]|not provided [RCV000482406] |
Chr16:23638061 [GRCh38] Chr16:23649382 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1463G>C (p.Ser488Thr) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315431]|Familial cancer of breast [RCV000538747]|Hereditary cancer-predisposing syndrome [RCV002395159]|not provided [RCV000486572] |
Chr16:23635083 [GRCh38] Chr16:23646404 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1210T>C (p.Phe404Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000795526]|Hereditary cancer-predisposing syndrome [RCV000572900]|not provided [RCV000486674] |
Chr16:23635336 [GRCh38] Chr16:23646657 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3239A>G (p.Lys1080Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000531690]|Hereditary cancer-predisposing syndrome [RCV004943961] |
Chr16:23607975 [GRCh38] Chr16:23619296 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.119G>A (p.Arg40Lys) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003446134]|Familial cancer of breast [RCV001063588]|Hereditary cancer-predisposing syndrome [RCV000774647]|not provided [RCV000523351] |
Chr16:23637942 [GRCh38] Chr16:23649263 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2677G>T (p.Asp893Tyr) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003991027]|Familial cancer of breast [RCV000457988]|Hereditary cancer-predisposing syndrome [RCV001016287]|not provided [RCV005243235] |
Chr16:23626307 [GRCh38] Chr16:23637628 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1759G>A (p.Ala587Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000458094]|Familial cancer of breast [RCV000764050]|Hereditary cancer-predisposing syndrome [RCV000563170]|not provided [RCV004767272] |
Chr16:23630395 [GRCh38] Chr16:23641716 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2514+9C>T |
single nucleotide variant |
Familial cancer of breast [RCV000461761] |
Chr16:23629631 [GRCh38] Chr16:23640952 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.932_933insC (p.Lys311fs) |
insertion |
Breast carcinoma [RCV001554294]|Familial cancer of breast [RCV000469258]|Hereditary cancer-predisposing syndrome [RCV001005051]|not provided [RCV002281094] |
Chr16:23635613..23635614 [GRCh38] Chr16:23646934..23646935 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1650A>G (p.Lys550=) |
single nucleotide variant |
Familial cancer of breast [RCV001482731]|Hereditary cancer-predisposing syndrome [RCV000572338] |
Chr16:23634896 [GRCh38] Chr16:23646217 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3311G>T (p.Gly1104Val) |
single nucleotide variant |
Familial cancer of breast [RCV000476813]|Hereditary cancer-predisposing syndrome [RCV004659048] |
Chr16:23607903 [GRCh38] Chr16:23619224 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1144A>C (p.Ser382Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000476970]|Hereditary cancer-predisposing syndrome [RCV000775933] |
Chr16:23635402 [GRCh38] Chr16:23646723 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2438T>C (p.Ile813Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000476976]|Hereditary cancer-predisposing syndrome [RCV000564912]|PALB2-related disorder [RCV004533194]|not provided [RCV000588415] |
Chr16:23629716 [GRCh38] Chr16:23641037 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2275del (p.Gln759fs) |
deletion |
not provided [RCV000478873] |
Chr16:23629879 [GRCh38] Chr16:23641200 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1163dup (p.Leu389fs) |
duplication |
Familial cancer of breast [RCV000635719]|Hereditary cancer-predisposing syndrome [RCV000568264]|Malignant tumor of breast [RCV001731713]|not provided [RCV000479016] |
Chr16:23635382..23635383 [GRCh38] Chr16:23646703..23646704 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3213T>C (p.Phe1071=) |
single nucleotide variant |
Familial cancer of breast [RCV000553869]|Hereditary cancer-predisposing syndrome [RCV002448659] |
Chr16:23608001 [GRCh38] Chr16:23619322 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.742G>C (p.Val248Leu) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005355924]|Familial cancer of breast [RCV000635771]|Hereditary cancer-predisposing syndrome [RCV002383910]|not provided [RCV000478004] |
Chr16:23635804 [GRCh38] Chr16:23647125 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2780A>G (p.Asp927Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000530094]|Hereditary cancer-predisposing syndrome [RCV002438179]|not provided [RCV000482542] |
Chr16:23624063 [GRCh38] Chr16:23635384 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1619A>G (p.Asn540Ser) |
single nucleotide variant |
Familial cancer of breast [RCV003607289]|Hereditary cancer-predisposing syndrome [RCV002402384]|not provided [RCV000486906] |
Chr16:23634927 [GRCh38] Chr16:23646248 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2422G>A (p.Gly808Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000698122]|Hereditary cancer-predisposing syndrome [RCV000775954]|not provided [RCV000486954] |
Chr16:23629732 [GRCh38] Chr16:23641053 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.721A>C (p.Asn241His) |
single nucleotide variant |
Familial cancer of breast [RCV000458196]|Hereditary cancer-predisposing syndrome [RCV001192087] |
Chr16:23635825 [GRCh38] Chr16:23647146 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3202-5A>G |
single nucleotide variant |
Familial cancer of breast [RCV000458326]|Hereditary cancer-predisposing syndrome [RCV004649160] |
Chr16:23608017 [GRCh38] Chr16:23619338 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1706_1707del (p.Lys569fs) |
deletion |
Familial cancer of breast [RCV000462145]|Hereditary cancer-predisposing syndrome [RCV000561742] |
Chr16:23630447..23630448 [GRCh38] Chr16:23641768..23641769 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3124dup (p.Thr1042fs) |
duplication |
Familial cancer of breast [RCV000465905]|Hereditary cancer-predisposing syndrome [RCV000775816] |
Chr16:23614080..23614081 [GRCh38] Chr16:23625401..23625402 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.785T>G (p.Leu262Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000465982] |
Chr16:23635761 [GRCh38] Chr16:23647082 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2328C>A (p.Phe776Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000469475]|Fanconi anemia complementation group N [RCV005398628]|Hereditary cancer-predisposing syndrome [RCV004943901] |
Chr16:23629826 [GRCh38] Chr16:23641147 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.557dup (p.Asn186fs) |
duplication |
Breast carcinoma [RCV001554319]|Familial cancer of breast [RCV000469484]|Hereditary cancer-predisposing syndrome [RCV001183458] |
Chr16:23635988..23635989 [GRCh38] Chr16:23647309..23647310 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1469C>T (p.Pro490Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000469529]|Hereditary cancer-predisposing syndrome [RCV004659047] |
Chr16:23635077 [GRCh38] Chr16:23646398 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.7G>C (p.Glu3Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000469584] |
Chr16:23641151 [GRCh38] Chr16:23652472 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1553C>G (p.Ser518Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000469612]|Hereditary cancer-predisposing syndrome [RCV001012094]|PALB2-related disorder [RCV004529598] |
Chr16:23634993 [GRCh38] Chr16:23646314 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1103A>G (p.Asn368Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000469658]|Hereditary cancer-predisposing syndrome [RCV000563832]|not provided [RCV003153633] |
Chr16:23635443 [GRCh38] Chr16:23646764 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3122A>C (p.Lys1041Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000635632]|Hereditary cancer-predisposing syndrome [RCV000708730]|not provided [RCV000478421] |
Chr16:23614083 [GRCh38] Chr16:23625404 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2780A>T (p.Asp927Val) |
single nucleotide variant |
Familial cancer of breast [RCV000821959]|Hereditary cancer-predisposing syndrome [RCV000774626]|not provided [RCV000478472] |
Chr16:23624063 [GRCh38] Chr16:23635384 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3114-6T>C |
single nucleotide variant |
Familial cancer of breast [RCV001078733]|not provided [RCV000482960] |
Chr16:23614097 [GRCh38] Chr16:23625418 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2972T>G (p.Val991Gly) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV002438180]|not provided [RCV000482961] |
Chr16:23622993 [GRCh38] Chr16:23634314 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.661G>A (p.Val221Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000462286]|Hereditary breast ovarian cancer syndrome [RCV005355851]|Hereditary cancer-predisposing syndrome [RCV000569599]|not provided [RCV003324751] |
Chr16:23635885 [GRCh38] Chr16:23647206 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1871T>C (p.Leu624Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000462381] |
Chr16:23630283 [GRCh38] Chr16:23641604 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.224_228del (p.Lys75fs) |
microsatellite |
Familial cancer of breast [RCV001238319]|Hereditary cancer-predisposing syndrome [RCV001178087]|not provided [RCV000487278] |
Chr16:23636318..23636322 [GRCh38] Chr16:23647639..23647643 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1337A>G (p.Asp446Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000798423]|Hereditary cancer-predisposing syndrome [RCV001010834]|not provided [RCV000478568] |
Chr16:23635209 [GRCh38] Chr16:23646530 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2835-22dup |
duplication |
Familial cancer of breast [RCV002063722]|Hereditary cancer-predisposing syndrome [RCV001178850]|not specified [RCV000478678] |
Chr16:23623147..23623148 [GRCh38] Chr16:23634468..23634469 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.82T>A (p.Tyr28Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000458643]|Hereditary cancer-predisposing syndrome [RCV000564398] |
Chr16:23638096 [GRCh38] Chr16:23649417 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2028T>G (p.Ile676Met) |
single nucleotide variant |
Familial cancer of breast [RCV000462496]|Hereditary cancer-predisposing syndrome [RCV001014131] |
Chr16:23630126 [GRCh38] Chr16:23641447 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3351-2A>G |
single nucleotide variant |
Familial cancer of breast [RCV000466376]|Hereditary cancer-predisposing syndrome [RCV001020064]|not provided [RCV004721374] |
Chr16:23603671 [GRCh38] Chr16:23614992 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2678A>C (p.Asp893Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000470081] |
Chr16:23626306 [GRCh38] Chr16:23637627 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.813T>G (p.Ser271Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000477612] |
Chr16:23635733 [GRCh38] Chr16:23647054 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2634_2635del (p.Arg879fs) |
deletion |
Familial cancer of breast [RCV002525797]|Hereditary cancer-predisposing syndrome [RCV002455916]|not provided [RCV000480125] |
Chr16:23626349..23626350 [GRCh38] Chr16:23637670..23637671 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2749-16_2749-14del |
microsatellite |
Familial cancer of breast [RCV000662767]|Familial pancreatic carcinoma [RCV005365354]|Hereditary cancer-predisposing syndrome [RCV000580010]|not specified [RCV000478938] |
Chr16:23624108..23624110 [GRCh38] Chr16:23635429..23635431 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2266T>C (p.Cys756Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001222102]|not provided [RCV000478990] |
Chr16:23629888 [GRCh38] Chr16:23641209 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.-19dup |
duplication |
not specified [RCV000479020] |
Chr16:23641175..23641176 [GRCh38] Chr16:23652496..23652497 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3490T>C (p.Trp1164Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001853731]|Hereditary cancer-predisposing syndrome [RCV000568566]|not specified [RCV003994024] |
Chr16:23603530 [GRCh38] Chr16:23614851 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2494C>T (p.His832Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000635698]|Hereditary cancer-predisposing syndrome [RCV000568602]|not specified [RCV001174939] |
Chr16:23629660 [GRCh38] Chr16:23640981 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NC_000016.10:g.(?_23603459)_(23626397_?)del |
deletion |
Familial cancer of breast [RCV000168323] |
Chr16:23603459..23626397 [GRCh38] Chr16:23614780..23637718 [GRCh37] Chr16:16p12.2 |
pathogenic |
NC_000016.10:g.(?_23603459)_(23608012_?)del |
deletion |
Familial cancer of breast [RCV000205329] |
Chr16:23603459..23608012 [GRCh38] Chr16:23614780..23619333 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.3(PALB2):c.2325dup (p.Phe776Ilefs) |
duplication |
not provided [RCV000508431] |
Chr16:23629829 [GRCh38] Chr16:23641150 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1753del (p.Asp585fs) |
deletion |
Familial cancer of breast [RCV000823680]|Hereditary cancer-predisposing syndrome [RCV003362804]|not provided [RCV000506134] |
Chr16:23630401 [GRCh38] Chr16:23641722 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.3(PALB2):c.2642_2645dup (p.Cys882Trpfs) |
duplication |
not provided [RCV000506147] |
Chr16:23626339..23626342 [GRCh38] Chr16:23637660..23637663 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.571C>A (p.Pro191Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001225933]|Hereditary cancer-predisposing syndrome [RCV000561187]|not provided [RCV001558217]|not specified [RCV000506516] |
Chr16:23635975 [GRCh38] Chr16:23647296 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1778A>G (p.His593Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000698252]|Hereditary cancer-predisposing syndrome [RCV001013144]|not provided [RCV000759180] |
Chr16:23630376 [GRCh38] Chr16:23641697 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p13.2-q24.3(chr16:9273328-89548493)x3 |
copy number gain |
See cases [RCV000511622] |
Chr16:9273328..89548493 [GRCh37] Chr16:16p13.2-q24.3 |
uncertain significance |
NM_024675.4(PALB2):c.3517G>T (p.Ala1173Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000560068]|Hereditary cancer-predisposing syndrome [RCV004649179]|not provided [RCV004719846]|not specified [RCV000507124] |
Chr16:23603503 [GRCh38] Chr16:23614824 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.62T>G (p.Leu21Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000535566]|Hereditary cancer-predisposing syndrome [RCV000575810]|not provided [RCV000507280] |
Chr16:23638116 [GRCh38] Chr16:23649437 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2298dup (p.Val767fs) |
duplication |
Familial cancer of breast [RCV001241216]|not provided [RCV000507324] |
Chr16:23629855..23629856 [GRCh38] Chr16:23641176..23641177 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
GRCh37/hg19 16p12.2-11.2(chr16:22718350-28858721)x4 |
copy number gain |
See cases [RCV000511587] |
Chr16:22718350..28858721 [GRCh37] Chr16:16p12.2-11.2 |
pathogenic |
NM_024675.4(PALB2):c.1631A>G (p.Glu544Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000698109]|Hereditary cancer-predisposing syndrome [RCV003303163] |
Chr16:23634915 [GRCh38] Chr16:23646236 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2179G>C (p.Ala727Pro) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000570354] |
Chr16:23629975 [GRCh38] Chr16:23641296 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2-11.2(chr16:21596299-30399167)x1 |
copy number loss |
See cases [RCV000511271] |
Chr16:21596299..30399167 [GRCh37] Chr16:16p12.2-11.2 |
pathogenic |
NM_024675.4(PALB2):c.797C>T (p.Pro266Leu) |
single nucleotide variant |
Familial cancer of breast [RCV001858208]|Hereditary cancer-predisposing syndrome [RCV000561813] |
Chr16:23635749 [GRCh38] Chr16:23647070 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2857G>A (p.Asp953Asn) |
single nucleotide variant |
Familial cancer of breast [RCV001858133]|Hereditary cancer-predisposing syndrome [RCV000561887] |
Chr16:23623108 [GRCh38] Chr16:23634429 [GRCh37] Chr16:16p12.2 |
uncertain significance |
maternal UPD(16p) |
complex |
Hemimegalencephaly [RCV000494707] |
Chr16:1280042..33710558 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic |
NM_024675.4(PALB2):c.2913C>T (p.Gly971=) |
single nucleotide variant |
Familial cancer of breast [RCV000531355]|Hereditary cancer-predisposing syndrome [RCV001016945] |
Chr16:23623052 [GRCh38] Chr16:23634373 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.3(PALB2):c.3350+1090_*1278dup |
duplication |
Familial cancer of breast [RCV000495500] |
Chr16:23602181..23606774 [GRCh38] Chr16:23613502..23618095 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.1232G>A (p.Arg411Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000699441]|Hereditary cancer-predisposing syndrome [RCV003302758]|not provided [RCV000524039] |
Chr16:23635314 [GRCh38] Chr16:23646635 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3436C>T (p.Gln1146Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000533343]|Hereditary cancer-predisposing syndrome [RCV002456088] |
Chr16:23603584 [GRCh38] Chr16:23614905 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1051A>G (p.Thr351Ala) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000572475] |
Chr16:23635495 [GRCh38] Chr16:23646816 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1424del (p.Ser474_Ser475insTer) |
deletion |
Familial cancer of breast [RCV000537968]|Hereditary cancer-predisposing syndrome [RCV002395342] |
Chr16:23635122 [GRCh38] Chr16:23646443 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1726A>T (p.Ser576Cys) |
single nucleotide variant |
Familial cancer of breast [RCV001858165]|Hereditary cancer-predisposing syndrome [RCV000574954] |
Chr16:23630428 [GRCh38] Chr16:23641749 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.187C>G (p.Leu63Val) |
single nucleotide variant |
Familial cancer of breast [RCV001858327]|Hereditary cancer-predisposing syndrome [RCV000575025] |
Chr16:23637874 [GRCh38] Chr16:23649195 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2892A>C (p.Gly964=) |
single nucleotide variant |
Familial cancer of breast [RCV000541934] |
Chr16:23623073 [GRCh38] Chr16:23634394 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1648A>G (p.Lys550Glu) |
single nucleotide variant |
Familial cancer of breast [RCV001051273]|Hereditary cancer-predisposing syndrome [RCV000569675] |
Chr16:23634898 [GRCh38] Chr16:23646219 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1875A>G (p.Glu625=) |
single nucleotide variant |
Familial cancer of breast [RCV000556101]|Hereditary cancer-predisposing syndrome [RCV002413487] |
Chr16:23630279 [GRCh38] Chr16:23641600 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.531G>A (p.Lys177=) |
single nucleotide variant |
Familial cancer of breast [RCV000873953]|Hereditary cancer-predisposing syndrome [RCV000572729] |
Chr16:23636015 [GRCh38] Chr16:23647336 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1833C>A (p.Asp611Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000801789]|Hereditary cancer-predisposing syndrome [RCV000575169]|not provided [RCV000586706] |
Chr16:23630321 [GRCh38] Chr16:23641642 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3138G>A (p.Leu1046=) |
single nucleotide variant |
Familial cancer of breast [RCV001456932]|Hereditary cancer-predisposing syndrome [RCV000575172]|not provided [RCV000929524] |
Chr16:23614067 [GRCh38] Chr16:23625388 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.505C>G (p.Leu169Val) |
single nucleotide variant |
Familial cancer of breast [RCV001345557]|Hereditary cancer-predisposing syndrome [RCV000575213] |
Chr16:23636041 [GRCh38] Chr16:23647362 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2255_2267dup (p.Cys756fs) |
duplication |
Familial cancer of breast [RCV003316741]|Hereditary cancer-predisposing syndrome [RCV000575223] |
Chr16:23629886..23629887 [GRCh38] Chr16:23641207..23641208 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2197ACT[1] (p.Thr734del) |
microsatellite |
Familial cancer of breast [RCV000662605]|Hereditary cancer-predisposing syndrome [RCV000575293] |
Chr16:23629952..23629954 [GRCh38] Chr16:23641273..23641275 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1073C>A (p.Pro358His) |
single nucleotide variant |
Familial cancer of breast [RCV000635616]|Hereditary cancer-predisposing syndrome [RCV000572759]|not provided [RCV000985882] |
Chr16:23635473 [GRCh38] Chr16:23646794 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1278G>A (p.Glu426=) |
single nucleotide variant |
Familial cancer of breast [RCV000554872]|Hereditary cancer-predisposing syndrome [RCV000572799]|Malignant tumor of breast [RCV001356740] |
Chr16:23635268 [GRCh38] Chr16:23646589 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1537A>C (p.Thr513Pro) |
single nucleotide variant |
Familial cancer of breast [RCV001202792]|Hereditary cancer-predisposing syndrome [RCV000575420] |
Chr16:23635009 [GRCh38] Chr16:23646330 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3074C>T (p.Ala1025Val) |
single nucleotide variant |
Familial cancer of breast [RCV000635630]|Familial pancreatic carcinoma [RCV005357708]|Hereditary cancer-predisposing syndrome [RCV000575426] |
Chr16:23621401 [GRCh38] Chr16:23632722 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2864G>A (p.Ser955Asn) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000575512] |
Chr16:23623101 [GRCh38] Chr16:23634422 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2514+20T>C |
single nucleotide variant |
Familial cancer of breast [RCV002531546]|not specified [RCV000601708] |
Chr16:23629620 [GRCh38] Chr16:23640941 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3066G>C (p.Met1022Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000534411]|Hereditary cancer-predisposing syndrome [RCV002448658] |
Chr16:23621409 [GRCh38] Chr16:23632730 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.44A>T (p.Glu15Val) |
single nucleotide variant |
Familial cancer of breast [RCV001058727]|Hereditary cancer-predisposing syndrome [RCV000573021] |
Chr16:23641114 [GRCh38] Chr16:23652435 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2214C>T (p.Gly738=) |
single nucleotide variant |
Familial cancer of breast [RCV001415606]|Hereditary cancer-predisposing syndrome [RCV000573109] |
Chr16:23629940 [GRCh38] Chr16:23641261 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2115T>C (p.Tyr705=) |
single nucleotide variant |
Familial cancer of breast [RCV001396727]|Hereditary cancer-predisposing syndrome [RCV000575536] |
Chr16:23630039 [GRCh38] Chr16:23641360 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2835-5C>T |
single nucleotide variant |
Familial cancer of breast [RCV002060484]|Hereditary cancer-predisposing syndrome [RCV000575583] |
Chr16:23623135 [GRCh38] Chr16:23634456 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2974A>G (p.Met992Val) |
single nucleotide variant |
Familial cancer of breast [RCV001853730]|Hereditary cancer-predisposing syndrome [RCV000575699] |
Chr16:23622991 [GRCh38] Chr16:23634312 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.394G>C (p.Val132Leu) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000575712] |
Chr16:23636152 [GRCh38] Chr16:23647473 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2276A>G (p.Gln759Arg) |
single nucleotide variant |
Familial cancer of breast [RCV005091394]|Hereditary cancer-predisposing syndrome [RCV000566619] |
Chr16:23629878 [GRCh38] Chr16:23641199 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1082C>G (p.Thr361Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000557004]|Hereditary cancer-predisposing syndrome [RCV005384760] |
Chr16:23635464 [GRCh38] Chr16:23646785 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2042A>C (p.Lys681Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001035439]|Hereditary cancer-predisposing syndrome [RCV000570278] |
Chr16:23630112 [GRCh38] Chr16:23641433 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.22C>T (p.Pro8Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001858135]|Hereditary cancer-predisposing syndrome [RCV000575831] |
Chr16:23641136 [GRCh38] Chr16:23652457 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2656T>A (p.Cys886Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000635652]|Hereditary cancer-predisposing syndrome [RCV000575941] |
Chr16:23626328 [GRCh38] Chr16:23637649 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.620del (p.Pro207fs) |
deletion |
Familial cancer of breast [RCV000576777]|Hereditary cancer-predisposing syndrome [RCV003159970]|not provided [RCV001008192] |
Chr16:23635926 [GRCh38] Chr16:23647247 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3421G>C (p.Asp1141His) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000579489] |
Chr16:23603599 [GRCh38] Chr16:23614920 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1031del (p.Asn344fs) |
deletion |
Familial cancer of breast [RCV000690752]|Hereditary cancer-predisposing syndrome [RCV000570666] |
Chr16:23635515 [GRCh38] Chr16:23646836 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.21G>A (p.Lys7=) |
single nucleotide variant |
Familial cancer of breast [RCV000636032]|Hereditary cancer-predisposing syndrome [RCV000573279]|Malignant tumor of breast [RCV001357736]|not provided [RCV004569130] |
Chr16:23641137 [GRCh38] Chr16:23652458 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.386C>G (p.Pro129Arg) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000573367] |
Chr16:23636160 [GRCh38] Chr16:23647481 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1897A>G (p.Lys633Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000689600]|Hereditary cancer-predisposing syndrome [RCV000576039] |
Chr16:23630257 [GRCh38] Chr16:23641578 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.945G>T (p.Leu315=) |
single nucleotide variant |
Familial cancer of breast [RCV002060405]|Hereditary cancer-predisposing syndrome [RCV000576063] |
Chr16:23635601 [GRCh38] Chr16:23646922 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.38A>C (p.Glu13Ala) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000579852] |
Chr16:23641120 [GRCh38] Chr16:23652441 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.223A>T (p.Lys75Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005357565]|Familial cancer of breast [RCV000557714]|Hereditary cancer-predisposing syndrome [RCV001014881]|not provided [RCV001008028] |
Chr16:23636323 [GRCh38] Chr16:23647644 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1176A>G (p.Glu392=) |
single nucleotide variant |
Familial cancer of breast [RCV001423280]|Hereditary cancer-predisposing syndrome [RCV000570728]|not specified [RCV003321674] |
Chr16:23635370 [GRCh38] Chr16:23646691 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.1990A>C (p.Met664Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000535309] |
Chr16:23630164 [GRCh38] Chr16:23641485 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1204C>T (p.Leu402Phe) |
single nucleotide variant |
Familial cancer of breast [RCV001858212]|Hereditary cancer-predisposing syndrome [RCV000573520] |
Chr16:23635342 [GRCh38] Chr16:23646663 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.829_832del (p.His276_Asp277insTer) |
deletion |
Familial cancer of breast [RCV003451337]|Hereditary breast ovarian cancer syndrome [RCV000590429] |
Chr16:23635714..23635717 [GRCh38] Chr16:23647035..23647038 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1081A>T (p.Thr361Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000822321]|Hereditary cancer-predisposing syndrome [RCV000570839] |
Chr16:23635465 [GRCh38] Chr16:23646786 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1125A>C (p.Leu375=) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005357654]|Familial cancer of breast [RCV000931888]|Hereditary cancer-predisposing syndrome [RCV000570843]|not specified [RCV000611012] |
Chr16:23635421 [GRCh38] Chr16:23646742 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1999_2001dup (p.Glu667dup) |
duplication |
Familial cancer of breast [RCV001359579]|Hereditary cancer-predisposing syndrome [RCV000570879] |
Chr16:23630152..23630153 [GRCh38] Chr16:23641473..23641474 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3021G>A (p.Met1007Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000558068]|Hereditary cancer-predisposing syndrome [RCV002438337]|not provided [RCV001775855] |
Chr16:23621454 [GRCh38] Chr16:23632775 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.109-7C>A |
single nucleotide variant |
Familial cancer of breast [RCV002066696]|Hereditary cancer-predisposing syndrome [RCV003584674]|not specified [RCV000605132] |
Chr16:23637959 [GRCh38] Chr16:23649280 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1562C>T (p.Thr521Ile) |
single nucleotide variant |
Familial cancer of breast [RCV001304806]|Hereditary cancer-predisposing syndrome [RCV000571175] |
Chr16:23634984 [GRCh38] Chr16:23646305 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3121A>G (p.Lys1041Glu) |
single nucleotide variant |
Familial cancer of breast [RCV001853734]|Hereditary cancer-predisposing syndrome [RCV000573740] |
Chr16:23614084 [GRCh38] Chr16:23625405 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2158A>C (p.Thr720Pro) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000573754] |
Chr16:23629996 [GRCh38] Chr16:23641317 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.734_735dup (p.Thr246fs) |
duplication |
Familial cancer of breast [RCV003451272]|Hereditary cancer-predisposing syndrome [RCV000573756] |
Chr16:23635810..23635811 [GRCh38] Chr16:23647131..23647132 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.839del (p.Asn280fs) |
deletion |
Familial cancer of breast [RCV001865724]|Hereditary cancer-predisposing syndrome [RCV000573816]|PALB2-related disorder [RCV004530600]|not provided [RCV001030181] |
Chr16:23635707 [GRCh38] Chr16:23647028 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1461C>A (p.Val487=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000571212] |
Chr16:23635085 [GRCh38] Chr16:23646406 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.860T>C (p.Val287Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000558642]|Hereditary cancer-predisposing syndrome [RCV001805159] |
Chr16:23635686 [GRCh38] Chr16:23647007 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.313G>C (p.Glu105Gln) |
single nucleotide variant |
Familial cancer of breast [RCV001240857]|Hereditary cancer-predisposing syndrome [RCV000573997] |
Chr16:23636233 [GRCh38] Chr16:23647554 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2911G>C (p.Gly971Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000700356]|Hereditary cancer-predisposing syndrome [RCV000574054] |
Chr16:23623054 [GRCh38] Chr16:23634375 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.472del (p.Gln158fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV003278570] |
Chr16:23636074 [GRCh38] Chr16:23647395 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.152C>A (p.Thr51Lys) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003278579] |
Chr16:23637909 [GRCh38] Chr16:23649230 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2680G>C (p.Val894Leu) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003278580] |
Chr16:23626304 [GRCh38] Chr16:23637625 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1238C>G (p.Thr413Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000635666]|Hereditary cancer-predisposing syndrome [RCV001010492]|not provided [RCV000586513] |
Chr16:23635308 [GRCh38] Chr16:23646629 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2874A>G (p.Gln958=) |
single nucleotide variant |
Familial cancer of breast [RCV002060404]|Hereditary cancer-predisposing syndrome [RCV000571596] |
Chr16:23623091 [GRCh38] Chr16:23634412 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1677del (p.Gln559_Val560insTer) |
deletion |
Familial cancer of breast [RCV001067572]|Hereditary cancer-predisposing syndrome [RCV000571605]|not provided [RCV003320695] |
Chr16:23634869 [GRCh38] Chr16:23646190 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1480A>C (p.Thr494Pro) |
single nucleotide variant |
Familial cancer of breast [RCV003767129]|Hereditary cancer-predisposing syndrome [RCV000571709] |
Chr16:23635066 [GRCh38] Chr16:23646387 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.192A>G (p.Ser64=) |
single nucleotide variant |
Fanconi anemia complementation group N [RCV005398900]|Hereditary cancer-predisposing syndrome [RCV000574144] |
Chr16:23637869 [GRCh38] Chr16:23649190 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2724A>T (p.Lys908Asn) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005357836]|Familial cancer of breast [RCV000635620]|Hereditary cancer-predisposing syndrome [RCV003162841] |
Chr16:23626260 [GRCh38] Chr16:23637581 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2120C>T (p.Pro707Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000635623]|Hereditary cancer-predisposing syndrome [RCV001014519] |
Chr16:23630034 [GRCh38] Chr16:23641355 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.899del (p.Thr300fs) |
deletion |
Familial cancer of breast [RCV000635627] |
Chr16:23635647 [GRCh38] Chr16:23646968 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2869A>T (p.Lys957Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000635650] |
Chr16:23623096 [GRCh38] Chr16:23634417 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2834+5G>A |
single nucleotide variant |
Familial cancer of breast [RCV000635658]|Hereditary cancer-predisposing syndrome [RCV001016729]|PALB2-related disorder [RCV004723006] |
Chr16:23624004 [GRCh38] Chr16:23635325 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1908G>C (p.Glu636Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000635664]|Hereditary cancer-predisposing syndrome [RCV002406361] |
Chr16:23630246 [GRCh38] Chr16:23641567 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1988G>T (p.Arg663Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000635668]|Hereditary cancer-predisposing syndrome [RCV001013921] |
Chr16:23630166 [GRCh38] Chr16:23641487 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.921A>G (p.Lys307=) |
single nucleotide variant |
Familial cancer of breast [RCV000635669] |
Chr16:23635625 [GRCh38] Chr16:23646946 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2137C>T (p.Pro713Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000635680]|Hereditary cancer-predisposing syndrome [RCV002424395] |
Chr16:23630017 [GRCh38] Chr16:23641338 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2531T>G (p.Leu844Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000635685]|Hereditary cancer-predisposing syndrome [RCV004944038] |
Chr16:23629259 [GRCh38] Chr16:23640580 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3523C>T (p.Gln1175Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000635687]|Hereditary cancer-predisposing syndrome [RCV002334080]|not provided [RCV001702535] |
Chr16:23603497 [GRCh38] Chr16:23614818 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2673_2674delinsGA (p.Cys891_Glu892delinsTrpLys) |
indel |
Familial cancer of breast [RCV000635713] |
Chr16:23626310..23626311 [GRCh38] Chr16:23637631..23637632 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2835-5C>G |
single nucleotide variant |
Familial cancer of breast [RCV000635740] |
Chr16:23623135 [GRCh38] Chr16:23634456 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2207C>T (p.Ala736Val) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003492122]|Familial cancer of breast [RCV000635751]|Hereditary cancer-predisposing syndrome [RCV002424397] |
Chr16:23629947 [GRCh38] Chr16:23641268 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.841A>G (p.Ile281Val) |
single nucleotide variant |
Familial cancer of breast [RCV000635759]|Hereditary cancer-predisposing syndrome [RCV001017739] |
Chr16:23635705 [GRCh38] Chr16:23647026 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3415A>T (p.Ile1139Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000635781]|Hereditary cancer-predisposing syndrome [RCV001182081] |
Chr16:23603605 [GRCh38] Chr16:23614926 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2804C>G (p.Ala935Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000635784]|Familial cancer of breast [RCV002492981]|Hereditary cancer-predisposing syndrome [RCV001016626]|Pancreatic cancer, susceptibility to, 3 [RCV005357838]|not provided [RCV003156270] |
Chr16:23624039 [GRCh38] Chr16:23635360 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1984A>T (p.Lys662Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000635787]|Hereditary cancer-predisposing syndrome [RCV001190673] |
Chr16:23630170 [GRCh38] Chr16:23641491 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2345C>A (p.Pro782Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000635803]|Hereditary cancer-predisposing syndrome [RCV002424398] |
Chr16:23629809 [GRCh38] Chr16:23641130 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2832C>G (p.Ile944Met) |
single nucleotide variant |
Familial cancer of breast [RCV000635805]|Hereditary cancer-predisposing syndrome [RCV002438683] |
Chr16:23624011 [GRCh38] Chr16:23635332 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.388C>A (p.His130Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000635806] |
Chr16:23636158 [GRCh38] Chr16:23647479 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2267G>A (p.Cys756Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000635807]|Fanconi anemia complementation group N [RCV003133422]|Hereditary cancer-predisposing syndrome [RCV001014983]|not provided [RCV001030292] |
Chr16:23629887 [GRCh38] Chr16:23641208 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3110T>C (p.Ile1037Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000693855]|Hereditary cancer-predisposing syndrome [RCV000571745] |
Chr16:23621365 [GRCh38] Chr16:23632686 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3500C>T (p.Thr1167Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000635737]|Fanconi anemia complementation group N [RCV005018978]|Hereditary cancer-predisposing syndrome [RCV000571848]|not provided [RCV000756459] |
Chr16:23603520 [GRCh38] Chr16:23614841 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1183del (p.Ser395fs) |
deletion |
Familial cancer of breast [RCV001388322]|Fanconi anemia complementation group N [RCV005018970]|Hereditary cancer-predisposing syndrome [RCV000574408]|not provided [RCV000657391] |
Chr16:23635363 [GRCh38] Chr16:23646684 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.280G>C (p.Glu94Gln) |
single nucleotide variant |
Familial cancer of breast [RCV001853787]|Hereditary cancer-predisposing syndrome [RCV000566283] |
Chr16:23636266 [GRCh38] Chr16:23647587 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.882A>G (p.Lys294=) |
single nucleotide variant |
Familial cancer of breast [RCV001479285]|Hereditary cancer-predisposing syndrome [RCV000777324]|not specified [RCV000601015] |
Chr16:23635664 [GRCh38] Chr16:23646985 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1874A>G (p.Glu625Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000635838] |
Chr16:23630280 [GRCh38] Chr16:23641601 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1448C>A (p.Ser483Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000635841]|Hereditary cancer-predisposing syndrome [RCV002388041]|not provided [RCV001591416] |
Chr16:23635098 [GRCh38] Chr16:23646419 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2612A>T (p.Asp871Val) |
single nucleotide variant |
Familial cancer of breast [RCV000635870]|Hereditary cancer-predisposing syndrome [RCV002438684] |
Chr16:23626372 [GRCh38] Chr16:23637693 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3104T>C (p.Ile1035Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000635879]|Hereditary cancer-predisposing syndrome [RCV001018654] |
Chr16:23621371 [GRCh38] Chr16:23632692 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2150A>T (p.Asp717Val) |
single nucleotide variant |
Familial cancer of breast [RCV000635881]|Hereditary cancer-predisposing syndrome [RCV002424399] |
Chr16:23630004 [GRCh38] Chr16:23641325 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.846A>T (p.Arg282Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000635901]|Hereditary cancer-predisposing syndrome [RCV002448970] |
Chr16:23635700 [GRCh38] Chr16:23647021 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2430_2431del (p.Pro811fs) |
deletion |
Familial cancer of breast [RCV000635908]|Familial cancer of breast [RCV002507076]|not provided [RCV000657454] |
Chr16:23629723..23629724 [GRCh38] Chr16:23641044..23641045 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1362del (p.Asn455fs) |
deletion |
Familial cancer of breast [RCV000635921] |
Chr16:23635184 [GRCh38] Chr16:23646505 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.821C>G (p.Thr274Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000635926]|Hereditary cancer-predisposing syndrome [RCV002406364] |
Chr16:23635725 [GRCh38] Chr16:23647046 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.932A>G (p.Lys311Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000635946]|Hereditary cancer-predisposing syndrome [RCV001019174]|not provided [RCV001030189]|not specified [RCV001194138] |
Chr16:23635614 [GRCh38] Chr16:23646935 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2733C>A (p.Thr911=) |
single nucleotide variant |
Familial cancer of breast [RCV001426534]|Hereditary cancer-predisposing syndrome [RCV000772827] |
Chr16:23626251 [GRCh38] Chr16:23637572 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3009C>T (p.Asn1003=) |
single nucleotide variant |
Familial cancer of breast [RCV000635971] |
Chr16:23621466 [GRCh38] Chr16:23632787 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.244T>C (p.Leu82=) |
single nucleotide variant |
Familial cancer of breast [RCV000635996] |
Chr16:23636302 [GRCh38] Chr16:23647623 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3351-6T>C |
single nucleotide variant |
Familial cancer of breast [RCV000636000]|Hereditary cancer-predisposing syndrome [RCV001525532] |
Chr16:23603675 [GRCh38] Chr16:23614996 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.792C>T (p.His264=) |
single nucleotide variant |
Familial cancer of breast [RCV000636001]|Hereditary cancer-predisposing syndrome [RCV002420708]|not specified [RCV005231209] |
Chr16:23635754 [GRCh38] Chr16:23647075 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.164A>T (p.Gln55Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000559691] |
Chr16:23637897 [GRCh38] Chr16:23649218 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2682A>G (p.Val894=) |
single nucleotide variant |
Familial cancer of breast [RCV002526793]|Hereditary cancer-predisposing syndrome [RCV000572031] |
Chr16:23626302 [GRCh38] Chr16:23637623 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.311C>T (p.Pro104Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000635862]|Hereditary cancer-predisposing syndrome [RCV000574476] |
Chr16:23636235 [GRCh38] Chr16:23647556 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.109-5T>C |
single nucleotide variant |
Familial cancer of breast [RCV001030121]|Hereditary cancer-predisposing syndrome [RCV001017270]|not provided [RCV001706691] |
Chr16:23637957 [GRCh38] Chr16:23649278 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.109-10TC[3] |
microsatellite |
Familial cancer of breast [RCV000636014] |
Chr16:23637958..23637959 [GRCh38] Chr16:23649279..23649280 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.211+10G>A |
single nucleotide variant |
Familial cancer of breast [RCV000636017] |
Chr16:23637840 [GRCh38] Chr16:23649161 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1686G>A (p.Gly562=) |
single nucleotide variant |
Familial cancer of breast [RCV000636034]|Hereditary cancer-predisposing syndrome [RCV001012708] |
Chr16:23630468 [GRCh38] Chr16:23641789 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2748+8G>A |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005357839]|Familial cancer of breast [RCV000636047]|Hereditary cancer-predisposing syndrome [RCV001182085] |
Chr16:23626228 [GRCh38] Chr16:23637549 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2953T>C (p.Ser985Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000635674]|Hereditary cancer-predisposing syndrome [RCV000572069] |
Chr16:23623012 [GRCh38] Chr16:23634333 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.513G>A (p.Leu171=) |
single nucleotide variant |
Familial cancer of breast [RCV001504546]|Hereditary cancer-predisposing syndrome [RCV000574703] |
Chr16:23636033 [GRCh38] Chr16:23647354 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3515T>C (p.Leu1172Pro) |
single nucleotide variant |
Familial cancer of breast [RCV001853729]|Hereditary cancer-predisposing syndrome [RCV000574725] |
Chr16:23603505 [GRCh38] Chr16:23614826 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2038G>A (p.Gly680Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000541413] |
Chr16:23630116 [GRCh38] Chr16:23641437 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.108+2T>G |
single nucleotide variant |
Familial cancer of breast [RCV003316941] |
Chr16:23638068 [GRCh38] Chr16:23649389 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.945_954del (p.Pro316fs) |
deletion |
Familial cancer of breast [RCV003316967] |
Chr16:23635592..23635601 [GRCh38] Chr16:23646913..23646922 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1597A>G (p.Thr533Ala) |
single nucleotide variant |
Breast carcinoma [RCV000626962]|Familial cancer of breast [RCV000815815]|Hereditary cancer-predisposing syndrome [RCV001012327]|Malignant tumor of breast [RCV001356890]|not provided [RCV003478331] |
Chr16:23634949 [GRCh38] Chr16:23646270 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2126A>G (p.Asn709Ser) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000572395] |
Chr16:23630028 [GRCh38] Chr16:23641349 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2410T>C (p.Ser804Pro) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000572399] |
Chr16:23629744 [GRCh38] Chr16:23641065 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2175_2176del (p.Pro726fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000572411] |
Chr16:23629978..23629979 [GRCh38] Chr16:23641299..23641300 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3339G>A (p.Gly1113=) |
single nucleotide variant |
Familial cancer of breast [RCV001484965]|Hereditary cancer-predisposing syndrome [RCV000574778] |
Chr16:23607875 [GRCh38] Chr16:23619196 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1182T>C (p.His394=) |
single nucleotide variant |
Familial cancer of breast [RCV001469719]|Hereditary cancer-predisposing syndrome [RCV004023845] |
Chr16:23635364 [GRCh38] Chr16:23646685 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3300T>A (p.Thr1100=) |
single nucleotide variant |
Familial cancer of breast [RCV002060437]|Hereditary cancer-predisposing syndrome [RCV000574833] |
Chr16:23607914 [GRCh38] Chr16:23619235 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1417_1433del (p.Pro473fs) |
deletion |
Familial cancer of breast [RCV003316978] |
Chr16:23635113..23635129 [GRCh38] Chr16:23646434..23646450 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.295dup (p.Thr99fs) |
duplication |
Familial cancer of breast [RCV003317001] |
Chr16:23636250..23636251 [GRCh38] Chr16:23647571..23647572 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.603T>A (p.Ser201Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000686735]|Familial cancer of breast [RCV002491124]|Hereditary cancer-predisposing syndrome [RCV000569806]|not specified [RCV002271530] |
Chr16:23635943 [GRCh38] Chr16:23647264 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2240C>G (p.Ser747Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000533900]|Hereditary cancer-predisposing syndrome [RCV001189375] |
Chr16:23629914 [GRCh38] Chr16:23641235 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.416A>G (p.Gln139Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001352086]|Hereditary cancer-predisposing syndrome [RCV000569883]|not provided [RCV002293463] |
Chr16:23636130 [GRCh38] Chr16:23647451 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.21G>C (p.Lys7Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000556948] |
Chr16:23641137 [GRCh38] Chr16:23652458 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1340C>A (p.Ala447Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000635800]|Familial cancer of breast [RCV000765275]|Hereditary cancer-predisposing syndrome [RCV000570239] |
Chr16:23635206 [GRCh38] Chr16:23646527 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.887T>G (p.Met296Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000534516]|Hereditary cancer-predisposing syndrome [RCV002377044]|not provided [RCV004767346] |
Chr16:23635659 [GRCh38] Chr16:23646980 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1628A>C (p.Lys543Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000534542]|Familial cancer of breast [RCV002490995] |
Chr16:23634918 [GRCh38] Chr16:23646239 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.228A>G (p.Ile76Met) |
single nucleotide variant |
Familial cancer of breast [RCV000534687]|not provided [RCV003237908] |
Chr16:23636318 [GRCh38] Chr16:23647639 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.875A>G (p.Gln292Arg) |
single nucleotide variant |
Familial cancer of breast [RCV002526837]|Hereditary cancer-predisposing syndrome [RCV000570560] |
Chr16:23635671 [GRCh38] Chr16:23646992 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3011A>C (p.Gln1004Pro) |
single nucleotide variant |
Familial cancer of breast [RCV003607322]|Hereditary cancer-predisposing syndrome [RCV000570568] |
Chr16:23621464 [GRCh38] Chr16:23632785 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.206A>C (p.His69Pro) |
single nucleotide variant |
Familial cancer of breast [RCV003500551]|Hereditary cancer-predisposing syndrome [RCV000561540]|not provided [RCV004696946]|not specified [RCV004596269] |
Chr16:23637855 [GRCh38] Chr16:23649176 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2079T>C (p.His693=) |
single nucleotide variant |
Familial cancer of breast [RCV000907014]|Hereditary cancer-predisposing syndrome [RCV000567037]|not specified [RCV000611016] |
Chr16:23630075 [GRCh38] Chr16:23641396 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2834+13C>A |
single nucleotide variant |
Familial cancer of breast [RCV002064368]|Familial cancer of breast [RCV002506479]|Familial pancreatic carcinoma [RCV005357814]|Hereditary cancer-predisposing syndrome [RCV001180326]|not specified [RCV000602761] |
Chr16:23623996 [GRCh38] Chr16:23635317 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1485del (p.Asp496fs) |
deletion |
Familial cancer of breast [RCV000576705]|Hereditary cancer-predisposing syndrome [RCV002395497] |
Chr16:23635061 [GRCh38] Chr16:23646382 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2456_2463del (p.Lys819fs) |
deletion |
Familial cancer of breast [RCV000576469]|not provided [RCV000657317] |
Chr16:23629691..23629698 [GRCh38] Chr16:23641012..23641019 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.444del (p.Lys149fs) |
deletion |
Familial cancer of breast [RCV000576472]|Fanconi anemia complementation group N [RCV004796236]|Hereditary breast ovarian cancer syndrome [RCV004782452]|Hereditary cancer-predisposing syndrome [RCV002330992] |
Chr16:23636102 [GRCh38] Chr16:23647423 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.866T>A (p.Leu289Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000576557] |
Chr16:23635680 [GRCh38] Chr16:23647001 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2440G>A (p.Glu814Lys) |
single nucleotide variant |
Familial cancer of breast [RCV005102670]|Hereditary cancer-predisposing syndrome [RCV003301004] |
Chr16:23629714 [GRCh38] Chr16:23641035 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3039A>G (p.Ile1013Met) |
single nucleotide variant |
Familial cancer of breast [RCV003607577]|Hereditary cancer-predisposing syndrome [RCV003301010] |
Chr16:23621436 [GRCh38] Chr16:23632757 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1968A>T (p.Pro656=) |
single nucleotide variant |
Familial cancer of breast [RCV003607337]|Hereditary cancer-predisposing syndrome [RCV004944021]|not specified [RCV000607641] |
Chr16:23630186 [GRCh38] Chr16:23641507 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1164T>C (p.Pro388=) |
single nucleotide variant |
Familial cancer of breast [RCV001395018]|Familial cancer of breast [RCV002506486]|Hereditary cancer-predisposing syndrome [RCV001186248]|not specified [RCV000602541] |
Chr16:23635382 [GRCh38] Chr16:23646703 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 |
copy number gain |
See cases [RCV000512138] |
Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_024675.4(PALB2):c.2333G>A (p.Ser778Asn) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003278569] |
Chr16:23629821 [GRCh38] Chr16:23641142 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3233G>A (p.Cys1078Tyr) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003278574] |
Chr16:23607981 [GRCh38] Chr16:23619302 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3235G>A (p.Ala1079Thr) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003278576] |
Chr16:23607979 [GRCh38] Chr16:23619300 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2464C>A (p.Gln822Lys) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003278577] |
Chr16:23629690 [GRCh38] Chr16:23641011 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3074dup (p.Leu1026fs) |
duplication |
Familial cancer of breast [RCV003455791]|Hereditary cancer-predisposing syndrome [RCV003278578] |
Chr16:23621400..23621401 [GRCh38] Chr16:23632721..23632722 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2162C>G (p.Thr721Arg) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003278582] |
Chr16:23629992 [GRCh38] Chr16:23641313 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2420C>G (p.Pro807Arg) |
single nucleotide variant |
Familial cancer of breast [RCV005102815]|Hereditary cancer-predisposing syndrome [RCV003278588] |
Chr16:23629734 [GRCh38] Chr16:23641055 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1903G>A (p.Val635Met) |
single nucleotide variant |
Familial cancer of breast [RCV000533092]|Hereditary cancer-predisposing syndrome [RCV000774636] |
Chr16:23630251 [GRCh38] Chr16:23641572 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2938del (p.Ser980fs) |
deletion |
Familial cancer of breast [RCV000699114]|Fanconi anemia complementation group N [RCV005018995]|Hereditary breast ovarian cancer syndrome [RCV004800477]|Hereditary cancer-predisposing syndrome [RCV000569592]|not provided [RCV000657531] |
Chr16:23623027 [GRCh38] Chr16:23634348 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.336C>T (p.Gly112=) |
single nucleotide variant |
Familial cancer of breast [RCV000939160]|Hereditary cancer-predisposing syndrome [RCV000569617]|PALB2-related disorder [RCV004543265] |
Chr16:23636210 [GRCh38] Chr16:23647531 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3444T>C (p.Thr1148=) |
single nucleotide variant |
Familial cancer of breast [RCV001472005]|Hereditary cancer-predisposing syndrome [RCV004649228]|not specified [RCV000609434] |
Chr16:23603576 [GRCh38] Chr16:23614897 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2809G>A (p.Gly937Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000819797]|Hereditary cancer-predisposing syndrome [RCV000571752] |
Chr16:23624034 [GRCh38] Chr16:23635355 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3113+10C>T |
single nucleotide variant |
Familial cancer of breast [RCV005427154]|not specified [RCV000605330] |
Chr16:23621352 [GRCh38] Chr16:23632673 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1083T>C (p.Thr361=) |
single nucleotide variant |
Familial cancer of breast [RCV001441102]|not specified [RCV000609674] |
Chr16:23635463 [GRCh38] Chr16:23646784 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.108+8dup |
duplication |
not specified [RCV000615659] |
Chr16:23638060..23638061 [GRCh38] Chr16:23649381..23649382 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.129G>T (p.Lys43Asn) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV003150278]|Familial cancer of breast [RCV000696505]|Fanconi anemia complementation group N [RCV005398883]|Hereditary cancer-predisposing syndrome [RCV000571771]|PALB2-related disorder [RCV004740332] |
Chr16:23637932 [GRCh38] Chr16:23649253 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2411C>G (p.Ser804Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000540803]|Hereditary cancer-predisposing syndrome [RCV001015450] |
Chr16:23629743 [GRCh38] Chr16:23641064 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1802A>G (p.Lys601Arg) |
single nucleotide variant |
Familial cancer of breast [RCV002491125]|Hereditary cancer-predisposing syndrome [RCV000574357]|not specified [RCV001821670] |
Chr16:23630352 [GRCh38] Chr16:23641673 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2515-12T>C |
single nucleotide variant |
Familial cancer of breast [RCV003607334]|not specified [RCV000612638] |
Chr16:23629287 [GRCh38] Chr16:23640608 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3493T>C (p.Ser1165Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000559715]|Hereditary cancer-predisposing syndrome [RCV001020438] |
Chr16:23603527 [GRCh38] Chr16:23614848 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2835-5C>A |
single nucleotide variant |
Familial cancer of breast [RCV000559855] |
Chr16:23623135 [GRCh38] Chr16:23634456 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1664A>G (p.Lys555Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000692233]|Hereditary cancer-predisposing syndrome [RCV000574386] |
Chr16:23634882 [GRCh38] Chr16:23646203 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.932A>C (p.Lys311Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000540940] |
Chr16:23635614 [GRCh38] Chr16:23646935 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1962T>C (p.Ile654=) |
single nucleotide variant |
Familial cancer of breast [RCV000975717]|Hereditary cancer-predisposing syndrome [RCV000574472] |
Chr16:23630192 [GRCh38] Chr16:23641513 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2515-16A>G |
single nucleotide variant |
Familial cancer of breast [RCV003500582]|not specified [RCV000601621] |
Chr16:23629291 [GRCh38] Chr16:23640612 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1408_1411dup (p.Gly471fs) |
duplication |
Familial cancer of breast [RCV003317000] |
Chr16:23635134..23635135 [GRCh38] Chr16:23646455..23646456 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3076C>T (p.Leu1026=) |
single nucleotide variant |
Familial cancer of breast [RCV001435662]|Hereditary breast ovarian cancer syndrome [RCV005357799]|Hereditary cancer-predisposing syndrome [RCV000777569]|not specified [RCV000609935] |
Chr16:23621399 [GRCh38] Chr16:23632720 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2316T>C (p.Asp772=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000572135] |
Chr16:23629838 [GRCh38] Chr16:23641159 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2787T>G (p.Tyr929Ter) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000568858] |
Chr16:23624056 [GRCh38] Chr16:23635377 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2448C>A (p.Phe816Leu) |
single nucleotide variant |
Familial cancer of breast [RCV002298671]|Hereditary cancer-predisposing syndrome [RCV000568875] |
Chr16:23629706 [GRCh38] Chr16:23641027 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1942_1948delinsA (p.Leu648_Glu650delinsLys) |
indel |
Familial cancer of breast [RCV000816487]|Hereditary cancer-predisposing syndrome [RCV000569464]|not provided [RCV004773003] |
Chr16:23630206..23630212 [GRCh38] Chr16:23641527..23641533 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1476G>T (p.Gly492=) |
single nucleotide variant |
Familial cancer of breast [RCV005426183]|Hereditary cancer-predisposing syndrome [RCV000572319]|not specified [RCV002268180] |
Chr16:23635070 [GRCh38] Chr16:23646391 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.840C>T (p.Asn280=) |
single nucleotide variant |
Familial cancer of breast [RCV000537730]|Hereditary cancer-predisposing syndrome [RCV000774640] |
Chr16:23635706 [GRCh38] Chr16:23647027 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2607del (p.Ser869_Val870insTer) |
deletion |
Familial cancer of breast [RCV001030332]|Hereditary breast ovarian cancer syndrome [RCV000589273]|Hereditary cancer-predisposing syndrome [RCV001016046]|not provided [RCV003478324] |
Chr16:23626377 [GRCh38] Chr16:23637698 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3210C>T (p.Leu1070=) |
single nucleotide variant |
Familial cancer of breast [RCV001463651]|Hereditary cancer-predisposing syndrome [RCV002325182]|not specified [RCV000607440] |
Chr16:23608004 [GRCh38] Chr16:23619325 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.211+4A>G |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000572493] |
Chr16:23637846 [GRCh38] Chr16:23649167 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1479C>T (p.Pro493=) |
single nucleotide variant |
Familial cancer of breast [RCV005427029]|Hereditary cancer-predisposing syndrome [RCV000572605] |
Chr16:23635067 [GRCh38] Chr16:23646388 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.834A>G (p.Leu278=) |
single nucleotide variant |
Familial cancer of breast [RCV002063116]|Hereditary cancer-predisposing syndrome [RCV002438565]|not specified [RCV000602378] |
Chr16:23635712 [GRCh38] Chr16:23647033 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1393A>G (p.Met465Val) |
single nucleotide variant |
Familial cancer of breast [RCV000556420] |
Chr16:23635153 [GRCh38] Chr16:23646474 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2835-4T>C |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000569907] |
Chr16:23623134 [GRCh38] Chr16:23634455 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1538C>A (p.Thr513Lys) |
single nucleotide variant |
Familial cancer of breast [RCV002289778]|Hereditary cancer-predisposing syndrome [RCV000569909] |
Chr16:23635008 [GRCh38] Chr16:23646329 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1648A>T (p.Lys550Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001853819]|Hereditary cancer-predisposing syndrome [RCV000569937] |
Chr16:23634898 [GRCh38] Chr16:23646219 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1684+1G>T |
single nucleotide variant |
Familial cancer of breast [RCV003485609]|Hereditary cancer-predisposing syndrome [RCV000572683]|not provided [RCV002221556] |
Chr16:23634861 [GRCh38] Chr16:23646182 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.2533C>T (p.Pro845Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000560857]|Hereditary cancer-predisposing syndrome [RCV000771396] |
Chr16:23629257 [GRCh38] Chr16:23640578 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1053A>G (p.Thr351=) |
single nucleotide variant |
Familial cancer of breast [RCV000560884]|Hereditary cancer-predisposing syndrome [RCV004023844] |
Chr16:23635493 [GRCh38] Chr16:23646814 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2997-2A>C |
single nucleotide variant |
Familial cancer of breast [RCV002530254]|Hereditary cancer-predisposing syndrome [RCV000569963] |
Chr16:23621480 [GRCh38] Chr16:23632801 [GRCh37] Chr16:16p12.2 |
likely pathogenic|uncertain significance |
NM_024675.4(PALB2):c.2834+1G>C |
single nucleotide variant |
Familial cancer of breast [RCV001858210]|Hereditary cancer-predisposing syndrome [RCV000569964]|not provided [RCV003320696] |
Chr16:23624008 [GRCh38] Chr16:23635329 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1059_1077delinsGG (p.Ser354fs) |
indel |
Familial cancer of breast [RCV003451259]|Hereditary cancer-predisposing syndrome [RCV000570053]|Malignant tumor of breast [RCV004800474] |
Chr16:23635469..23635487 [GRCh38] Chr16:23646790..23646808 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1243A>C (p.Ser415Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001039556]|Hereditary cancer-predisposing syndrome [RCV000570108] |
Chr16:23635303 [GRCh38] Chr16:23646624 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2698G>A (p.Ala900Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000538630]|Hereditary cancer-predisposing syndrome [RCV001016340] |
Chr16:23626286 [GRCh38] Chr16:23637607 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1972G>A (p.Glu658Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000534427]|Hereditary cancer-predisposing syndrome [RCV003362832] |
Chr16:23630182 [GRCh38] Chr16:23641503 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3358G>A (p.Glu1120Lys) |
single nucleotide variant |
Familial cancer of breast [RCV001226156]|Hereditary cancer-predisposing syndrome [RCV000573002] |
Chr16:23603662 [GRCh38] Chr16:23614983 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.682C>T (p.Gln228Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000635756]|Hereditary breast ovarian cancer syndrome [RCV003987611]|Hereditary cancer-predisposing syndrome [RCV000573011] |
Chr16:23635864 [GRCh38] Chr16:23647185 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.442AAG[1] (p.Lys149del) |
microsatellite |
Hereditary cancer-predisposing syndrome [RCV000570602] |
Chr16:23636099..23636101 [GRCh38] Chr16:23647420..23647422 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2668G>A (p.Ala890Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001350668]|Hereditary cancer-predisposing syndrome [RCV000573129] |
Chr16:23626316 [GRCh38] Chr16:23637637 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3343G>T (p.Ala1115Ser) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003296464] |
Chr16:23607871 [GRCh38] Chr16:23619192 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.566G>T (p.Arg189Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000535087]|Hereditary cancer-predisposing syndrome [RCV001189068] |
Chr16:23635980 [GRCh38] Chr16:23647301 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1109A>G (p.Gln370Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000557818] |
Chr16:23635437 [GRCh38] Chr16:23646758 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.554A>C (p.Lys185Thr) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000573269] |
Chr16:23635992 [GRCh38] Chr16:23647313 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3369G>A (p.Val1123=) |
single nucleotide variant |
Familial cancer of breast [RCV000539325]|Hereditary cancer-predisposing syndrome [RCV000582196]|not provided [RCV001358500]|not specified [RCV004767345] |
Chr16:23603651 [GRCh38] Chr16:23614972 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1238C>T (p.Thr413Ile) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV003315482] |
Chr16:23635308 [GRCh38] Chr16:23646629 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1008_1009del (p.Leu337fs) |
deletion |
Familial cancer of breast [RCV005091395]|Hereditary cancer-predisposing syndrome [RCV000573428] |
Chr16:23635537..23635538 [GRCh38] Chr16:23646858..23646859 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2713C>A (p.Gln905Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000539422]|Hereditary cancer-predisposing syndrome [RCV003159786] |
Chr16:23626271 [GRCh38] Chr16:23637592 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2075A>G (p.Gln692Arg) |
single nucleotide variant |
Familial cancer of breast [RCV003607311]|Hereditary cancer-predisposing syndrome [RCV000573473] |
Chr16:23630079 [GRCh38] Chr16:23641400 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.936T>C (p.Ser312=) |
single nucleotide variant |
Familial cancer of breast [RCV001415492]|Hereditary cancer-predisposing syndrome [RCV000570984]|PALB2-related disorder [RCV004530601]|not provided [RCV001356051] |
Chr16:23635610 [GRCh38] Chr16:23646931 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.639del (p.Thr214fs) |
deletion |
Familial cancer of breast [RCV000810538]|Hereditary cancer-predisposing syndrome [RCV000573531] |
Chr16:23635907 [GRCh38] Chr16:23647228 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1623G>C (p.Arg541Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001858132]|Hereditary cancer-predisposing syndrome [RCV000573547]|not provided [RCV002509442] |
Chr16:23634923 [GRCh38] Chr16:23646244 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2959_2966dup (p.Glu990fs) |
duplication |
Familial cancer of breast [RCV000532289] |
Chr16:23622998..23622999 [GRCh38] Chr16:23634319..23634320 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.874C>T (p.Gln292Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003455798]|Hereditary breast ovarian cancer syndrome [RCV003317953] |
Chr16:23635672 [GRCh38] Chr16:23646993 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1741_1744del (p.Leu581fs) |
microsatellite |
Familial cancer of breast [RCV002526836]|Hereditary cancer-predisposing syndrome [RCV000571165]|not provided [RCV000657320] |
Chr16:23630410..23630413 [GRCh38] Chr16:23641731..23641734 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2774T>C (p.Val925Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000558592]|Familial cancer of breast [RCV002490996]|Hereditary cancer-predisposing syndrome [RCV001016552] |
Chr16:23624069 [GRCh38] Chr16:23635390 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2164G>A (p.Asp722Asn) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000573674] |
Chr16:23629990 [GRCh38] Chr16:23641311 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2262T>C (p.Thr754=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000573712] |
Chr16:23629892 [GRCh38] Chr16:23641213 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2081C>A (p.Thr694Lys) |
single nucleotide variant |
Familial cancer of breast [RCV001069620]|Hereditary cancer-predisposing syndrome [RCV000573805] |
Chr16:23630073 [GRCh38] Chr16:23641394 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1396T>C (p.Ser466Pro) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003311297] |
Chr16:23635150 [GRCh38] Chr16:23646471 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1300G>A (p.Asp434Asn) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003311305] |
Chr16:23635246 [GRCh38] Chr16:23646567 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1446C>G (p.Leu482=) |
single nucleotide variant |
Familial cancer of breast [RCV001393327]|Hereditary cancer-predisposing syndrome [RCV001011624]|Malignant tumor of breast [RCV001357437]|not specified [RCV000611780] |
Chr16:23635100 [GRCh38] Chr16:23646421 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3518C>T (p.Ala1173Val) |
single nucleotide variant |
Familial cancer of breast [RCV000536109]|Fanconi anemia complementation group N [RCV005018923]|Hereditary cancer-predisposing syndrome [RCV001190817]|not provided [RCV001580512]|not specified [RCV002465701] |
Chr16:23603502 [GRCh38] Chr16:23614823 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1356C>T (p.Asn452=) |
single nucleotide variant |
Familial cancer of breast [RCV000536365]|Hereditary cancer-predisposing syndrome [RCV002384086] |
Chr16:23635190 [GRCh38] Chr16:23646511 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2107T>C (p.Leu703=) |
single nucleotide variant |
Familial cancer of breast [RCV001404698]|Hereditary cancer-predisposing syndrome [RCV000573818] |
Chr16:23630047 [GRCh38] Chr16:23641368 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.3376C>T (p.His1126Tyr) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV003311302] |
Chr16:23603644 [GRCh38] Chr16:23614965 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.435C>T (p.Ser145=) |
single nucleotide variant |
Familial cancer of breast [RCV003607586]|Hereditary cancer-predisposing syndrome [RCV003311303] |
Chr16:23636111 [GRCh38] Chr16:23647432 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.250A>G (p.Ile84Val) |
single nucleotide variant |
Familial cancer of breast [RCV003607587]|Hereditary cancer-predisposing syndrome [RCV003311307] |
Chr16:23636296 [GRCh38] Chr16:23647617 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2466G>A (p.Gln822=) |
single nucleotide variant |
Familial cancer of breast [RCV001431344]|Hereditary cancer-predisposing syndrome [RCV002456341]|not specified [RCV000604236] |
Chr16:23629688 [GRCh38] Chr16:23641009 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1974A>T (p.Glu658Asp) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000571480] |
Chr16:23630180 [GRCh38] Chr16:23641501 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.-36G>C |
single nucleotide variant |
not specified [RCV000604077] |
Chr16:23641193 [GRCh38] Chr16:23652514 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.48+6G>C |
single nucleotide variant |
Familial cancer of breast [RCV001860267]|not specified [RCV000603533] |
Chr16:23641104 [GRCh38] Chr16:23652425 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2968G>C (p.Glu990Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000635602]|Hereditary cancer-predisposing syndrome [RCV002438681]|not provided [RCV001796150] |
Chr16:23622997 [GRCh38] Chr16:23634318 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2587-7G>A |
single nucleotide variant |
Familial cancer of breast [RCV000635604]|Hereditary cancer-predisposing syndrome [RCV003584684]|not provided [RCV001558518] |
Chr16:23626404 [GRCh38] Chr16:23637725 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.212A>G (p.Glu71Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000635608]|Hereditary cancer-predisposing syndrome [RCV003584685]|not provided [RCV005231207] |
Chr16:23636334 [GRCh38] Chr16:23647655 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2737C>T (p.His913Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000635631] |
Chr16:23626247 [GRCh38] Chr16:23637568 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2736G>C (p.Trp912Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000635639] |
Chr16:23626248 [GRCh38] Chr16:23637569 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2943T>G (p.Ser981Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000635644]|Hereditary cancer-predisposing syndrome [RCV004649234] |
Chr16:23623022 [GRCh38] Chr16:23634343 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.325C>G (p.Pro109Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000635678] |
Chr16:23636221 [GRCh38] Chr16:23647542 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2650G>C (p.Glu884Gln) |
single nucleotide variant |
Familial cancer of breast [RCV000635681] |
Chr16:23626334 [GRCh38] Chr16:23637655 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2906T>A (p.Val969Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000635682] |
Chr16:23623059 [GRCh38] Chr16:23634380 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.338del (p.Pro113fs) |
deletion |
Familial cancer of breast [RCV000635690] |
Chr16:23636208 [GRCh38] Chr16:23647529 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3163T>C (p.Tyr1055His) |
single nucleotide variant |
Familial cancer of breast [RCV000635694]|Hereditary cancer-predisposing syndrome [RCV002325228] |
Chr16:23614042 [GRCh38] Chr16:23625363 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2861A>G (p.Glu954Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000635705]|Familial cancer of breast [RCV002492979]|Hereditary cancer-predisposing syndrome [RCV000771431]|not provided [RCV001775933] |
Chr16:23623104 [GRCh38] Chr16:23634425 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.116A>T (p.Gln39Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000635709] |
Chr16:23637945 [GRCh38] Chr16:23649266 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2603G>A (p.Cys868Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000635726]|Hereditary cancer-predisposing syndrome [RCV002424396] |
Chr16:23626381 [GRCh38] Chr16:23637702 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2694G>A (p.Trp898Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000635736] |
Chr16:23626290 [GRCh38] Chr16:23637611 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.137A>G (p.His46Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000635748]|Hereditary cancer-predisposing syndrome [RCV001011256]|not provided [RCV001527324] |
Chr16:23637924 [GRCh38] Chr16:23649245 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2777C>T (p.Pro926Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000635754]|Familial cancer of breast [RCV002492980]|Hereditary cancer-predisposing syndrome [RCV000776706] |
Chr16:23624066 [GRCh38] Chr16:23635387 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3463T>C (p.Ser1155Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000635762]|Hereditary cancer-predisposing syndrome [RCV004944039] |
Chr16:23603557 [GRCh38] Chr16:23614878 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3022C>A (p.Pro1008Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000635767] |
Chr16:23621453 [GRCh38] Chr16:23632774 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2934TAG[1] (p.Ser981del) |
microsatellite |
Familial cancer of breast [RCV000635772] |
Chr16:23623026..23623028 [GRCh38] Chr16:23634347..23634349 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3415A>C (p.Ile1139Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000635774] |
Chr16:23603605 [GRCh38] Chr16:23614926 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3495G>C (p.Ser1165=) |
single nucleotide variant |
Familial cancer of breast [RCV003607335]|Hereditary cancer-predisposing syndrome [RCV001020441]|not provided [RCV001722601] |
Chr16:23603525 [GRCh38] Chr16:23614846 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.157G>A (p.Glu53Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000635779]|Hereditary cancer-predisposing syndrome [RCV000709389] |
Chr16:23637904 [GRCh38] Chr16:23649225 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1070C>G (p.Ser357Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000635780] |
Chr16:23635476 [GRCh38] Chr16:23646797 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.926T>G (p.Ile309Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000635796]|Hereditary cancer-predisposing syndrome [RCV001189067] |
Chr16:23635620 [GRCh38] Chr16:23646941 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2809G>C (p.Gly937Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000635798]|Hereditary cancer-predisposing syndrome [RCV001525839] |
Chr16:23624034 [GRCh38] Chr16:23635355 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.693del (p.Gly232fs) |
deletion |
Familial cancer of breast [RCV000635811]|Hereditary cancer-predisposing syndrome [RCV004025467]|not provided [RCV004721508] |
Chr16:23635853 [GRCh38] Chr16:23647174 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.526C>G (p.Leu176Val) |
single nucleotide variant |
Familial cancer of breast [RCV000635817]|Hereditary cancer-predisposing syndrome [RCV003162843] |
Chr16:23636020 [GRCh38] Chr16:23647341 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1607T>C (p.Leu536Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000635825]|Hereditary cancer-predisposing syndrome [RCV004649235]|not provided [RCV003233767] |
Chr16:23634939 [GRCh38] Chr16:23646260 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2068C>G (p.Gln690Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000635837]|Hereditary cancer-predisposing syndrome [RCV002420707] |
Chr16:23630086 [GRCh38] Chr16:23641407 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2650G>T (p.Glu884Ter) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005416117]|Familial cancer of breast [RCV000635848]|not provided [RCV000760341] |
Chr16:23626334 [GRCh38] Chr16:23637655 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2989G>T (p.Asp997Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000635883]|Hereditary cancer-predisposing syndrome [RCV000776383]|not provided [RCV004721509]|not specified [RCV001192766] |
Chr16:23622976 [GRCh38] Chr16:23634297 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.623A>C (p.Asp208Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000635893] |
Chr16:23635923 [GRCh38] Chr16:23647244 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2828A>C (p.Glu943Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000635900] |
Chr16:23624015 [GRCh38] Chr16:23635336 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.845G>A (p.Arg282Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000635923]|Hereditary cancer-predisposing syndrome [RCV002448971] |
Chr16:23635701 [GRCh38] Chr16:23647022 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3494C>A (p.Ser1165Ter) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001270994]|Familial cancer of breast [RCV000635924]|Hereditary cancer-predisposing syndrome [RCV003303005] |
Chr16:23603526 [GRCh38] Chr16:23614847 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1628A>G (p.Lys543Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000635930]|Hereditary cancer-predisposing syndrome [RCV001012482]|not provided [RCV003441984] |
Chr16:23634918 [GRCh38] Chr16:23646239 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.211+6T>A |
single nucleotide variant |
Familial cancer of breast [RCV000635949] |
Chr16:23637844 [GRCh38] Chr16:23649165 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2966_2968del (p.Val989del) |
deletion |
Familial cancer of breast [RCV000635952]|Hereditary cancer-predisposing syndrome [RCV004659133]|not provided [RCV001030359]|not specified [RCV003987634] |
Chr16:23622997..23622999 [GRCh38] Chr16:23634318..23634320 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.781C>A (p.His261Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000635958] |
Chr16:23635765 [GRCh38] Chr16:23647086 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2834+8A>G |
single nucleotide variant |
Familial cancer of breast [RCV000635968]|Hereditary cancer-predisposing syndrome [RCV000776620] |
Chr16:23624001 [GRCh38] Chr16:23635322 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2919A>T (p.Thr973=) |
single nucleotide variant |
Familial cancer of breast [RCV000635984] |
Chr16:23623046 [GRCh38] Chr16:23634367 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2544T>C (p.Asp848=) |
single nucleotide variant |
Familial cancer of breast [RCV000635986]|Hereditary cancer-predisposing syndrome [RCV000774628]|not provided [RCV003420106] |
Chr16:23629246 [GRCh38] Chr16:23640567 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1684+6del |
deletion |
Familial cancer of breast [RCV000635989]|Hereditary cancer-predisposing syndrome [RCV001182084] |
Chr16:23634856 [GRCh38] Chr16:23646177 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1685-3T>C |
single nucleotide variant |
Familial cancer of breast [RCV000635992]|Hereditary cancer-predisposing syndrome [RCV002404773]|not provided [RCV003128674] |
Chr16:23630472 [GRCh38] Chr16:23641793 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.522A>G (p.Lys174=) |
single nucleotide variant |
Familial cancer of breast [RCV000636012]|Hereditary cancer-predisposing syndrome [RCV002343239] |
Chr16:23636024 [GRCh38] Chr16:23647345 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1422T>C (p.Ser474=) |
single nucleotide variant |
Familial cancer of breast [RCV000636023] |
Chr16:23635124 [GRCh38] Chr16:23646445 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2834+10T>G |
single nucleotide variant |
Familial cancer of breast [RCV000636026] |
Chr16:23623999 [GRCh38] Chr16:23635320 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.508A>C (p.Arg170=) |
single nucleotide variant |
Familial cancer of breast [RCV000636043]|Hereditary cancer-predisposing syndrome [RCV000771725] |
Chr16:23636038 [GRCh38] Chr16:23647359 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1242A>G (p.Arg414=) |
single nucleotide variant |
Familial cancer of breast [RCV000636048] |
Chr16:23635304 [GRCh38] Chr16:23646625 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.108+8A>G |
single nucleotide variant |
Familial cancer of breast [RCV000636050] |
Chr16:23638062 [GRCh38] Chr16:23649383 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2829G>A (p.Glu943=) |
single nucleotide variant |
Familial cancer of breast [RCV000636051] |
Chr16:23624014 [GRCh38] Chr16:23635335 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2181T>C (p.Ala727=) |
single nucleotide variant |
Familial cancer of breast [RCV000636052]|Hereditary cancer-predisposing syndrome [RCV000777503] |
Chr16:23629973 [GRCh38] Chr16:23641294 [GRCh37] Chr16:16p12.2 |
likely benign |
NC_000016.9:g.(?_23614774)_(23614996_?)dup |
duplication |
Familial cancer of breast [RCV000636058] |
Chr16:23603453..23603675 [GRCh38] Chr16:23614774..23614996 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.3-11.2(chr16:18238275-30177240)x3 |
copy number gain |
See cases [RCV000512428] |
Chr16:18238275..30177240 [GRCh37] Chr16:16p12.3-11.2 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) |
copy number gain |
See cases [RCV000511296] |
Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_024675.4(PALB2):c.114C>T (p.Ala38=) |
single nucleotide variant |
Familial cancer of breast [RCV005422830]|Hereditary cancer-predisposing syndrome [RCV001017482]|not specified [RCV000606064] |
Chr16:23637947 [GRCh38] Chr16:23649268 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.94C>T (p.Leu32=) |
single nucleotide variant |
Familial cancer of breast [RCV002063006]|Hereditary cancer-predisposing syndrome [RCV002377254]|not specified [RCV000600799] |
Chr16:23638084 [GRCh38] Chr16:23649405 [GRCh37] Chr16:16p12.2 |
likely benign |
GRCh37/hg19 16p12.2-11.2(chr16:21379628-29351826)x3 |
copy number gain |
See cases [RCV000512478] |
Chr16:21379628..29351826 [GRCh37] Chr16:16p12.2-11.2 |
pathogenic |
NM_024675.4(PALB2):c.2834+16G>A |
single nucleotide variant |
Familial cancer of breast [RCV001868078]|not specified [RCV000606612] |
Chr16:23623993 [GRCh38] Chr16:23635314 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3540_3543del (p.Ile1180fs) |
deletion |
Familial cancer of breast [RCV003450523] |
Chr16:23603477..23603480 [GRCh38] Chr16:23614798..23614801 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.841del (p.Ile281fs) |
deletion |
Familial cancer of breast [RCV003451587]|not provided [RCV000657298] |
Chr16:23635705 [GRCh38] Chr16:23647026 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.502dup (p.Ser168fs) |
duplication |
Familial cancer of breast [RCV000693352]|Hereditary cancer-predisposing syndrome [RCV005384809]|not provided [RCV000657443] |
Chr16:23636043..23636044 [GRCh38] Chr16:23647364..23647365 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1288C>T (p.Gln430Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000662965]|Hereditary cancer-predisposing syndrome [RCV002386129]|not provided [RCV000657764] |
Chr16:23635258 [GRCh38] Chr16:23646579 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.704C>A (p.Thr235Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000686690]|Hereditary cancer-predisposing syndrome [RCV001179355]|not provided [RCV004588106]|not specified [RCV002232849] |
Chr16:23635842 [GRCh38] Chr16:23647163 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2860G>A (p.Glu954Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000701093] |
Chr16:23623105 [GRCh38] Chr16:23634426 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.204del (p.Lys68fs) |
deletion |
Familial cancer of breast [RCV003451584]|Hereditary cancer-predisposing syndrome [RCV002422438]|not provided [RCV000657270] |
Chr16:23637857 [GRCh38] Chr16:23649178 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.770del (p.Gly257fs) |
deletion |
Familial cancer of breast [RCV003451596]|not provided [RCV000657438] |
Chr16:23635776 [GRCh38] Chr16:23647097 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1725del (p.Ser574_Trp575insTer) |
deletion |
Familial cancer of breast [RCV000662937] |
Chr16:23630429 [GRCh38] Chr16:23641750 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.117_120dup (p.Ala41fs) |
duplication |
Familial cancer of breast [RCV004792352]|not provided [RCV000657271] |
Chr16:23637940..23637941 [GRCh38] Chr16:23649261..23649262 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1789del (p.Met597fs) |
deletion |
Familial cancer of breast [RCV001230455]|Hereditary cancer-predisposing syndrome [RCV003362882]|not provided [RCV000657295] |
Chr16:23630365 [GRCh38] Chr16:23641686 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.774_775insC (p.Ser259fs) |
insertion |
not provided [RCV000657350] |
Chr16:23635771..23635772 [GRCh38] Chr16:23647092..23647093 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.475G>T (p.Glu159Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000662619] |
Chr16:23636071 [GRCh38] Chr16:23647392 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2100_2110del (p.Ser701fs) |
deletion |
Familial cancer of breast [RCV001855356]|Hereditary breast ovarian cancer syndrome [RCV001775143]|Hereditary cancer-predisposing syndrome [RCV004659158]|not provided [RCV000657524] |
Chr16:23630044..23630054 [GRCh38] Chr16:23641365..23641375 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3441T>A (p.Cys1147Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001213219]|Fanconi anemia complementation group N [RCV005019096]|Hereditary cancer-predisposing syndrome [RCV002458171]|Malignant tumor of breast [RCV004526734]|PALB2-related disorder [RCV004740390]|not provided [RCV000657758] |
Chr16:23603579 [GRCh38] Chr16:23614900 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3425T>A (p.Leu1142Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001234062]|not provided [RCV000657760] |
Chr16:23603595 [GRCh38] Chr16:23614916 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1227_1231del (p.Tyr409_Arg411delinsTer) |
deletion |
Familial cancer of breast [RCV001030207]|Hereditary cancer-predisposing syndrome [RCV002360680]|not provided [RCV000657801] |
Chr16:23635315..23635319 [GRCh38] Chr16:23646636..23646640 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.666_669del (p.Leu222fs) |
deletion |
Familial cancer of breast [RCV000662696] |
Chr16:23635877..23635880 [GRCh38] Chr16:23647198..23647201 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.212-2A>T |
single nucleotide variant |
Familial cancer of breast [RCV000662995] |
Chr16:23636336 [GRCh38] Chr16:23647657 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.994C>T (p.Leu332Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000685532]|Hereditary cancer-predisposing syndrome [RCV004944085]|not provided [RCV003225111] |
Chr16:23635552 [GRCh38] Chr16:23646873 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1103del (p.Asn368fs) |
deletion |
Familial cancer of breast [RCV000662949]|Hereditary cancer-predisposing syndrome [RCV001177937] |
Chr16:23635443 [GRCh38] Chr16:23646764 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.778C>T (p.Gln260Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003453394]|Hereditary cancer-predisposing syndrome [RCV002406519]|Neuroendocrine tumor of pancreas [RCV000677896] |
Chr16:23635768 [GRCh38] Chr16:23647089 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1652dup (p.Tyr551Ter) |
duplication |
Familial cancer of breast [RCV001386777]|Hereditary cancer-predisposing syndrome [RCV004944081]|Malignant tumor of pancreas [RCV000677895] |
Chr16:23634893..23634894 [GRCh38] Chr16:23646214..23646215 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2659A>G (p.Ile887Val) |
single nucleotide variant |
Familial cancer of breast [RCV000698770]|Familial cancer of breast [RCV002485708]|Fanconi anemia complementation group N [RCV003133551]|Hereditary cancer-predisposing syndrome [RCV000774627] |
Chr16:23626325 [GRCh38] Chr16:23637646 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2881_2883del (p.Leu961del) |
deletion |
Familial cancer of breast [RCV000686314]|Hereditary cancer-predisposing syndrome [RCV002440423] |
Chr16:23623082..23623084 [GRCh38] Chr16:23634403..23634405 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2096C>T (p.Ser699Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000686073]|Hereditary cancer-predisposing syndrome [RCV005384814] |
Chr16:23630058 [GRCh38] Chr16:23641379 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1805A>C (p.Gln602Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000700898] |
Chr16:23630349 [GRCh38] Chr16:23641670 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2-11.2(chr16:21379628-29379768)x1 |
copy number loss |
not provided [RCV000683786] |
Chr16:21379628..29379768 [GRCh37] Chr16:16p12.2-11.2 |
pathogenic |
NM_024675.4(PALB2):c.2515-11T>C |
single nucleotide variant |
Familial cancer of breast [RCV002066995]|Hereditary cancer-predisposing syndrome [RCV000771301]|not provided [RCV000679764] |
Chr16:23629286 [GRCh38] Chr16:23640607 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity |
NM_024675.4(PALB2):c.3386C>T (p.Ala1129Val) |
single nucleotide variant |
Familial cancer of breast [RCV001039207]|not provided [RCV000679771] |
Chr16:23603634 [GRCh38] Chr16:23614955 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3048T>G (p.Phe1016Leu) |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005357902]|Familial cancer of breast [RCV001861873]|Fanconi anemia complementation group N [RCV005019168]|Hereditary cancer-predisposing syndrome [RCV001018293]|not provided [RCV000679768] |
Chr16:23621427 [GRCh38] Chr16:23632748 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1991T>G (p.Met664Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000801768]|Hereditary cancer-predisposing syndrome [RCV001013949]|not provided [RCV000679762] |
Chr16:23630163 [GRCh38] Chr16:23641484 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
GRCh37/hg19 16p12.2-12.1(chr16:23610466-24743657)x1 |
copy number loss |
not provided [RCV000683797] |
Chr16:23610466..24743657 [GRCh37] Chr16:16p12.2-12.1 |
uncertain significance |
NM_024675.4(PALB2):c.902A>T (p.Asp301Val) |
single nucleotide variant |
Familial cancer of breast [RCV001869525]|Hereditary cancer-predisposing syndrome [RCV001804639] |
Chr16:23635644 [GRCh38] Chr16:23646965 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.763G>C (p.Asp255His) |
single nucleotide variant |
Familial cancer of breast [RCV000701247] |
Chr16:23635783 [GRCh38] Chr16:23647104 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1006A>C (p.Asn336His) |
single nucleotide variant |
Familial cancer of breast [RCV000701789]|Hereditary cancer-predisposing syndrome [RCV002422574]|not provided [RCV000985881]|not specified [RCV003479202] |
Chr16:23635540 [GRCh38] Chr16:23646861 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1212dup (p.Pro405fs) |
duplication |
Familial cancer of breast [RCV000701919] |
Chr16:23635333..23635334 [GRCh38] Chr16:23646654..23646655 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.92C>T (p.Thr31Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000688103] |
Chr16:23638086 [GRCh38] Chr16:23649407 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2973C>T (p.Val991=) |
single nucleotide variant |
Familial cancer of breast [RCV003607427]|Hereditary cancer-predisposing syndrome [RCV001804659] |
Chr16:23622992 [GRCh38] Chr16:23634313 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2089G>A (p.Gly697Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000699438]|Hereditary cancer-predisposing syndrome [RCV002422555] |
Chr16:23630065 [GRCh38] Chr16:23641386 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1975C>G (p.Leu659Val) |
single nucleotide variant |
Familial cancer of breast [RCV000685759]|Hereditary cancer-predisposing syndrome [RCV001191642] |
Chr16:23630179 [GRCh38] Chr16:23641500 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2083A>G (p.Lys695Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000700130] |
Chr16:23630071 [GRCh38] Chr16:23641392 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1208T>G (p.Leu403Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000699808] |
Chr16:23635338 [GRCh38] Chr16:23646659 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2656T>C (p.Cys886Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000685515]|Hereditary cancer-predisposing syndrome [RCV002424583] |
Chr16:23626328 [GRCh38] Chr16:23637649 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1685-3T>G |
single nucleotide variant |
Familial cancer of breast [RCV000701002] |
Chr16:23630472 [GRCh38] Chr16:23641793 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1885T>C (p.Ser629Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000686968]|Hereditary cancer-predisposing syndrome [RCV002406541] |
Chr16:23630269 [GRCh38] Chr16:23641590 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2899A>G (p.Lys967Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000686887] |
Chr16:23623066 [GRCh38] Chr16:23634387 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1485A>T (p.Glu495Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000701590] |
Chr16:23635061 [GRCh38] Chr16:23646382 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.626C>T (p.Ser209Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000701591]|Hereditary cancer-predisposing syndrome [RCV001177156] |
Chr16:23635920 [GRCh38] Chr16:23647241 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1448C>T (p.Ser483Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000696071]|Hereditary cancer-predisposing syndrome [RCV000708728]|Pancreatic cancer, susceptibility to, 3 [RCV005357929]|not provided [RCV001824361] |
Chr16:23635098 [GRCh38] Chr16:23646419 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1377C>G (p.Asp459Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000687394]|Hereditary cancer-predisposing syndrome [RCV000774945] |
Chr16:23635169 [GRCh38] Chr16:23646490 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1331A>G (p.Asn444Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000704371] |
Chr16:23635215 [GRCh38] Chr16:23646536 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.938G>A (p.Gly313Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000704478] |
Chr16:23635608 [GRCh38] Chr16:23646929 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2515-1G>A |
single nucleotide variant |
Familial cancer of breast [RCV000707120]|Hereditary cancer-predisposing syndrome [RCV001015744]|Pancreatic cancer, susceptibility to, 3 [RCV001258101] |
Chr16:23629276 [GRCh38] Chr16:23640597 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.3233G>C (p.Cys1078Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001202011]|Hereditary cancer-predisposing syndrome [RCV000709375] |
Chr16:23607981 [GRCh38] Chr16:23619302 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3184A>G (p.Lys1062Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000989550] |
Chr16:23614021 [GRCh38] Chr16:23625342 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3085A>G (p.Thr1029Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000989551] |
Chr16:23621390 [GRCh38] Chr16:23632711 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3008del (p.Asn1003fs) |
deletion |
Familial cancer of breast [RCV000989552] |
Chr16:23621467 [GRCh38] Chr16:23632788 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2927G>C (p.Arg976Thr) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000709379] |
Chr16:23623038 [GRCh38] Chr16:23634359 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2398T>A (p.Cys800Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000989558] |
Chr16:23629756 [GRCh38] Chr16:23641077 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1848dup (p.Glu617Ter) |
duplication |
Familial cancer of breast [RCV000989566] |
Chr16:23630305..23630306 [GRCh38] Chr16:23641626..23641627 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1539dup (p.Gly514fs) |
duplication |
Familial cancer of breast [RCV000989571] |
Chr16:23635006..23635007 [GRCh38] Chr16:23646327..23646328 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.715del (p.Arg239fs) |
deletion |
Familial cancer of breast [RCV000989575] |
Chr16:23635831 [GRCh38] Chr16:23647152 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.50T>G (p.Leu17Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000989583]|Hereditary cancer-predisposing syndrome [RCV000709390] |
Chr16:23638128 [GRCh38] Chr16:23649449 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2587-1G>C |
single nucleotide variant |
Breast-ovarian cancer, familial, susceptibility to, 5 [RCV005357957]|Familial cancer of breast [RCV000989555]|Hereditary cancer-predisposing syndrome [RCV000709380]|not provided [RCV001759427] |
Chr16:23626398 [GRCh38] Chr16:23637719 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2116_2129delinsG (p.Thr706fs) |
indel |
Hereditary cancer-predisposing syndrome [RCV000709382] |
Chr16:23630025..23630038 [GRCh38] Chr16:23641346..23641359 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.820A>C (p.Thr274Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000704500] |
Chr16:23635726 [GRCh38] Chr16:23647047 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2332A>G (p.Ser778Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000690317]|Hereditary cancer-predisposing syndrome [RCV001015212] |
Chr16:23629822 [GRCh38] Chr16:23641143 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.995_996del (p.Leu332fs) |
deletion |
Familial cancer of breast [RCV000690347] |
Chr16:23635550..23635551 [GRCh38] Chr16:23646871..23646872 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2499A>T (p.Lys833Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000704597] |
Chr16:23629655 [GRCh38] Chr16:23640976 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.532del (p.Glu178fs) |
deletion |
Familial cancer of breast [RCV000704651]|Hereditary cancer-predisposing syndrome [RCV001186986] |
Chr16:23636014 [GRCh38] Chr16:23647335 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.167A>G (p.Asp56Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000693429] |
Chr16:23637894 [GRCh38] Chr16:23649215 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2645G>T (p.Cys882Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000704896]|Hereditary cancer-predisposing syndrome [RCV001184091] |
Chr16:23626339 [GRCh38] Chr16:23637660 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2668G>C (p.Ala890Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000704901]|Hereditary cancer-predisposing syndrome [RCV002424706] |
Chr16:23626316 [GRCh38] Chr16:23637637 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3129dup (p.Gln1044fs) |
duplication |
Familial cancer of breast [RCV000693623] |
Chr16:23614075..23614076 [GRCh38] Chr16:23625396..23625397 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1060T>G (p.Ser354Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000705104] |
Chr16:23635486 [GRCh38] Chr16:23646807 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1165C>T (p.Leu389Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000693750]|Hereditary cancer-predisposing syndrome [RCV000774095] |
Chr16:23635381 [GRCh38] Chr16:23646702 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1039_1042delinsAAAAAA (p.Glu347fs) |
indel |
Familial cancer of breast [RCV000702548]|Hereditary breast ovarian cancer syndrome [RCV002271571]|Hereditary cancer-predisposing syndrome [RCV002388318] |
Chr16:23635504..23635507 [GRCh38] Chr16:23646825..23646828 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NC_000016.10:g.(?_23621352)_(23641167_?)del |
deletion |
Familial cancer of breast [RCV000707857] |
Chr16:23621352..23641167 [GRCh38] Chr16:23632673..23652488 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2698G>C (p.Ala900Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000691295]|Hereditary cancer-predisposing syndrome [RCV001016341]|not provided [RCV001729686] |
Chr16:23626286 [GRCh38] Chr16:23637607 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.396_397del (p.Val132_Ser133insTer) |
deletion |
Familial cancer of breast [RCV000705480]|Hereditary cancer-predisposing syndrome [RCV000774810] |
Chr16:23636149..23636150 [GRCh38] Chr16:23647470..23647471 [GRCh37] Chr16:16p12.2 |
pathogenic |
NC_000016.9:g.(?_23625315)_(23625422_?)dup |
duplication |
Familial cancer of breast [RCV000707904] |
Chr16:23613994..23614101 [GRCh38] Chr16:23625315..23625422 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.3542_3543dup (p.Val1182fs) |
duplication |
Familial cancer of breast [RCV000702713] |
Chr16:23603476..23603477 [GRCh38] Chr16:23614797..23614798 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.739_891dup (p.Thr247_Thr297dup) |
duplication |
Familial cancer of breast [RCV000705653] |
Chr16:23635654..23635655 [GRCh38] Chr16:23646975..23646976 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1462A>C (p.Ser488Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000703059]|Hereditary cancer-predisposing syndrome [RCV003165890] |
Chr16:23635084 [GRCh38] Chr16:23646405 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1204C>A (p.Leu402Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000688879] |
Chr16:23635342 [GRCh38] Chr16:23646663 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1669T>C (p.Phe557Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000691574]|Hereditary cancer-predisposing syndrome [RCV003584709]|not provided [RCV001030244]|not specified [RCV001192763] |
Chr16:23634877 [GRCh38] Chr16:23646198 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3262C>T (p.Pro1088Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000691622]|Hereditary cancer-predisposing syndrome [RCV001019527] |
Chr16:23607952 [GRCh38] Chr16:23619273 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2590C>A (p.Pro864Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000694090] |
Chr16:23626394 [GRCh38] Chr16:23637715 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_23613994)_(23626407_?)del |
deletion |
Familial cancer of breast [RCV000708069] |
Chr16:23613994..23626407 [GRCh38] Chr16:23625315..23637728 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NC_000016.9:g.(?_23619175)_(23619343_?)dup |
duplication |
Familial cancer of breast [RCV000708075] |
Chr16:23607854..23608022 [GRCh38] Chr16:23619175..23619343 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.977C>T (p.Ser326Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000694139]|Hereditary cancer-predisposing syndrome [RCV002386209]|not provided [RCV001547138] |
Chr16:23635569 [GRCh38] Chr16:23646890 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3008dup (p.Asn1003fs) |
duplication |
Familial cancer of breast [RCV000684958]|Hereditary cancer-predisposing syndrome [RCV004944083] |
Chr16:23621466..23621467 [GRCh38] Chr16:23632787..23632788 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2824A>G (p.Arg942Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000691828]|Hereditary cancer-predisposing syndrome [RCV001175785] |
Chr16:23624019 [GRCh38] Chr16:23635340 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.590C>T (p.Thr197Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000705972]|Hereditary cancer-predisposing syndrome [RCV002352213] |
Chr16:23635956 [GRCh38] Chr16:23647277 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2984C>T (p.Ala995Val) |
single nucleotide variant |
Familial cancer of breast [RCV000685221]|Hereditary cancer-predisposing syndrome [RCV003584702] |
Chr16:23622981 [GRCh38] Chr16:23634302 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1898A>G (p.Lys633Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000691917]|Hereditary cancer-predisposing syndrome [RCV001525886] |
Chr16:23630256 [GRCh38] Chr16:23641577 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.173T>C (p.Leu58Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000691964]|Hereditary cancer-predisposing syndrome [RCV004944099] |
Chr16:23637888 [GRCh38] Chr16:23649209 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.321T>G (p.Phe107Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000706028]|Fanconi anemia complementation group N [RCV001825397]|Hereditary cancer-predisposing syndrome [RCV001189070] |
Chr16:23636225 [GRCh38] Chr16:23647546 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_23623999)_(23626407_?)del |
deletion |
Familial cancer of breast [RCV000708331] |
Chr16:23623999..23626407 [GRCh38] Chr16:23635320..23637728 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.838A>C (p.Asn280His) |
single nucleotide variant |
Familial cancer of breast [RCV000689373] |
Chr16:23635708 [GRCh38] Chr16:23647029 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.265G>C (p.Asp89His) |
single nucleotide variant |
Familial cancer of breast [RCV000692121]|Hereditary cancer-predisposing syndrome [RCV001016143] |
Chr16:23636281 [GRCh38] Chr16:23647602 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1784_1785delinsCG (p.Asp595Ala) |
indel |
Familial cancer of breast [RCV000700253] |
Chr16:23630369..23630370 [GRCh38] Chr16:23641690..23641691 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3340C>T (p.Gln1114Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000700359]|Hereditary cancer-predisposing syndrome [RCV000708618] |
Chr16:23607874 [GRCh38] Chr16:23619195 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2540C>G (p.Ser847Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000686106]|Familial cancer of breast [RCV002485597]|Hereditary cancer-predisposing syndrome [RCV001015881] |
Chr16:23629250 [GRCh38] Chr16:23640571 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2273C>T (p.Pro758Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000700574]|Hereditary cancer-predisposing syndrome [RCV002442498]|PALB2-related disorder [RCV004527749]|not provided [RCV001284196] |
Chr16:23629881 [GRCh38] Chr16:23641202 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.829G>T (p.Asp277Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV000706386]|Hereditary cancer-predisposing syndrome [RCV001027378] |
Chr16:23635717 [GRCh38] Chr16:23647038 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.998C>T (p.Thr333Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000692358] |
Chr16:23635548 [GRCh38] Chr16:23646869 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.9:g.(?_23614770)_(23615000_?)dup |
duplication |
Familial cancer of breast [RCV000708365] |
Chr16:23603449..23603679 [GRCh38] Chr16:23614770..23615000 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3537T>A (p.Asn1179Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000686594] |
Chr16:23603483 [GRCh38] Chr16:23614804 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1315G>C (p.Gly439Arg) |
single nucleotide variant |
Familial cancer of breast [RCV000701052]|Hereditary cancer-predisposing syndrome [RCV001192207] |
Chr16:23635231 [GRCh38] Chr16:23646552 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3433G>T (p.Gly1145Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000692571]|Hereditary cancer-predisposing syndrome [RCV002458236]|PALB2-related disorder [RCV004527744] |
Chr16:23603587 [GRCh38] Chr16:23614908 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_23603449)_(23603679_?)del |
deletion |
Familial cancer of breast [RCV000708508] |
Chr16:23603449..23603679 [GRCh38] Chr16:23614770..23615000 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.10C>A (p.Pro4Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000706431] |
Chr16:23641148 [GRCh38] Chr16:23652469 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2813A>G (p.Asn938Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000802486]|Hereditary cancer-predisposing syndrome [RCV000708729]|not provided [RCV002298749] |
Chr16:23624030 [GRCh38] Chr16:23635351 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1152A>G (p.Glu384=) |
single nucleotide variant |
Familial cancer of breast [RCV005422950]|Hereditary cancer-predisposing syndrome [RCV000708727] |
Chr16:23635394 [GRCh38] Chr16:23646715 [GRCh37] Chr16:16p12.2 |
benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.3302_3303del (p.Leu1101fs) |
microsatellite |
Familial cancer of breast [RCV000697381]|Hereditary cancer-predisposing syndrome [RCV001176912] |
Chr16:23607911..23607912 [GRCh38] Chr16:23619232..23619233 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2006A>G (p.Glu669Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000701660]|Hereditary cancer-predisposing syndrome [RCV001014045] |
Chr16:23630148 [GRCh38] Chr16:23641469 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1346A>C (p.Lys449Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000689628]|Hereditary cancer-predisposing syndrome [RCV002386183] |
Chr16:23635200 [GRCh38] Chr16:23646521 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.350C>T (p.Pro117Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000706656]|Hereditary cancer-predisposing syndrome [RCV002458319] |
Chr16:23636196 [GRCh38] Chr16:23647517 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.611C>G (p.Ser204Cys) |
single nucleotide variant |
Familial cancer of breast [RCV000692658]|Hereditary cancer-predisposing syndrome [RCV002352143] |
Chr16:23635935 [GRCh38] Chr16:23647256 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3133C>T (p.Leu1045Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000697436]|Hereditary cancer-predisposing syndrome [RCV001018761]|not provided [RCV001797130] |
Chr16:23614072 [GRCh38] Chr16:23625393 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1138_1139del (p.Ser380_Leu381insTer) |
microsatellite |
Familial cancer of breast [RCV000697453]|Hereditary cancer-predisposing syndrome [RCV002257939] |
Chr16:23635407..23635408 [GRCh38] Chr16:23646728..23646729 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2531T>C (p.Leu844Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000689844] |
Chr16:23629259 [GRCh38] Chr16:23640580 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.410G>T (p.Gly137Val) |
single nucleotide variant |
Familial cancer of breast [RCV000692797] |
Chr16:23636136 [GRCh38] Chr16:23647457 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.97G>C (p.Ala33Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000689943]|Hereditary breast ovarian cancer syndrome [RCV003483707] |
Chr16:23638081 [GRCh38] Chr16:23649402 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3547T>G (p.Tyr1183Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000695107]|Hereditary cancer-predisposing syndrome [RCV001020571] |
Chr16:23603473 [GRCh38] Chr16:23614794 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2080A>G (p.Thr694Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000702228]|Hereditary cancer-predisposing syndrome [RCV001014361] |
Chr16:23630074 [GRCh38] Chr16:23641395 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3297_3301del (p.Thr1100fs) |
deletion |
Familial cancer of breast [RCV000704420]|Hereditary cancer-predisposing syndrome [RCV001019756] |
Chr16:23607913..23607917 [GRCh38] Chr16:23619234..23619238 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3342G>C (p.Gln1114His) |
single nucleotide variant |
Familial cancer of breast [RCV000707157]|Hereditary cancer-predisposing syndrome [RCV000776589] |
Chr16:23607872 [GRCh38] Chr16:23619193 [GRCh37] Chr16:16p12.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.494G>A (p.Gly165Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000693175] |
Chr16:23636052 [GRCh38] Chr16:23647373 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.712AGA[1] (p.Arg239del) |
microsatellite |
Familial cancer of breast [RCV000704567]|Hereditary cancer-predisposing syndrome [RCV001184088] |
Chr16:23635829..23635831 [GRCh38] Chr16:23647150..23647152 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1150G>A (p.Glu384Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000693232]|Familial cancer of breast [RCV002493183]|Hereditary cancer-predisposing syndrome [RCV001181141] |
Chr16:23635396 [GRCh38] Chr16:23646717 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1869_1874del (p.Leu624_Glu625del) |
deletion |
Familial cancer of breast [RCV000693307] |
Chr16:23630280..23630285 [GRCh38] Chr16:23641601..23641606 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2587-6T>C |
single nucleotide variant |
Familial cancer of breast [RCV000690519] |
Chr16:23626403 [GRCh38] Chr16:23637724 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3350+6T>C |
single nucleotide variant |
Familial cancer of breast [RCV000704793] |
Chr16:23607858 [GRCh38] Chr16:23619179 [GRCh37] Chr16:16p12.2 |
pathogenic|uncertain significance |
NM_024675.4(PALB2):c.329G>A (p.Gly110Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000693372] |
Chr16:23636217 [GRCh38] Chr16:23647538 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.108+5G>A |
single nucleotide variant |
Familial cancer of breast [RCV000688342] |
Chr16:23638065 [GRCh38] Chr16:23649386 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1585C>G (p.Pro529Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000707654]|Hereditary cancer-predisposing syndrome [RCV002397492] |
Chr16:23634961 [GRCh38] Chr16:23646282 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2762del (p.Gln921fs) |
deletion |
Familial cancer of breast [RCV000693774]|Hereditary cancer-predisposing syndrome [RCV001179107] |
Chr16:23624081 [GRCh38] Chr16:23635402 [GRCh37] Chr16:16p12.2 |
pathogenic |
NC_000016.10:g.(?_23603449)_(23626407_?)del |
deletion |
Familial cancer of breast [RCV000707762] |
Chr16:23603449..23626407 [GRCh38] Chr16:23614770..23637728 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3037A>G (p.Ile1013Val) |
single nucleotide variant |
Familial cancer of breast [RCV000695855]|Familial cancer of breast [RCV002507213]|Hereditary cancer-predisposing syndrome [RCV003362904]|not provided [RCV001030369] |
Chr16:23621438 [GRCh38] Chr16:23632759 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2299G>C (p.Val767Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000695964]|not provided [RCV001756208] |
Chr16:23629855 [GRCh38] Chr16:23641176 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2363C>A (p.Thr788Asn) |
single nucleotide variant |
Familial cancer of breast [RCV000693835]|Hereditary cancer-predisposing syndrome [RCV002442454] |
Chr16:23629791 [GRCh38] Chr16:23641112 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.802A>G (p.Lys268Glu) |
single nucleotide variant |
Familial cancer of breast [RCV000688929]|Hereditary cancer-predisposing syndrome [RCV000772300] |
Chr16:23635744 [GRCh38] Chr16:23647065 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2186_2187del (p.Pro729fs) |
deletion |
Familial cancer of breast [RCV000691345] |
Chr16:23629967..23629968 [GRCh38] Chr16:23641288..23641289 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3362G>A (p.Gly1121Asp) |
single nucleotide variant |
Familial cancer of breast [RCV000699335]|Hereditary cancer-predisposing syndrome [RCV000774623] |
Chr16:23603658 [GRCh38] Chr16:23614979 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1819C>A (p.Leu607Ile) |
single nucleotide variant |
Familial cancer of breast [RCV000698031] |
Chr16:23630335 [GRCh38] Chr16:23641656 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.274dup (p.Thr92fs) |
duplication |
Familial cancer of breast [RCV000691368] |
Chr16:23636271..23636272 [GRCh38] Chr16:23647592..23647593 [GRCh37] Chr16:16p12.2 |
pathogenic |
NC_000016.10:g.(?_23634856)_(23641163_?)del |
deletion |
Familial cancer of breast [RCV000708114] |
Chr16:23634856..23641163 [GRCh38] Chr16:23646177..23652484 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3153T>G (p.Ile1051Met) |
single nucleotide variant |
Familial cancer of breast [RCV000696521]|Hereditary cancer-predisposing syndrome [RCV003163203] |
Chr16:23614052 [GRCh38] Chr16:23625373 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3053A>C (p.Glu1018Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000699589]|Hereditary cancer-predisposing syndrome [RCV000773319]|not provided [RCV004696981] |
Chr16:23621422 [GRCh38] Chr16:23632743 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.527T>C (p.Leu176Pro) |
single nucleotide variant |
Familial cancer of breast [RCV000691478] |
Chr16:23636019 [GRCh38] Chr16:23647340 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.113C>T (p.Ala38Val) |
single nucleotide variant |
Familial cancer of breast [RCV000694173]|Familial cancer of breast [RCV002477574]|Hereditary cancer-predisposing syndrome [RCV000774648]|Ovarian cancer [RCV003153807] |
Chr16:23637948 [GRCh38] Chr16:23649269 [GRCh37] Chr16:16p12.2 |
benign|uncertain significance |
NC_000016.10:g.(?_23626226)_(23630479_?)del |
deletion |
Familial cancer of breast [RCV000708223] |
Chr16:23626226..23630479 [GRCh38] Chr16:23637547..23641800 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3038T>C (p.Ile1013Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000696581]|Hereditary cancer-predisposing syndrome [RCV001018227] |
Chr16:23621437 [GRCh38] Chr16:23632758 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2458G>A (p.Glu820Lys) |
single nucleotide variant |
Familial cancer of breast [RCV000696705]|Hereditary cancer-predisposing syndrome [RCV001180221]|PALB2-related disorder [RCV004527746] |
Chr16:23629696 [GRCh38] Chr16:23641017 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1736C>T (p.Ala579Val) |
single nucleotide variant |
Familial cancer of breast [RCV000698506]|Familial pancreatic carcinoma [RCV005367514]|Hereditary cancer-predisposing syndrome [RCV002397433]|not provided [RCV004777842] |
Chr16:23630418 [GRCh38] Chr16:23641739 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_23603449)_(23608022_?)del |
deletion |
Familial cancer of breast [RCV000708313] |
Chr16:23603449..23608022 [GRCh38] Chr16:23614770..23619343 [GRCh37] Chr16:16p12.2 |
pathogenic |
NC_000016.10:g.(?_23629194)_(23630479_?)del |
deletion |
Familial cancer of breast [RCV000708315] |
Chr16:23629194..23630479 [GRCh38] Chr16:23640515..23641800 [GRCh37] Chr16:16p12.2 |
pathogenic |
NC_000016.10:g.(?_23623999)_(23624104_?)del |
deletion |
Familial cancer of breast [RCV000708363] |
Chr16:23623999..23624104 [GRCh38] Chr16:23635320..23635425 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2996+3A>C |
single nucleotide variant |
Familial cancer of breast [RCV000686952]|Hereditary cancer-predisposing syndrome [RCV005384815]|not provided [RCV003478404] |
Chr16:23622966 [GRCh38] Chr16:23634287 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.868G>T (p.Glu290Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000794070]|Hereditary cancer-predisposing syndrome [RCV000708621] |
Chr16:23635678 [GRCh38] Chr16:23646999 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.49-1G>A |
single nucleotide variant |
Familial cancer of breast [RCV005092051]|Hereditary cancer-predisposing syndrome [RCV000708620] |
Chr16:23638130 [GRCh38] Chr16:23649451 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2278C>T (p.Leu760Phe) |
single nucleotide variant |
Familial cancer of breast [RCV000689420]|Hereditary cancer-predisposing syndrome [RCV000772877] |
Chr16:23629876 [GRCh38] Chr16:23641197 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1152del (p.Ala385fs) |
deletion |
Familial cancer of breast [RCV000706271]|Hereditary cancer-predisposing syndrome [RCV002360830] |
Chr16:23635394 [GRCh38] Chr16:23646715 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3242A>G (p.Glu1081Gly) |
single nucleotide variant |
Familial cancer of breast [RCV000706354]|Hereditary cancer-predisposing syndrome [RCV002442535] |
Chr16:23607972 [GRCh38] Chr16:23619293 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3329_3331del (p.Leu1110del) |
deletion |
not provided [RCV000722935] |
Chr16:23607883..23607885 [GRCh38] Chr16:23619204..23619206 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.682del (p.Gln228fs) |
deletion |
Familial cancer of breast [RCV003453606]|Hereditary cancer-predisposing syndrome [RCV000776407]|PALB2-related disorder [RCV004740447] |
Chr16:23635864 [GRCh38] Chr16:23647185 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3164dup (p.Tyr1055Ter) |
duplication |
Familial cancer of breast [RCV003453538]|Hereditary cancer-predisposing syndrome [RCV000755034] |
Chr16:23614040..23614041 [GRCh38] Chr16:23625361..23625362 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 |
copy number gain |
not provided [RCV000738917] |
Chr16:88165..90163275 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_024675.4(PALB2):c.2270C>T (p.Thr757Ile) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV002449375]|not provided [RCV001571386] |
Chr16:23629884 [GRCh38] Chr16:23641205 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 |
copy number gain |
not provided [RCV000738918] |
Chr16:88165..90274695 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 |
copy number gain |
not provided [RCV000738915] |
Chr16:61451..90294632 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_024675.4(PALB2):c.2136G>T (p.Ala712=) |
single nucleotide variant |
Familial cancer of breast [RCV005423955]|Hereditary cancer-predisposing syndrome [RCV003584878]|not provided [RCV001284031] |
Chr16:23630018 [GRCh38] Chr16:23641339 [GRCh37] Chr16:16p12.2 |
benign|uncertain significance |
NM_024675.4(PALB2):c.2878C>T (p.Leu960=) |
single nucleotide variant |
Familial cancer of breast [RCV002069504]|not provided [RCV001284199] |
Chr16:23623087 [GRCh38] Chr16:23634408 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3288C>T (p.Asn1096=) |
single nucleotide variant |
Familial cancer of breast [RCV001501000]|Hereditary cancer-predisposing syndrome [RCV003584780] |
Chr16:23607926 [GRCh38] Chr16:23619247 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1684+238del |
deletion |
not provided [RCV001585033] |
Chr16:23634624 [GRCh38] Chr16:23645945 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3351-53del |
deletion |
not provided [RCV001610171] |
Chr16:23603722 [GRCh38] Chr16:23615043 [GRCh37] Chr16:16p12.2 |
benign |
NM_024675.4(PALB2):c.1665A>G (p.Lys555=) |
single nucleotide variant |
Familial cancer of breast [RCV001476960]|Hereditary cancer-predisposing syndrome [RCV002400140] |
Chr16:23634881 [GRCh38] Chr16:23646202 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2784G>T (p.Val928=) |
single nucleotide variant |
Familial cancer of breast [RCV005421024]|not provided [RCV001586216] |
Chr16:23624059 [GRCh38] Chr16:23635380 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1080C>T (p.Asp360=) |
single nucleotide variant |
Familial cancer of breast [RCV000917885]|Hereditary cancer-predisposing syndrome [RCV001009845] |
Chr16:23635466 [GRCh38] Chr16:23646787 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2192T>G (p.Leu731Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001855858]|Hereditary cancer-predisposing syndrome [RCV000755035]|not provided [RCV001354086] |
Chr16:23629962 [GRCh38] Chr16:23641283 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.1046A>C (p.Asn349Thr) |
single nucleotide variant |
Familial cancer of breast [RCV000806524]|Hereditary cancer-predisposing syndrome [RCV003279043]|not provided [RCV000759891] |
Chr16:23635500 [GRCh38] Chr16:23646821 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1525G>T (p.Gly509Cys) |
single nucleotide variant |
Familial cancer of breast [RCV005092187]|Hereditary cancer-predisposing syndrome [RCV003362931]|not provided [RCV000759894] |
Chr16:23635021 [GRCh38] Chr16:23646342 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1551_1552del (p.Lys517fs) |
deletion |
Hereditary cancer-predisposing syndrome [RCV001012123]|not provided [RCV000759895] |
Chr16:23634994..23634995 [GRCh38] Chr16:23646315..23646316 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2678A>T (p.Asp893Val) |
single nucleotide variant |
Familial cancer of breast [RCV003607343]|Hereditary cancer-predisposing syndrome [RCV001016288]|not provided [RCV000759900] |
Chr16:23626306 [GRCh38] Chr16:23637627 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2560A>C (p.Asn854His) |
single nucleotide variant |
not provided [RCV000759898] |
Chr16:23629230 [GRCh38] Chr16:23640551 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1673T>C (p.Ile558Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001340380]|Hereditary cancer-predisposing syndrome [RCV003166013]|not provided [RCV000759897] |
Chr16:23634873 [GRCh38] Chr16:23646194 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2484C>G (p.Cys828Trp) |
single nucleotide variant |
not provided [RCV000762215] |
Chr16:23629670 [GRCh38] Chr16:23640991 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.2-11.2(chr16:21475039-29043958)x1 |
copy number loss |
Chromosome 16p12.2-p11.2 deletion syndrome [RCV003315282] |
Chr16:21475039..29043958 [GRCh37] Chr16:16p12.2-11.2 |
pathogenic |
NM_024675.4(PALB2):c.1684+183TAAA[9] |
microsatellite |
not provided [RCV001645784] |
Chr16:23634640..23634643 [GRCh38] Chr16:23645961..23645964 [GRCh37] Chr16:16p12.2 |
benign |
NC_000016.10:g.(?_23603449)_(23641167_?)del |
deletion |
Familial cancer of breast [RCV001032011] |
Chr16:23614770..23652488 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1389dup (p.Arg464Ter) |
duplication |
Breast carcinoma [RCV001554338] |
Chr16:23635156..23635157 [GRCh38] Chr16:23646477..23646478 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.1990del (p.Met664fs) |
deletion |
Familial cancer of breast [RCV001066073] |
Chr16:23630164 [GRCh38] Chr16:23641485 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3202-4T>C |
single nucleotide variant |
Familial cancer of breast [RCV001411007]|Hereditary cancer-predisposing syndrome [RCV001019202]|not provided [RCV001284320] |
Chr16:23608016 [GRCh38] Chr16:23619337 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NG_007406.1:g.(5249_8228)_(17155_19960)del |
deletion |
Fanconi anemia complementation group N [RCV001030111] |
Chr16:23640524..23649451 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.696dup (p.Val233fs) |
duplication |
Familial cancer of breast [RCV001030166] |
Chr16:23635849..23635850 [GRCh38] Chr16:23647170..23647171 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.759dup (p.Ser254fs) |
duplication |
Familial cancer of breast [RCV001030173] |
Chr16:23635786..23635787 [GRCh38] Chr16:23647107..23647108 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2496_2513del (p.His832_Glu837del) |
deletion |
Familial cancer of breast [RCV001047761]|not provided [RCV001030311] |
Chr16:23629641..23629658 [GRCh38] Chr16:23640962..23640979 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3113+1376C>G |
single nucleotide variant |
Familial cancer of breast [RCV001030383]|not provided [RCV004716654]|not specified [RCV002249636] |
Chr16:23619986 [GRCh38] Chr16:23631307 [GRCh37] Chr16:16p12.2 |
pathogenic|benign |
NM_024675.4(PALB2):c.3294_3298del (p.Lys1098fs) |
deletion |
Fanconi anemia complementation group N [RCV001030405] |
Chr16:23607916..23607920 [GRCh38] Chr16:23619237..23619241 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2827_2830del (p.Glu943fs) |
microsatellite |
Familial cancer of breast [RCV001045281]|Gastric cancer [RCV003160336]|Hereditary cancer-predisposing syndrome [RCV002436571]|not provided [RCV004998596] |
Chr16:23624013..23624016 [GRCh38] Chr16:23635334..23635337 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NC_000016.10:g.(?_23621352)_(23626407_?)del |
deletion |
Familial cancer of breast [RCV001031433] |
Chr16:23632673..23637728 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2514+2T>C |
single nucleotide variant |
not provided [RCV000786800] |
Chr16:23629638 [GRCh38] Chr16:23640959 [GRCh37] Chr16:16p12.2 |
pathogenic|not provided |
NM_024675.3(PALB2):c.2835-324_3202-1757dup |
duplication |
Familial cancer of breast [RCV001031018] |
Chr16:23609769..23623454 [GRCh38] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2835-72_2835-71del |
deletion |
not provided [RCV001612156] |
Chr16:23623201..23623202 [GRCh38] Chr16:23634522..23634523 [GRCh37] Chr16:16p12.2 |
benign |
NM_024675.4(PALB2):c.2463delinsAA (p.Asn821fs) |
indel |
Familial cancer of breast [RCV003452251] |
Chr16:23629691 [GRCh38] Chr16:23641012 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NC_000016.10:g.(?_23603313)_(23608022_?)del |
deletion |
Familial cancer of breast [RCV001031748] |
Chr16:23614634..23619343 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1506G>A (p.Lys502=) |
single nucleotide variant |
Familial cancer of breast [RCV000924767] |
Chr16:23635040 [GRCh38] Chr16:23646361 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.212-8C>T |
single nucleotide variant |
Familial cancer of breast [RCV000989579] |
Chr16:23636342 [GRCh38] Chr16:23647663 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2148T>C (p.Asn716=) |
single nucleotide variant |
Familial cancer of breast [RCV000928489]|Hereditary cancer-predisposing syndrome [RCV002427305]|not provided [RCV005427383] |
Chr16:23630006 [GRCh38] Chr16:23641327 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.915A>T (p.Val305=) |
single nucleotide variant |
Familial cancer of breast [RCV001471589] |
Chr16:23635631 [GRCh38] Chr16:23646952 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.333T>C (p.Asp111=) |
single nucleotide variant |
Familial cancer of breast [RCV001400238]|Hereditary cancer-predisposing syndrome [RCV001181953] |
Chr16:23636213 [GRCh38] Chr16:23647534 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1773A>G (p.Pro591=) |
single nucleotide variant |
Familial cancer of breast [RCV001471088]|Hereditary cancer-predisposing syndrome [RCV002409196]|not specified [RCV003321763] |
Chr16:23630381 [GRCh38] Chr16:23641702 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2515-6T>C |
single nucleotide variant |
Familial cancer of breast [RCV001459652]|not specified [RCV003323771] |
Chr16:23629281 [GRCh38] Chr16:23640602 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.1621A>C (p.Arg541=) |
single nucleotide variant |
Familial cancer of breast [RCV001407327]|Hereditary cancer-predisposing syndrome [RCV001805944]|not provided [RCV000966551] |
Chr16:23634925 [GRCh38] Chr16:23646246 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1305C>T (p.Val435=) |
single nucleotide variant |
Familial cancer of breast [RCV001404697]|Hereditary cancer-predisposing syndrome [RCV002382162] |
Chr16:23635241 [GRCh38] Chr16:23646562 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1215T>G (p.Pro405=) |
single nucleotide variant |
Familial cancer of breast [RCV001412711] |
Chr16:23635331 [GRCh38] Chr16:23646652 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.172T>C (p.Leu58=) |
single nucleotide variant |
Familial cancer of breast [RCV001406003]|Hereditary cancer-predisposing syndrome [RCV003363007] |
Chr16:23637889 [GRCh38] Chr16:23649210 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2815T>C (p.Leu939=) |
single nucleotide variant |
Familial cancer of breast [RCV000983752] |
Chr16:23624028 [GRCh38] Chr16:23635349 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2998G>A (p.Gly1000Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001036729] |
Chr16:23621477 [GRCh38] Chr16:23632798 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.9:g.21530207_29332245del |
deletion |
not provided [RCV001030428] |
Chr16:21530207..29332245 [GRCh37] Chr16:16p12.2-11.2 |
pathogenic |
NM_024675.4(PALB2):c.3536A>G (p.Asn1179Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001873334]|Hereditary cancer-predisposing syndrome [RCV001020549] |
Chr16:23603484 [GRCh38] Chr16:23614805 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.398G>C (p.Ser133Thr) |
single nucleotide variant |
Chordoma [RCV002267068]|Familial cancer of breast [RCV001038666]|Hereditary cancer-predisposing syndrome [RCV001178878] |
Chr16:23636148 [GRCh38] Chr16:23647469 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2922G>C (p.Lys974Asn) |
single nucleotide variant |
Familial cancer of breast [RCV001058172] |
Chr16:23623043 [GRCh38] Chr16:23634364 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1553C>T (p.Ser518Leu) |
single nucleotide variant |
Familial cancer of breast [RCV001036902] |
Chr16:23634993 [GRCh38] Chr16:23646314 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1921A>G (p.Lys641Glu) |
single nucleotide variant |
not provided [RCV001030269] |
Chr16:23630233 [GRCh38] Chr16:23641554 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2083A>T (p.Lys695Ter) |
single nucleotide variant |
Familial cancer of breast [RCV003455145]|not provided [RCV001030276] |
Chr16:23630071 [GRCh38] Chr16:23641392 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.3499A>C (p.Thr1167Pro) |
single nucleotide variant |
not provided [RCV001030421] |
Chr16:23603521 [GRCh38] Chr16:23614842 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3549C>T (p.Tyr1183=) |
single nucleotide variant |
not provided [RCV001030424] |
Chr16:23603471 [GRCh38] Chr16:23614792 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2302T>C (p.Cys768Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001321770]|Hereditary cancer-predisposing syndrome [RCV001015013]|not provided [RCV003389728] |
Chr16:23629852 [GRCh38] Chr16:23641173 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.91A>G (p.Thr31Ala) |
single nucleotide variant |
Familial cancer of breast [RCV001055209]|Hereditary cancer-predisposing syndrome [RCV002445290] |
Chr16:23638087 [GRCh38] Chr16:23649408 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1480A>G (p.Thr494Ala) |
single nucleotide variant |
Familial cancer of breast [RCV001051470]|Hereditary cancer [RCV004702605]|Hereditary cancer-predisposing syndrome [RCV002393258] |
Chr16:23635066 [GRCh38] Chr16:23646387 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3540A>G (p.Ile1180Met) |
single nucleotide variant |
Breast and/or ovarian cancer [RCV001799027]|not provided [RCV001030423] |
Chr16:23603480 [GRCh38] Chr16:23614801 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3552C>G (p.His1184Gln) |
single nucleotide variant |
not provided [RCV001030425] |
Chr16:23603468 [GRCh38] Chr16:23614789 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3453C>T (p.Leu1151=) |
single nucleotide variant |
Familial cancer of breast [RCV002552040]|Hereditary cancer-predisposing syndrome [RCV002454256]|not provided [RCV001030418] |
Chr16:23603567 [GRCh38] Chr16:23614888 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.3537_3542delinsAA (p.Asn1179fs) |
indel |
Hereditary cancer-predisposing syndrome [RCV001020550] |
Chr16:23603478..23603483 [GRCh38] Chr16:23614799..23614804 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2587A>G (p.Asn863Asp) |
single nucleotide variant |
Familial cancer of breast [RCV001038715]|Hereditary cancer-predisposing syndrome [RCV002454280] |
Chr16:23626397 [GRCh38] Chr16:23637718 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3086C>T (p.Thr1029Ile) |
single nucleotide variant |
Familial cancer of breast [RCV001062146]|Hereditary cancer-predisposing syndrome [RCV003160502] |
Chr16:23621389 [GRCh38] Chr16:23632710 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1988dup (p.Met664fs) |
duplication |
Familial cancer of breast [RCV001062175]|Hereditary cancer-predisposing syndrome [RCV005055451]|not provided [RCV002268424] |
Chr16:23630165..23630166 [GRCh38] Chr16:23641486..23641487 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1652A>G (p.Tyr551Cys) |
single nucleotide variant |
Familial cancer of breast [RCV001062287]|Hereditary cancer-predisposing syndrome [RCV002393305] |
Chr16:23634894 [GRCh38] Chr16:23646215 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2997-3C>G |
single nucleotide variant |
Familial cancer of breast [RCV001051571] |
Chr16:23621481 [GRCh38] Chr16:23632802 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3551del (p.His1184fs) |
deletion |
Familial cancer of breast [RCV001229333]|Hereditary cancer-predisposing syndrome [RCV001020590] |
Chr16:23603469 [GRCh38] Chr16:23614790 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.961T>G (p.Leu321Val) |
single nucleotide variant |
Familial cancer of breast [RCV001053032] |
Chr16:23635585 [GRCh38] Chr16:23646906 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2762A>C (p.Gln921Pro) |
single nucleotide variant |
Familial cancer of breast [RCV001061633] |
Chr16:23624081 [GRCh38] Chr16:23635402 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1061C>A (p.Ser354Tyr) |
single nucleotide variant |
Familial cancer of breast [RCV001049498] |
Chr16:23635485 [GRCh38] Chr16:23646806 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2399G>C (p.Cys800Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001035292]|Hereditary cancer-predisposing syndrome [RCV002445207] |
Chr16:23629755 [GRCh38] Chr16:23641076 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1356_2586+201del |
deletion |
Familial cancer of breast [RCV001058567] |
Chr16:23629003..23635190 [GRCh38] Chr16:23640324..23646511 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.2923_2924del (p.Arg975fs) |
microsatellite |
Familial cancer of breast [RCV001071265] |
Chr16:23623041..23623042 [GRCh38] Chr16:23634362..23634363 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1988G>A (p.Arg663His) |
single nucleotide variant |
Familial cancer of breast [RCV001061994]|Hereditary cancer-predisposing syndrome [RCV002418525]|not specified [RCV003323791] |
Chr16:23630166 [GRCh38] Chr16:23641487 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NC_000016.10:g.(?_23603313)_(23603679_?)dup |
duplication |
Familial cancer of breast [RCV001033418] |
Chr16:23614634..23615000 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1568C>G (p.Ala523Gly) |
single nucleotide variant |
Familial cancer of breast [RCV001071418]|Hereditary cancer-predisposing syndrome [RCV004030790] |
Chr16:23634978 [GRCh38] Chr16:23646299 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.700G>C (p.Asp234His) |
single nucleotide variant |
Familial cancer of breast [RCV001056514] |
Chr16:23635846 [GRCh38] Chr16:23647167 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1837C>G (p.Gln613Glu) |
single nucleotide variant |
Familial cancer of breast [RCV001056515]|Hereditary cancer-predisposing syndrome [RCV002409463]|Malignant tumor of breast [RCV001356102] |
Chr16:23630317 [GRCh38] Chr16:23641638 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.728C>T (p.Thr243Ile) |
single nucleotide variant |
Familial cancer of breast [RCV001051761]|Hereditary cancer-predisposing syndrome [RCV005394683] |
Chr16:23635818 [GRCh38] Chr16:23647139 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2716del (p.Trp906fs) |
deletion |
Familial cancer of breast [RCV001048107] |
Chr16:23626268 [GRCh38] Chr16:23637589 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.-2C>G |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV004944771]|not provided [RCV001030101] |
Chr16:23641159 [GRCh38] Chr16:23652480 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3457C>T (p.Pro1153Ser) |
single nucleotide variant |
Familial cancer of breast [RCV001037506]|Hereditary cancer-predisposing syndrome [RCV002454271] |
Chr16:23603563 [GRCh38] Chr16:23614884 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NC_000016.10:g.(?_23621352)_(23624104_?)dup |
duplication |
Familial cancer of breast [RCV001032494] |
Chr16:23632673..23635425 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.1706A>C (p.Lys569Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001035960]|Hereditary cancer-predisposing syndrome [RCV003363049]|not provided [RCV001560084] |
Chr16:23630448 [GRCh38] Chr16:23641769 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1153G>A (p.Ala385Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001052293]|Hereditary cancer-predisposing syndrome [RCV004944813] |
Chr16:23635393 [GRCh38] Chr16:23646714 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2220A>C (p.Gln740His) |
single nucleotide variant |
Familial cancer of breast [RCV001038086]|Hereditary cancer-predisposing syndrome [RCV001185460] |
Chr16:23629934 [GRCh38] Chr16:23641255 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.678T>A (p.Thr226=) |
single nucleotide variant |
Familial cancer of breast [RCV001042954] |
Chr16:23635868 [GRCh38] Chr16:23647189 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.413_414dup (p.Gln139fs) |
duplication |
Familial cancer of breast [RCV003316958] |
Chr16:23636131..23636132 [GRCh38] Chr16:23647452..23647453 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2549T>G (p.Ile850Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001059849]|Hereditary cancer-predisposing syndrome [RCV003584811] |
Chr16:23629241 [GRCh38] Chr16:23640562 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1319_1320insSVAelement |
insertion |
Familial cancer of breast [RCV001089796] |
Chr16:23635226..23635227 [GRCh38] Chr16:23646547..23646548 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1499C>T (p.Ser500Phe) |
single nucleotide variant |
Familial cancer of breast [RCV001052440] |
Chr16:23635047 [GRCh38] Chr16:23646368 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.647T>C (p.Ile216Thr) |
single nucleotide variant |
Familial cancer of breast [RCV001039734]|Hereditary cancer-predisposing syndrome [RCV004944785] |
Chr16:23635899 [GRCh38] Chr16:23647220 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.679G>C (p.Ala227Pro) |
single nucleotide variant |
not provided [RCV001030164] |
Chr16:23635867 [GRCh38] Chr16:23647188 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.695G>A (p.Gly232Asp) |
single nucleotide variant |
not provided [RCV001030165] |
Chr16:23635851 [GRCh38] Chr16:23647172 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2144A>G (p.Asp715Gly) |
single nucleotide variant |
not provided [RCV001030282] |
Chr16:23630010 [GRCh38] Chr16:23641331 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2160C>T (p.Thr720=) |
single nucleotide variant |
Familial cancer of breast [RCV005423834]|not provided [RCV001030284] |
Chr16:23629994 [GRCh38] Chr16:23641315 [GRCh37] Chr16:16p12.2 |
benign|uncertain significance |
NM_024675.4(PALB2):c.2206G>T (p.Ala736Ser) |
single nucleotide variant |
not provided [RCV001030286] |
Chr16:23629948 [GRCh38] Chr16:23641269 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1099G>A (p.Glu367Lys) |
single nucleotide variant |
Familial cancer of breast [RCV001037865] |
Chr16:23635447 [GRCh38] Chr16:23646768 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.298C>G (p.Leu100Val) |
single nucleotide variant |
Familial cancer of breast [RCV001054341] |
Chr16:23636248 [GRCh38] Chr16:23647569 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2514+1G>A |
single nucleotide variant |
Familial cancer of breast [RCV001069194]|Hereditary cancer-predisposing syndrome [RCV001187628] |
Chr16:23629639 [GRCh38] Chr16:23640960 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.1501A>G (p.Arg501Gly) |
single nucleotide variant |
Familial cancer of breast [RCV001048955]|Hereditary cancer-predisposing syndrome [RCV003363076] |
Chr16:23635045 [GRCh38] Chr16:23646366 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.211+2T>C |
single nucleotide variant |
Familial cancer of breast [RCV001036628] |
Chr16:23637848 [GRCh38] Chr16:23649169 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_024675.4(PALB2):c.2272C>T (p.Pro758Ser) |
single nucleotide variant |
not provided [RCV001030293] |
Chr16:23629882 [GRCh38] Chr16:23641203 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2373G>A (p.Val791=) |
single nucleotide variant |
not provided [RCV001030302] |
Chr16:23629781 [GRCh38] Chr16:23641102 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2383C>A (p.Gln795Lys) |
single nucleotide variant |
not provided [RCV001030303] |
Chr16:23629771 [GRCh38] Chr16:23641092 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2426C>T (p.Thr809Ile) |
single nucleotide variant |
not provided [RCV001030307] |
Chr16:23629728 [GRCh38] Chr16:23641049 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2525C>G (p.Ala842Gly) |
single nucleotide variant |
not provided [RCV001030319] |
Chr16:23629265 [GRCh38] Chr16:23640586 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2540C>T (p.Ser847Phe) |
single nucleotide variant |
Familial cancer of breast [RCV005056795]|not provided [RCV001030320] |
Chr16:23629250 [GRCh38] Chr16:23640571 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2554C>A (p.Pro852Thr) |
single nucleotide variant |
not provided [RCV001030321] |
Chr16:23629236 [GRCh38] Chr16:23640557 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2562C>T (p.Asn854=) |
single nucleotide variant |
Familial cancer of breast [RCV002552436]|not provided [RCV001030322] |
Chr16:23629228 [GRCh38] Chr16:23640549 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.3039A>T (p.Ile1013=) |
single nucleotide variant |
not provided [RCV001030370] |
Chr16:23621436 [GRCh38] Chr16:23632757 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2235del (p.Ala746fs) |
deletion |
Familial cancer of breast [RCV001253549]|Gastric cancer [RCV003160194]|not provided [RCV001030289] |
Chr16:23629919 [GRCh38] Chr16:23641240 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.2242A>G (p.Thr748Ala) |
single nucleotide variant |
Familial cancer of breast [RCV005093298]|Hereditary cancer-predisposing syndrome [RCV002427473]|not provided [RCV001030290] |
Chr16:23629912 [GRCh38] Chr16:23641233 [GRCh37] Chr16:16p12.2 |
likely benign|uncertain significance |
NM_024675.4(PALB2):c.2834+19G>A |
single nucleotide variant |
Familial cancer of breast [RCV002061068]|Hereditary cancer-predisposing syndrome [RCV000772396] |
Chr16:23623990 [GRCh38] Chr16:23635311 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.1532G>T (p.Arg511Ile) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000772428] |
Chr16:23635014 [GRCh38] Chr16:23646335 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.511T>C (p.Leu171=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000772437] |
Chr16:23636035 [GRCh38] Chr16:23647356 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2317A>G (p.Thr773Ala) |
single nucleotide variant |
Familial cancer of breast [RCV002534023]|Hereditary cancer-predisposing syndrome [RCV000772532]|not provided [RCV003229861] |
Chr16:23629837 [GRCh38] Chr16:23641158 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2441A>T (p.Glu814Val) |
single nucleotide variant |
Familial cancer of breast [RCV005092234]|Hereditary cancer-predisposing syndrome [RCV000772540] |
Chr16:23629713 [GRCh38] Chr16:23641034 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3202-17_3202-16insA |
insertion |
Hereditary cancer-predisposing syndrome [RCV000772541] |
Chr16:23608028..23608029 [GRCh38] Chr16:23619349..23619350 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3201+6T>A |
single nucleotide variant |
Familial cancer of breast [RCV001041333]|Hereditary cancer-predisposing syndrome [RCV000772550]|not provided [RCV001585698] |
Chr16:23613998 [GRCh38] Chr16:23625319 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2871G>A (p.Lys957=) |
single nucleotide variant |
Familial cancer of breast [RCV001433030]|Hereditary cancer-predisposing syndrome [RCV000772606] |
Chr16:23623094 [GRCh38] Chr16:23634415 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.983C>T (p.Ser328Phe) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000772618] |
Chr16:23635563 [GRCh38] Chr16:23646884 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2136G>C (p.Ala712=) |
single nucleotide variant |
Familial cancer of breast [RCV005427278]|Hereditary cancer-predisposing syndrome [RCV000774795] |
Chr16:23630018 [GRCh38] Chr16:23641339 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.1156A>T (p.Thr386Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000817409]|Hereditary cancer-predisposing syndrome [RCV000774803] |
Chr16:23635390 [GRCh38] Chr16:23646711 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3499A>G (p.Thr1167Ala) |
single nucleotide variant |
Familial cancer of breast [RCV000793694] |
Chr16:23603521 [GRCh38] Chr16:23614842 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3470A>C (p.Gln1157Pro) |
single nucleotide variant |
Familial cancer of breast [RCV002534031]|Hereditary cancer-predisposing syndrome [RCV000772709] |
Chr16:23603550 [GRCh38] Chr16:23614871 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2414T>A (p.Val805Asp) |
single nucleotide variant |
Familial cancer of breast [RCV003607346]|Hereditary cancer-predisposing syndrome [RCV000772795] |
Chr16:23629740 [GRCh38] Chr16:23641061 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.163C>G (p.Gln55Glu) |
single nucleotide variant |
Familial cancer of breast [RCV001850966]|Hereditary cancer-predisposing syndrome [RCV000772804] |
Chr16:23637898 [GRCh38] Chr16:23649219 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3458C>T (p.Pro1153Leu) |
single nucleotide variant |
Familial cancer of breast [RCV001850967]|Hereditary cancer-predisposing syndrome [RCV000772811]|not specified [RCV002465768] |
Chr16:23603562 [GRCh38] Chr16:23614883 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1954A>G (p.Ser652Gly) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000772813] |
Chr16:23630200 [GRCh38] Chr16:23641521 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3431T>C (p.Leu1144Pro) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000772818] |
Chr16:23603589 [GRCh38] Chr16:23614910 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1013C>T (p.Pro338Leu) |
single nucleotide variant |
Familial cancer of breast [RCV001856030]|Hereditary cancer-predisposing syndrome [RCV000772843] |
Chr16:23635533 [GRCh38] Chr16:23646854 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.73A>T (p.Lys25Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001030115]|Hereditary breast ovarian cancer syndrome [RCV003155956]|Hereditary cancer-predisposing syndrome [RCV000772890] |
Chr16:23638105 [GRCh38] Chr16:23649426 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1296T>C (p.His432=) |
single nucleotide variant |
Familial cancer of breast [RCV005092243]|Hereditary cancer-predisposing syndrome [RCV000772893] |
Chr16:23635250 [GRCh38] Chr16:23646571 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2872C>G (p.Gln958Glu) |
single nucleotide variant |
Familial cancer of breast [RCV001324178]|Hereditary cancer-predisposing syndrome [RCV000772897] |
Chr16:23623093 [GRCh38] Chr16:23634414 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2866G>T (p.Glu956Ter) |
single nucleotide variant |
Familial cancer of breast [RCV001388158]|Hereditary cancer-predisposing syndrome [RCV000772898] |
Chr16:23623099 [GRCh38] Chr16:23634420 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.3350+14A>G |
single nucleotide variant |
Familial cancer of breast [RCV003768334]|Hereditary cancer-predisposing syndrome [RCV000772925] |
Chr16:23607850 [GRCh38] Chr16:23619171 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.3129T>C (p.Gly1043=) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000772958] |
Chr16:23614076 [GRCh38] Chr16:23625397 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.2759T>G (p.Leu920Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000780562]|Hereditary cancer-predisposing syndrome [RCV002440616] |
Chr16:23624084 [GRCh38] Chr16:23635405 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.761C>G (p.Ser254Ter) |
single nucleotide variant |
Familial cancer of breast [RCV000780563]|Hereditary cancer-predisposing syndrome [RCV001026625]|Uterine corpus cancer [RCV003128160] |
Chr16:23635785 [GRCh38] Chr16:23647106 [GRCh37] Chr16:16p12.2 |
pathogenic|likely pathogenic |
NM_024675.4(PALB2):c.2616G>T (p.Val872=) |
single nucleotide variant |
Familial cancer of breast [RCV001078566]|Hereditary cancer-predisposing syndrome [RCV002440617]|not provided [RCV000878247]|not specified [RCV000780565] |
Chr16:23626368 [GRCh38] Chr16:23637689 [GRCh37] Chr16:16p12.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2990A>G (p.Asp997Gly) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000773043] |
Chr16:23622975 [GRCh38] Chr16:23634296 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.207C>A (p.His69Gln) |
single nucleotide variant |
Familial cancer of breast [RCV001042330]|Hereditary cancer-predisposing syndrome [RCV000773047] |
Chr16:23637854 [GRCh38] Chr16:23649175 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1685-1G>A |
single nucleotide variant |
Familial cancer of breast [RCV001064056]|Hereditary cancer-predisposing syndrome [RCV000773053] |
Chr16:23630470 [GRCh38] Chr16:23641791 [GRCh37] Chr16:16p12.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.1729A>G (p.Asn577Asp) |
single nucleotide variant |
Familial cancer of breast [RCV001065828]|Hereditary cancer-predisposing syndrome [RCV000773082] |
Chr16:23630425 [GRCh38] Chr16:23641746 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1895A>C (p.Glu632Ala) |
single nucleotide variant |
Familial cancer of breast [RCV003607348]|Hereditary cancer-predisposing syndrome [RCV000773115] |
Chr16:23630259 [GRCh38] Chr16:23641580 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.*2T>G |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000773130] |
Chr16:23603457 [GRCh38] Chr16:23614778 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_024675.4(PALB2):c.743T>C (p.Val248Ala) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000773144] |
Chr16:23635803 [GRCh38] Chr16:23647124 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2336C>T (p.Ser779Leu) |
single nucleotide variant |
Familial cancer of breast [RCV000819396]|Familial cancer of breast [RCV002507340]|Hereditary cancer-predisposing syndrome [RCV000773204] |
Chr16:23629818 [GRCh38] Chr16:23641139 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.409G>A (p.Gly137Ser) |
single nucleotide variant |
Familial cancer of breast [RCV000803385]|Hereditary cancer-predisposing syndrome [RCV000773246] |
Chr16:23636137 [GRCh38] Chr16:23647458 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.3369G>C (p.Val1123=) |
single nucleotide variant |
Familial cancer of breast [RCV005427262]|Hereditary cancer-predisposing syndrome [RCV000773317] |
Chr16:23603651 [GRCh38] Chr16:23614972 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
NM_024675.4(PALB2):c.2317A>C (p.Thr773Pro) |
single nucleotide variant |
Hereditary cancer-predisposing syndrome [RCV000774823] |
Chr16:23629837 [GRCh38] Chr16:23641158 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2522C>T (p.Thr841Ile) |
single nucleotide variant |
Familial cancer of breast [RCV003768340]|Hereditary cancer-predisposing syndrome [RCV000773403] |
Chr16:23629268 [GRCh38] Chr16:23640589 [GRCh37] Chr16:16p12.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_024675.4(PALB2):c.2107_2109dup (p.Leu704dup) |
duplication |
Hereditary cancer-predisposing syndrome [RCV000773455] |
Chr16:23630044..23630045 [GRCh38] Chr16:23641365..23641366 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.1162C>T (p.Pro388Ser) |
single nucleotide variant |
Familial cancer of breast [RCV002534067]|Hereditary cancer-predisposing syndrome [RCV000773467]|not provided [RCV001775990] |
Chr16:23635384 [GRCh38] Chr16:23646705 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2136G>A (p.Ala712=) |
single nucleotide variant |
Familial cancer of breast [RCV001406005]|Hereditary cancer-predisposing syndrome [RCV000773497]|not provided [RCV001030281] |
Chr16:23630018 [GRCh38] Chr16:23641339 [GRCh37] Chr16:16p12.2 |
benign|likely benign|uncertain significance |
NM_024675.4(PALB2):c.810C>A (p.Ser270Arg) |
single nucleotide variant |
Familial cancer of breast [RCV001856056]|Hereditary cancer-predisposing syndrome [RCV000773541] |
Chr16:23635736 [GRCh38] Chr16:23647057 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_024675.4(PALB2):c.2816_2823del (p.Asn938_Leu939insTer) |
deletion |
Hereditary cancer-predisposing syndrome [RCV000773791] |
Chr16:23624020..23624027 [GRCh38] Chr16:23635341..23635348 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_024675.4(PALB2):c.1941T>C (p.His647=) |
single nucleotide variant |
Familial cancer of breast [RCV001080752]|Hereditary cancer-predisposing syndrome [RCV002406684]|not provided [ |